View
22.691
Download
10
Category
Preview:
Citation preview
Anexa 2FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA A - MEDICAMENTE CU NIVEL DE COMPENSARE 90% DIN PREŢUL DE REFERINŢĂ
1 RANITIDINUMA02BA02
Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mgA02BA02 RANITIDINUM CAPS.ULCORAN 150mg EUROPHARM SA
150mgA02BA02 RANITIDINUM COMPR.RANITIDIN 150mg ARENA GROUP SA
RANITIDINA 150 mg 150mg MAGISTRA C & C
150mgA02BA02 RANITIDINUM COMPR. EFF.DIGEN EFF 150 mg 150mg OZONE LABORATORIES LTD.
150mgA02BA02 RANITIDINUM COMPR. FILM.GERTOCALM 150mg FARAN LABORATORIES S.A.
RANITIDIN 150 mg 150mg AC HELCOR SRL
RANITIDINA 150 mg 150mg FILDAS TRADING SRL
RANITIDINA ANTIBIOTICE 150 mg 150mg ANTIBIOTICE SA
RANITIDINA LPH 150 mg 150mg LABORMED PHARMA SA
ZANTAC 150 mg 150mg GLAXO WELLCOME UK LTD.
25mg/mlA02BA02 RANITIDINUM SOL. INJ.ARNETIN 25mg/ml MEDOCHEMIE LTD.
ZANTAC SOLUTIE INJECTABILA 25mg/ml GLAXO WELLCOME UK LTD.
300mgA02BA02 RANITIDINUM COMPR. FILM.RANITIDIN 300 mg 300mg AC HELCOR SRL
RANITIDINA 300 mg 300mg FILDAS TRADING SRL
RANITIDINA LPH 300 mg 300mg LABORMED PHARMA SA
2 FAMOTIDINUMA02BA03
Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR ABR 10mg DAR AL DAWA PHARMA S.R.L.
20mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR 20 20mg DAR AL DAWA PHARMA S.R.L
FAMODIN 20 20mg AC HELCOR PHARMA SRL
FAMOTAK 20mg SEDICO IMPEX S.R.L.
QUAMATEL® 20 mg 20mg GEDEON RICHTER PLC
20mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR 20 20mg DAR AL DAWA PHARMA S.R.L
FAMODIN 20 20mg AC HELCOR PHARMA SRL
FAMOTAK 20mg SEDICO IMPEX S.R.L.
QUAMATEL® 20 mg 20mg GEDEON RICHTER PLC
20mgA02BA03 FAMOTIDINUM LIOF. + SOLV. PT. SOL. INJ.QUAMATEL® 20 mg 20mg GEDEON RICHTER PLC
40mgA02BA03 FAMOTIDINUM COMPR. FILM.FAMODAR 40 40mg DAR AL DAWA PHARMA SRL
FAMODIN 40 40mg AC HELCOR PHARMA SRL
FAMOTAK 40mg SEDICO IMPEX S.R.L.
FAMOTIDINA ZENTIVA 40 mg 40mg ZENTIVA S.A
GASTROSIDIN 40mg ECZACIBASI PHARMACEUTICALS S.R.L.
QUAMATEL® 40 mg 40mg GEDEON RICHTER PLC
3 NIZATIDINUMA02BA04
Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mgA02BA04 NIZATIDINUM CAPS.NIZATIDIN 150 mg 150mg VIM SPECTRUM SRL
NIZATIDINA LAROPHARM 150 mg 150mg LAROPHARM S.R.L.
4 OMEPRAZOLUMA02BC01
Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgA02BC01 OMEPRAZOLUM CAPS. GASTROREZ.ORTANOL® S 10mg LEK PHARMACEUTICALS D.D.
Boala de reflux gastro-esofagian. Se aplica pentru toate denumirile comerciale si formele farmaceutice ale concentratiei de 10 mg.Prescriere limitata:
10mgA02BC01 OMEPRAZOLUM COMPR. FILM. GASTROREZ.LOSEC MUPS 10 mg 10mg ASTRAZENECA AB
20mgA02BC01 OMEPRAZOLUM CAPS GASTROREZ.HELICID 20 20mg ZENTIVA AS
OMEPRAZOL 20 mg 20mg GEDEON RICHTER ROMANIA SA
OMEPRAZOL BIOFARM 20 mg 20mg BIOFARM S.A.
OMEPRAZOL LPH 20 mg 20mg LABORMED PHARMA SA
OMEPRAZOL TERAPIA 20 mg 20mg TERAPIA S.A.
OMERAN 20 20mg EUROPHARM SA
OMEZ 20mg DR. REDDY'S LABORATORIES
ORTANOL® 20 mg 20mg LEK PHARMACEUTICALS D.D.
ULTOP 20mg KRKA D.D.
Boala de reflux gastro-esofagianPrescriere limitata:
Sclerodermia esofagului.Prescriere limitata:
Sindromul Zollinger-EllisonPrescriere limitata:
Tratamentul ulcerului gastric si duodenal.Prescriere limitata:
Profilaxia ulcerului gastro-duodenal la pacientii in tratament cu AINS pe termen lung si care prezinta factori de risc gastrointestinal.Prescriere limitata:
1 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiilor de 20 mg..
20mgA02BC01 OMEPRAZOLUM CAPS. ENTER.RISEK 20mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.
20mgA02BC01 OMEPRAZOLUM COMPR. FILM. GASTROREZ.LOSEC MUPS 20 mg 20mg ASTRAZENECA AB
OMEDAR® 20mg DAR AL DAWA PHARMA S.R.L
40mgA02BC01 OMEPRAZOLUM CAPS. GASTROREZ.OMERAN 40 40mg EUROPHARM SA
ORTANOL® 40mg LEK PHARMACEUTICALS D.D.
ULTOP 40mg KRKA D.D. NOVO MESTO
Boala de reflux gastro-esofagianPrescriere limitata:
Sclerodermia esofagului.Prescriere limitata:
Sindromul Zollinger-EllisonPrescriere limitata:
Tratamentul ulcerului gastric si duodenal.Prescriere limitata:
NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiilor de 40mg..
5 LANSOPRAZOLUMA02BC03
15mgA02BC03 LANSOPRAZOLUM CAPS. GASTROREZ.LEVANT 15 mg 15mg RANBAXY UK LTD.
Boala de reflux gastro-esofagianPrescriere limitata:
30mgA02BC03 LANSOPRAZOLUM CAPS. GASTROREZ.LANZAP 30mg 30mg DR. REDDY'S LABORATORIES
LANZUL 30mg KRKA D.D. NOVO MESTO
LEVANT 30 mg 30mg RANBAXY UK LTD.
Boala de reflux gastro-esofagianPrescriere limitata:
Sindromul Zollinger-Ellison.Prescriere limitata:
Tratamentul ulcerului gastric si duodenal.Prescriere limitata:
Profilaxia ulcerului gastro-duodenal la pacientii in tratament cu AINS pe termen lung si care prezinta factori de risc gastrointestinal.Prescriere limitata:
NOTA: Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiiei de 30 mg..
6 MEBEVERINUMA03AA04
200mgA03AA04 MEBEVERINUM CAPS. ELIB. PREL.DUSPATALIN® 200 mg 200mg SOLVAY PHARMACEUTICALS BV
7 TRIMEBUTINUMA03AA05
100mgA03AA05 TRIMEBUTINUM COMPR.COLOBUTINE® 100mg LAB. FOURNIER SA
COLPERIN 100 mg 100mg GEDEON RICHTER ROMANIA S.A.
PROMEBUTIN® 100 mg 100mg TERAPIA SA
TRIMEBUTIN 100 100mg MAGISTRA C & C
100mgA03AA05 TRIMEBUTINUM COMPR. FILM.DEBRIDAT 100 mg 100mg PFIZER EUROPE MA EEIG
24mg/5mlA03AA05 TRIMEBUTINUM GRAN. PT. SUSP. ORALADEBRIDAT 24mg/5ml PFIZER EUROPE MA EEIG
300mgA03AA05 TRIMEBUTINUM COMPR. FILM. ELIB. PREL.IBUTIN® 300 mg 300mg ZENTIVA SA
8 PAPAVERINI HYDROCHLORIDUMA03AD01
100mgA03AD01 PAPAVERINI HYDROCHLORIDUM COMPR.PAPAVERINA 100 mg 100mg SINTOFARM SA
200mgA03AD01 PAPAVERINI HYDROCHLORIDUM COMPR.PAPAVERINA 200mg FARMACOM SA
9 METOCLOPRAMIDUMA03FA01
10mgA03FA01 METOCLOPRAMIDUM COMPR.METOCLOPRAMID 10mg SLAVIA PHARM SRL
METOCLOPRAMID 10 mg 10mg TERAPIA SA
N - METOCLOPRAMID 10mg MEDUMAN SA
1mg/5mlA03FA01 METOCLOPRAMIDUM SIROPMETOCLOPRAMID BIOFARM 1mg/5ml 1mg/5ml BIOFARM S.A.
5mg/mlA03FA01 METOCLOPRAMIDUM SOL. INJ.METOCLOPRAMID 10 mg 5mg/ml TERAPIA SA
7mg/mlA03FA01 METOCLOPRAMIDUM PIC. ORALE-SOL.METOCLOPRAMID 7mg/ml BIOFARM SA
10 DOMPERIDONUMA03FA03
10mgA03FA03 DOMPERIDONUM COMPR. FILM.MOTILIUM 10mg JANSSEN PHARMACEUTICA NV
MOTILIUM 10 mg 10mg TERAPIA SA
11 ACIDUM URSODEOXYCHOLICUM *A05AA02
Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:
250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH
URSOSAN 250mg PRO. MED. CS PRAHA AS
12 LACTULOSUMA06AD11
Prescriere limitata: Tratamentul encefalopatiei cronice porto-sistemice
Tratamentul constipatiei la pacientii neoplazici.
66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV
66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG
670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH
66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG
670mg/mlA06AD11 LACTULOSUM SOL. ORALA
2 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
LAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH
66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG
670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH
66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV
65%A06AD11 LACTULOSUM SIROPLACTULOSE 65% E.I.P.I.CO. MED S.R.L.
13 NYSTATINUMA07AA02
500.000uiA07AA02 NYSTATINUM COMPR. FILM.NISTATINA 500.000ui ANTIBIOTICE SA
500000uiA07AA02 NYSTATINUM COMPR. FILM.STAMICIN® 500000 U.I. 500000ui ZENTIVA SA
14 SULFASALAZINUMA07EC01
500mgA07EC01 SULFASALAZINUM COMPR. FILM.SALAZIDIN 500mg AC HELCOR SRL
500mgA07EC01 SULFASALAZINUM COMPR. FILM. GASTROREZ.SULFASALAZIN EN 500mg KRKA D.D. NOVO MESTO
15 MESALAZINUM **A07EC02
1gA07EC02 MESALAZINUM SUPOZ.PENTASA 1g FERRING A/S
Episod acut de proctita ulcerativa forma moderataPrescriere limitata:
NOTA: A nu se administra in tratamentul bolii Crohn..
250mgA07EC02 MESALAZINUM COMPR. GASTROREZ.SALOFALK 250 mg COMPRIMATE GASTROREZISTENTE 250mg DR. FALK PHARMA GMBH
Colita ulcerativa asociata cu hipersensibilitate la sulfonamideCod restrictie 1708:
Colita ulcerativa asociata cu intoleranta la sulfasalazinumCod restrictie 1709:
Boala Crohn in cazul in care exista hipersensibilitate la sulfonamideCod restrictie 2268:
Boala Crohn in cazul in care exista intoleranta la sulfasalazinumCod restrictie 2269:
250mgA07EC02 MESALAZINUM SUPOZ.SALOFALK® 250 mg 250mg DR. FALK PHARMA GMBH
Episod acut de proctita ulcerativa forma moderataPrescriere limitata:
4g/60mlA07EC02 MESALAZINUM SUSP. RECTALASALOFALK 4 g/ 60 ml 4g/60ml DR. FALK PHARMA GMBH
Episod acut de colita ulcerativa forma moderataCod restrictie 1707:
500mgA07EC02 MESALAZINUM COMPR. ELIB. PREL.PENTASA 500mg FERRING A/S
Colita ulcerativa asociata cu hipersensibilitate la sulfonamideCod restrictie 1708:
Colita ulcerativa asociata cu intoleranta la sulfasalazinumCod restrictie 1709:
Boala Crohn in cazul in care exista hipersensibilitate la sulfonamideCod restrictie 2268:
Boala Crohn in cazul in care exista intoleranta la sulfasalazinumCod restrictie 2269:
500mgA07EC02 MESALAZINUM COMPR. GASTROREZ.SALOFALK 500 mg COMPRIMATE GASTROREZISTENTE 500mg DR. FALK PHARMA GMBH
Colita ulcerativa asociata cu hipersensibilitate la sulfonamideCod restrictie 1708:
Colita ulcerativa asociata cu intoleranta la sulfasalazinumCod restrictie 1709:
Boala Crohn in cazul in care exista hipersensibilitate la sulfonamideCod restrictie 2268:
Boala Crohn in cazul in care exista intoleranta la sulfasalazinumCod restrictie 2269:
500mgA07EC02 MESALAZINUM SUPOZ.SALOFALK® 500 mg 500mg DR. FALK PHARMA GMBH
Episod acut de proctita ulcerativa forma moderataPrescriere limitata:
16 ACENOCUMAROLUMB01AA07
2mgB01AA07 ACENOCUMAROLUM COMPR.TROMBOSTOP 2 mg 2mg TERAPIA SA
4mgB01AA07 ACENOCUMAROLUM COMPR.SINTROM® 4mg NOVARTIS PHARMA GMBH
17 TICLOPIDINUM (1)B01AC05
250mgB01AC05 TICLOPIDINUM COMPR. FILM.IPATON 250mg EGIS PHARMACEUTICALS PLC
TICLID® 250 mg 250mg SANOFI-SYNTHELABO FRANCE
TICLODIN 250mg AC HELCOR SRL
TICLOPIDIN SANDOZ 250mg HEXAL AG
Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare in timpul
terapiei cu doze reduse de aspirina
Cod restrictie 1719:
Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii la care terapia cu doze reduse de aspirina prezinta un risc major
(inacceptabil) de sangerare gastrointestinala;
Cod restrictie 1720:
Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de reactie anafilactica , urticarie sau astm bronsic in
decurs de 4 ore de la administrarea de aspirina, alţi salicilati sau AINS
Cod restrictie 1721:
Neutropenia severa este un efect advers comun in primele luni de terapie. Monitorizarea hematologica se impune la inceputul tratamentului si apoi la fiecare doua saptamani in primele
patru luni de tratament.
18 PHYTOMENADIONUMB02BA01
10mg/mlB02BA01 PHYTOMENADIONUM SOL. INJ.FITOMENADION 10 mg/ml 10mg/ml TERAPIA SA
19 FERROSI SULFASB03AA07
105mgB03AA07 FERROSI SULFAS COMPR. ELIB. PREL.FERROGRADUMET® 105mg TEOFARMA SRL
80mgB03AA07 FERROSI SULFAS DRAJ. ELIB. PREL.TARDYFERON 80 mg 80mg LAB. PIERRE FABRE
B03AA07 FERROSI SULFAS COMPR.FILM.ELIB.PRELFERRO-GRADUMET POLIPHARMA INDUSTRIES S.R.L.
3 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
20 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZATB03AB05
100mgB03AB05 COMPLEX DE HIDROXID DE FER (III)
POLIMALTOZAT
COMPR. MAST.
MALTOFER 100mg VIFOR FRANCE S.A.
10mg/mlB03AB05 COMPLEX DE HIDROXID DE FER (III)
POLIMALTOZAT
SIROP
FERRUM HAUSMANN® 10mg/ml VIFOR FRANCE S.A.
50mg/5mlB03AB05 COMPLEX DE HIDROXID DE FER (III)
POLIMALTOZAT
SIROP
FERGLUROM 50mg/5ml 50mg/5ml BIOFARM S.A.
5%B03AB05 COMPLEX DE HIDROXID DE FER (III)
POLIMALTOZAT
PICATURI ORALE-SOL.
PHARMA-FERRUM® 5% TERAPIA SA
50mg/mlB03AB05 COMPLEX DE HIDROXID DE FER (III)
POLIMALTOZAT
PICATURI ORALE-SOL.
FERRUM HAUSMANN® 50mg/ml VIFOR FRANCE S.A.
21 COMBINATII (FERROSI SULFAS+ACIDUM ASCORBICUM)B03AEN1
B03AEN1 COMBINATII (FERROSI SULFAS+ACIDUM
ASCORBICUM)
COMPR. FILM.
SORBIFER DURULES EGIS PHARMACEUTICALS LTD.
22 ACIDUM FOLICUMB03BB01
5mgB03BB01 ACIDUM FOLICUM COMPR. FILM.ACIFOL 5 mg 5mg ZENTIVA S.A.
23 DIGOXINUMC01AA05
0.05mg/mlC01AA05 DIGOXINUM SOL. ORALALANOXIN SOLUTIE ORALA 0.05mg/ml THE WELLCOME FOUNDATION LTD.
0.25mgC01AA05 DIGOXINUM COMPR.DIGOXIN 0,25 mg 0.25mg ZENTIVA S.A.
0.5mg/mlC01AA05 DIGOXINUM SOL. INJ.DIGOXIN 0,5 mg/2 ml 0.5mg/ml ZENTIVA S.A.
24 CHINIDINI SULFASC01BA01
200mgC01BA01 CHINIDINI SULFAS COMPR.CHINIDINA LAROPHARM 200 mg 200mg LAROPHARM SRL
CHINIDINA SULFAT 200 mg 200mg ARENA GROUP SA
25 PROPAFENONUMC01BC03
150mgC01BC03 PROPAFENONUM COMPR.PROPAFENONA 150 mg 150mg ARENA GROUP SA
150mgC01BC03 PROPAFENONUM COMPR. FILM.PROPAFENON AL 150 150mg ALIUD® PHARMA GMBH & CO.KG
PROPAFENON SANDOZ 150 mg 150mg HEXAL AG
RYTMONORM® 150mg ABBOTT GMBH&CO.KG
70mg/20mlC01BC03 PROPAFENONUM SOL. INJ.RYTMONORM 70mg/20ml ABBOTT GMBH&CO.KG
26 AMIODARONUMC01BD01
Prescriere limitata: Tratamentul tulburarilor de ritm severe care nu raspund la alte terapii sau cand alte antiaritmice nu pot fi folosite: a) tahiaritmii asociate sidromului
Wolff-Parkinson-White; .b) flutter/fibrilatie atriala, atunci cand alte antiaritmice nu pot fi folosite; c) toate tahiaritmiile paroxistice, incluzand tahicardii
supraventriculare, tahicardii ventriculare si nodale, fibrilatie ventriculara, atunci cand alte antiaritmice nu pot fi folosite.
Exista dovezi ca amiodarona poate produce toxicitate frecventă şi potenţial severă. Se recomandă monitorizarea periodică a funcţiilor hepatice şi tiroidiene.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgC01BD01 AMIODARONUM COMPR.AMIODARONA 200 mg 200mg ARENA GROUP SA
AMIODARONA LPH 200 mg 200mg LABORMED PHARMA SA
DARITMIN® 200 mg 200mg GEDEON RICHTER ROMANIA SA
SEDACORON® 200mg EBEWE PHARMA GMBH NFG. KG
200mgC01BD01 AMIODARONUM COMPR. DIVIZ.CORDARONE 200 mg 200mg SANOFI-AVENTIS FRANCE
27 NITROGLYCERINUMC01DA02
0.4mg/dozaC01DA02 NITROGLYCERINUM SPRAY SUBLINGUALNITROMINT 0.4mg/doza EGIS PHARMACEUTICALS P.L.C.
NOTA: Sprayul nu trebuie inhalat..
0.5mgC01DA02 NITROGLYCERINUM COMPR. SUBLING.NITROGLICERINA 0,5 mg 0.5mg ZENTIVA SA
2.6mgC01DA02 NITROGLYCERINUM COMPR. ELIB. PREL.NITROMINT 2,6 mg 2.6mg EGIS PHARMACEUTICALS LTD.
25mgC01DA02 NITROGLYCERINUM SIST. TERAP. TRANSDERM.NITRODERM® TTS 5 25mg NOVARTIS PHARMA GMBH
28 ISOSORBIDI DINITRASC01DA08
10mgC01DA08 ISOSORBIDI DINITRAS COMPR.ISOSORBIDE DINITRATE 10 mg 10mg E.I.P.I.CO. MED S.R.L.
20mgC01DA08 ISOSORBIDI DINITRAS CAPS. ELIB. PREL.DINITER SR 20 mg 20mg TERAPIA SA
20mgC01DA08 ISOSORBIDI DINITRAS COMPR. ELIB. PREL.ISODINIT® RETARD 20mg BALKAN PHARMA DUPNITZA AD
40mgC01DA08 ISOSORBIDI DINITRAS CAPS. ELIB. PREL.DINITER SR 40 mg 40mg TERAPIA SA
29 ISOSORBIDI MONONITRASC01DA14
40mgC01DA14 ISOSORBIDI MONONITRAS CAPS. ELIB. PREL.OLICARD 40 mg RETARD 40mg SOLVAY PHARMACEUTICALS GMBH
4 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
60mgC01DA14 ISOSORBIDI MONONITRAS CAPS. ELIB. PREL.OLICARD 60 mg RETARD 60mg SOLVAY PHARMACEUTICALS GMBH
60mgC01DA14 ISOSORBIDI MONONITRAS COMPR. FILM. ELIB. PREL.MONONITRON® EP 60 mg 60mg ZENTIVA S.A
30 ALPROSTADILUM *** Protocol: C002IC01EA01
20µgC01EA01 ALPROSTADILUM CONC. PT. SOL. PERF.ALPROSTADIL "PINT" 20 µg 20µg PINT-PHARMA GMBH
20µgC01EA01 ALPROSTADILUM LIOF. PT. SOL. PERF.VASAPROSTAN 20 20µg SCHWARZ PHARMA AG
31 TRIMETAZIDINUMC01EB15
20mgC01EB15 TRIMETAZIDINUM CAPS.TRIMETAZIDIN 20 mg 20mg VIM SPECTRUM SRL
20mgC01EB15 TRIMETAZIDINUM COMPR. FILM.DILATAN 20 mg 20mg TERAPIA SA
MODUXIN® 20 mg 20mg GEDEON RICHTER ROMANIA SA
PREDOZONE 20 mg 20mg OZONE LABORATORIES LTD.
PREDUCTAL® 20mg LES LAB. SERVIER IND.
TRIMETAZIDINA LPH® 20 mg 20mg LABORMED PHARMA SA
TRIVEDON 20 20mg CIPLA (UK) LIMITED
20mgC01EB15 TRIMETAZIDINUM DRAJ.TRIMETAZIDINA 20 mg 20mg TERAPIA SA
35mgC01EB15 TRIMETAZIDINUM COMPR. FILM. ELIB. MODIF.DILATAN MR 35 mg 35mg TERAPIA SA
PREDUCTAL MR 35 mg 35mg LES LAB. SERVIER IND.
TRIMETAZIDINA LPH® 35 mg 35mg LABORMED PHARMA SA
32 METHYLDOPUMC02AB01
250mgC02AB01 METHYLDOPUM COMPR.DOPEGYT 250mg EGIS PHARMACEUTICALS PLC
33 CLONIDINUMC02AC01
0.15mgC02AC01 CLONIDINUM COMPR.CLONIDINA 0,15 mg 0.15mg ARENA GROUP SA
CLONIDINA SINTOFARM 0,15 mg 0.15mg SINTOFARM SA
34 DOXAZOSINUMC02CA04
1mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 1mg KRKA D.D. NOVO MESTO
MAGUROL 1mg MEDOCHEMIE LTD.
2mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG
DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG
KAMIREN 2mg KRKA D.D. NOVO MESTO
MAGUROL 2mg MEDOCHEMIE LTD.
4mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 4mg KRKA D.D. NOVO MESTO
MAGUROL 4mg MEDOCHEMIE LTD.
4mgC02CA04 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION
4mgC02CA04 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO
1mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 1mg KRKA D.D. NOVO MESTO
MAGUROL 1mg MEDOCHEMIE LTD.
2mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG
DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG
KAMIREN 2mg KRKA D.D. NOVO MESTO
MAGUROL 2mg MEDOCHEMIE LTD.
4mgC02CA04 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 4mg KRKA D.D. NOVO MESTO
MAGUROL 4mg MEDOCHEMIE LTD.
4mgC02CA04 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION
4mgC02CA04 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO
35 HYDROCHLOROTHIAZIDUMC03AA03
25mgC03AA03 HYDROCHLOROTHIAZIDUM COMPR.NEFRIX 25 mg 25mg ZENTIVA SA
36 INDAPAMIDUMC03BA11
1,5mgC03BA11 INDAPAMIDUM COMPR. FILM. ELIB. PREL.IMPAMID SR 1,5 mg 1,5mg GEDEON RICHTER ROMANIA S.A.
INDATER SR 1,5 mg 1,5mg TERAPIA SA
1.5 mgC03BA11 INDAPAMIDUM COMPR. FILM. ELIB. PREL.INDAPAMID SR 1,5 mg LAROPHARM 1.5 mg LAROPHARM SRL
5 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
1.5mgC03BA11 INDAPAMIDUM COMPR. ELIB. PREL.INDAPAMID MCC 1,5 mg 1.5mg MAGISTRA C & C SRL
1.5mgC03BA11 INDAPAMIDUM COMPR. FILM. ELIB. PREL.INDAPAMID LPH® 1,5 mg 1.5mg LABORMED PHARMA SA
RAWEL SR 1,5 mg 1.5mg KRKA D.D. NOVO MESTO
TERTENSIF® SR 1.5mg LES LAB. SERVIER IND.
2.5mgC03BA11 INDAPAMIDUM COMPR.IMPAMID® 2,5 mg 2.5mg GEDEON RICHTER ROMANIA SA
2.5mgC03BA11 INDAPAMIDUM COMPR. FILM.INDAPAMID LPH® 2,5 mg 2.5mg LABORMED PHARMA SA
INDAPAMIDE 2,5 mg 2.5mg HEMOFARM S.R.L.
INDATER® 2,5 mg 2.5mg TERAPIA SA
37 FUROSEMIDUMC03CA01Electroliţii serici trebuie să fie verificaţi periodic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
10mg/mlC03CA01 FUROSEMIDUM SOL. INJ.FUROSEMID 20 mg/2 ml 10mg/ml ZENTIVA SA
40mgC03CA01 FUROSEMIDUM COMPR.FUROSEMID ARENA 40 mg 40mg ARENA GROUP S.A.
FUROSEMID EEL 40mg BIO EEL SRL
FUROSEMID LPH 40 mg 40mg LABORMED PHARMA SA
FUROSEMID MCC 40 mg 40mg MAGISTRA C & C SRL
FUROSEMID SLAVIA 40mg SLAVIA PHARM SRL
FUROSEMID ZENTIVA 40mg ZENTIVA SA
38 SPIRONOLACTONUMC03DA01
Electroliţii serici trebuie să fie verificaţi periodic.
Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
100mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 100mg GEDEON RICHTER LTD.
25mgC03DA01 SPIRONOLACTONUM COMPR.SPIRONOLACTONA 25 mg 25mg BIO EEL SRL
25mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 25 mg 25mg AC HELCOR PHARMA SRL
SPIRONOLACTONA 25 mg 25mg TERAPIA SA
50mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 50mg GEDEON RICHTER LTD.
50mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 50 mg 50mg AC HELCOR PHARMA SRL
39 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM) C03EB01
C03EB01 COMBINATII
(SPIRONOLACTONUM+FUROSEMIDUM)
CAPS.
DIUREX 50 TERAPIA SA
40 PENTOXIFYLLINUMC04AD03
400mgC04AD03 PENTOXIFYLLINUM COMPR. FILM. ELIB. PREL.ANGIOPENT 400 mg 400mg AC HELCOR PHARMA SRL
PENTOXI RETARD 400 mg 400mg TERAPIA SA
400mgC04AD03 PENTOXIFYLLINUM DRAJ. ELIB. PREL.TRENTAL® 400mg AVENTIS PHARMA DEUTSCHLAND GMBH
600mgC04AD03 PENTOXIFYLLINUM COMPR. FILM. ELIB. PREL.ANGIOPENT 600 mg 600mg AC HELCOR PHARMA SRL
41 PROPRANOLOLUMC07AA05
10mgC07AA05 PROPRANOLOLUM COMPR.N - PROPRANOLOL 10 mg 10mg SC MEDUMAN SA
PROPRANOLOL 10mg BIO EEL SRL
PROPRANOLOL 10 mg 10mg SINTOFARM SA
40mgC07AA05 PROPRANOLOLUM COMPR.PROPRANOLOL 40 mg 40mg SINTOFARM SA
PROPRANOLOL EEL 40 mg 40mg BIO EEL SRL
42 SOTALOLUMC07AA07
Prescriere limitata: Tratamentul aritmiilor ventriculare severe.
Tratamentul aritmiilor supraventriculare.
Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare denumirii comune internationale.
160mgC07AA07 SOTALOLUM COMPR.ALS-SOTALOL 160 mg 160mg ALSIFCOM INTERMED SRL
DAROB® 160 mg 160mg ABBOTT GMBH&CO.KG
SOTAGAMMA 160 160mg WORWAG PHARMA GMBH & CO. KG
SOTALOL AL 160 160mg ALIUD PHARMA GMBH & CO.KG
80mgC07AA07 SOTALOLUM COMPR.ALS-SOTALOL 80 mg 80mg ALSIFCOM INTERMED SRL
DAROB® 80 mg 80mg ABBOTT GMBH&CO.KG
SOTAGAMMA 80 80mg WORWAG PHARMA GMBH & CO. KG
43 METOPROLOLUMC07AB02
100mgC07AB02 METOPROLOLUM COMPR.BETAPROL 100 mg 100mg AC HELCOR PHARMA SRL
BLOXAN 100mg KRKA D.D. NOVO MESTO
EGILOK 100 mg 100mg EGIS PHARMACEUTICALS P.L.C.
METOPRO TAD 100 100mg TAD PHARMA GMBH
METOPROLOL 100 mg 100mg MAGISTRA C & C SRL
METOPROLOL AL 100 100mg ALIUD® PHARMA GMBH & CO.KG
METOPROLOL LPH 100 mg 100mg LABORMED PHARMA SA
METOPROLOL MEDICO UNO 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.
6 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
METOPROLOL TERAPIA 100 mg 100mg TERAPIA SA
VASOCARDIN® 100 100mg SLOVAKOFARMA
100mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.METOPROLOL RETARD 100 mg 100mg TERAPIA S.A.
100mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 100 mg 100mg ASTRAZENECA AB
190mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 190 mg 190mg HEXAL AG
200mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.VASOCARDIN® SR 200 200mg ZENTIVA AS
25mgC07AB02 METOPROLOLUM COMPR.EGILOK 25 mg 25mg EGIS PHARMACEUTICALS P.L.C.
METOPROLOL 25 mg 25mg ARENA GROUP S.A.
METOPROLOL LPH 25 mg 25mg LABORMED PHARMA SA
METOPROLOL MEDICO UNO 25 mg 25mg MEDICO UNO PHARMACEUTICAL S.R.L.
47.5mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 47,5 mg 47.5mg HEXAL AG
50mgC07AB02 METOPROLOLUM COMPR.BETAPROL 50 mg 50mg AC HELCOR PHARMA SRL
EGILOK 50 mg 50mg EGIS PHARMACEUTICALS P.L.C.
METOPRO TAD 50 50mg TAD PHARMA GMBH
METOPROLOL 50 mg 50mg MAGISTRA C & C SRL
METOPROLOL AL 50 50mg ALIUD PHARMA GMBH & CO.KG
METOPROLOL LPH 50 mg 50mg LABORMED PHARMA SA
METOPROLOL MEDICO UNO 50 mg 50mg MEDICO UNO PHARMACEUTICAL S.R.L.
METOPROLOL TERAPIA 50 mg 50mg TERAPIA SA
50mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 50 mg 50mg ASTRAZENECA AB
95mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 95 mg 95mg HEXAL AG
44 ATENOLOLUMC07AB03
100mgC07AB03 ATENOLOLUM COMPR.ATECOR 100mg WIN - MEDICARE LTD.
ATENOCOR 100 mg 100mg AC HELCOR SRL
ATENOLOL 100 mg 100mg ARENA GROUP SA
ATENOLOL LPH 100 mg 100mg LABORMED PHARMA SA
100mgC07AB03 ATENOLOLUM COMPR. FILM.ATENOLOL 100 mg 100mg TERAPIA SA
ATENOLOL 100 mg MEDO 100mg MEDOCHEMIE ROMANIA SRL
VASCOTEN 100mg MEDOCHEMIE LTD.
50mgC07AB03 ATENOLOLUM COMPR.ATENOCOR 50 mg 50mg AC HELCOR SRL
ATENOLOL 50 mg 50mg SLAVIA PHARM SRL
ATENOLOL LPH 50 mg 50mg LABORMED PHARMA SA
50mgC07AB03 ATENOLOLUM COMPR. FILM.ATENOLOL 50 mg 50mg TERAPIA SA
45 BETAXOLOLUMC07AB05
20mgC07AB05 BETAXOLOLUM COMPR. FILM.BETAC 20mg MEDOCHEMIE LTD.
LOKREN 20 mg 20mg SANOFI-AVENTIS FRANCE
46 BISOPROLOLUMC07AB07
10mgC07AB07 BISOPROLOLUM COMPR.BISOBLOCK 10 mg 10mg KERI PHARMA GENERICS LTD.
10mgC07AB07 BISOPROLOLUM COMPR. FILM.BISOGAMMA® 10 10mg WORWAG PHARMA GMBH & CO. KG
BISOTENS 10 mg 10mg ANTIBIOTICE S.A.
CONCOR 10 mg 10mg MERCK KGAA
2.5mgC07AB07 BISOPROLOLUM COMPR. FILM.CONCOR COR 2,5 mg 2.5mg MERCK KGAA
5mgC07AB07 BISOPROLOLUM COMPR.BISOBLOCK 5 mg 5mg KERI PHARMA GENERICS LTD.
5mgC07AB07 BISOPROLOLUM COMPR. FILM.BISOGAMMA® 5 5mg WORWAG PHARMA GMBH & CO. KG
BISOTENS 5 mg 5mg ANTIBIOTICE S.A.
CONCOR 5 mg 5mg MERCK KGAA
47 CARVEDILOLUMC07AG02
12,5 mgC07AG02 CARVEDILOLUM COMPR.CARVEDILOL SANDOZ 12,5 mg HEXAL AG
12.5mgC07AG02 CARVEDILOLUM COMPR.ATRAM 12,5 12.5mg ZENTIVA AS
CARVEDILOL 12,5 mg 12.5mg VIM SPECTRUM SRL
CARVEDILOL HELCOR 12,5 mg 12.5mg AC HELCOR PHARMA SRL
CARVEDILOL LPH 12,5 mg 12.5mg LABORMED PHARMA SA
CARVEDILOL TEVA 12,5 mg 12.5mg TEVA PHARMACEUTICAL S.R.L.
CORYOL® 12.5mg KRKA D.D.
DILATREND® 12,5 mg 12.5mg ROCHE ROMANIA S.R.L.
TALLITON® 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.
12.5mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 12,5 mg 12.5mg WORWAG PHARMA GMBH & CO. KG
25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 25 25mg ZENTIVA AS
CARVEDILOL HELCOR 25 mg 25mg AC HELCOR PHARMA SRL
CARVEDILOL LPH 25 mg 25mg LABORMED PHARMA SA
7 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CARVEDILOL SANDOZ 25mg HEXAL AG
CARVEDILOL TEVA 25 mg 25mg TEVA PHARMACEUTICAL S.R.L.
CORYOL® 25mg KRKA D.D.
DILATREND® 25 mg 25mg ROCHE ROMANIA S.R.L.
TALLITON® 25 mg 25mg EGIS PHARMACEUTICALS LTD.
25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 25 mg 25mg WORWAG PHARMA GMBH & CO. KG
3.125mgC07AG02 CARVEDILOLUM COMPR.CORYOL® 3,125 mg 3.125mg KRKA D.D.
6.25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 6,25 6.25mg ZENTIVA AS
CARVEDILOL 6,25 mg 6.25mg VIM SPECTRUM SRL
CARVEDILOL LPH 6,25 mg 6.25mg LABORMED PHARMA SA
CARVEDILOL SANDOZ 6.25mg HEXAL AG
CARVEDILOL TEVA 6,25 mg 6.25mg TEVA PHARMACEUTICAL S.R.L.
CORYOL® 6.25mg KRKA D.D.
DILATREND® 6,25 mg 6.25mg ROCHE ROMANIA S.R.L.
TALLITON 6,25 mg 6.25mg EGIS PHARMACEUTICALS LTD.
6.25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 6,25 mg 6.25mg WORWAG PHARMA GMBH & CO. KG
48 AMLODIPINUMC08CA01
10mgC08CA01 AMLODIPINUM COMPR.ALOZUR 10 mg 10mg OZONE LABORATORIES BV
AMLO TAD 10 mg 10mg TAD PHARMA GMBH
AMLODIPIN 10 mg 10mg VIM SPECTRUM SRL
AMLODIPINE-TEVA 10 mg 10mg TEVA PHARMACEUTICAL S.R.L.
AMLOHEXAL 10 mg 10mg HEXAL AG
NORVASC 10 mg 10mg PFIZER EUROPE MA EEIG
STAMLO M 10 mg 10mg DR. REDDY'S LABORATORIES
TENOX® 10 10mg KRKA D.D.
VASOREX 10 mg 10mg LABORMED PHARMA S.A.
5mgC08CA01 AMLODIPINUM COMPR.ALOZUR 5 mg 5mg OZONE LABORATORIES BV
AMLO TAD 5 mg 5mg TAD PHARMA GMBH
AMLODIPIN 5 mg 5mg VIM SPECTRUM SRL
AMLODIPINE-TEVA 5 mg 5mg TEVA PHARMACEUTICAL S.R.L.
AMLOHEXAL 5 mg 5mg HEXAL AG
NORVASC 5 mg 5mg PFIZER EUROPE MA EEIG
STAMLO M 5 mg 5mg DR. REDDY'S LABORATORIES
TENOX® 5 5mg KRKA D.D.
VASOREX 5 mg 5mg LABORMED PHARMA S.A.
49 FELODIPINUMC08CA02
10mgC08CA02 FELODIPINUM COMPR. ELIB. MODIF.FELODIPIN AL 10 RETARD 10mg ALIUD® PHARMA GMBH & CO.KG
10mgC08CA02 FELODIPINUM COMPR. ELIB. PREL.PLENDIL 10mg ASTRAZENECA AB
10mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. MODIF.SISTAR 10 mg 10mg GEDEON RICHTER ROMANIA SA
10mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. PREL.AURONAL 10 mg 10mg EGIS PHARMACEUTICALS PLC
MIVARA 10 mg 10mg STADA ARZNEIMITTEL AG
PRESID® 10 mg 10mg IVAX - PHARMACEUTICALS S.R.O.
2.5mgC08CA02 FELODIPINUM COMPR. ELIB. MODIF.FELODIPIN AL 2,5 RETARD 2.5mg ALIUD® PHARMA GMBH & CO.KG
2.5mgC08CA02 FELODIPINUM COMPR. ELIB. PREL.PLENDIL 2.5mg ASTRAZENECA AB
2.5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. MODIF.SISTAR 2,5 mg 2.5mg GEDEON RICHTER ROMANIA SA
2.5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. PREL.AURONAL 2,5 mg 2.5mg EGIS PHARMACEUTICALS PLC
PRESID® 2,5 mg 2.5mg IVAX - PHARMACEUTICALS S.R.O.
5mgC08CA02 FELODIPINUM COMPR. ELIB. MODIF.FELODIPIN AL 5 RETARD 5mg ALIUD® PHARMA GMBH & CO.KG
5mgC08CA02 FELODIPINUM COMPR. ELIB. PREL.PLENDIL 5mg ASTRAZENECA AB
5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. MODIF.SISTAR 5 mg 5mg GEDEON RICHTER ROMANIA SA
5mgC08CA02 FELODIPINUM COMPR. FILM. ELIB. PREL.AURONAL 5 mg 5mg EGIS PHARMACEUTICALS PLC
MIVARA 5 mg 5mg STADA ARZNEIMITTEL AG
PRESID® 5 mg 5mg IVAX - PHARMACEUTICALS S.R.O.
50 NIFEDIPINUMC08CA05
20mgC08CA05 NIFEDIPINUM COMPR. ELIB. MODIF.ADALAT CR 20 20mg BAYER HEALTHCARE AG
20mgC08CA05 NIFEDIPINUM COMPR. FILM. ELIB. PREL.ADALAT® RETARD 20mg BAYER HEALTHCARE AG
NIFEDIPIN RETARD TERAPIA 20 mg 20mg TERAPIA SA
20mgC08CA05 NIFEDIPINUM DRAJ.EPILAT RETARD 20mg E.I.P.I.CO. MED S.R.L.
30mgC08CA05 NIFEDIPINUM COMPR. ELIB. MODIF.ADALAT CR 30 30mg BAYER HEALTHCARE AG
20mgC08CA05 NIFEDIPINUM COMPR. ELIB. MODIF.ADALAT CR 20 20mg BAYER HEALTHCARE AG
20mgC08CA05 NIFEDIPINUM COMPR. FILM. ELIB. PREL.
8 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
ADALAT® RETARD 20mg BAYER HEALTHCARE AG
NIFEDIPIN RETARD TERAPIA 20 mg 20mg TERAPIA SA
51 VERAPAMILUMC08DA01Efectele de inhibare a funcţiei miocardice ale acestui medicament se cumulează cu cele ale beta-blocantelor
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
240mgC08DA01 VERAPAMILUM COMPR. FILM. ELIB. PREL.ISOPTIN RR 240mg ABBOTT GMBH&CO.KG
VEROGALID® ER 240 mg 240mg IVAX - PHARMACEUTICALS S.R.O.
40mgC08DA01 VERAPAMILUM COMPR. FILM.ISOPTIN® 40 mg 40mg ABBOTT GMBH&CO.KG
VERAPAMIL AL 40 40mg ALIUD® PHARMA GMBH & CO.KG
80mgC08DA01 VERAPAMILUM COMPR. FILM.ISOPTIN® 80 mg 80mg ABBOTT GMBH&CO.KG
VERAPAMIL AL 80 80mg ALIUD® PHARMA GMBH & CO.KG
52 DILTIAZEMUMC08DB01Efectele de inhibare a funcţiei miocardice ale acestui medicament se cumulează cu cele ale beta-blocantelor
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
60mgC08DB01 DILTIAZEMUM COMPR.DILTIAZEM ALKALOID 60 mg 60mg ALKALOID DOO
DILTIAZEM EIPICO 60 mg 60mg E.I.P.I.CO. MED S.R.L.
DILTIAZEM LPH 60 mg 60mg LABORMED PHARMA SA
DILZEM 60 mg 60mg PFIZER EUROPE MA EEIG
90mgC08DB01 DILTIAZEMUM COMPR.DILTIAZEM ALKALOID 90 mg 90mg ALKALOID DOO
90mgC08DB01 DILTIAZEMUM COMPR. FILM. ELIB. PREL.DILZEM 90 mg RETARD 90mg PFIZER EUROPE MA EEIG
53 CAPTOPRILUMC09AA01
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
12,5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL MCC 12,5 mg 12,5mg MAGISTRA C & C
12.5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.
25mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 25 mg 25mg AC HELCOR PHARMA SRL
CAPTOPRIL SINTOFARM 25 mg 25mg SINTOFARM SA
CAPTOPRIL 25 EEL 25mg BIO EEL SRL
CAPTOPRIL 25 mg 25mg EGIS PHARMACEUTICALS LTD.
CAPTOPRIL LPH 25 mg 25mg LABORMED PHARMA SA
CAPTOPRIL MCC 25 mg 25mg MAGISTRA C & C
50 mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 50 mg 50 mg ARENA GROUP SA
50mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 50 mg 50mg AC HELCOR PHARMA SRL
CAPTOPRIL 50 EEL 50mg BIO EEL SRL
CAPTOPRIL 50 mg 50mg EGIS PHARMACEUTICALS LTD.
CAPTOPRIL LPH 50 mg 50mg LABORMED PHARMA SA
CAPTOPRIL MCC 50 mg 50mg MAGISTRA C & C
54 ENALAPRILUMC09AA02
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
1.25mg/mlC09AA02 ENALAPRILUM SOL. INJ.ENAP® 1.25mg/ml KRKA D.D.
10mgC09AA02 ENALAPRILUM COMPR.EDNYT® 10 mg 10mg GEDEON RICHTER LTD.
ENAHEXAL® 10 mg 10mg HEXAL AG
ENALA TAD 10 10mg TAD PHARMA GMBH
ENALAP 10mg E.I.P.I.CO. MED S.R.L.
ENALAPRIL 10 mg 10mg MAGISTRA C & C
ENALAPRIL AL 10 10mg ALIUD® PHARMA GMBH & CO.KG
ENALAPRIL FABIOL 10 mg 10mg FABIOL SA
ENALAPRIL LPH 10 mg 10mg LABORMED PHARMA SA
ENALAPRIL SANDOZ 10 mg 10mg SANDOZ SRL
ENALAPRIL TERAPIA 10 mg 10mg TERAPIA SA
ENAM 10 mg 10mg REPREZENTANTA DR. REDDY'S LABORATORIES LTD.
ENAP 10 mg 10mg KRKA D.D. NOVO MESTO
RENITEC 10 mg 10mg MERCK SHARP & DOHME ROMANIA S.R.L.
2.5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 2,5 mg 2.5mg GEDEON RICHTER LTD.
20mgC09AA02 ENALAPRILUM COMPR.EDNYT® 20 mg 20mg GEDEON RICHTER LTD.
ENAHEXAL® 20 mg 20mg HEXAL AG
ENALA TAD 20 20mg TAD PHARMA GMBH
ENALAPRIL 20mg OZONE LABORATORIES LTD.
ENALAPRIL 20 mg 20mg MAGISTRA C & C
ENALAPRIL AL 20 20mg ALIUD® PHARMA GMBH & CO.KG
ENALAPRIL FABIOL 20 mg 20mg FABIOL SA
ENALAPRIL LPH 20 mg 20mg LABORMED PHARMA SA
ENALAPRIL SANDOZ 20 mg 20mg SANDOZ SRL
ENALAPRIL TERAPIA 20 mg 20mg TERAPIA SA
ENAP 20 mg 20mg KRKA D.D. NOVO MESTO
RENITEC 20 mg 20mg MERCK SHARP & DOHME ROMANIA S.R.L.
9 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 5 mg 5mg GEDEON RICHTER LTD.
ENAHEXAL® 5 mg 5mg HEXAL AG
ENALA TAD 5 5mg TAD PHARMA GMBH
ENALAPRIL 5 mg 5mg OZONE LABORATORIES LTD.
ENALAPRIL AL 5 5mg ALIUD® PHARMA GMBH & CO.KG
ENALAPRIL LPH® 5 mg 5mg LABORMED PHARMA SA
ENALAPRIL SANDOZ 5 mg 5mg SANDOZ SRL
ENAP 5 mg 5mg KRKA D.D. NOVO MESTO
RENITEC 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.
55 LISINOPRILUMC09AA03
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
10mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG
LISINOPRIL 10 MEDO 10mg MEDOCHEMIE ROMANIA SRL
LISINOPRIL ANTIBIOTICE 10 mg 10mg ANTIBIOTICE SA
LISINOPRIL SANDOZ 10 mg 10mg HEXAL AG
LISIREN 10 mg 10mg AC HELCOR SRL
MEDAPRIL 10 10mg MEDOCHEMIE LTD.
RANOLIP 10mg RANBAXY U.K. LIMITED
SINOPRYL® 10 10mg ECZACIBASI PHARMACEUTICALS S.R.L.
TONOLYSIN 10 mg 10mg GEDEON RICHTER LTD.
2.5mgC09AA03 LISINOPRILUM COMPR.TONOLYSIN 2,5 mg 2.5mg GEDEON RICHTER LTD.
20mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 20 mg 20mg WORWAG PHARMA GMBH & CO. KG
LISINOPRIL 20 MEDO 20mg MEDOCHEMIE ROMANIA SRL
LISINOPRIL ANTIBIOTICE 20 mg 20mg ANTIBIOTICE SA
LISINOPRIL SANDOZ 20 mg 20mg HEXAL AG
LISIREN 20 mg 20mg AC HELCOR SRL
MEDAPRIL 20 20mg MEDOCHEMIE LTD.
RANOLIP 20mg RANBAXY U.K. LIMITED
TONOLYSIN 20 mg 20mg GEDEON RICHTER LTD.
40mgC09AA03 LISINOPRILUM COMPR.LISINOPRIL ANTIBIOTICE 40 mg 40mg ANTIBIOTICE SA
5mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG
LISINOPRIL 5 MEDO 5mg MEDOCHEMIE ROMANIA SRL
LISINOPRIL SANDOZ 5 mg 5mg HEXAL AG
MEDAPRIL 5 5mg MEDOCHEMIE LTD.
RANOLIP 5mg RANBAXY U.K. LIMITED
TONOLYSIN 5 mg 5mg GEDEON RICHTER LTD.
56 RAMIPRILUMC09AA05
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
1.25mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 1,25 mg 1.25mg RANBAXY U.K. LIMITED
10 mgC09AA05 RAMIPRILUM COMPR.EMREN 10 mg 10 mg GEDEON RICHTER ROMANIA S.A.
VIVACE 10 mg 10 mg ACTAVIS GROUP HF
10mgC09AA05 RAMIPRILUM COMPR.AMPRIL 10 mg 10mg KRKA D.D. NOVO MESTO
PIRAMIL 10 mg 10mg SANDOZ SRL
RAMIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG
RAMIPRIL-AC 10 mg 10mg AC HELCOR PHARMA SRL
TRITACE 10 10mg SANOFI - AVENTIS DEUTSCHLAND GMBH
ZENRA 10 10mg ZENTIVA S.A.
10mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 10 mg 10mg RANBAXY U.K. LIMITED
2,5 mgC09AA05 RAMIPRILUM COMPR.EMREN 2,5 mg 2,5 mg GEDEON RICHTER ROMANIA S.A.
VIVACE 2,5 mg 2,5 mg ACTAVIS GROUP HF
2.5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 2,5 mg 2.5mg KRKA D.D. NOVO MESTO
PIRAMIL 2,5 mg 2.5mg SANDOZ SRL
RAMIPRIL-AC 2,5 mg 2.5mg AC HELCOR PHARMA SRL
TRITACE® 2,5 2.5mg AVENTIS PHARMA DEUTSCHLAND GMBH
ZENRA 2,5 2.5mg ZENTIVA S.A.
2.5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 2,5 mg 2.5mg RANBAXY U.K. LIMITED
5 mgC09AA05 RAMIPRILUM COMPR.EMREN 5 mg 5 mg GEDEON RICHTER ROMANIA S.A.
VIVACE 5 mg 5 mg ACTAVIS GROUP HF
5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 5 mg 5mg KRKA D.D. NOVO MESTO
PIRAMIL 5 mg 5mg SANDOZ SRL
RAMIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG
RAMIPRIL-AC 5 mg 5mg AC HELCOR PHARMA SRL
TRITACE® 5 5mg AVENTIS PHARMA DEUTSCHLAND GMBH
ZENRA 5 5mg ZENTIVA S.A.
5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 5 mg 5mg RANBAXY U.K. LIMITED
10 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
57 QUINAPRILUMC09AA06
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
10 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 10 mg 10 mg HEXAL AG
10mgC09AA06 QUINAPRILUM COMPR. FILM.ACCUPRO 10 mg 10mg PFIZER EUROPE MA EEIG
AQUIRIL 10 mg 10mg LABORMED PHARMA SA
QUINARAN 10 mg 10mg RANBAXY UK LIMITED
20 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 20 mg 20 mg HEXAL AG
20mgC09AA06 QUINAPRILUM COMPR. FILM.ACCUPRO® 20 20mg PFIZER EUROPE MA EEIG
QUINARAN 20 mg 20mg RANBAXY UK LIMITED
40 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 40 mg 40 mg HEXAL AG
40mgC09AA06 QUINAPRILUM COMPR. FILM.QUINARAN 40 mg 40mg RANBAXY UK LIMITED
5 mgC09AA06 QUINAPRILUM COMPR. FILM.QUINAPRIL SANDOZ 5 mg 5 mg HEXAL AG
5mgC09AA06 QUINAPRILUM COMPR. FILM.ACCUPRO® 5 5mg PFIZER EUROPE MA EEIG
QUINARAN 5 mg 5mg RANBAXY UK LIMITED
58 FOSINOPRILUMC09AA09
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
10mgC09AA09 FOSINOPRILUM COMPR.FOSINOPRIL TERAPIA 10 mg 10mg TERAPIA SA
FOSYPRIL 10 mg 10mg TERAPIA S.A.
MONOPRIL 10 mg 10mg BRISTOL MYERS SQUIBB KFT
20mgC09AA09 FOSINOPRILUM COMPR.FOSINOPRIL TERAPIA 20 mg 20mg TERAPIA SA
FOSINOPRIL TEVA 20 mg 20mg TEVA PHARMACEUTICAL S.R.L.
FOSYPRIL 20 mg 20mg TERAPIA S.A.
MONOPRIL 20 mg 20mg BRISTOL-MYERS SQUIBB KFT
59 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)C09BA02
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in
utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
10mg/25mgC09BA02 COMBINATII
(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
ENALAPRIL HCT SANDOZ 10 mg/25 mg 10mg/25mg HEXAL AG
10mg+12.5mgC09BA02 COMBINATII
(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
ENAP HL 10mg+12.5mg KRKA D.D. NOVO MESTO
10mg+25mgC09BA02 COMBINATII
(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
ENAP H 10mg+25mg KRKA D.D. NOVO MESTO
20 mg/12.5mgC09BA02 COMBINATII
(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
ENAP® HL 20 mg/12,5 mg 20 mg/12.5mg KRKA D.D. NOVO MESTO
20mg/12.5mgC09BA02 COMBINATII
(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
ENALAPRIL HCT SANDOZ 20 mg/12,5 mg 20mg/12.5mg HEXAL AG
C09BA02 COMBINATII
(ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
VIMAPRIL H VIM SPECTRUM SRL
VIMAPRIL HL VIM SPECTRUM SRL
60 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)C09BA05
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in
utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
2.5mg/12.5mgC09BA05 COMBINATII
(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
HARTIL HCT 2,5 mg/12,5mg 2.5mg/12.5mg EGIS PHARMACEUTICALS PLC
PIRAMIL HCT 2,5 mg/12,5 mg 2.5mg/12.5mg HEXAL AG
RAMIPRIL HCT-MEDOCHEMIE 2.5mg/12.5mg MEDOCHEMIE LTD.
2.5mg+12.5mgC09BA05 COMBINATII
(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
AMPRIL HL 2.5mg+12.5mg KRKA D.D. NOVO MESTO
5mg/25mgC09BA05 COMBINATII
(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
HARTIL HCT 5 mg/25mg 5mg/25mg EGIS PHARMACEUTICALS PLC
PIRAMIL HCT 5 mg/25 mg 5mg/25mg HEXAL AG
RAMIPRIL HCT-MEDOCHEMIE 5mg/25mg MEDOCHEMIE LTD.
5mg+25mgC09BA05 COMBINATII
(RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR.
AMPRIL HD 5mg+25mg KRKA D.D. NOVO MESTO
11 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
61 LOSARTANUMC09CA01
50mgC09CA01 LOSARTANUM COMPR. FILM.COZAAR 50mg MERCK SHARP & DOHME ROMANIA S.R.L.
62 SIMVASTATINUM Protocol: CE01EC10AA01
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
10 mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN 10 mg 10 mg TERAPIA S.A.
10mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMGAL® 10 mg 10mg IVAX - PHARMACEUTICALS S.R.O.
SIMVA TAD 10 mg 10mg TAD PHARMA GMBH
SIMVACARD® 10 10mg ZENTIVA AS
SIMVAGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG
SIMVAHEXAL® 10 mg 10mg HEXAL AG
SIMVASTATIN LPH 10 mg 10mg LABORMED PHARMA SA
SIMVOR 10 mg 10mg RANBAXY U.K. LIMITED
SINTENAL 10 mg 10mg AC HELCOR PHARMA SRL
VABADIN 10 mg 10mg MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A.
VASILIP 10 mg 10mg KRKA D.D.
ZAREDIL 10 mg 10mg OZONE LABORATORIES LTD.
ZEPLAN® 10 mg 10mg GEDEON RICHTER ROMANIA SA
ZOCOR 10 mg 10mg MERCK SHARP & DOHME ROMANIA S.R.L.
20 mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN 20 mg 20 mg TERAPIA S.A.
20mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMCOR 20 mg 20mg ANTIBIOTICE SA
SIMGAL® 20 mg 20mg IVAX - PHARMACEUTICALS S.R.O.
SIMVA TAD 20 mg 20mg TAD PHARMA GMBH
SIMVACARD® 20 20mg ZENTIVA AS
SIMVAGAMMA 20 mg 20mg WORWAG PHARMA GMBH & CO. KG
SIMVAHEXAL® 20 mg 20mg HEXAL AG
SIMVASTATIN LPH 20 mg 20mg LABORMED PHARMA SA
SIMVOR 20 mg 20mg RANBAXY U.K. LIMITED
SINTENAL 20 mg 20mg AC HELCOR PHARMA SRL
VABADIN 20 mg 20mg MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A.
VASILIP 20 mg 20mg KRKA D.D.
ZAREDIL 20 mg 20mg OZONE LABORATORIES LTD.
ZEPLAN® 20 mg 20mg GEDEON RICHTER ROMANIA SA
ZOCOR 20 mg 20mg MERCK SHARP & DOHME ROMANIA S.R.L.
30mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVAHEXAL® 30 mg 30mg HEXAL AG
40 mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN 40 mg 40 mg TERAPIA S.A.
40mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMCOR 40 mg 40mg ANTIBIOTICE S.A.
SIMGAL® 40 mg 40mg IVAX - PHARMACEUTICALS S.R.O.
SIMVA TAD 40 mg 40mg TAD PHARMA GMBH
SIMVACARD® 40 40mg ZENTIVA AS
SIMVAGAMMA 40 mg 40mg WORWAG PHARMA GMBH & CO. KG
SIMVAHEXAL® 40 mg 40mg HEXAL AG
SIMVASTATIN LPH 40 mg 40mg LABORMED PHARMA S.A.
SIMVOR 40 mg 40mg RANBAXY U.K. LIMITED
SINTENAL 40 mg 40mg AC HELCOR PHARMA SRL
VABADIN 40 mg 40mg MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A.
VASILIP® 40 mg 40mg KRKA D.D.
ZAREDIL 40 mg 40mg OZONE LABORATORIES LTD.
ZEPLAN® 40 mg 40mg GEDEON RICHTER ROMANIA SA
ZOCOR FORTE 40mg MERCK SHARP & DOHME ROMANIA S.R.L.
5mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVOR 5 mg 5mg RANBAXY U.K. LIMITED
80mgC10AA01 SIMVASTATINUM COMPR. FILM.SIMVASTATIN LPH 80 mg 80mg LABORMED PHARMA S.A.
63 LOVASTATINUM Protocol: CE01EC10AA02
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mgC10AA02 LOVASTATINUM COMPR.MEDOSTATIN 20mg MEDOCHEMIE LTD.
64 PRAVASTATINUM Protocol: CE01EC10AA03
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgC10AA03 PRAVASTATINUM COMPR.PRALIP 10 mg 10mg SANDOZ SRL
PRAVATOR 10 mg 10mg RANBAXY U.K. LIMITED
20mgC10AA03 PRAVASTATINUM COMPR.PRALIP 20 mg 20mg SANDOZ SRL
PRAVATOR 20 mg 20mg RANBAXY U.K. LIMITED
40mgC10AA03 PRAVASTATINUM COMPR.PRALIP 40 mg 40mg SANDOZ SRL
PRAVATOR 40 mg 40mg RANBAXY U.K. LIMITED
65 FENOFIBRATUM Protocol: CE01EC10AB05
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
12 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Riscul de toxicitate musculară severă creste dacă fenofibratum este utilizat simultan cu inhibitori de HMG CoA reductaza sau alţi fibraţi. Terapia combinata trebuie folosită cu
precautie la pacienţii cu dislipidemie mixta severă combinată cu risc cardiovascular înalt, in absenta antecedentelor de afectiune musculară. Pacienţii vor fi monitorizaţi regulat
pentru semne cronice de toxicitate musculară
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgC10AB05 FENOFIBRATUM CAPS.LIPANTHYL® 100 100mg LAB. FOURNIER SA
160mgC10AB05 FENOFIBRATUM CAPS.LIPOFIB 160 mg 160mg TERAPIA S.A.
160mgC10AB05 FENOFIBRATUM COMPR. FILM. ELIB. MODIF.LIPANTHYL® SUPRA 160 mg 160mg LAB. FOURNIER SA
200mgC10AB05 FENOFIBRATUM CAPS.LIPOFIB 200 mg 200mg TERAPIA S.A.
200mgC10AB05 FENOFIBRATUM CAPS. PULB. MICRONIZATAFENOFIBRAT LPH 200 mg 200mg LABORMED PHARMA SA
LIPANTHYL 200 M 200mg LAB. FOURNIER SA
LIPIVIM 200mg VIM SPECTRUM SRL
66 MICONAZOLUMD01AC02
20mg/gD01AC02 MICONAZOLUM CREMAMICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S
2%D01AC02 MICONAZOLUM CREMAMEDACTER 2% FARAN LABORATORIES S.A.
MICONAZOL NITRAT 2% 2% SLAVIA PHARM SRL
2%D01AC02 MICONAZOLUM GELDERMOZOL 2% PHARCO IMPEX 93 S.R.L.
67 BIFONAZOLUMD01AC10
0,01g/mlD01AC10 BIFONAZOLUM SOL. CUT.MYCOSPOR 0,01g/ml BAYER HEALTHCARE AG
100gD01AC10 BIFONAZOLUM CREMAMYCO - FLUSEMIDON 100g ANFARM HELLAS S.A. PHARMACEUTICALS
10mg/gD01AC10 BIFONAZOLUM CREMABIAZOL 10 mg/g 10mg/g GEDEON RICHTER ROMANIA SA
1%D01AC10 BIFONAZOLUM CREMAMYCOSPOR 1% BAYER HEALTHCARE AG
68 ACICLOVIRUMD06BB03
50mg/gD06BB03 ACICLOVIRUM CREMAACICLOVIR HYPERION 50mg/g HYPERION S.A.
ACIKLOVIR CREMA 50mg/g A & G MED TRADING S.R.L.
5%D06BB03 ACICLOVIRUM CREMAACICLOVIR 5% OZONE LABORATORIES LTD.
ACICLOVIR 5% 5% GEDEON RICHTER ROMANIA SA
CLOVIRAL® 5% 5% ANTIBIOTICE SA
ZOVIRAX 5% THE WELLCOME FOUNDATION LTD.
69 HYDROCORTISONUM Protocol: D001LD07AA02
1,00%D07AA02 HYDROCORTISONUM UNGUENTHIDROCORTIZON 1% 1% ANTIBIOTICE SA
70 BETAMETHASONUM Protocol: D001LD07AC01
0,5mg/gD07AC01 BETAMETHASONUM CREMABELODERM CREMA 0,5mg/g A & G MED TRADING S.R.L.
0,5mg/gD07AC01 BETAMETHASONUM UNGUENTBELODERM UNGUENT 0,5mg/g A & G MED TRADING S.R.L.
0.1%D07AC01 BETAMETHASONUM CREMABETADERM 0.1% E.I.P.I.CO. MED S.R.L.
0.1%D07AC01 BETAMETHASONUM UNGUENTBETADERM 0.1% E.I.P.I.CO. MED S.R.L.
71 MICONAZOLUMG01AF04
1.2gG01AF04 MICONAZOLUM CAPS. MOI VAG.MICONAL ECOBI 1.2g FARMACEUTICI ECOBI S.A.S
20mg/gG01AF04 MICONAZOLUM CREMA VAG.MICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S
2mg/mlG01AF04 MICONAZOLUM SOL. VAGINALAMICONAL ECOBI 2mg/ml FARMACEUTICI ECOBI S.A.S
50mgG01AF04 MICONAZOLUM OVULEMICONAL ECOBI 50mg FARMACEUTICI ECOBI S.A.S
2%G01AF04 MICONAZOLUM CREMA VAG.MEDACTER 2% FARAN LABORATORIES S.A.
MYCOHEAL 2% DAR AL DAWA PHARMA S.R.L.
72 ERGOMETRINUMG02AB03
0.2mg/mlG02AB03 ERGOMETRINUM SOL. INJ.MALEAT DE ERGOMETRINA 0,2 mg/ml 0.2mg/ml ZENTIVA S.A.
73 TESTOSTERONUM *G03BA03
1000mg/4mlG03BA03 TESTOSTERONUM SOL. INJ.NEBIDO 1000 mg/4 ml 1000mg/4ml SCHERING AG
40mgG03BA03 TESTOSTERONUM CAPS. MOIUNDESTOR® TESTOCAPS® 40mg ORGANON NV
Deficit androgenic la barbati de cauza primara testiculara sau secundara hipotalamo-hipofizara (confirmat prin nivel plasmatic al testosteronului la cel putin 2
determinari in doua dimineti diferite mai mic sau egal cu limita inferioara a valorilor reactivului utilizat).
Prescriere limitata:
Micropenis, inducerea pubertatii sau intarzierea constitutionala a cresterii sau a pubertatii la baieti sub 18 ani.Prescriere limitata:
50mgG03BA03 TESTOSTERONUM GELANDROGEL 50 mg 50mg LAB. BESINS INTERNATIONAL
74 ESTRADIOLUM *G03CA03
13 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni.
Aceasta limitare este valabila doar pentru formele farmaceutice Sistem terapeutic transdermic si plasture transdermic.
Estradiol trebuie folosit împreuna cu un progestativ oral la femeile nehisterectomizate.NOTA:
0.06%G03CA03 ESTRADIOLUM GELOESTROGEL® 0.06% LAB. BESINS INTERNATIONAL
0.1%G03CA03 ESTRADIOLUM GELESTREVA® 0.1% LAB. THERAMEX
1mgG03CA03 ESTRADIOLUM COMPR. FILM.ESTROFEM 1 mg 1mg NOVO NORDISK A/S
25µgG03CA03 ESTRADIOLUM COMPR. VAG.VAGIFEM 25µg NOVO NORDISK A/S
25mgG03CA03 ESTRADIOLUM IMPLANTRISELLE 25 mg 25mg ORGANON NV
50µg/24oreG03CA03 ESTRADIOLUM PLASTURE TRANSDERM.CLIMARA 50µg/24ore SCHERING AG
75 DOXAZOSINUMG04CAN1
1mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 1mg KRKA D.D. NOVO MESTO
MAGUROL 1mg MEDOCHEMIE LTD.
2mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG
DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG
KAMIREN 2mg KRKA D.D. NOVO MESTO
MAGUROL 2mg MEDOCHEMIE LTD.
4mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 4mg KRKA D.D. NOVO MESTO
MAGUROL 4mg MEDOCHEMIE LTD.
4mgG04CAN1 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION
4mgG04CAN1 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO
1mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 1 MEDOCHEMIE 1mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 1 1mg ALIUD® PHARMA GMBH & CO.KG
KAMIREN 1mg KRKA D.D. NOVO MESTO
MAGUROL 1mg MEDOCHEMIE LTD.
2mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 2 MEDOCHEMIE 2mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 2 2mg ALIUD® PHARMA GMBH & CO.KG
DOXAZOSIN SANDOZ 2 mg 2mg HEXAL AG
KAMIREN 2mg KRKA D.D. NOVO MESTO
MAGUROL 2mg MEDOCHEMIE LTD.
4mgG04CAN1 DOXAZOSINUM COMPR.DOXAZOSIN 4 MEDOCHEMIE 4mg MEDOCHEMIE ROMANIA SRL
DOXAZOSIN AL 4 4mg ALIUD® PHARMA GMBH & CO.KG
DOXAZOSIN SANDOZ 4 mg 4mg HEXAL AG
KAMIREN 4mg KRKA D.D. NOVO MESTO
MAGUROL 4mg MEDOCHEMIE LTD.
4mgG04CAN1 DOXAZOSINUM COMPR. ELIB. MODIF.CARDURA XL 4 mg 4mg PFIZER H.C.P. CORPORATION
4mgG04CAN1 DOXAZOSINUM COMPR. FILM. ELIB. PREL.KAMIREN XL 4 mg 4mg KRKA D.D. NOVO MESTO
76 METHYLPREDNISOLONUM *H02AB04
125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.
125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG
20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.
250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG
40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.
40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG
500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.
500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG
77 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
78 HYDROCORTISONUM *H02AB09
14 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
100mgH02AB09 HYDROCORTISONUM LIOF. + SOLV. PT. SOL. INJ.HYDROCORTISONE 100 mg 100mg HEMOFARM S.R.L.
HYDROCORTISONE SUCCINAT SODIC 100mg E.I.P.I.CO. MED S.R.L.
25mg/5mlH02AB09 HYDROCORTISONUM SOL. INJ. I.V.HIDROCORTIZON HEMISUCCINAT 25mg/5ml ZENTIVA S.A.
500mgH02AB09 HYDROCORTISONUM LIOF. PT. SOL. INJ. + SOLV.HYDROCORTISONE 500 mg 500mg HEMOFARM S.R.L.
79 DOXYCYCLINUMJ01AA02
100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg EUROPHARM SA
DOXICICLINA 100 mg 100mg ANTIBIOTICE SA
DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL
100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.
100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA
DOXICICLINA 100 mg 100mg ANTIBIOTICE SA
DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL
100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.
100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA
DOXICICLINA 100 mg 100mg ANTIBIOTICE SA
DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL
100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.
80 AMOXICILLINUMJ01CA04
1000mgJ01CA04 AMOXICILLINUM COMPR. FILM.OSPAMOX 1000 mg 1000mg SANDOZ GMBH
125mg/5mlJ01CA04 AMOXICILLINUM PULB. PT. SUSP. ORALAAMOXICILINA 125 mg/5 ml 125mg/5ml OZONE LABORATORIES LTD.
AMOXICILINA SANDOZ 125 mg/5 ml PULBERE PENTRU
SUSPENSIE ORALA
125mg/5ml SANDOZ S.R.L.
JULPHAMOX 125mg/5ml GULF PHARMACEUTICAL INDUSTRIES S.R.L.
OSPAMOX® 125 mg/5 ml 125mg/5ml SANDOZ GMBH
125mg/5mlJ01CA04 AMOXICILLINUM PULB. SUSP.MOXILEN 125mg/5ml MEDOCHEMIE LTD.
250mgJ01CA04 AMOXICILLINUM CAPS.AMOXICILINA 250mg EUROPHARM SA
AMOXICILINA SANDOZ 250 mg CAPSULE 250mg SANDOZ SRL
AMOXICILINA 250 mg 250mg OZONE LABORATORIES LTD.
AMOXICILINA ANTIBIOTICE 250 mg 250mg ANTIBIOTICE SA
AMOXICILINA ARENA 250 mg 250mg ARENA GROUP SA
AMOXICILINA MEDICO UNO 250 mg 250mg MEDICO UNO PHARMACEUTICAL S.R.L.
OSPAMOX 250 mg 250mg SANDOZ GMBH
250mg/5mlJ01CA04 AMOXICILLINUM PULB. PT. SUSP. ORALA
AMOXICILINA SANDOZ 250 mg/ 5 ml PULBERE PENTRU
SUSPENSIE ORALA
250mg/5ml SANDOZ S.R.L.
AMOXICILINA 250 mg/5 ml 250mg/5ml OZONE LABORATORIES LTD.
E - MOX 250mg/5ml E.I.P.I.CO. MED S.R.L.
JULPHAMOX 250mg/5ml GULF PHARMACEUTICAL INDUSTRIES S.R.L.
OSPAMOX 250 mg/5 ml 250mg/5ml SANDOZ GMBH
250mg/5mlJ01CA04 AMOXICILLINUM PULB. SUSP.MOXILEN FORTE 250mg/5ml MEDOCHEMIE LTD.
500mgJ01CA04 AMOXICILLINUM CAPS.AMOXICILINA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE SA
AMOXICILINA ARENA 500 mg 500mg ARENA GROUP SA
AMOXICILINA FORTE 500 mg 500mg OZONE LABORATORIES LTD.
AMOXICILINA SANDOZ 500 mg CAPSULE 500mg SANDOZ SRL
E - MOX 500mg E.I.P.I.CO. MED S.R.L.
EPHAMOX 500mg EUROPHARM SA
MOXILEN 500mg MEDOCHEMIE LTD.
500mgJ01CA04 AMOXICILLINUM COMPR. FILM.OSPAMOX 500 mg 500mg SANDOZ GMBH
1000mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 1000 mg 1000mg ASTELLAS PHARMA EUROPE BV
250mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 250 mg 250mg ASTELLAS PHARMA EUROPE BV
500mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 500 mg 500mg ASTELLAS PHARMA EUROPE BV
750mgJ01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE ORALADUOMOX 750 mg 750mg ASTELLAS PHARMA EUROPE BV
81 PHENOXYMETHYLPENICILLINUMJ01CE02
1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR.PENICILINA V 1 000 000 U.I. 1000000ui EUROPHARM SA
1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1000 1000000ui SANDOZ GMBH
1500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1500 1500000ui SANDOZ GMBH
400000ui/5mlJ01CE02 PHENOXYMETHYLPENICILLINUM SIROPOSPEN 400 400000ui/5ml SANDOZ GMBH
500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 500 500000ui SANDOZ GMBH
15 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
82 BENZATHINI BENZYLPENICILLINUMJ01CE08
1200000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 1200000ui ANTIBIOTICE SA
600000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 600000ui ANTIBIOTICE SA
83 OXACILLINUMJ01CF04
250mgJ01CF04 OXACILLINUM CAPS.OXACILINA 250mg FARMACOM SA
OXACILINA 250 mg 250mg ANTIBIOTICE SA
OXACILINA ARENA 250 mg 250mg ARENA GROUP SA
OXACILINA FARMEX 250 mg 250mg FARMEX COMPANY SRL
OXACILINA SANDOZ 250 mg 250mg SANDOZ SRL
500mgJ01CF04 OXACILLINUM CAPS.OXACILINA 500 mg 500mg ANTIBIOTICE SA
OXACILINA ARENA 500 mg 500mg ARENA GROUP SA
OXACILINA FORTE 500 mg 500mg OZONE LABORATORIES LTD.
OXACILINA SANDOZ 500 mg 500mg SANDOZ SRL
OXALIN 500 mg 500mg EUROPHARM SA
1gJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF.I.M./I.V.OXACILINA ANTIBIOTICE 1 g 1g ANTIBIOTICE SA
84 AMOXICILLINUM + ACIDUM CLAVULANICUMJ01CR02
Prescriere limitata: Tratamentul de scurta durata a infectiilor bacteriene atunci cand este suspectata rezistenta la amoxicilina.
Infectii la care este dovedita rezistenta la amoxicilina.
A fost raportată hepatotoxicitate la acest medicament.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1000mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AMOKSIKLAV 2 x 1000 mg 1000mg LEK PHARMACEUTICALS D.D.
MEDOCLAV 1000 mg 1000mg MEDOCHEMIE LTD.
1062.5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM. ELIB. PREL.AUGMENTIN™ SR 1062.5mg BEECHAM GROUP PLC
125mg+31.25/5m
l
J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA
MEDOCLAV 156,25 mg/5 ml 125mg+31.25/5ml MEDOCHEMIE LTD.
156.25mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAMOKSIKLAV 156,25mg/5ml 156.25mg/5ml LEK PHARMACEUTICALS D.D.
BIOCLAVID 156.25mg/5ml 156.25mg/5ml SANDOZ GMBH
250/62,5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 250/62,5 250/62,5mg ASTELLAS PHARMA EUROPE BV
250mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.MEDOCLAV 375 mg 250mg+125mg MEDOCHEMIE LTD.
250mg+62.5mg/5
ml
J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA
MEDOCLAV FORTE 312,5mg/5ml 250mg+62.5mg/5
ml
MEDOCHEMIE LTD.
312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALABIOCLAVID 312.5mg/5ml 312.5mg/5ml SANDOZ GMBH
312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT.SUSP. ORALAAMOKSIKLAV 312.5mg/5ml 312.5mg/5ml LEK PHARMACEUTICALS D.D.
ENHANCIN 312,5 mg/5 ml 312.5mg/5ml RANBAXY UK LIMITED
400mg+57mg/5m
l
J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA
AUGMENTIN BIS 400mg+57mg/5ml SMITHKLINE BEECHAM PLC
500/125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 500/125 500/125mg ASTELLAS PHARMA EUROPE BV
500mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 625 mg 500mg+125mg BEECHAM GROUP PLC
MEDOCLAV 625 mg 500mg+125mg MEDOCHEMIE LTD.
625mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AMOKSIKLAV 2 x 625 mg 625mg LEK PHARMACEUTICALS D.D.
BIOCLAVID 625 mg 625mg SANDOZ GMBH
642.90mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAUGMENTIN® ES 642.90mg/5ml SMITHKLINE BEECHAM PLC
875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 875/125 875mg+125mg ASTELLAS PHARMA EUROPE BV
875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 1 g 875mg+125mg BEECHAM GROUP PLC
85 CEFALEXINUMJ01DB01
1000mgJ01DB01 CEFALEXINUM COMPR. FILM.OSPEXIN 1000 mg 1000mg SANDOZ GMBH
125mg/5mlJ01DB01 CEFALEXINUM GRAN. PT. SUSP. ORALA
CEFALEXIN SANDOZ 125 mg/5 ml GRANULE PENTRU
SUSPENSIE ORALA
125mg/5ml SANDOZ SRL
KEFLEX® 125 mg/5 ml 125mg/5ml ACTAVIS GROUP HF
OSPEXIN® 125 mg/5 ml 125mg/5ml SANDOZ GMBH
125mg/5mlJ01DB01 CEFALEXINUM PULB. PT. SUSP. ORALACEFALEXIN 125 mg/5 ml 125mg/5ml OZONE LABORATORIES LTD.
250mgJ01DB01 CEFALEXINUM CAPS.CEFALEXIN 250 mg 250mg OZONE LABORATORIES LTD.
CEFALEXIN SANDOZ 250 mg CAPSULE 250mg SANDOZ SRL
CEFALEXINA 250 mg 250mg ANTIBIOTICE SA
CEFALEXINA ARENA 250 mg 250mg ARENA GROUP SA
CEFALEXINA MEDICO UNO 250 mg 250mg MEDICO UNO PHARMACEUTICAL S.R.L.
16 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
OSPEXIN® 250 mg 250mg SANDOZ GMBH
SPORIDEX 250 mg 250mg TERAPIA S.A.
250mg/5mlJ01DB01 CEFALEXINUM GRAN. PT. SUSP. ORALA
CEFALEXIN SANDOZ 250 mg/5 ml GRANULE PENTRU
SUSPENSIE ORALA
250mg/5ml SANDOZ SRL
KEFLEX® 250 mg/5 ml 250mg/5ml ACTAVIS GROUP HF
OSPEXIN® 250 mg/5 ml 250mg/5ml SANDOZ GMBH
250mg/5mlJ01DB01 CEFALEXINUM PULB. PT. SUSP. ORALACEFALEXIN 250 mg/5 ml 250mg/5ml OZONE LABORATORIES LTD.
500mgJ01DB01 CEFALEXINUM CAPS.CEFALEXIN 500 mg 500mg OZONE LABORATORIES LTD.
CEFALEXINA 500 mg 500mg ANTIBIOTICE SA
CEFALEXINA ARENA 500 mg 500mg ARENA GROUP SA
SPORIDEX 500 mg 500mg TERAPIA S.A.
500mgJ01DB01 CEFALEXINUM COMPR. FILM.CEFALEXIN SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ SRL
OSPEXIN 500 mg 500mg SANDOZ GMBH
86 CEFADROXILUMJ01DB05
1000mgJ01DB05 CEFADROXILUM COMPR. FILM.CEXYL 1000 mg 1000mg SANDOZ S.R.L.
125mg/5mlJ01DB05 CEFADROXILUM GRAN. PT. SUSP. ORALACEXYL 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.
250mgJ01DB05 CEFADROXILUM CAPS.CEXYL 250 mg 250mg SANDOZ S.R.L.
250mg/5mlJ01DB05 CEFADROXILUM GRAN. SUSP. ORALACEXYL 250 mg/5 ml 250mg/5ml SANDOZ S.R.L.
500mgJ01DB05 CEFADROXILUM CAPS.CEFADROXIL 500mg OZONE LABORATORIES LTD.
CEFADROXIL TERAPIA 500mg TERAPIA S.A.
CEFORAN® 500 mg 500mg ANTIBIOTICE SA
CEXYL 500 mg 500mg SANDOZ S.R.L.
500mg/5mlJ01DB05 CEFADROXILUM GRAN. SUSP. ORALACEXYL 500 mg/5 ml 500mg/5ml SANDOZ S.R.L.
87 CEFUROXIMUMJ01DC02
125mgJ01DC02 CEFUROXIMUM COMPR. ACOPERITEAXYCEF® 125 125mg SANDOZ SRL
125mgJ01DC02 CEFUROXIMUM COMPR. FILM.ZINNAT® 125 mg 125mg GLAXOWELLCOME UK LTD.
125mg/5mlJ01DC02 CEFUROXIMUM GRAN. PT. SUSP. ORALACEROXIM 125mg/5ml 125mg/5ml RANBAXY UK LIMITED
ZINNAT 125mg/5ml GLAXO WELLCOME UK LTD.
125mg/5mlJ01DC02 CEFUROXIMUM PULB. PT. SUSP. ORALAAXYCEF® 125 mg/5 ml 125mg/5ml SANDOZ SRL
250mgJ01DC02 CEFUROXIMUM COMPR.CEROXIM 250 mg 250mg RANBAXY U.K. LIMITED
250mgJ01DC02 CEFUROXIMUM COMPR. ACOPERITEAXYCEF® 250 250mg SANDOZ SRL
250mgJ01DC02 CEFUROXIMUM COMPR. FILM.ZINNAT® 250 mg 250mg GLAXOWELLCOME UK LTD.
250mg/5mlJ01DC02 CEFUROXIMUM GRAN. PT. SUSP. ORALACEROXIM 250mg/5ml 250mg/5ml RANBAXY UK LIMITED
500mgJ01DC02 CEFUROXIMUM COMPR.CEROXIM 500 mg 500mg RANBAXY U.K. LIMITED
500mgJ01DC02 CEFUROXIMUM COMPR. ACOPERITEAXYCEF® 500 500mg SANDOZ SRL
500mgJ01DC02 CEFUROXIMUM COMPR. FILM.ZINNAT® 500 mg 500mg GLAXOWELLCOME UK LTD.
88 CEFACLORUMJ01DC04Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
125mg/5mlJ01DC04 CEFACLORUM GRAN. PT. SUSP. ORALACECLODYNE 125 mg/5 ml 125mg/5ml SANDOZ SRL
CECLOR® 125 mg/5 ml 125mg/5ml ACTAVIS GROUP HF
CEFACLOR 125 mg/5ml 125mg/5ml OZONE LABORATORIES LTD.
VERCEF 125 mg/5 ml 125mg/5ml TERAPIA S.A.
125mg/5mlJ01DC04 CEFACLORUM PULB. PT. SUSP. ORALACEFAKLOR 125 mg/5 ml 125mg/5ml HEMOFARM S.R.L.
CLORACEF® 125 125mg/5ml DAR AL DAWA PHARMA S.R.L
250mgJ01DC04 CEFACLORUM CAPS.CECLODYNE 250 mg 250mg SANDOZ SRL
CEFACLOR 250 mg 250mg OZONE LABORATORIES LTD.
CLORACEF® 250 250mg DAR AL DAWA PHARMA S.R.L
MEDOCLOR 250 250mg MEDOCHEMIE LTD.
250mg/5mlJ01DC04 CEFACLORUM GRAN. PT. SUSP. ORALACECLODYNE 250 mg/ 5 ml 250mg/5ml SANDOZ SRL
CECLOR® 250 mg/5 ml 250mg/5ml ACTAVIS GROUP HF
CEFACLOR 250 mg/5ml 250mg/5ml OZONE LABORATORIES LTD.
250mg/5mlJ01DC04 CEFACLORUM PULB. PT. SUSP. ORALACEC HEXAL FORTE 250mg/5ml 250mg/5ml HEXAL AG
CEFAKLOR 250 mg/5 ml 250mg/5ml HEMOFARM S.R.L.
CLORACEF® 250 250mg/5ml DAR AL DAWA PHARMA S.R.L
375mgJ01DC04 CEFACLORUM COMPR. ELIB. PREL.CECLOR® MR 375mg ACTAVIS GROUP HF
17 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CECLOZONE MR 375 mg 375mg OZONE LABORATORIES LTD.
375mgJ01DC04 CEFACLORUM COMPR. FILM. ELIB. MODIF.CECLODYNE® MR 375 mg 375mg SANDOZ SRL
500mgJ01DC04 CEFACLORUM CAPS.CECLODYNE FORTE 500 mg 500mg SANDOZ SRL
CEFACLOR 500 mg 500mg OZONE LABORATORIES LTD.
CLORACEF® FORTE 500 500mg DAR AL DAWA PHARMA S.R.L
MEDOCLOR 500 500mg MEDOCHEMIE LTD.
500mgJ01DC04 CEFACLORUM COMPR. ELIB. PREL.CECLOR® MR 500mg ACTAVIS GROUP HF
500mgJ01DC04 CEFACLORUM COMPR. FILM. ELIB. MODIF.CECLODYNE® MR 500 mg 500mg SANDOZ SRL
750mgJ01DC04 CEFACLORUM COMPR. ELIB. PREL.CECLOR® MR 750mg ACTAVIS GROUP HF
CECLOZONE MR 750 mg 750mg OZONE LABORATORIES LTD.
750mgJ01DC04 CEFACLORUM COMPR. FILM. ELIB. MODIF.CECLODYNE® MR 750 mg 750mg SANDOZ SRL
89 CEFIXIMUMJ01DD08
100mg/5mlJ01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALASUPRAX 100mg/5ml GEDEON RICHTER LTD.
200mgJ01DD08 CEFIXIMUM CAPS.EFICEF® 200 mg 200mg ANTIBIOTICE SA
200mgJ01DD08 CEFIXIMUM COMPR. FILM.SUPRAX 200mg GEDEON RICHTER LTD.
90 SULFAMETHOXAZOLUM + TRIMETHOPRIMUMJ01EE01Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mg/40mg
/5ml
J01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SUSP. ORALA
EPITRIM 200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.
25mg/5mg/mlJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SIROP
SUMETROLIM 25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.
400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
COMPR.
BISEPTRIM 400mg/80mg EUROPHARM SA
CO - TRIM ELL 400mg/80mg ARENA GROUP S.A.
SUMETROLIM 400mg/80mg EGIS PHARMACEUTICALS P.L.C.
TAGREMIN 400mg/80mg ZENTIVA S.A.
91 ERYTHROMYCINUMJ01FA01
200mgJ01FA01 ERYTHROMYCINUM COMPR.ERITROMAGIS 200 mg 200mg ARENA GROUP SA
ERITROMICINA 200 mg 200mg ANTIBIOTICE SA
ERITROMICINA EUROPHARM 200 mg 200mg EUROPHARM SA
ERITROMICINA SANDOZ 200 mg COMPRIMATE 200mg SANDOZ S.R.L.
200mg/5mlJ01FA01 ERYTHROMYCINUM PULB. PT. SUSP. ORALAERITRO 200 200mg/5ml LEK PHARMATECH SRL
92 CLARITHROMYCINUMJ01FA09
125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.
KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.
KLACID® 125mg/5ml ABBOTT SPA
LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.
250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.
FROMILID 250 250mg KRKA D.D. NOVO MESTO
KLABAX 250 mg 250mg TERAPIA S.A.
KLACID® 250mg ABBOTT SPA
KLERIMED® 250 250mg MEDOCHEMIE LTD.
LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.
250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.
LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.
FROMILID 500 500mg KRKA D.D. NOVO MESTO
KLABAX 500 mg 500mg TERAPIA S.A.
KLERIMED® 500 500mg MEDOCHEMIE LTD.
LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.
LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.
KLACID SR 500mg ABBOTT LABORATORIES LTD.
93 OFLOXACINUMJ01MA01
200mgJ01MA01 OFLOXACINUM COMPR. FILM.OFLOXACIN 200 mg 200mg ANTIBIOTICE SA
OFLOXIN 200 200mg ZENTIVA AS
ZANOCIN 200mg RANBAXY UK LIMITED
18 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
400mgJ01MA01 OFLOXACINUM COMPR. FILM. ELIB. PREL.ZANOCIN® OD 400 400mg RANBAXY U.K. LIMITED
94 CIPROFLOXACINUMJ01MA02
250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA
250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED
CIPHIN 250 250mg ZENTIVA A.S.
CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO
CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.
CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.
CIPROLEN® 250 mg 250mg AC HELCOR SRL
CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES
CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.
CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA
500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED
CIPHIN 500 500mg ZENTIVA A.S.
CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO
CIPRO QUIN® 500mg ANTIBIOTICE SA
CIPROBAY® 500 500mg BAYER HEALTHCARE AG
CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.
CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L
CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.
CIPROLEN® 500 mg 500mg AC HELCOR SRL
CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES
CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.
CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA
SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS
750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO
95 PEFLOXACINUMJ01MA03
400mgJ01MA03 PEFLOXACINUM COMPR. FILM.PEFLOXACIN LAROPHARM 400mg LAROPHARM S.R.L.
96 NORFLOXACINUMJ01MA06
Prescriere limitata: Enterocolita bacteriana.
Infectii de tract urinar.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
400mgJ01MA06 NORFLOXACINUM COMPR. FILM.EPINOR 400mg E.I.P.I.CO. MED S.R.L.
H - NORFLOXACIN 400 mg 400mg AC HELCOR SRL
NOLICIN 400 mg 400mg KRKA D.D. NOVO MESTO
NORFLOX - 400 400mg LEK PHARMATECH SRL
NORFLOXACIN 400 mg 400mg OZONE LABORATORIES LTD.
NORFLOXACIN OZONE 400 mg 400mg OZONE LABORATORIES LTD.
NORFLOXACINA LPH 400 mg 400mg LABORMED PHARMA SA
97 ACIDUM NALIDIXICUMJ01MB02
500mgJ01MB02 ACIDUM NALIDIXICUM CAPS.NALIXID 500 mg 500mg ZENTIVA SA
98 METRONIDAZOLUMJ01XD01
Prescriere limitata: Tratamentul infectiilor cu anaerobi.
Tratamentul infectiilor cu protozoare sensibile la metronidazol.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgJ01XD01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (J01XD01) 250mg ARENA GROUP SA
250mgJ01XD01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS
4%J01XD01 METRONIDAZOLUM SUSP. ORALAFLAGYL 4 % (J01XD01) 4% LABORATOIRE AVENTIS
99 TINIDAZOLUMJ01XD02
Prescriere limitata: Tratamentul infectiilor cu anaerobi.
Tratamentul infectiilor cu protozoare sensibile la tinidazol.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
500mgJ01XD02 TINIDAZOLUM COMPR. FILM.FASIGYN (J01XD02) 500mg PFIZER EUROPE MA EEIG
TINIZOL® 500 mg (J01XD02) 500mg ZENTIVA S.A.
TIPROGYN 500 500mg AC HELCOR SRL
100 KETOCONAZOLUMJ02AB02
Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade.
Tratamentul candidozelor muco-cutanate cronice si candidozelor orofaringiene care nu pot fi tratate cu antifungice locale, la pacientii care prezinta rezistenta sau
intoleranta la fluconazol si intraconazol
Micoze sistemice la care alte forme de terapie antifungica nu au avut efect.
A fost raportată hepatotoxicitate la ketoconazol.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA
KETOCONAZOL 200 mg 200mg MAGISTRA C & C
KETOSTIN 200 mg 200mg AC HELCOR SRL
NIZORAL 200mg JANSSEN PHARMACEUTICA NV
NIZORAL 200 mg 200mg TERAPIA SA
101 FLUCONAZOLUMJ02AC01
19 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Prescriere limitata: Candidoze genitale.
Candidoze ale mucoaselor orofaringiene, esofargiene, bronhopulmonare non-invazive.
Infectii cu candida ale pielii.
Candidoze sistemice.
Profilaxia candidozelor la pacientii cu risc aflati in tratament cu antibiotic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg SLAVIA PHARM SRL
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
102 ACICLOVIRUMJ05AB01
Prescriere limitata: Herpes genital.
Tratamentul episodic sau supresiv al herpesului genital recurent.
Herpes cutanat initial moderat/sever.
Tratamentul episodic sau supresiv al herpesului cutanat recurent (forme moderate/severe).
Herpes zoster.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg SLAVIA PHARM SRL
EUVIROX 200 mg 200mg EUROPHARM SA
200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA
CLOVIRAL 200 mg 200mg ANTIBIOTICE SA
ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.
200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.
LOVIR 200 mg 200mg RANBAXY UK LIMITED
250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO
400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.
400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.
400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.
103 AMINOGLUTETHIMIDUML02BG01
250mgL02BG01 AMINOGLUTETHIMIDUM COMPR.ROGLUTEN® 250 mg 250mg ACTAVIS S.R.L.
104 INDOMETACINUMM01AB01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale
50mgM01AB01 INDOMETACINUM SUPOZ.INDOMETACIN 50 mg 50mg MAGISTRA C & C
105 DICLOFENACUMM01AB05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM01AB05 DICLOFENACUM COMPR. FILM. ELIB. PREL.DICLOTARD® 100 mg 100mg TERAPIA SA
REFEN® RETARD 100mg HEMOFARM S.R.L.
VOLTAREN® RETARD 100mg NOVARTIS PHARMA GMBH
100mgM01AB05 DICLOFENACUM SUPOZ.CLAFEN 100 mg 100mg ANTIBIOTICE SA
DICLOFENAC 100 mg 100mg SINTOFARM SA
20 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
DICLOFENAC SODIC 100 mg 100mg MAGISTRA C & C
DICLOGESIC 100 SUPOZITOARE 100mg DAR AL DAWA PHARMA SRL
EPIFENAC 100mg E.I.P.I.CO. MED S.R.L.
VOLTAREN® 100mg NOVARTIS PHARMA GMBH
120mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 120 120mg GEROT PHARMAZEUTIKA GMBH
150mgM01AB05 DICLOFENACUM CAPS. ELIB. PREL.DICLOREUM 150 mg 150mg ALFA WASSERMANN SPA
25mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.RHEUMAVEK 25mg FARAN LABORATORIES S.A.
VOLTAREN® 25 25mg NOVARTIS PHARMA GMBH
25mgM01AB05 DICLOFENACUM COMPR. GASTROREZ.EPIFENAC 25mg E.I.P.I.CO. MED S.R.L.
25mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 25 mg 25mg ARENA GROUP SA
25mg/mlM01AB05 DICLOFENACUM SOL. INJ.RHEUMAVEK 25mg/ml FARAN LABORATORIES S.A.
VOLTAREN® 25mg/ml NOVARTIS PHARMA GMBH
30mg/mlM01AB05 DICLOFENACUM SOL. INJ.TRATUL® 30mg/ml GEROT PHARMAZEUTIKA GMBH
50mgM01AB05 DICLOFENACUM CAPS. GASTROREZ.TRATUL 50 50mg GEROT PHARMAZEUTIKA GMBH
50mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.CLAFEN 50 mg 50mg ANTIBIOTICE SA
DICLOFENAC 50 mg 50mg AC HELCOR PHARMA SRL
VOLTAREN® 50 50mg NOVARTIS PHARMA GMBH
50mgM01AB05 DICLOFENACUM DRAJ.VOLTAREN RAPID® 50mg NOVARTIS PHARMA GMBH
50mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 50 mg 50mg ARENA GROUP SA
50mgM01AB05 DICLOFENACUM SUPOZ.VOLTAREN® 50mg NOVARTIS PHARMA GMBH
60mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 60 60mg GEROT PHARMAZEUTIKA GMBH
75mgM01AB05 DICLOFENACUM COMPR. ELIB. MODIF.DICLAC® 75 ID 75mg HEXAL AG
75mgM01AB05 DICLOFENACUM SOL. INJ.DICLAC 75mg HEXAL AG
VURDON 75mg HELP S.A. PHARMACEUTICALS
75mg/3mlM01AB05 DICLOFENACUM SOL. INJ.ALMIRAL 75mg/3ml MEDOCHEMIE LTD.
DICLOFENAC 75 mg 75mg/3ml TERAPIA SA
DICLOFENAC AL I.M. 75mg/3ml ALIUD PHARMA GMBH & CO.KG
106 KETOROLACUM TROMETHAMINM01AB15
10mgM01AB15 KETOROLACUM TROMETHAMIN COMPR. FILM.KETANOV 10 mg 10mg TERAPIA S.A.
KETOROL 10mg DR. REDDY'S LABORATORIES
30mg/mlM01AB15 KETOROLACUM TROMETHAMIN SOL. INJ.KETANOV 30mg/ml TERAPIA S.A.
KETOROL 30mg/ml DR. REDDY'S LABORATORIES
107 ACECLOFENACUMM01AB16
Prescriere limitata: Tratamentul simptomatic al puseelor de poliartrita reumatoida, osteoartrita, spondilita anchilozanta, artroza sau afectiunilor musculo-scheletale acute.
A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM01AB16 ACECLOFENACUM COMPR. FILM.AFLAMIL 100mg GEDEON RICHTER PLC.
108 TENOXICAMUMM01AC02A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mgM01AC02 TENOXICAMUM CAPS.TENOXICAM LPH 20 mg 20mg LABORMED PHARMA SA
20mgM01AC02 TENOXICAMUM COMPR.TENOXICAM 20 mg 20mg ARENA GROUP SA
20mgM01AC02 TENOXICAMUM COMPR. FILM.NEO - ENDUSIX® 20mg ANFARM HELLAS S.A. PHARMACEUTICALS
TILCOTIL 20mg ROCHE ROMANIA S.R.L.
20mgM01AC02 TENOXICAMUM LIOF. + SOLV. PT. SOL. INJ.NEO - ENDUSIX® 20mg ANFARM HELLAS S.A. PHARMACEUTICALS
20mgM01AC02 TENOXICAMUM LIOF. SI SOLV.PT.SOL.INJTILCOTIL 20mg ROCHE ROMANIA S.R.L.
109 MELOXICAMUMM01AC06A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
15mgM01AC06 MELOXICAMUM COMPR.CELOMIX 15mg ACTAVIS GROUP HF.
MELARTRIN 15 mg 15mg TERAPIA SA
MELOX 15 mg 15mg MEDOCHEMIE LTD
MELOXICAM 15 mg 15mg VIM SPECTRUM SRL
MELOXICAM LPH 15 mg 15mg LABORMED PHARMA SA
MELOXICAM MCC 15 mg 15mg MAGISTRA C & C SRL
MELOXICAM SANDOZ 15 mg 15mg HEXAL AG
MOVALIS® 15 mg 15mg BOEHRINGER INGELHEIM INT. GMBH
21 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
RECOXA 15 15mg ZENTIVA AS
15mgM01AC06 MELOXICAMUM SUPOZ.MELOXICAM 15 mg 15mg MAGISTRA C & C
MOVALIS® 15 mg 15mg BOEHRINGER INGELHEIM INT. GMBH
15mg/1.5mlM01AC06 MELOXICAMUM SOL. INJ.MOVALIS® 15mg/1.5ml BOEHRINGER INGELHEIM INT. GMBH
7.5 mgM01AC06 MELOXICAMUM COMPR.MELOX 7,5 mg 7.5 mg MEDOCHEMIE LTD
7.5mgM01AC06 MELOXICAMUM COMPR.MELOXICAM 7,5 mg 7.5mg VIM SPECTRUM SRL
MELOXICAM LPH 7,5 mg 7.5mg LABORMED PHARMA SA
MELOXICAM MCC 7,5 mg 7.5mg MAGISTRA C & C SRL
MELOXICAM SANDOZ 7,5 mg 7.5mg HEXAL AG
MOVALIS® 7,5 mg 7.5mg BOEHRINGER INGELHEIM INT. GMBH
7.5mgM01AC06 MELOXICAMUM SUPOZ.MELOXICAM 7,5 mg 7.5mg MAGISTRA C & C
110 KETOPROFENUMM01AE03A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100 mgM01AE03 KETOPROFENUM COMPR. FILM.RUBIFEN 100 mg 100 mg ANTIBIOTICE SA
100mgM01AE03 KETOPROFENUM CAPS. ELIB. PREL.KETOPROFEN SR 100 mg 100mg TERAPIA SA
100mgM01AE03 KETOPROFENUM COMPR. FILM.KETONAL FORTE 100 mg 100mg LEK PHARMACEUTICALS D.D.
KETOPROXIN 100 mg 100mg AC HELCOR PHARMA SRL
PROFENID® 100 mg 100mg LAB. AVENTIS
100mgM01AE03 KETOPROFENUM LIOF. + SOLV. PT. SOL. INJ.PROFENID® 100 mg 100mg LAB. AVENTIS
100mgM01AE03 KETOPROFENUM SUPOZ.KETOMAG 100mg MAGISTRA C & C
KETONAL 100 mg 100mg LEK PHARMACEUTICALS D.D.
RUBIFEN® 100 mg 100mg ANTIBIOTICE SA
100mg/2mlM01AE03 KETOPROFENUM SOL. INJ.KETONAL 100 mg/ 2 ml 100mg/2ml LEK PHARMACEUTICALS D.D.
100mg/2mlM01AE03 KETOPROFENUM SOL. INJ./CONC. SOL. PERF.KETOPROFEN 100mg/2ml 100mg/2ml TERAPIA SA
150mgM01AE03 KETOPROFENUM CAPS. ELIB. PREL.KETONAL® DUO 150 mg 150mg SANDOZ S.R.L.
150mgM01AE03 KETOPROFENUM COMPR. ELIB. PREL.KETONAL RETARD 150mg LEK PHARMACEUTICALS D.D.
200mgM01AE03 KETOPROFENUM CAPS. ELIB. PREL.KETALGON 200 mg 200mg NOVIA FARM SOLUTIONS SRL
KETONAL UNO 200mg SANDOZ S.R.L.
KETOPROFEN SR 200 mg 200mg TERAPIA SA
200mgM01AE03 KETOPROFENUM COMPR. FILM. ELIB. PREL.PROFENID® LP 200 mg 200mg LAB. AVENTIS
50mgM01AE03 KETOPROFENUM COMPR. FILM.KETOPROXIN 50 mg 50mg AC HELCOR PHARMA SRL
111 TETRAZEPAMUMM03BX07
50mgM03BX07 TETRAZEPAMUM COMPR. FILM.MYOLASTAN® 50 mg 50mg SANOFI-SYNTHELABO FRANCE
112 ALLOPURINOLUM *M04AA01
Doza trebuie ajustata in concordanta cu functia renala.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM04AA01 ALLOPURINOLUM COMPR.MILURIT 100 mg 100mg EGIS PHARMACEUTICALS LTD.
300mgM04AA01 ALLOPURINOLUM COMPR.MILURIT 300 mg 300mg EGIS PHARMACEUTICALS LTD.
113 COLCHICINUMM04AC01
1mgM04AC01 COLCHICINUM COMPR.COLCHICINA 1mg BIOFARM SA
114 PENTAZOCINUMN02AD01
Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCIului.
30mg/mlN02AD01 PENTAZOCINUM SOL. INJ.FORTRAL 30mg/ml KRKA D.D. NOVO MESTO
FORTWIN® 30mg/ml TERAPIA S.A.
50mgN02AD01 PENTAZOCINUM COMPR.FORTRAL 50 mg 50mg KRKA D.D. NOVO MESTO
115 TRAMADOLUMN02AX02
Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.
Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice (mai putin formele injectabile) si concentratiilor corespunzatoare DCI-ului.
100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG
100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 100 100mg ZENTIVA AS
TRAMADOL® RETARD 100mg KRKA D.D.
100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH
22 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.
TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
TRAMADOL 100mg KRKA D.D.
TRAMAG 100 100mg MAGISTRA C & C
TRAMAL® 100mg GRUNENTHAL GMBH
100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.
100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH
150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS
150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH
200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 200 200mg ZENTIVA AS
200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH
50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA
MABRON 50 mg 50mg MEDOCHEMIE LTD.
TRALGIT 50 50mg ZENTIVA A.S.
TRAMACALM 50mg AC HELCOR SRL
TRAMADOL 50mg KRKA D.D.
TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA
TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG
TRAMADOL ARENA 50mg ARENA GROUP S.A.
TRAMAL® 50mg GRUNENTHAL GMBH
URGENDOL 50mg MEDICAROM GROUP SRL
50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.
TRAMADOL EEL 50mg BIO EEL SRL
TRAMAG 50 50mg MAGISTRA C & C
50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.
TRAMADOL 50mg/ml KRKA D.D.
TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG
TRAMAL® 100 50mg/ml GRUNENTHAL GMBH
TRAMAL® 50 50mg/ml GRUNENTHAL GMBH
URGENDOL 50mg/ml MEDICAROM GROUP SRL
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG
100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH
116 SUMATRIPTANUM *N02CC01
Prescriere limitata: Atacurile de migrena la pacientii care primesc sau au primit medicatie profilactica si la care crizele migrenoase nu au raspuns la tratamentul oral cu ergotamina sau
alte medicamente antimigrenoase, sau la care aceste medicamente sunt contraindicate.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgN02CC01 SUMATRIPTANUM COMPR.SUMIGRA 100 mg 100mg SANDOZ S.R.L.
100mgN02CC01 SUMATRIPTANUM COMPR. FILM.IMIGRAN® 100 100mg GLAXO WELLCOME UK LTD.
SUMACTA 100 mg 100mg ACTAVIS GROUP PTC EHF.
SUMATRIPTAN 100mg DR. REDDY'S LABORATORIES
50mgN02CC01 SUMATRIPTANUM COMPR.SUMIGRA 50 mg 50mg SANDOZ S.R.L.
50mgN02CC01 SUMATRIPTANUM COMPR. FILM.IMIGRAN® 50 50mg GLAXO WELLCOME UK LTD.
SUMACTA 50 mg 50mg ACTAVIS GROUP PTC EHF.
SUMATRIPTAN 50mg DR. REDDY'S LABORATORIES
117 CARBAMAZEPINUM Protocol: N025GN03AF01
100mg/5mlN03AF01 CARBAMAZEPINUM SUSP. ORALATIMONIL SIROP 100mg/5ml DESITIN ARZNEIMITTEL GMBH
150mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 150 RETARD 150mg DESITIN
200mgN03AF01 CARBAMAZEPINUM COMPR.CARBAMAZEPIN 200mg SLAVIA PHARM SRL
CARBAMAZEPIN EEL 200mg BIO EEL SRL
CARBAMAZEPINA 200mg OZONE LABORATORIES LTD.
23 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CARBAMAZEPINA ARENA 200 mg 200mg ARENA GROUP SA
CARBAMAZEPINA LPH 200 mg 200mg LABORMED PHARMA SA
CARBAVIM 200mg VIM SPECTRUM SRL
CARBEPSIL 200 200mg AC HELCOR SRL
FINLEPSIN 200mg AWD PHARMA GMBH & CO.KG
NEUROTOP 200mg GEROT PHARMAZEUTIKA GMBH
TAVER 200mg MEDOCHEMIE LTD.
TEGRETOL® 200 200mg NOVARTIS PHARMA GMBH
200mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 200 200mg NOVARTIS PHARMA GMBH
300mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 300 mg 300mg GEROT PHARMAZEUTIKA GMBH
300mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 300 RETARD 300mg DESITIN
400mgN03AF01 CARBAMAZEPINUM COMPR.CARBEPSIL 400 400mg AC HELCOR SRL
TEGRETOL® 400 400mg NOVARTIS PHARMA GMBH
400mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 400 400mg NOVARTIS PHARMA GMBH
400mgN03AF01 CARBAMAZEPINUM COMPR. RET.FINLEPSIN 400 RETARD 400mg AWD PHARMA GMBH & CO.KG
600mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 600 mg 600mg GEROT PHARMAZEUTIKA GMBH
600mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 600 RETARD 600mg DESITIN
200mgN03AF01 CARBAMAZEPINUM COMPR.FILM.ELIB.PRELFINLEPSIN 200 RETARD 200mg AWD PHARMA GMBH & CO.KG
118 GABAPENTINUM Protocol: N025GN03AX12
100mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 100 mg 100mg WORWAG PHARMA GMBH & CO. KG
GABALEPT 100 mg 100mg PLIVA LJUBLJANA D.O.O.
300mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 300 mg 300mg WORWAG PHARMA GMBH & CO. KG
GABALEPT 300 mg 300mg PLIVA LJUBLJANA D.O.O.
GABARAN 300 mg 300mg RANBAXY UK LTD.
400mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 400 mg 400mg WORWAG PHARMA GMBH & CO. KG
GABALEPT 400 mg 400mg PLIVA LJUBLJANA D.O.O.
GABARAN 400 mg 400mg RANBAXY UK LTD.
600mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 600 mg 600mg RANBAXY UK LTD.
800mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 800 mg 800mg RANBAXY UK LTD.
119 HALOPERIDOLUMN05AD01
50mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL DECANOAT 50mg/ml GEDEON RICHTER LTD.
5mgN05AD01 HALOPERIDOLUM COMPR.HALDOL 5mg JANSSEN PHARMACEUTICA NV
5mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL 5 mg/ml 5mg/ml GEDEON RICHTER LTD.
2mg/mlN05AD01 HALOPERIDOLUM PIC. ORALE-SOL.HALOPERIDOL 2 mg/ml 2mg/ml GEDEON RICHTER ROMANIA SA
2mg/mlN05AD01 HALOPERIDOLUM PICATURI ORALE-SOL.HALOPERIDOL 2mg/ml TERAPIA SA
120 DIAZEPAMUMN05BA01
Diazepamum este utilizat ca agent anxiolitic, anticonvulsivant si relaxant muscular de tip central. In tratamentul anxietatii se utilizeaza ca sedativ in anxietatea acuta de tip sever
cat si in tratamentul agitatiei asociata cu delirium tremens.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgN05BA01 DIAZEPAMUM COMPR.DIAZEPAM 10mg TERAPIA SA
DIAZEPAM 10 mg 10mg GEDEON RICHTER ROMANIA SA
10mg/2.5mlN05BA01 DIAZEPAMUM SOL. RECTALADIAZEPAM DESITIN® SOLUTIE RECTALA 10 mg 10mg/2.5ml DESITIN
10mg/2mlN05BA01 DIAZEPAMUM SOL. INJ.DIAZEPAM 10 mg 10mg/2ml TERAPIA SA
5mg/2.5mlN05BA01 DIAZEPAMUM SOL. RECTALADIAZEPAM DESITIN® SOLUTIE RECTALA 5 mg 5mg/2.5ml DESITIN
121 MEDAZEPAMUM *N05BA03
10 mgN05BA03 MEDAZEPAMUM COMPR.MEDAZEPAM 10 mg ARENA GROUP SA
10mgN05BA03 MEDAZEPAMUM CAPS.ANSILAN 10 mg 10mg LEK PHARMACEUTICALS D.D.
10mgN05BA03 MEDAZEPAMUM COMPR.MEDAZEPAM 10 mg 10mg LABORMED PHARMA SA
RUDOTEL 10mg AWD PHARMA GMBH & CO.KG
122 LORAZEPAMUM *N05BA06
1 mgN05BA06 LORAZEPAMUM COMPR.ANXIAR® 1 mg 1 mg GEDEON RICHTER ROMANIA SA
123 BROMAZEPAMUM *N05BA08
1.5mgN05BA08 BROMAZEPAMUM COMPR.BROMAZEPAM LPH 1,5 mg 1.5mg LABORMED PHARMA SA
24 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CALMEPAM® 1.5mg GLAXOSMITHKLINE (GSK) SRL
3mgN05BA08 BROMAZEPAMUM COMPR.BROMAZEPAM LPH 3 mg 3mg LABORMED PHARMA SA
CALMEPAM® 3mg GLAXOSMITHKLINE (GSK) SRL
LEXOTAN 3mg ROCHE ROMANIA S.R.L.
LEXOTANIL 3mg TERAPIA S.A.
124 ALPRAZOLAMUM *N05BA12
Prescriere limitata: Tulburari de panica, in cazul esecului la tratamente similare.
Pentru tratamentul de scurta durata al anxietatii moderate sau severe si al anxietatii asociate cu depresia.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0,25mgN05BA12 ALPRAZOLAMUM COMPR.XANAX 0,25 mg 0,25mg PFIZER EUROPE MA EEIG
0,5mgN05BA12 ALPRAZOLAMUM COMPR.XANAX 0,5 mg 0,5mg PFIZER EUROPE MA EEIG
0.25mgN05BA12 ALPRAZOLAMUM COMPR.ALPRAZOLAM LPH® 0,25 mg 0.25mg LABORMED PHARMA SA
FRONTIN 0,25 mg 0.25mg EGIS PHARMACEUTICALS PLC
PRAZOLEX® 0,25 mg 0.25mg GEDEON RICHTER ROMANIA SA
0.5mgN05BA12 ALPRAZOLAMUM COMPR.ALPRAZOLAM LPH® 0,5 mg 0.5mg LABORMED PHARMA SA
FRONTIN 0,5 mg 0.5mg EGIS PHARMACEUTICALS PLC
PRAZOLEX® 0,5 mg 0.5mg GEDEON RICHTER ROMANIA SA
0.5mgN05BA12 ALPRAZOLAMUM COMPR. ELIB. PREL.NEUROL® SR 0,5 0.5mg ZENTIVA AS
1mgN05BA12 ALPRAZOLAMUM COMPR.ALPRAZOLAM LPH® 1 mg 1mg LABORMED PHARMA SA
FRONTIN 1mg EGIS PHARMACEUTICALS PLC
PRAZOLEX® 1 mg 1mg GEDEON RICHTER ROMANIA SA
XANAX 1 mg 1mg PFIZER EUROPE MA EEIG
1mgN05BA12 ALPRAZOLAMUM COMPR. ELIB. PREL.NEUROL® SR 1 1mg ZENTIVA AS
2mgN05BA12 ALPRAZOLAMUM COMPR.XANAX 2 mg 2mg PFIZER EUROPE MA EEIG
2mgN05BA12 ALPRAZOLAMUM COMPR. ELIB. PREL.NEUROL® SR 2 2mg ZENTIVA AS
125 NITRAZEPAMUMN05CD02
Cod restrictie 3007: Tratamentul de scurta durata al insomniei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2.5mgN05CD02 NITRAZEPAMUM COMPR.NITRAZEPAM LPH® 2,5 mg 2.5mg LABORMED PHARMA SA
5mgN05CD02 NITRAZEPAMUM COMPR.NITRAZEPAM 5 mg 5mg GEDEON RICHTER ROMANIA SA
NITRAZEPAM LPH® 5 mg 5mg LABORMED PHARMA SA
5mgN05CD02 NITRAZEPAMUM COMPR.NITRAZEPAM 5 mg 5mg GEDEON RICHTER ROMANIA SA
NITRAZEPAM LPH® 5 mg 5mg LABORMED PHARMA SA
126 ZOPICLONUM *N05CF01
Cod restrictie 3007: Pentru tratamentul de scurta durata al insomniei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
7.5mgN05CF01 ZOPICLONUM COMPR. FILM.ALS-ZOPICLON 7,5 mg 7.5mg ALSIFCOM INTERMED SRL
IMOVANE 7,5 mg 7.5mg SANOFI AVENTIS
127 ZOLPIDEMUM *N05CF02
Cod restrictie 3007: Pentru tratamentul de scurta durata al insomniei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgN05CF02 ZOLPIDEMUM COMPR. FILM.HYPNOGEN 10 mg 10mg ZENTIVA AS
LADINOX 10mg GEDEON RICHTER ROMANIA S.A.
SANVAL® 10 mg 10mg LEK PHARMACEUTICALS D.D.
ZOLPIDEM 10 mg 10mg LABORMED PHARMA SA
ZOLPIDEM ANTIBIOTICE 10 mg 10mg ANTIBIOTICE S.A.
128 CLOMIPRAMINUM *N06AA04
Prescriere limitata: Tratamentul simptomatic al depresiei in special atunci cand este necesara sedarea.
Tratamentul starilor fobice si obsesiv-compulsive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgN06AA04 CLOMIPRAMINUM DRAJ.ANAFRANIL® 10 mg 10mg NOVARTIS PHARMA GMBH
25mgN06AA04 CLOMIPRAMINUM DRAJ.ANAFRANIL® 25 mg 25mg NOVARTIS PHARMA GMBH
129 AMITRIPTYLINUM *N06AA09
25mgN06AA09 AMITRIPTYLINUM CAPS. RET.AMITRIPTILIN 25 R. DESITIN 25mg DESITIN
25mgN06AA09 AMITRIPTYLINUM COMPR. FILM.AMITRIPTILINA ARENA 25 mg 25mg ARENA GROUP S.A.
50mgN06AA09 AMITRIPTYLINUM CAPS. RET.AMITRIPTILIN 50 R. DESITIN 50mg DESITIN
130 DOXEPINUM *N06AA12
25mgN06AA12 DOXEPINUM DRAJ.DOXEPIN 25 mg 25mg TERAPIA SA
131 FLUOXETINUM *N06AB03
25 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Prescriere limitata: Tratamentul depresiilor cu sau fara anxietate in special cand componenta de sedare nu este necesara.
Tratamentul bulimiei nervoase.
Tratamentul tulburarilor obsesiv compulsive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mgN06AB03 FLUOXETINUM CAPS.FLUOXETINE 20 mg 20mg DR. REDDY'S LABORATORIES
FLUOXIN 20mg VIM SPECTRUM SRL
FLURAN 20mg RANBAXY U.K. LIMITED
MAGRILAN 20 mg 20mg MEDOCHEMIE LTD.
20mgN06AB03 FLUOXETINUM COMPR. DISP.PROZAC 20 mg 20mg ELI LILLY SA
132 CITALOPRAMUM ** Protocol: N008FN06AB04
10mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 10 mg 10mg RANBAXY UK LIMITED
LINISAN 10 mg 10mg GEDEON RICHTER ROMANIA S.A.
20mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 20mg 20mg RANBAXY UK LIMITED
LINISAN 20 mg 20mg GEDEON RICHTER ROMANIA S.A.
40mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 40 mg 40mg RANBAXY UK LIMITED
LINISAN 40 mg 40mg GEDEON RICHTER ROMANIA S.A.
133 PAROXETINUM *N06AB05
Prescriere limitata: Tratamentul tulburarilor depresive majore.
Tratamentul tulburarilor obsesiv-compulsive.
Tratamentul atacurilor de panica.
Tratamentul anxietatii.
Tratamentul fobiei sociale.
Tratamentul bolii de stres posttraumatic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mgN06AB05 PAROXETINUM COMPR.ARKETIS 20mg MEDOCHEMIE LTD.
20mgN06AB05 PAROXETINUM COMPR. FILM.ALS-PAROXETIN 20 mg 20mg ALSIFCOM INTERMED SRL
PALUXETIL 20 mg 20mg HEXAL AG
PAXETEN 20 mg 20mg ACTAVIS GROUP HF.
REXETIN 20mg GEDEON RICHTER PLC.
SEROXAT 20 mg 20mg SMITHKLINE BEECHAM PLC
40mgN06AB05 PAROXETINUM COMPR. FILM.PALUXETIL 40 mg 40mg HEXAL AG
134 SERTRALINUM *N06AB06
Prescriere limitata: Tratamentul tulburarilor depresive inclusiv cu componenta anxioasa.
Tratamentul tulburari obsesiv-compulsive.
Tratamentul atacurilor de panica.
Tratamentul fobiei sociale.
Tratamentul bolii de stres posttraumatic.
Eficienta tratamentului in boala de stres posttraumatic a fost demonstrata doar pentru sexul feminin.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgN06AB06 SERTRALINUM COMPR. FILM.ALS-SERTRALINA 100 mg 100mg ALSIFCOM INTERMED SRL
ASENTRA® 100mg KRKA D.D.
SERLIFT 100 mg 100mg TERAPIA S.A.
SERTRALIN SANDOZ 100 mg 100mg HEXAL AG
SERTRALINA 100 mg 100mg ARENA GROUP S.A.
SERTRALINA DR. REDDY'S 100 mg 100mg DR. REDDY'S LABORATORIES
STIMULOTON® 100 mg 100mg EGIS PHARMACEUTICALS LTD.
20mg/mlN06AB06 SERTRALINUM SOL. ORALAZOLOFT® 20mg/ml PFIZER EUROPE MA EEIG
50mgN06AB06 SERTRALINUM COMPR. FILM.ALS-SERTRALINA 50 mg 50mg ALSIFCOM INTERMED SRL
ASENTRA® 50mg KRKA D.D.
SERLIFT 50 mg 50mg TERAPIA S.A.
SERTRALIN 50 mg 50mg OZONE LABORATORIES LTD.
SERTRALIN SANDOZ 50 mg 50mg HEXAL AG
SERTRALINA 50 mg 50mg ARENA GROUP SA
SERTRALINA DR. REDDY'S 50 mg 50mg DR. REDDY'S LABORATORIES
STIMULOTON® 50 mg 50mg EGIS PHARMACEUTICALS LTD.
ZOLOFT 50 mg 50mg PFIZER EUROPE MA EEIG
135 FLUVOXAMINUM *N06AB08
Prescriere limitata: Tratamentul tulburarilor depresive majore.
Tratamentul tulburarilor obsesiv-compulsive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgN06AB08 FLUVOXAMINUM COMPR. FILM.FEVARIN® 100 100mg SOLVAY PHARMACEUTICALS BV
FLUVOXAMINE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
50mgN06AB08 FLUVOXAMINUM COMPR. FILM.FEVARIN® 50 50mg SOLVAY PHARMACEUTICALS BV
FLUVOXAMINE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
136 MIANSERINUM *N06AX03
10mgN06AX03 MIANSERINUM COMPR. FILM.MIANSERIN 10 10mg REMEDICA LTD.
10mgN06AX03 MIANSERINUM DRAJ.MIANSERIN 10 mg 10mg TERAPIA SA
26 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
30mgN06AX03 MIANSERINUM COMPR. FILM.MIANSERIN 30 30mg REMEDICA LTD.
30mgN06AX03 MIANSERINUM DRAJ.MIANSERIN 30 mg 30mg TERAPIA SA
137 MIRTAZAPINUM *N06AX11
Prescriere limitata: Tratamentul episoadelor depresive majore.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
15mgN06AX11 MIRTAZAPINUM COMPR. DISP.REMERON® SOLTAB 15 mg 15mg ORGANON NV
15mgN06AX11 MIRTAZAPINUM COMPR. FILM.ESPRITAL® 15 15mg ZENTIVA AS
MIRZATEN® 15 mg 15mg KRKA D.D.
30mgN06AX11 MIRTAZAPINUM COMPR. DISP.REMERON® SOLTAB 30 mg 30mg ORGANON NV
30mgN06AX11 MIRTAZAPINUM COMPR. FILM.ESPRITAL® 30 30mg ZENTIVA AS
MIRTAZAPINE-TEVA 30 mg 30mg TEVA PHARMACEUTICALS SRL
MIRZATEN® 30 mg 30mg KRKA D.D.
PHARMATAZ 30 mg 30mg ACTAVIS GROUP HF.
45mgN06AX11 MIRTAZAPINUM COMPR. DISP.REMERON® SOLTAB 45 mg 45mg ORGANON NV
45mgN06AX11 MIRTAZAPINUM COMPR. FILM.ESPRITAL® 45 45mg ZENTIVA AS
MIRZATEN® 45 mg 45mg KRKA D.D.
138 VENLAFAXINUM ** Protocol: N013FN06AX16
150mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 150 mg 150mg WYETH LEDERLE PHARMA GMBH
VELAXIN 150 mg 150mg EGIS PHARMACEUTICALS P.L.C.
37.5mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 37,5 mg 37.5mg EGIS PHARMACEUTICALS PLC
VENLAFAXINA LPH 37,5 mg 37.5mg LABORMED PHARMA SA
75mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 75 mg 75mg WYETH LEDERLE PHARMA GMBH
VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS P.L.C.
75mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS PLC
VENLAFAXINA LPH 75 mg 75mg LABORMED PHARMA SA
139 NEOSTIGMINI BROMIDUMN07AA01
0.5mg/mlN07AA01 NEOSTIGMINI BROMIDUM SOL. INJ.MIOSTIN 0,5 mg/ml 0.5mg/ml ZENTIVA S.A.
15mgN07AA01 NEOSTIGMINI BROMIDUM COMPR.NEOSTIGMINA LPH 15 mg 15mg LABORMED PHARMA SA
140 METRONIDAZOLUMP01AB01
Prescriere limitata: Tratamentul infectiilor cu anaerobi.
Tratamentul infectiilor cu protozoare sensibile la metronidazol.
250mgP01AB01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (P01AB01) 250mg ZENTIVA SA
METRONIDAZOL 250 mg (P01AB1) 250mg ARENA GROUP SA
250mgP01AB01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS
4%P01AB01 METRONIDAZOLUM SUSP. ORALAFLAGYL 4% (P01AB01) 4% LABORATOIRE AVENTIS
141 TINIDAZOLUMP01AB02
Prescriere limitata: Tratamentul infectiilor cu anaerobi.
Tratamentul infectiilor cu protozoare sensibile la metronidazol.
500mgP01AB02 TINIDAZOLUM COMPR. FILM.FASIGYN (P01AB02) 500mg PFIZER EUROPE MA EEIG
TINIZOL® 500 mg (P01AB02) 500mg ZENTIVA S.A.
TIPROGYN 500 500mg AC HELCOR SRL
500mgP01AB02 TINIDAZOLUM COMPR. FILM.FASIGYN (P01AB02) 500mg PFIZER EUROPE MA EEIG
TINIZOL® 500 mg (J01XD02) 500mg ZENTIVA S.A.
TIPROGYN 500 500mg AC HELCOR SRL
142 ALBENDAZOLUMP02CA03
0.4g/10mlP02CA03 ALBENDAZOLUM SUSP. ORALAZENTEL 0,4 g/10 ml 0.4g/10ml GLAXOSMITHKLINE EXPORT LTD.
200mgP02CA03 ALBENDAZOLUM COMPR. FILM.DUADOR 200 mg 200mg GEDEON RICHTER ROMANIA SA
ZENTEL 200 mg 200mg GLAXOSMITHKLINE EXPORT LTD.
400mgP02CA03 ALBENDAZOLUM COMPR.ESKAZOLE 400mg GLAXO SMITHKLINE EXPORT LTD.
400mgP02CA03 ALBENDAZOLUM SUSP. ORALAALBENDAZOL BIOFARM 400 mg 400mg BIOFARM S.A.
200mgP02CA03 ALBENDAZOLUM COMPR.FILMALBENDAZOL 200mg OZONE LABORATORIES LTD.
143 LEVAMISOLUMP02CE01
150mgP02CE01 LEVAMISOLUM COMPR.DECARIS 150 mg 150mg GEDEON RICHTER ROMANIA SA
50mgP02CE01 LEVAMISOLUM COMPR.DECARIS 50 mg 50mg GEDEON RICHTER ROMANIA SA
27 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
144 SALBUTAMOLUMR03AC02
100µg/dozaR03AC02 SALBUTAMOLUM SUSP. INHAL. PRESURIZATAASTHALIN INHALER 100µg/doza CIPLA (UK) LIMITED
ECOSAL Easi-Breath 100µg/doza IVAX - PHARMACEUTICALS S.R.O.
VENTOLIN 100 INHALER CFC-FREE 100µg/doza GLAXOWELLCOME UK LTD.
5mg/mlR03AC02 SALBUTAMOLUM SOL. INHAL.VENTOLIN® 5mg/ml GLAXOWELLCOME UK LTD.
145 BECLOMETASONUM *R03BA01
100µg/dozaR03BA01 BECLOMETASONUM AEROSOL SOL. INHAL.ECOBEC 100 µg CFC FREE 100µg/doza IVAX - PHARMACEUTICALS S.R.O.
ECOBEC EASI - BREATHE 100 µg CFC FREE 100µg/doza IVAX - PHARMACEUTICALS S.R.O.
100µg/dozaR03BA01 BECLOMETASONUM SPRAY NAZ.,SUSP.RINOCLENIL 100 100µg/doza CHIESI FARMACEUTICI S.P.A.
250µg/dozaR03BA01 BECLOMETASONUM AEROSOL SOL. INHAL.ECOBEC 250 µg CFC FREE 250µg/doza IVAX - PHARMACEUTICALS S.R.O.
ECOBEC EASI - BREATHE 250 µg CFC FREE 250µg/doza IVAX - PHARMACEUTICALS S.R.O.
250µg/dozaR03BA01 BECLOMETASONUM SOL. DE INHALAT PRESURIZATABECLOFORTE® CFC-Free 250µg/doza GLAXO WELLCOME UK LTD.
250µg/dozaR03BA01 BECLOMETASONUM SOL. INHALAT PRESURIZATACLENIL® JET 250 µg 250µg/doza CHIESI FARMACEUTICI SPA
50µg/dozaR03BA01 BECLOMETASONUM SOL. DE INHALAT PRESURIZATABECOTIDE® CFC-Free 50µg/doza GLAXO WELLCOME UK LTD.
146 BUDESONIDUM *R03BA02
200 µg/dozaR03BA02 BUDESONIDUM PULB. INHAL.FRENOLYN 200 200 µg/doza MEDOCHEMIE ROMANIA SRL
200µg/dozaR03BA02 BUDESONIDUM PULB. INHAL.PULMICORT TURBUHALER 200 µg/doza 200µg/doza ASTRAZENECA AB
400 µg/dozaR03BA02 BUDESONIDUM PULB. INHAL.FRENOLYN 400 400 µg/doza MEDOCHEMIE ROMANIA SRL
147 IPRATROPII BROMIDUM *R03BB01
20µg/dozaR03BB01 IPRATROPII BROMIDUM AEROSOLIPRAVENT 20 - INHALER 20µg/doza CIPLA (UK) LIMITED
148 SALBUTAMOLUMR03CC02
0.04%R03CC02 SALBUTAMOLUM SOL. ORALASALBUTAMOL T 0.04% TIS FARMACEUTIC SA
0.5mg/mlR03CC02 SALBUTAMOLUM SOL. INJ.VENTOLIN® 0.5mg/ml GLAXO WELLCOME UK LTD.
2mg/5mlR03CC02 SALBUTAMOLUM SIROPSALBUTAMOL EIPICO 2mg/5ml 2mg/5ml E.I.P.I.CO. MED S.R.L.
VENTOLIN® 2mg/5ml GLAXOWELLCOME UK LTD.
2mg/5mlR03CC02 SALBUTAMOLUM SOL. ORALASALBUTAMOL 2mg/5ml TERAPIA S.A.
149 THEOPHYLLINUMR03DA04Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 100 mg 100mg TERAPIA SA
THEO SR 100 100mg GLAXOSMITHKLINE (GSK) SRL
200mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 200 mg 200mg TERAPIA SA
TEOTARD® 200 200mg KRKA D.D.
THEO SR 200 200mg GLAXOSMITHKLINE (GSK) SRL
300mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 300 mg 300mg TERAPIA SA
THEO SR 300 300mg GLAXOSMITHKLINE (GSK) SRL
350mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOTARD® 350 350mg KRKA D.D.
50mgR03DA04 THEOPHYLLINUM CAPS. ELIB. PREL.TEOFILINA SR 50 mg 50mg TERAPIA SA
150 CODEINUMR05DA04
15mgR05DA04 CODEINUM COMPR.CODEINA FOSFAT 15mg SLAVIA PHARM SRL
CODEINA FOSFAT 15 mg 15mg OZONE LABORATORIES LTD.
CODEINA FOSFAT LPH 15 mg 15mg LABORMED PHARMA SA
CODEINA FOSFORICA 15mg BIO EEL SRL
CODEINA FOSFORICA 15 mg 15mg MAGISTRA C & C
FARMACOD 15mg FARMACOM SA
FOSFAT DE CODEINA 15 mg 15mg SINTOFARM SA
151 CHLORPHENAMINUMR06AB04
4mgR06AB04 CHLORPHENAMINUM COMPR.CLORFENIRAMIN 4mg LABORMED PHARMA SA
152 CETIRIZINUMR06AE07
10 mgR06AE07 CETIRIZINUM COMPR. FILM.CELERG 10 mg AC HELCOR PHARMA SRL
10mgR06AE07 CETIRIZINUM COMPR. FILM.LETIZEN® 10 mg 10mg KRKA D.D.
1mg/mlR06AE07 CETIRIZINUM SOL. ORALALETIZEN 1mg/ml KRKA D.D.
10mg/mlR06AE07 CETIRIZINUM PICATURI ORALE-SOL.ZYRTEC® 10mg/ml U.C.B. GMBH
28 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
153 KETOTIFENUMR06AX17
1mgR06AX17 KETOTIFENUM CAPS.KETOF 1 mg 1mg HEXAL AG
1mgR06AX17 KETOTIFENUM COMPR.H - KETOTIFEN 1mg AC HELCOR SRL
KETOTIFEN 1mg MAGISTRA C & C
KETOTIFEN LPH® 1 mg 1mg LABORMED PHARMA SA
1mg/5mlR06AX17 KETOTIFENUM SIROPFRENASMA 1mg/5ml FARAN LABORATORIES S.A.
KETOF 1 mg/5 ml 1mg/5ml HEXAL AG
154 CIPROFLOXACINUMS01AX13
0.3%S01AX13 CIPROFLOXACINUM UNG. OFT.CIPLOX 0.3% CIPLA (UK) LIMITED
155 DICLOFENACUMS01BC03
0.1%S01BC03 DICLOFENACUM PICATURI OFT.-SOL.DICLOGESIC 0,1% PICATURI OFTALMICE, SOLUTIE 0.1% DAR AL DAWA PHARMA S.R.L.
UNICLOPHEN® 0,1% 0.1% UNIMED PHARMA LTD.
VOLTAREN OPHTHA CD 0.1% NOVARTIS PHARMA GMBH
1mg/mlS01BC03 DICLOFENACUM PIC. OFT.-SOL.DICLOFENAC RPH 1mg/ml ROMPHARM COMPANY SRL
1mg/mlS01BC03 DICLOFENACUM PIC.OFT.-SOL.VURDON 1mg/ml HELP S.A. PHARMACEUTICALS
156 COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)S01CA05
0,2g+0,5gS01CA05 COMBINATII
(BETHAMETASONUM+ANTIINFECTIOASE)
UNG. OFT.
BETABIOPTAL 0,2g+0,5g FARMILA FARMACEUTICI
0,2g+0,5gS01CA05 COMBINATII
(BETHAMETASONUM+ANTIINFECTIOASE)
PICATURI OFT.SUSP.
BETABIOPTAL 0,2g+0,5g FARMILA FARMACEUTICI MILANO SPA
29 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA B - MEDICAMENTE CU NIVEL DE COMPENSARE 50% DIN PREŢUL DE REFERINŢĂ
157 PANTOPRAZOLUMA02BC02
20mgA02BC02 PANTOPRAZOLUM COMPR. FILM. GASTROREZ.CONTROLOC 20 mg 20mg ALTANA PHARMA AG
Mentinerea rezultatelor terapiei refluxului gastro-esofagianPrescriere limitata:
Boala de reflux gastro-esofagianPrescriere limitata:
Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacientii la pacientii cu factori de risc gastrointestinal.Prescriere limitata:
Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 20 mg.
40mgA02BC02 PANTOPRAZOLUM COMPR. FILM. GASTROREZ.CONTROLOC 40mg 40mg ALTANA PHARMA AG
Boala de reflux gastro-esofagian.Prescriere limitata:
Sindromul Zollinger-EllisonPrescriere limitata:
Tratamentul ulcerului gastric si duodenal.Prescriere limitata:
Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiiei de 40mg.
40mgA02BC02 PANTOPRAZOLUM LIOF. PT. SOL. INJ.
CONTROLOC 40mg LIOFILIZAT PENTRU SOLUTIE
INJECTABILA
40mg ALTANA PHARMA AG
158 ESOMEPRAZOLUMA02BC05
40mgA02BC05 ESOMEPRAZOLUM COMPR. FILM. GASTROREZ.NEXIUM 40 mg 40mg ASTRAZENECA AB
Terapia refluxului gastro-esofagian.Prescriere limitata:
Sindromul Zollinger-Ellison.Prescriere limitata:
Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 40 mg.
40mgA02BC05 ESOMEPRAZOLUM LIOF. PT. SOL. INJ./PERF.NEXIUM® 40mg ASTRAZENECA AB
20mgA02BC05 ESOMEPRAZOLUM COMPR. FILM. GASTROREZ.NEXIUM 20 mg 20mg ASTRAZENECA AB
Tratamentul ulcerului gastric si duodenal.Prescriere limitata:
Mentinerea rezultatelor terapiei refluxului gastro-esofagian.Prescriere limitata:
Profilaxia ulcerului gastro-duodenal asociat tratamentului cu antiinflamatoare nesteroidiene pe termen lung la pacientii cu factori de risc gastrointestinali.Prescriere limitata:
Se aplica pentru toate denumirile comerciale si formele farmaceutice corespunzatoare concentratiei de 20 mg.
159 SUCRALFATUMA02BX02
1gA02BX02 SUCRALFATUM COMPR.GASTROFAIT 1g E.I.P.I.CO. MED S.R.L.
SUCRALAN® 1g LANNACHER HEILMITTEL GMBH
VENTER 1g KRKA D.D.
160 BISMUTHI SUBCITRASA02BX05
120mgA02BX05 BISMUTHI SUBCITRAS COMPR. FILM.DE - NOL 120mg ASTELLAS PHARMA EUROPE B.V.
161 OTILONIUM BROMIDUMA03AB06
40mgA03AB06 OTILONIUM BROMIDUM COMPR. FILM.SPASMOMEN® 40mg A. MENARINI IND. FARM. RIUNITE SRL
162 MACROGOLUM *(2)A06AD15
A06AD15 MACROGOLUM PULB. PT. SOL. ORALAFORTRANS® BEAUFOUR IPSEN INT.
163 RIFAXIMINUMA07AA11
200mgA07AA11 RIFAXIMINUM COMPR. FILM.NORMIX 200 mg 200mg ALFA WASSERMANN SPA
164 BUDESONIDUM **A07EA06
Prescriere limitata: Inducerea remisiunii formelor usoare/moderate de boala Crohn cu afectare ileala sau / si de colon ascendent.
3mgA07EA06 BUDESONIDUM CAPS. GASTROREZ.BUDENOFALK 3mg DR. FALK PHARMA GMBH
165 RACECADOTRILUMA07XA04
100mgA07XA04 RACECADOTRILUM CAPS.HIDRASEC 100 mg 100mg LAB. FOURNIER SA
10mgA07XA04 RACECADOTRILUM PULB. PT. SOL. ORALAHIDRASEC 10 mg 10mg LAB. FOURNIER SA
30mgA07XA04 RACECADOTRILUM PULB. PT. SOL. ORALAHIDRASEC 30 mg 30mg LAB. FOURNIER SA
166 SIBUTRAMINUM **** Protocol: A003EA08AA10
10mgA08AA10 SIBUTRAMINUM CAPS.LINDAXA 10 10mg ZENTIVA A.S.
REDUCTIL 10mg 10mg ABBOTT GMBH&CO.KG
15mgA08AA10 SIBUTRAMINUM CAPS.LINDAXA 15 15mg ZENTIVA A.S.
REDUCTIL 15 mg 15mg ABBOTT GMBH&CO.KG
167 ORLISTATUM **** Protocol: A001EA08AB01
120mgA08AB01 ORLISTATUM CAPS.XENICAL 120mg 120mg ROCHE REGISTRATION LTD.
168 RIMONABANTUM **** Protocol: A031EA08AX01
20mgA08AX01 RIMONABANTUM COMPR. FILM.ACOMPLIA 20mg 20mg SANOFI AVENTIS
169 ALFACALCIDOLUMA11CC03
0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL
0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.
30 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
170 ACIDUM TIOCTICUM (ALFA-LIPOICUM) **# Protocol: A021EA16AX01
12mg/mlA16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM) SOL. PERF.THIOGAMMA® TURBO-SE 12mg/ml WORWAG PHARMA GMBH & CO. KG
THIOGAMMA® TURBO-SET 12mg/ml WORWAG PHARMA GMBH & CO. KG
30mg/mlA16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM) CONC. PT. SOL. PERF.THIOGAMMA® 600 INJEKT 30mg/ml WORWAG PHARMA GMBH & CO. KG
600mgA16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM) COMPR. FILM.THIOGAMMA® 600 oral 600mg WORWAG PHARMA GMBH & CO. KG
171 DALTEPARINUM **# Protocol: B008DB01AB04
10000ui/mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 10000 UI/ml 10000ui/ml PFIZER EUROPE MA EEIG
15000ui/0.6mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN15000 UI/0,6 ml 15000ui/0.6ml PFIZER EUROPE MA EEIG
2500ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 2500 UI/0,2 ml 2500ui/0.2ml PFIZER EUROPE MA EEIG
5000ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 5000 UI/0,2 ml 5000ui/0.2ml PFIZER EUROPE MA EEIG
7500ui/0.3mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 7500 UI/0,3 ml 7500ui/0.3ml PFIZER EUROPE MA EEIG
172 ENOXAPARINUM **# Protocol: B008DB01AB05
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
8000ui
anti-Xa/0.8ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 8000ui anti-Xa/0.8ml 8000ui
anti-Xa/0.8ml
LAB. AVENTIS
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
173 NADROPARINUM **# Protocol: B008DB01AB06
11400
uiAXa/0.6ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXODI 11400 UI anti-factor Xa/0,6ml 11400 uiAXa/0.6ml GLAXO GROUP LTD.
15200
uiAXa/0.8ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXODI 15200 UI anti-factor Xa/0,8ml 15200 uiAXa/0.8ml GLAXO GROUP LTD.
2850 ui
AFXa/0.3ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 2850 UI anti-factor Xa/0,3 ml 2850 ui
AFXa/0.3ml
GLAXO GROUP LTD.
3800 ui
AFXa/0.4ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 3800 UI anti-factor Xa/0,4 ml 3800 ui
AFXa/0.4ml
GLAXO GROUP LTD.
5700 ui
AFXa/0.6ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 5700 UI anti-factor Xa/0,6 ml 5700 ui
AFXa/0.6ml
GLAXO GROUP LTD.
7600 ui
AXa/0.8ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 7600 UI anti-factor Xa/0,8 ml 7600 ui AXa/0.8ml GLAXO GROUP LTD.
174 REVIPARINUM **# Protocol: B008DB01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
175 TINZAPARINUM **# Protocol: B008DB01AB10
10000u ANTIF.
Xa/ml
B01AB10 TINZAPARINUM SOL. INJ.
31 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
INNOHEP 10000u ANTIF.
Xa/ml
LEO PHARMACEUTICAL PRODUCTS
20000u ANTIF.
Xa/ml
B01AB10 TINZAPARINUM SOL. INJ.
INNOHEP 20000u ANTIF.
Xa/ml
LEO PHARMACEUTICAL PRODUCTS
176 SULODEXIDUM ** Protocol: B014IB01AB11
250ULSB01AB11 SULODEXIDUM CAPS. MOIVESSEL DUE F 250ULS ALFA WASSERMANN SPA
600ULS/2mlB01AB11 SULODEXIDUM SOL. INJ.VESSEL DUE F 600ULS/2ml ALFA WASSERMANN SPA
177 CLOPIDOGRELUM ** Protocol: B009I;B010IB01AC04
75mgB01AC04 CLOPIDOGRELUM COMPR. FILM.PLAVIX 75mg 75mg SANOFI PHARMA - BRISTOL MYERS SQUIBB
Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare conform
protocolului de prescriere.
Cod restrictie 1719:
Preventia recurentei infarctului de miocard sau a anginei instabile la pacienţii cu istoric de evenimente ischiemice cardiace simptomatice conform protocolului de
prescriere.
Cod restrictie 1722:
Tratamentul antiagregant al ateromatozei extensive (carotidiene, coronariene si perfierice).Cod restrictie 3008:
178 COMBINATII (DIPYRIDAMOLUM+ACIDUM
ACETYLSALICYLICUM) **
Protocol: B010IB01AC30
B01AC30 COMBINATII (DIPYRIDAMOLUM+ACIDUM
ACETYLSALICYLICUM)
CAPS. ELIB. MODIF.
AGGRENOX BOEHRINGER INGELHEIM INTERNATIONAL GMBH
179 FONDAPARINUX SODIUM **# Protocol: B008DB01AX05
10mg/0.8mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 10mg/0.8ml 10mg/0.8ml GLAXO GROUP LTD.
2.5mg/0.5mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 2.5mg/0.5ml 2.5mg/0.5ml GLAXO GROUP LTD.
5mg/0.4mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 5mg/0.4ml 5mg/0.4ml GLAXO GROUP LTD.
7.5mg/0.6mlB01AX05 FONDAPARINUX SODIUM SOL. INJ. IN SERINGA PREUMPLUTAARIXTRA 7.5mg/0.6ml 7.5mg/0.6ml GLAXO GROUP LTD.
180 COMPLEX DE HIDROXID DE FER (III) SUCROZAB03AC02
20mg/mlB03AC02 COMPLEX DE HIDROXID DE FER (III)
SUCROZA
SOL. INJ./PERF.
VENOFER® 20mg/ml VIFOR FRANCE S.A.
Anemie feriprivă, la pacienţii care au prezentat o reacţie de hipersensibilitate documentată la fier polimaltozat şi la care este indicată administrarea continuă
intravenoasă.
Cod restrictie 2070:
181 TRIFLUSALUMB01AC18
300mgB01AC18 TRIFLUSALUM CAPS.AFLEN® 300mg ZENTIVA S.A.
182 MEXILETINUMC01BB02
200mgC01BB02 MEXILETINUM CAPS.MEXITIL® 200 mg 200mg BOEHRINGER INGELHEIM INT. GMBH
183 IVABRADINUM ** Protocol: C003IC01EB17
5mgC01EB17 IVABRADINUM COMPR. FILM.CORLENTOR 5mg 5mg LES LAB. SERVIER
7.5mgC01EB17 IVABRADINUM COMPR. FILM.CORLENTOR 7,5mg 7.5mg LES LAB. SERVIER
184 MOXONIDINUMC02AC05
Prescriere limitata: Hipertensiune arteriala esentiala la pacienţii care primesc tratament antihipertensiv concomitent.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.2mgC02AC05 MOXONIDINUM COMPR. FILM.MOXOGAMMA 0,2 mg 0.2mg WORWAG PHARMA GMBH
PHYSIOTENS 0,2 0.2mg SOLVAY PHARMACEUTICALS GMBH
0.3mgC02AC05 MOXONIDINUM COMPR. FILM.MOXOGAMMA 0,3 mg 0.3mg WORWAG PHARMA GMBH
0.4mgC02AC05 MOXONIDINUM COMPR. FILM.MOXOGAMMA 0,4 mg 0.4mg WORWAG PHARMA GMBH
PHYSIOTENS 0,4 0.4mg SOLVAY PHARMACEUTICALS GMBH
185 RILMENIDINUMC02AC06
1mgC02AC06 RILMENIDINUM COMPR.TENAXUM 1mg LES LABORATOIRES SERVIER INDUSTRIE
186 PRAZOSINUMC02CA01
1mgC02CA01 PRAZOSINUM COMPR.MINIPRESS® 1 mg 1mg PFIZER EUROPE MA EEIG
2mgC02CA01 PRAZOSINUM COMPR.MINIPRESS® 2 mg 2mg PFIZER EUROPE MA EEIG
187 EPLERENONUM *#C03DA04
Prescriere limitata: Insuficienţă cardiacă cu o fracţie de ejecţie a ventriculului stâng de 40% sau mai puţin, apărută la 3-14 zile de la un infarct miocardic acut. Tratmentul cu eplerenone
trebuie început la maximum 14 zile de la data aparitiei infarctului miocardic acut. Data infarctului miocardic acut şi data iniţierii tratamentului cu eplerenone trebuie
documentate în fişa pacientului.
Electroliţii serici trebuie să fie verificaţi periodic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
25mgC03DA04 EPLERENONUM COMPR. FILM.INSPRA 25 mg 25mg PFIZER EUROPE MA EEIG
50mgC03DA04 EPLERENONUM COMPR. FILM.
32 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
INSPRA 50 mg 50mg PFIZER EUROPE MA EEIG
188 NICERGOLINUMC04AE02
10mgC04AE02 NICERGOLINUM COMPR. FILM.NICERGOLINA LPH 10 mg 10mg LABORMED PHARMA SA
10mgC04AE02 NICERGOLINUM DRAJ.NICERIUM® 10 10mg HEXAL AG
SINERGOLIN 10 10mg SINTOFARM SA
15mgC04AE02 NICERGOLINUM CAPS. ELIB. MODIF.NICERIUM® 15 15mg HEXAL AG
30mgC04AE02 NICERGOLINUM CAPS. ELIB. MODIF.NICERIUM® 30 UNO 30mg HEXAL AG
30mgC04AE02 NICERGOLINUM COMPR. FILM.NICERGOLINA LPH 30 mg 30mg LABORMED PHARMA SA
SERMION 30mg PFIZER EUROPE MA EEIG
30mgC04AE02 NICERGOLINUM DRAJ.SINERGOLIN 30 30mg SINTOFARM SA
5mgC04AE02 NICERGOLINUM COMPR. FILM.NICERGOLINA LPH 5 mg 5mg LABORMED PHARMA SA
189 VINCAMINUMC04AX07
10mgC04AX07 VINCAMINUM DRAJ.VINCAMINA 10mg BIOFARM SA
20mgC04AX07 VINCAMINUM COMPR.VINCAMIL 20mg FARMACEUTICI ECOBI S.A.S
30mgC04AX07 VINCAMINUM CAPS. ELIB. PREL.OXYBRAL SR 30 mg 30mg GLAXOSMITHKLINE (GSK) SRL
190 GINKGO BILOBA ** Protocol: C001IC04AXN1
120mgC04AXN1 GINKGO BILOBA COMPR. FILM.GINGIUM 120m 120mg HEXAL AG
40mgC04AXN1 GINKGO BILOBA COMPR. FILM.GINGIUM 40mg 40mg HEXAL AG
TEBOKAN 40mg DR. WILLMAR SCHWABE GMBH & CO KG
80mgC04AXN1 GINKGO BILOBA CAPS.BILOBIL FORTE 80mg KRKA D.D. NOVO MESTO
80mgC04AXN1 GINKGO BILOBA COMPR. FILM.GINGIUM 80mg 80mg HEXAL AG
191 DIOSMINUM (COMBINATII) ** Protocol: B016IC05CA53
500mgC05CA53 DIOSMINUM (COMBINATII) COMPR. FILM.DETRALEX® 500mg LES LAB. SERVIER IND.
192 NEBIVOLOLUMC07AB12
5mgC07AB12 NEBIVOLOLUM COMPR.NEBILET® 5mg BERLIN CHEMIE AG MENARINI GROUP
193 COMBINATII (BISOPROLOLUM+HYDROCHLOROTHIAZIDUM)C07BB07
C07BB07 COMBINATII
(BISOPROLOLUM+HYDROCHLOROTHIAZIDU
M)
COMPR. FILM.
LODOZ 10 mg MERCK KGAA
LODOZ 2,5 mg MERCK KGAA
LODOZ 5 mg MERCK KGAA
194 COMBINATII (METOPROLOLUM+FELODIPINUM)C07EBN1
50mg+5mgC07EBN1 COMBINATII
(METOPROLOLUM+FELODIPINUM)
COMPR. ELIB. PREL.
LOGIMAX® 50mg+5mg ASTRAZENECA AB
195 LACIDIPINUMC08CA09
4mgC08CA09 LACIDIPINUM COMPR. FILM.LACIPIL 4 mg 4mg GLAXO OPERATIONS UK LTD.
196 LERCANIDIPINUMC08CA13
10mgC08CA13 LERCANIDIPINUM COMPR. FILM.LERIDIP 10mg BERLIN CHEMIE AG MENARINI GROUP
20mgC08CA13 LERCANIDIPINUM COMPR. FILM.LERIDIP 20 20mg BERLIN CHEMIE AG MENARINI GROUP
197 PERINDOPRILUMC09AA04
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10 mgC09AA04 PERINDOPRILUM COMPR. FILM.PRESTARIUM 10 mg 10 mg LES LAB. SERVIER IND.
4mgC09AA04 PERINDOPRILUM COMPR.PRESTARIUM® 4 mg 4mg LES LAB. SERVIER IND.
5mgC09AA04 PERINDOPRILUM COMPR. FILM.PRESTARIUM 5 mg 5mg LES LAB. SERVIER IND.
8mgC09AA04 PERINDOPRILUM COMPR.PRESTARIUM® 8 mg 8mg LES LAB. SERVIER IND.
198 BENAZEPRILUMC09AA07
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgC09AA07 BENAZEPRILUM COMPR. FILM.BENAZEPRIL STADA 10 mg 10mg STADA ARZNEIMITTEL AG
CIBACEN® 10 mg 10mg NOVARTIS PHARMA GMBH
33 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
20mgC09AA07 BENAZEPRILUM COMPR. FILM.BENAZEPRIL STADA 20 mg 20mg STADA ARZNEIMITTEL AG
CIBACEN® 20 mg 20mg NOVARTIS PHARMA GMBH
5mgC09AA07 BENAZEPRILUM COMPR. FILM.BENAZEPRIL STADA 5 mg 5mg STADA ARZNEIMITTEL AG
CIBACEN® 5 mg 5mg NOVARTIS PHARMA GMBH
199 TRANDOLAPRILUMC09AA10
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.5mgC09AA10 TRANDOLAPRILUM CAPS.GOPTEN® 0,5 mg 0.5mg ABBOTT GMBH&CO.KG
2mgC09AA10 TRANDOLAPRILUM CAPS.GOPTEN® 2 mg 2mg ABBOTT GMBH&CO.KG
4mgC09AA10 TRANDOLAPRILUM CAPS.GOPTEN® 4 mg 4mg ABBOTT GMBH&CO.KG
200 ZOFENOPRILUMC09AA15
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
30mgC09AA15 ZOFENOPRILUM COMPR. FILM.ZOMEN® 30 mg 30mg BERLIN CHEMIE AG
7.5mgC09AA15 ZOFENOPRILUM COMPR. FILM.ZOMEN® 7,5 mg 7.5mg BERLIN CHEMIE AG
201 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)C09BA04
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2mg+0.625mgC09BA04 COMBINATII
(PERINDOPRILUM+INDAPAMIDUM)
COMPR.
NOLIPREL® 2mg+0.625mg LES LAB. SERVIER IND.
4mg+1.25mgC09BA04 COMBINATII
(PERINDOPRILUM+INDAPAMIDUM)
COMPR.
NOLIPREL FORTE® 4mg+1.25mg LES LAB. SERVIER IND.
PRESTARIUM PLUS 4mg+1.25mg LES LAB. SERVIER IND.
202 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDUM)C09BA06
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg/12.5mgC09BA06 COMBINATII
(QUINAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM.
ACCUZIDE 10mg/12.5mg PFIZER EUROPE MA EEIG
20mg/12.5mgC09BA06 COMBINATII
(QUINAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM.
ACUZIDE FORTE 20mg/12.5mg PFIZER EUROPE MA EEIG
203 COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZIDUM)C09BA09
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mg/12.5mgC09BA09 COMBINATII
(FOSINOPRILUM+HYDROCHLOROTHIAZIDU
M)
COMPR.
FOSINOZIDE 20 mg/12,5 mg 20mg/12.5mg BRISTOL MYERS SQUIBB KFT
204 COMBINATII (NITRENDIPINUM+ENALAPRILUM)C09BB02
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg+20mgC09BB02 COMBINATII
(NITRENDIPINUM+ENALAPRILUM)
COMPR.
ENEAS 10mg+20mg VITA CIENTIFICA SL
205 COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)C09BB10
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului
in utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
180mg/2mgC09BB10 COMBINATII
(VERAPAMILUM+TRANDOLAPRILUM)
COMPR.FILM.ELIB.MODIF.
TARKA 180mg/2mg ABBOTT GMBH&CO.KG
206 VALSARTANUMC09CA03
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
160mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 160 mg 160mg NOVARTIS PHARMA GMBH
80mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 80 mg 80mg NOVARTIS PHARMA GMBH
207 IRBESARTANUMC09CA04
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
34 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
150mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 150mg 150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB
300mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 300mg 300mg SANOFI PHARMA - BRISTOL MYERS SQUIBB
208 CANDESARTANUM CILEXETILC09CA06
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
16mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 16mg ASTRAZENECA AB
8mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 8mg ASTRAZENECA AB
209 TELMISARTANUMC09CA07
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
40mgC09CA07 TELMISARTANUM COMPR.MICARDIS 40 mg 40mg BOEHRINGER INGELHEIM INT. GMBH
PRITOR 40 mg 40mg BAYER HEALTHCARE AG
80mgC09CA07 TELMISARTANUM COMPR.MICARDIS 80 mg 80mg BOEHRINGER INGELHEIM INT. GMBH
PRITOR 80 mg 80mg BAYER HEALTHCARE AG
210 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDUM)C09DA01
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
50mg+12.5mgC09DA01 COMBINATII
(LOSARTANUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM.
HYZAAR® 50 mg/12,5 mg 50mg+12.5mg MERCK SHARP & DOHME ROMANIA S.R.L.
211 COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZIDUM)C09DA03
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
80mg/12.5mgC09DA03 COMBINATII
(VALSARTANUM+HYDROCHLOROTHIAZIDUM
)
COMPR. FILM.
CO-DIOVAN 80 mg/12,5 mg 80mg/12.5mg NOVARTIS PHARMA GMBH
212 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZIDUM)C09DA04
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mg/12.5mgC09DA04 COMBINATII
(IRBERSARTANUM+HYDROCHLOROTHIAZID
UM)
COMPR.
COAPROVEL 150mg/12.5mg 150mg/12.5mg SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC
300mg/12.5mgC09DA04 COMBINATII
(IRBERSARTANUM+HYDROCHLOROTHIAZID
UM)
COMPR.
COAPROVEL 300mg/12.5mg 300mg/12.5mg SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC
213 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZIDUM)C09DA07
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
80/12.5mgC09DA07 COMBINATII
(TELMISARTANUM+HYDROCHLOROTHIAZID
UM)
COMPR.
MICARDISPLUS 80/12.5mg 80/12.5mg BOEHRINGER INGELHEIM INT. GMBH
80mg/12.5mgC09DA07 COMBINATII
(TELMISARTANUM+HYDROCHLOROTHIAZID
UM)
COMPR.
PRITOR PLUS 80mg/12,5mg 80mg/12.5mg BAYER HEALTHCARE AG
214 COMBINATII ( VALSARTANUM+AMLODIPINUM)C09DB01
Prescriere limitata: Tratamentul hipertensiunii arteriale la pacientii cu intoleranta la inhibitorii enzimei de conversie ai angiotensinei.
Tratamentul hipertensiunii arteriale la pacientii ale caror valori tensionale nu pot fi controlate adecvat cu celelalte clase de medicamente antihipertensive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg/160mgC09DB01 COMBINATII (
VALSARTANUM+AMLODIPINUM)
COMPR. FILM.
EXFORGE 10mg/160mg 10mg/160mg NOVARTIS EUROPHARM LTD.
5mg/160mgC09DB01 COMBINATII (
VALSARTANUM+AMLODIPINUM)
COMPR. FILM.
EXFORGE 5mg/160mg 5mg/160mg NOVARTIS EUROPHARM LTD.
5mg/80mgC09DB01 COMBINATII (
VALSARTANUM+AMLODIPINUM)
COMPR. FILM.
EXFORGE 5mg/80mg 5mg/80mg NOVARTIS EUROPHARM LTD.
215 FLUVASTATINUM Protocol: CE01EC10AA04
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
35 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
20mgC10AA04 FLUVASTATINUM CAPS.LESCOL® 20 20mg NOVARTIS PHARMA GMBH
40mgC10AA04 FLUVASTATINUM CAPS.LESCOL® 40 40mg NOVARTIS PHARMA GMBH
80mgC10AA04 FLUVASTATINUM COMPR. ELIB. PREL.LESCOL® XL 80mg NOVARTIS PHARMA GMBH
216 ATORVASTATINUM Protocol: CE01EC10AA05
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 10 mg 10mg PFIZER EUROPE MA EEIG
20mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 20 mg 20mg PFIZER EUROPE MA EEIG
40mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 40 mg 40mg PFIZER EUROPE MA EEIG
80mgC10AA05 ATORVASTATINUM COMPR. FILM.SORTIS 80 mg 80mg PFIZER EUROPE MA EEIG
217 ROSUVASTATINUM Protocol: CE01EC10AA07
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 10 mg 10mg ASTRAZENECA UK LTD.
20mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 20 mg 20mg ASTRAZENECA UK LTD.
40mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 40 mg 40mg ASTRAZENECA UK LTD.
5mgC10AA07 ROSUVASTATINUM COMPR. FILM.CRESTOR 5 mg 5mg ASTRAZENECA UK LTD.
218 BEZAFIBRATUM Protocol: CE01EC10AB02
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgC10AB02 BEZAFIBRATUM DRAJ.REGADRIN® B 200mg BERLIN CHEMIE AG MENARINI GROUP
219 CIPROFIBRATUM Protocol: CE01EC10AB08
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgC10AB08 CIPROFIBRATUM CAPS.LIPANOR® 100 mg 100mg SANOFI-AVENTIS FRANCE
220 ACID OMEGA-3-ESTERI ETILICI 90 ** Protocol: C004IC10AX06
1000mgC10AX06 ACID OMEGA-3-ESTERI ETILICI 90 CAPS. MOIOMACOR® 1000mg PRONOVA BIOCARE AS
221 EZETIMIBUMC10AX09
Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
Cod restrictie 2649: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(a) boală coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului
peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine concomitent cu dieta si exercitii fizice. Doza, durata
tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu
ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul
inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
Cod restrictie 2650: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste
pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata
tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu
ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul
inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib
Cod restrictie 2651: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al
colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.
Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii
tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)
Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155 mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
36 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Cod restrictie 2652: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)
nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii
fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul
initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;
SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib
Cod restrictie 2653: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)
nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii
fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul
initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;
SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
Cod restrictie 2667: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel
al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.
Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii
tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)
Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
Cod restrictie 2668: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul
initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu
statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb.
Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al
colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta
si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la
momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu
ezetimib.
Cod restrictie 1989: Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea
decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statine) este contraindicat
Cod restrictie 2669: Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea
decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statin) trebuie intrerupt sau redus la mai putin de 20 mg/zi datorita aparitiei efectelor
secundare urmatoare: (i) Mialgie severa (simptome mulsculare fara cresterea CK) care survine pe perioada tratamentului cu statine; sau (ii) Miozita (cresterea
importanta a CK, cu sau fara simptomatologie musculara) demonstrata prin valori de doua ori mai mari decat limita superioara a normalului la o singura
determinare sau o tendinta de crestere la determinari consecutive, neexplicate de alte cauze; sau (iii) Persistenta unor valori crescute ale transaminazelor,
neexplicata de alte cauze (mai mult de trei ori decat valoarea limita maxima a normalului) in timpul tratamentului cu o statina
Cod restrictie 1991: Homozygous sitosterolaemia;
Cod restrictie 2438: Pacienti cu hipercolesterolemie familiala (homozigota) care sunt eligibili pentru tratamentul cu hipolipemiante (in concordanta cu Protocolul de prescriere in
vederea decontarii), in combinatie cu un inhibitor de HMG CoA reductase (statin).
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgC10AX09 EZETIMIBUM COMPR.EZETROL® 10mg MERCK SHARP & DOHME ROMANIA SRL
222 COMBINATII (EZETIMIBUM + SIMVASTATINUM)C10BA02
Cod restrictie 2654: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(a) boală coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului
peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata
tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu
ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul
inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
Cod restrictie 2655: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste
pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata
tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu
ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul
inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib
Cod restrictie 2656: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al
colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.
Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii
tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)
Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
37 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Cod restrictie 2657: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)
nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii
fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul
initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;
SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib
Cod restrictie 2658: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1)
nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii
fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul
initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib;
SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul
initierii tratamentului cu ezetimib.
Cod restrictie 2678: Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel
al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice.
Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii
tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2)
Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel ptuin 3 luni de tratament cu o doza zilnica optima de statine
concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul
medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul
initierii tratamentului cu ezetimib.
Cod restrictie 2679:Tratamentul, în combinatie cu dieta şi exerciţiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statină) la pacienţii al căror nivel de colesterol
nu este controlat adecvat cu o statină şi care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul
initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica optima de statine, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu
statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb.
Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al
colesterolului cu nivele ale acestuia mai mari decat 155mg/dl dupa cel putin 3 luni de tratament cu o doza zilnica optima de statine concomitent cu dieta
si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la
momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu
ezetimib.
Cod restrictie 2431: Pacientii cu hipercolesterolemie familiala (heterozigota) care sunt eligibili pentru tratament cu hipo-lipemiante (in concordanta cu criteriile stabilite prin Protocolul
de prescriere in vederea decontarii).
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg/10mgC10BA02 COMBINATII (EZETIMIBUM +
SIMVASTATINUM)
COMPR.
INEGY® 10 mg/10 mg 10mg/10mg MERCK SHARP & DOHME ROMANIA S.R.L.
10mg/20mgC10BA02 COMBINATII (EZETIMIBUM +
SIMVASTATINUM)
COMPR.
INEGY® 10 mg/20 mg 10mg/20mg MERCK SHARP & DOHME ROMANIA S.R.L.
10mg/40mgC10BA02 COMBINATII (EZETIMIBUM +
SIMVASTATINUM)
COMPR.
INEGY® 10 mg/40 mg 10mg/40mg MERCK SHARP & DOHME ROMANIA S.R.L.
10mg/80mgC10BA02 COMBINATII (EZETIMIBUM +
SIMVASTATINUM)
COMPR.
INEGY® 10 mg/80 mg 10mg/80mg MERCK SHARP & DOHME ROMANIA S.R.L.
223 COMBINATII (ATORVASTATINUM + AMLODIPINUM) Protocol: CE01EC10BX03
Prescriere limitata: Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor
hipolipemiante in vederea decontarii, si:(a) care primesc in mod curent tratament cu un blocant de canale de calciu.
Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor
hipolipemiante in vederea decontarii, si:(b) al caror nivel al tensiunii arteriale si/sau angina pectorala sunt insuficient controlate cu alte clase de antihipertensive
si/sau medicamente anti-angina si la care terapia adjuvanta cu blocanti ai canalelor de calciu ar fi adecvata;
Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor
hipolipemiante in vederea decontarii, si (c) care nu tolereaza efectele secundare ale altor clase de antihipertensive si/sau medicamente anti-angina si la care
inlocuirea terapiei cu un blocant de canale de calciu ar fi indicata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg/10mgC10BX03 COMBINATII (ATORVASTATINUM +
AMLODIPINUM)
COMPR. FILM.
CADUET 10mg/10mg 10mg/10mg PFIZER EUROPE MA EEIG
5mg/10mgC10BX03 COMBINATII (ATORVASTATINUM +
AMLODIPINUM)
COMPR. FILM.
CADUET 5mg/10mg 5mg/10mg PFIZER EUROPE MA EEIG
224 NATAMYCINUMD01AA02
20mg/gD01AA02 NATAMYCINUM CREMAPIMAFUCIN 20mg/g ASTELLAS EUROPE B.V.
226 TERBINAFINUMD01BA02
Prescriere limitata: Tratamentul de prima intentie al onicomicozelor proximale sau extinse la care tratamentul topic a esuat.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgD01BA02 TERBINAFINUM COMPR.LAMISIL® 250mg NOVARTIS PHARMA GMBH
TERBINARAN 250mg RANBAXY UK LIMITED
TERBISIL® 250 mg 250mg GEDEON RICHTER LTD.
227 CALCIPOTRIOLUM *D05AX02
50µg/gD05AX02 CALCIPOTRIOLUM CREMA
38 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
DAIVONEX 50µg/g LEO PHARMACEUTICAL PRODUCTS
50µg/gD05AX02 CALCIPOTRIOLUM UNGUENTDAIVONEX UNGUENT 50µg/g LEO PHARMACEUTICAL PRODUCTS
50µg/mlD05AX02 CALCIPOTRIOLUM SOL. CUT.DAIVONEX SOLUTIE CUTANATA PENTRU SCALP 50µg/ml LEO PHARMACEUTICAL PRODUCTS
0.005%D05AX02 CALCIPOTRIOLUM UNGUENTSOREL® unguent 0,005% 0.005% LEK PHARMACEUTICALS D.D.
228 COMBINATII (CALCIPOTRIOLUM+BETAMETHASONUM) *D05AX52
D05AX52 COMBINATII
(CALCIPOTRIOLUM+BETAMETHASONUM)
UNGUENT
DAIVOBET® UNGUENT LEO PHARMACEUTICAL PRODUCTS
230 ACIDUM FUSIDICUMD06AX01
2,00%D06AX01 ACIDUM FUSIDICUM CREMAFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS
2,00%D06AX01 ACIDUM FUSIDICUM UNGUENTFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS
231 COMBINATII (NEOMYCINUM+BACITRACINUM)D06AXN1
D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM) PULB. CUT.BANEOCIN® SANDOZ GMBH
D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM) UNGUENTBANEOCIN® SANDOZ GMBH
NEOBACIN DAR AL DAWA PHARMA SRL
232 SULFADIAZINUMD06BA01
1,00%D06BA01 SULFADIAZINUM CREMADERMAZIN® 1% 1% LEK PHARMACEUTICALS D.D.
233 PODOPHYLLOTOXINUM *D06BB04
1,5 mg/gD06BB04 PODOPHYLLOTOXINUM CREMAWARTEC 1,5 mg/g 1,5 mg/g STIEFEL LABORATORIES (UK) LTD.
5mg/mlD06BB04 PODOPHYLLOTOXINUM SOL. CUT.CONDYLINE 5mg/ml ASTELLAS PHARMA EUROPE B.V.
Pentru tratamentul verucilor.Prescriere limitata:
235 HYDROCORTISONUM BUTYRATUM Protocol: D001LD07AB02
0.1%D07AB02 HYDROCORTISONUM BUTYRATUM CREMALOCOID® crema 0,1% 0.1% ASTELLAS PHARMA EUROPE BV
LOCOID® LIPOCREAM 0,1% 0.1% ASTELLAS PHARMA EUROPE B.V.
0.1%D07AB02 HYDROCORTISONUM BUTYRATUM EMULSIE CUT.LOCOID CRELO® 0,1% 0.1% ASTELLAS PHARMA EUROPE BV
0.1%D07AB02 HYDROCORTISONUM BUTYRATUM SOL. CUT.LOCOID® 0.1% ASTELLAS PHARMA EUROPE B.V.
236 MOMETASONUM Protocol: D001LD07AC13
1mg/gD07AC13 MOMETASONUM CREMAELOCOM 1mg/g SCHERING PLOUGH EUROPE
1mg/gD07AC13 MOMETASONUM SOL. CUT.ELOCOM 1mg/g SCHERING PLOUGH EUROPE
1mg/gD07AC13 MOMETASONUM UNGUENTELOCOM 1mg/g SCHERING PLOUGH EUROPE
237 METHYLPREDNISOLONUM ACEPONAT Protocol: D001LD07AC14
0.1%D07AC14 METHYLPREDNISOLONUM ACEPONAT EMULSIE CUT.ADVANTAN® MILK 0.1% INTENDIS GMBH
1mg/gD07AC14 METHYLPREDNISOLONUM ACEPONAT CREMAADVANTAN 1mg/g INTENDIS GmbH
1mg/gD07AC14 METHYLPREDNISOLONUM ACEPONAT UNGUENTADVANTAN 1mg/g INTENDIS GmbH
238 FLUTICASONUM Protocol: D001LD07AC17
0.05%D07AC17 FLUTICASONUM CREMACUTIVATE 0.05% GLAXO WELLCOME UK LIMITED
0.005%D07AC17 FLUTICASONUM UNGUENTCUTIVATE 0.005% GLAXO WELLCOME UK LIMITED
239 CLOBETASOLUM * Protocol: D001LD07AD01
0.05%D07AD01 CLOBETASOLUM CREMADERMOVATE 0.05% GLAXOWELLCOME UK LTD.
0.05%D07AD01 CLOBETASOLUM SOL. CUT.DERMOVATE® 0.05% GLAXO WELLCOME UK LTD.
0.05%D07AD01 CLOBETASOLUM UNGUENTDERMIONE 0.05% OZONE LABORATORIES LTD.
DERMOVATE 0.05% GLAXOWELLCOME UK LTD.
240 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE) Protocol: D001LD07CA01
D07CA01 COMBINATII
(HYDROCORTISONUM+ANTIINFECTIOASE)
CREMA
FUCIDIN® H LEO PHARMACEUTICAL PRODUCTS
PIMAFUCORT ASTELLAS PHARMA EUROPE B.V.
D07CA01 COMBINATII
(HYDROCORTISONUM+ANTIINFECTIOASE)
UNGUENT
PIMAFUCORT ASTELLAS PHARMA EUROPE B.V.
241 COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE) Protocol: D001LD07CC01
D07CC01 COMBINATII
(BETAMETHASONUM+ANTIINFECTIOASE)
CREMA
FUCICORT® LEO PHARMACEUTICAL PRODUCTS
39 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
242 COMBINATII (MOMETASONUM + AC. SALICILICUM) Protocol: D001LD07XC03
D07XC03 COMBINATII (MOMETASONUM + AC.
SALICILICUM)
UNGUENT
ELOSALIC SCHERING PLOUGH EUROPE
243 COMBINATII (ISOTRETINOINUM + ERITROMICINUM)D10AD54
0,05%/0,2%D10AD54 COMBINATII (ISOTRETINOINUM +
ERITROMICINUM)
GEL
ISOTREXIN GEL 0,05%/0,2% STIEFEL LABORATORIES (UK) LTD.
244 ACIDUM AZELAICUMD10AX03
200mg/gD10AX03 ACIDUM AZELAICUM CREMASKINOREN 200mg/g INTENDIS GmbH
15%D10AX03 ACIDUM AZELAICUM GELSKINOREN® 15% 15% INTENDIS GMBH
245 ISOTRETINOINUM **D10BA01
Cod restrictie 1354: Acnee chistica severa care nu raspunde la alte tipuri de tratamente.
Acest medicament poate cauza defecte la nastere. Isotretinoin a fost incriminat pentru cauzarea frecventa a altor efecte toxice cu potential sever.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgD10BA01 ISOTRETINOINUM CAPS. MOIROACCUTANE 10 mg 10mg ROCHE ROMANIA SRL
SOTRET 10 mg 10mg RANBAXY U.K. LIMITED
20mgD10BA01 ISOTRETINOINUM CAPS. MOISOTRET 20 mg 20mg RANBAXY U.K. LIMITED
246 NATAMYCINUMG01AA02
100mgG01AA02 NATAMYCINUM OVULEPIMAFUCIN® 100mg ASTELLAS PHARMA EUROPE B.V.
247 COMBINATIIG01AA51
10g/400000UIG01AA51 COMBINATII CREMA VAG.MACMIROR COMPLEX 10g/400000UI POLICHEM SA
500mg/200000UIG01AA51 COMBINATII CAPS. MOI VAG.MACMIROR COMPLEX 500mg/200000UI POLICHEM SA
G01AA51 COMBINATII CAPS. MOI VAG.POLYGYNAX LAB. INNOTECH INT.
248 FENTICONAZOLUMG01AF12
600mgG01AF12 FENTICONAZOLUM CAPS. MOI VAG.LOMEXIN 600 mg 600mg RECORDATI SPA
249 BUTOCONAZOLUMG01AF15
G01AF15 BUTOCONAZOLUM CREMA VAG.GYNOFORT 2% GEDEON RICHTER LTD.
251 NIFURATELUMG01AX05
200mgG01AX05 NIFURATELUM DRAJ.MACMIROR 200mg POLICHEM SA
252 CABERGOLINUM * Protocol: G001CG02CB03
0.5mgG02CB03 CABERGOLINUM COMPR.DOSTINEX 0.5mg PFIZER EUROPE MA EEG
Prevenirea aparitiei lactatiei in lauzie.Prescriere limitata:
Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicalaCod restrictie 2659:
Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incompleteCod restrictie 2660:
253 LYNESTRENOLUM *G03AC02
0.5mgG03AC02 LYNESTRENOLUM COMPR.EXLUTON® 0.5mg ORGANON NV
254 LEVONORGESTRELUM ***# Protocol: G005NG03AC03
52mgG03AC03 LEVONORGESTRELUM DISPOZITIV INTRAUTERINMIRENA 20 µg/24 h 52mg SCHERING OY (SCHERING AG)
255 ESTRIOLUM *G03CA04
0.1%G03CA04 ESTRIOLUM CREMA VAG.OVESTIN 0.1% ORGANON NV
0.5mgG03CA04 ESTRIOLUM OVULEOVESTIN 0.5mg ORGANON NV
256 PROMESTRIENUM *G03CA09
10mgG03CA09 PROMESTRIENUM CAPS. MOI VAG.COLPOTROPHINE® 10mg LAB. THERAMEX
1%G03CA09 PROMESTRIENUM CREMA VAG.COLPOTROPHINE® 1% LAB. THERAMEX
257 PROGESTERONUM *G03DA04
100mgG03DA04 PROGESTERONUM CAPS. MOIUTROGESTAN® 100 mg 100mg LAB. BESINS INTERNATIONAL
1%G03DA04 PROGESTERONUM GELMASTOPROFEN 1% 1% ANTIBIOTICE SA
PROGESTOGEL 1% LAB. BESINS INTERNATIONAL
258 DYDROGESTERONUM *G03DB01
10mgG03DB01 DYDROGESTERONUM COMPR. FILM.DUPHASTON® 10mg SOLVAY PHARMACEUTICALS BV
259 LYNESTRENOLUM *G03DC03
5mgG03DC03 LYNESTRENOLUM COMPR.ORGAMETRIL 5mg ORGANON NV
260 TIBOLONUM ** Protocol: G007NG03DC05
40 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
2,5mgG03DC05 TIBOLONUM COMPR.LADYBON 2,5mg ZENTIVA A.S.
2.5mgG03DC05 TIBOLONUM COMPR.LIVIAL® 2,5 mg 2.5mg ORGANON NV
261 COMBINATII ** Protocol: G002NG03FA01
1mg/0,5mgG03FA01 COMBINATII COMPR. FILM.ACTIVELLE 1mg/0,5mg 1mg/0,5mg NOVO NORDISK A/S
262 COMBINATII ** Protocol: G002NG03FA14
G03FA14 COMBINATII COMPR. FILM.FEMOSTON® conti 1/5 SOLVAY PHARMACEUTICALS BV
263 ESTRADIOLUMVALERAT+DIENOGEST ** Protocol: G002NG03FA15
G03FA15 ESTRADIOLUMVALERAT+DIENOGEST DRAJ.KLIMODIEN SCHERING AG
264 COMBINATII ** Protocol: G002NG03FA17
G03FA17 COMBINATII COMPR. FILM.ANGELIQ SCHERING AG
265 COMBINATII ** Protocol: G002NG03FB01
G03FB01 COMBINATII DRAJ.CYCLO PROGINOVA® SCHERING AG
266 COMBINATII ** Protocol: G002NG03FB05
G03FB05 COMBINATII COMPR. FILM.NOVOFEM NOVO NORDISK A/S
267 COMBINATII ** Protocol: G002NG03FB08
G03FB08 COMBINATII COMPR. FILM.FEMOSTON 2/10 SOLVAY PHARMACEUTICALS BV
G03FB08 COMBINATII COMPR. FILM.FEMOSTON 2/10 SOLVAY PHARMACEUTICALS BV
268 FOLITROPINUM ALFA ****# Protocol: G003NG03GA05
Prescriere limitata: Infertilitate anovulatorie.
Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără
efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare
laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150UIG03GA05 FOLITROPINUM ALFA PULB. + SOLV. PT. SOL. INJ.GONAL - f 150 UI 150UI SERONO EUROPE LTD.
75UIG03GA05 FOLITROPINUM ALFA PULB. + SOLV. PT. SOL. INJ.GONAL - f 75 UI 75UI SERONO EUROPE LTD.
Infertilitate anovulatoriePrescriere limitata:
269 FOLLITROPINUM BETA ****# Protocol: G008NG03GA06
Prescriere limitata: Infertilitate anovulatorie.
Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără
efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare
laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100UI/0.5mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 100UI/0,5ml 100UI/0.5ml N. V. ORGANON
300UI/0.36mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 300UI/0,36 ml 300UI/0.36ml N. V. ORGANON
50UI/0.5mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 50UI/0,5ml 50UI/0.5ml N. V. ORGANON
600UI/0.72mlG03GA06 FOLLITROPINUM BETA SOL. INJ.PUREGON 600UI/0,72 ml 600UI/0.72ml N. V. ORGANON
100UI/mlG03GA06 FOLLITROPINUM BETA PULB+SOLV. PT. SOL. INJ.PUREGON 100UI 100UI/ml ORGANON NV
50UI/mlG03GA06 FOLLITROPINUM BETA PULB+SOLV. PT. SOL. INJPUREGON 50UI 50UI/ml ORGANON NV
271 CLOMIFENUMG03GB02
50mgG03GB02 CLOMIFENUM COMPR.CLOSTILBEGYT 50mg EGIS PHARMACEUTICALS PLC
OVA - MIT 50mg REMEDICA LTD.
Infertilitate anovulatoriePrescriere limitata:
272 RALOXIFENUMG03XC01
60mgG03XC01 RALOXIFENUM COMPR. FILM.EVISTA 60mg 60mg ELI LILLY NEDERLAND BV
Monoterapie cu medicamente antiresorbtive pentru tratamentul si profilaxia osteoporozei sexoidoprive la femei pana la varsta de 60 ani.Cod restrictie 3006:
NOTA: Agentii antiresorbtivi utilizati in tratamentul osteoporozei instalate sunt: ALENDRONATE SODIUM, RISEDRONAT SODIUM, RALOXIFEN HYDROCHLORIDE, IBANDRONATE,
ZOLENDRONATE SI STRONTIUM RANELATE (agent antiresorbtiv si formator osos)..
273 OXYBUTYNINUMG04BD04
5mgG04BD04 OXYBUTYNINUM COMPR.DRIPTANE® 5 mg 5mg LAB. FOURNIER SA
Hipereactivitate a detrusoruluiPrescriere limitata:
274 TOLTERODINUM **# Protocol: G010NG04BD07
4mgG04BD07 TOLTERODINUM CAPS. ELIB. PREL.DETRUSITOL SR 4 mg 4mg PFIZER EUROPE MA EEIG
275 SOLIFENACINUM SUCCINATE **# Protocol: G009NG04BD08
10mgG04BD08 SOLIFENACINUM SUCCINATE COMPR. FILM.VESICARE 10 mg 10mg ASTELLAS PHARMA EUROPE B.V.
41 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
5mgG04BD08 SOLIFENACINUM SUCCINATE COMPR. FILM.VESICARE 5 mg 5mg ASTELLAS PHARMA EUROPE B.V.
276 TROSPIUMG04BD09
15mgG04BD09 TROSPIUM COMPR. FILM.INKONTAN 15 mg 15mg PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.
30mgG04BD09 TROSPIUM COMPR. FILM.INKONTAN 30 mg 30mg PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.
277 ALFUZOSINUMG04CA01
10mgG04CA01 ALFUZOSINUM COMPR. ELIB. PREL.ALFURAN MR 10 mg 10mg TERAPIA S.A.
XATRAL SR 10 mg 10mg SANOFI-SYNTHELABO FRANCE
5mgG04CA01 ALFUZOSINUM COMPR. FILM. ELIB. PREL.XATRAL® LP 5 mg 5mg SANOFI-SYNTHELABO FRANCE
278 TAMSULOSINUMG04CA02
Prescriere limitata: Tratamentul hiperplaziei benigne de prostata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
0,4mgG04CA02 TAMSULOSINUM CAPS. ELIB. MODIF.TAMSOL 0,4 mg 0,4mg GEDEON RICHTER ROMANIA
TAMSULOSIN ACTAVIS 0,4mg ACTAVIS GROUP HF.
0.4mgG04CA02 TAMSULOSINUM CAPS. ELIB. MODIF.FOKUSIN 0.4mg ZENTIVA AS
0.4mgG04CA02 TAMSULOSINUM CAPS. ELIB. PREL.CONTIFLO MR 0.4mg RANBAXY UK LTD.
TANYZ 0.4mg KRKA D.D. NOVO MESTO
0.4mgG04CA02 TAMSULOSINUM COMPR. FILM. ELIB. PREL.OMNIC TOCAS® 0,4 0.4mg ASTELLAS PHARMA EUROPE B.V.
279 FINASTERIDUM *G04CB01
Prescriere limitata: Tratamentul hiperplaziei benigne de prostata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
5mgG04CB01 FINASTERIDUM COMPR. FILM.MOSTRAFIN 5mg PLIVA LJUBLIJANA D.O.O.
PROSCAR 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.
TAREDOX 5 mg 5mg DR. REDDY'S LABORATORIES
5mgG04CB01 FINASTERIDUM COMPR. FILM.MOSTRAFIN 5mg PLIVA LJUBLIJANA D.O.O.
PROSCAR 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.
TAREDOX 5 mg 5mg DR. REDDY'S LABORATORIES
5 mgG04CB01 FINASTERIDUM COMPR. FILM.FINASTERID SANDOZ 5 mg 5 mg HEXAL AG
280 DUTASTERIDUM *G04CB02
Prescriere limitata: Tratamentul hiperplaziei benigne de prostata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
0.5mgG04CB02 DUTASTERIDUM CAPS. MOIAVODART® 0.5mg GLAXO GROUP LTD.
281 TETRACOSACTIDUMH01AA02
1mg/mlH01AA02 TETRACOSACTIDUM SUSP. INJ.SYNACHTEN DEPOT 1mg/ml NOVARTIS PHARMA GMBH
282 SOMATROPINUM ***# Protocol: H009EH01AC01
10mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEX x 10mg/1,5ml 10mg/1.5ml NOVO NORDISK A/S
10mg/2mlH01AC01 SOMATROPINUM SOL. INJ.NUTROPINAq 10 mg/2 ml 10mg/2ml IPSEN LIMITED
3,3mg/mlH01AC01 SOMATROPINUM SOL. INJ.OMNITROPE 3,3mg/ml 3,3mg/ml SANDOZ GMBH
4mg (12ui)H01AC01 SOMATROPINUM LIOF. + SOLV. PT. SOL. INJ.ZOMACTON 4mg (12ui) FERING GMBH
5.3mg/ml (16ui)H01AC01 SOMATROPINUM PULB. + SOLV. PT. SOL. INJ.GENOTROPIN® 16 ui (5,3 mg) 5.3mg/ml (16ui) PFIZER EUROPE MA EEIG
5mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEXx 5 mg/1,5 ml 5mg/1.5ml NOVO NORDISK A/S
283 GANIRELIXUM ***# Protocol: G004NH01CC01
0.25mg/0.5mlH01CC01 GANIRELIXUM SOL. INJ.ORGALUTRAN 0.25mg/0.5ml 0.25mg/0.5ml N. V. ORGANON
284 CETRORELIXUM ***# Protocol: H004EH01CC02
0.25mgH01CC02 CETRORELIXUM LIOF. + SOLV. PT. SOL. INJ.CETROTIDE 0,25 mg 0.25mg SERONO EUROPE LTD.
3mgH01CC02 CETRORELIXUM LIOF. + SOLV. PT. SOL. INJ.CETROTIDE 3 mg 3mg SERONO EUROPE LTD.
285 FLUDROCORTISONUMH02AA02
0.1mgH02AA02 FLUDROCORTISONUM COMPR.ASTONIN H 0.1mg MERCK KGAA
286 BETAMETHASONUMH02AB01
7mg/mlH02AB01 BETAMETHASONUM SUSP. INJ. I.M.DIPROPHOS® 7mg/ml SCHERING PLOUGH EUROPE
287 PREDNISOLONUMH02AB06
250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA
50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.
42 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SOLU - DECORTIN H 50 50mg MERCK KGAA
288 THIAMAZOLUMH03BB02
10mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 10 mg 10mg MERCK KGAA
20mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 20 mg 20mg MERCK KGAA
5mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 5 mg 5mg MERCK KGAA
289 CALCITONINUM (SOMON)H05BA01
100UIH05BA01 CALCITONINUM (SOMON) SOL. INJ.TONOCALCIN 100 UI 100UI ALFA WASSERMANN SPA
100ui/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZ.,SOL.NYLEX 100 UI/doza 100UI/doza PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA
100UI/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.NYLEX® 100UI/ml PROEL E.P. CORONIS SA
200UI/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZAL - SOL.MIACALCIC® NASAL 200 200ui/doza NOVARTIS PHARMA GMBH
NYLEX® 200UI/doza PROEL E.P. CORONIS SA
50ui/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.MIACALCIC® 50ui/ml NOVARTIS PHARMA GMBH
290 AMPICILLINUM + SULBACTAMJ01CR01
1g+500mgJ01CR01 AMPICILLINUM + SULBACTAM PULB. PT. SOL. INJ.AMPIPLUS® 1,5 g 1g+500mg ANTIBIOTICE SA
291 SULTAMICILLINUMJ01CR04
250mg/5mlJ01CR04 SULTAMICILLINUM PULB. PT. SUSP. ORALAUNASYN 250mg/5ml PFIZER EUROPE MA EEIG
375mgJ01CR04 SULTAMICILLINUM COMPR. FILM.UNASYN 375mg PFIZER EUROPE MA EEIG
292 CEFPROZILUMJ01DC10
125mg/5mlJ01DC10 CEFPROZILUM PULB. PT. SUSP. ORALACEFZIL 125 mg/5 ml 125mg/5ml BRISTOL-MYERS SQUIBB KFT.
250mgJ01DC10 CEFPROZILUM COMPR. FILM.CEFZIL 250 mg 250mg BRISTOL-MYERS SQUIBB KFT.
250mg/5mlJ01DC10 CEFPROZILUM PULB. PT. SUSP. ORALACEFZIL 250 mg/5 ml 250mg/5ml BRISTOL-MYERS SQUIBB KFT.
500mgJ01DC10 CEFPROZILUM COMPR. FILM.CEFZIL 500 mg 500mg BRISTOL-MYERS SQUIBB KFT.
293 CEFTIBUTENUMJ01DD14
36mg/mlJ01DD14 CEFTIBUTENUM PULB. PT. SUSP. ORALACEDAX 36mg/ml SCHERING PLOUGH EUROPE
400mgJ01DD14 CEFTIBUTENUM CAPS.CEDAX 400mg SCHERING PLOUGH EUROPE
294 SPIRAMYCINUMJ01FA02
1.5 M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 1,5 Mil. UI 1.5 M ui LAB. AVENTIS
3M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 3 Mil. UI 3M ui LAB. AVENTIS
295 AZITHROMYCINUMJ01FA10
100mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 100 mg/5 ml 100mg/5ml SANDOZ SRL
125mgJ01FA10 AZITHROMYCINUM COMPR. FILM.SUMAMED 125 mg 125mg PLIVA LJUBLJANA D.O.O.
200 mg/5 mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 200 mg/5 ml 200 mg/5 ml SANDOZ SRL
200mg/5mlJ01FA10 AZITHROMYCINUM PULB. + SOLV. SUSP. ORALAAZITROX 200 mg/5 ml 200mg/5ml ECZACIBASI PHARMACEUTICALS S.R.L.
200mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALASUMAMED FORTE 200mg/5ml PLIVA LJUBLIJANA D.O.O.
250mgJ01FA10 AZITHROMYCINUM CAPS.AZATRIL 250 mg 250mg BALKANPHARMA RAZGRAD AD
250mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE 250mg SANDOZ S.R.L.
AZITROX® 250 250mg ZENTIVA AS
500mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ S.R.L.
AZITROX® 500 500mg ZENTIVA AS
AZRO® 500 mg 500mg ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED 500 mg 500mg PLIVA LJUBLJANA D.O.O.
ZITROCIN 500 mg 500mg OZONE LABORATORIES LTD.
2gJ01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. SUSP. ORALAZMAX 2 g 2g PFIZER EUROPE MA EEIG
296 CLINDAMYCINUMJ01FF01
Prescriere limitata: Infectii cu coci Gram pozitivi care nu pot fi tratate eficient cu peniciline.
Infectii severe cu germeni anaerobi.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mgJ01FF01 CLINDAMYCINUM CAPS.DALACIN C 150 mg 150mg PFIZER EUROPE MA EEIG
300mgJ01FF01 CLINDAMYCINUM CAPS.DALACIN C 300 mg 300mg PFIZER EUROPE MA EEIG
43 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
297 LEVOFLOXACINUMJ01MA12
500mgJ01MA12 LEVOFLOXACINUM COMPR. FILM.TAVANIC® 500mg AVENTIS PHARMA DEUTSCHLAND GMBH
298 MOXIFLOXACINUMJ01MA14
400mgJ01MA14 MOXIFLOXACINUM COMPR. FILM.AVELOX® 400 mg 400mg BAYER HEALTHCARE AG
299 ITRACONAZOLUM *J02AC02
100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg TERAPIA S.A.
OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.
ORUNGAL 100mg JANSSEN PHARMACEUTICA NV
300 VALACYCLOVIRUM *J05AB11
500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.
Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-uluiPrescriere limitata:
Herpes zoster oftalmic.Prescriere limitata:
Herpes genital initial moderat/sever.Prescriere limitata:
Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe).Prescriere limitata:
301 BRIVUDINUM *#J05ABN1
Prescriere limitata: Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului.
125mgJ05ABN1 BRIVUDINUM COMPR.BRIVAL® 125mg BERLIN CHEMIE AG MENARINI GROUP
302 CYCLOPHOSPHAMIDUM *L01AA01
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
305 TRIPTORELINUM ***# Protocol: L013EL02AE04
Prescriere limitata: Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic.
Tratamentul pubertatii precoce.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului
0.1mgL02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SOL. INJ.DIPHERELINE 0,1 mg 0.1mg BEAUFOUR IPSEN PHARMA
11.25mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 11,25 mg 11.25mg BEAUFOUR IPSEN PHARMA
3.75mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 3,75 mg 3.75mg BEAUFOUR IPSEN PHARMA
306 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
307 PIROXICAMUMM01AC01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mgM01AC01 PIROXICAMUM COMPR.FLAMEXIN 20mg CHIESI FARMACEUTICI SPA
N - PIROXICAM MEDUMAN 20 mg 20mg MEDUMAN S.A.
PIROXICAM 20 mg 20mg ARENA GROUP SA
PIROXICAM LPH 20 mg 20mg LABORMED PHARMA SA
PIROXSAL 20mg SLAVIA PHARM SRL
20mgM01AC01 PIROXICAMUM COMPR. EFF.FLAMEXIN 20mg CHIESI FARMACEUTICI S.P.A.
20mgM01AC01 PIROXICAMUM SUPOZ.PIROXICAM 20 mg 20mg SINTOFARM SA
20mg/mlM01AC01 PIROXICAMUM SOL. INJ.FELDENE® 20 mg/ml 20mg/ml PFIZER EUROPE MA EEIG
HOTEMIN 20mg/ml EGIS PHARMACEUTICALS PLC
20mg/plicM01AC01 PIROXICAMUM PULB. PT. SOL. ORALAFLAMEXIN® 20mg/plic CHIESI FARMACEUTICI SPA
40mgM01AC01 PIROXICAMUM SUPOZ.PIROXICAM 40 mg 40mg ANTIBIOTICE SA
308 LORNOXICAMUMM01AC05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
4mgM01AC05 LORNOXICAMUM COMPR. FILM.XEFO® 4 mg 4mg NYCOMED AUSTRIA GMBH
8mgM01AC05 LORNOXICAMUM COMPR. FILM.XEFO® 8 mg 8mg NYCOMED AUSTRIA GMBH
8mg/2mlM01AC05 LORNOXICAMUM PULB. + SOLV. PT. SOL. INJ.XEFO 8 mg/ 2 ml 8mg/2ml NYCOMED AUSTRIA GMBH
309 DEXKETOPROFENUMM01AE17A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
25mgM01AE17 DEXKETOPROFENUM COMPR. FILM.TADOR 25mg BERLIN CHEMIE AG MENARINI GROUP
50mg/2mlM01AE17 DEXKETOPROFENUM SOL. INJ./CONC. PT. SOL. PERF.TADOR INJECT 50mg/2ml MENARINI INTERNATIONAL OPERATIONS S.A.
310 CELECOXIBUMM01AH01
Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM01AH01 CELECOXIBUM CAPS.
44 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CELEBREX 100 mg 100mg PFIZER EUROPE MA EEIG
200mgM01AH01 CELECOXIBUM CAPS.CELEBREX 200 mg 200mg PFIZER EUROPE MA EEIG
311 ETORICOXIBUMM01AH05
Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
120mgM01AH05 ETORICOXIBUM COMPR. FILM.ARCOXIA® 120 mg 120mg MERCK SHARP & DOHME ROMANIA S.R.L.
60mgM01AH05 ETORICOXIBUM COMPR. FILM.ARCOXIA® 60 mg 60mg MERCK SHARP & DOHME ROMANIA S.R.L.
90mgM01AH05 ETORICOXIBUM COMPR. FILM.ARCOXIA® 90 mg 90mg MERCK SHARP & DOHME ROMANIA S.R.L.
312 GLUCOSAMINUMM01AX05
150mg/plicM01AX05 GLUCOSAMINUM PULB. PT. SOL. ORALADONA® 150mg/plic ROTTAPHARM SPA
313 NIMESULIDUMM01AX17A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM01AX17 NIMESULIDUM COMPR.APONIL 100mg MEDOCHEMIE LTD
AULIN® 100 mg 100mg CSC PHARMACEUTICALS HANDELS GMBH
COXTRAL 100mg ZENTIVA AS
LEMESIL 100mg ANFARM HELLAS S.A. PHARMACEUTICALS
NIMESULID LPH 100 mg 100mg LABORMED PHARMA SA
NIMESULID 100 mg 100mg MAGISTRA C & C
NIMESULID ARENA 100 mg 100mg ARENA GROUP S.A.
NIMESULID SLAVIA 100mg SLAVIA PHARM SRL
NISE 100 mg 100mg DR. REDDY'S LABORATORIES
100mgM01AX17 NIMESULIDUM PULB. PT. SUSP. ORALASULIDAMOR 100mg FARMACEUTICI DAMOR SPA
100mg/plicM01AX17 NIMESULIDUM GRAN. PT. SUSP. ORALAAULIN® 100mg/plic CSC PHARMACEUTICALS HANDELS GMBH
NIMESIL 100mg/plic LAB. GUIDOTTI SPA
314 BACLOFENUMM03BX01
10mgM03BX01 BACLOFENUM COMPR.LIORESAL® 10mg NOVARTIS PHARMA GMBH
25mgM03BX01 BACLOFENUM COMPR.LIORESAL® 25mg NOVARTIS PHARMA GMBH
315 ACIDUM ALENDRONICUM *M05BA04
Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).
Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.
Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 10 mg 10mg MERCK SHARP & DOHME S.R.L.
70mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 70 mg 70mg MERCK SHARP & DOHME S.R.L.
316 ACIDUM IBANDRONICUM *M05BA06
Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).
Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.
Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mgM05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONVIVA 150mg 150mg ROCHE REGISTRATION LTD.
317 ACIDUM RISEDRONICUM *M05BA07
Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).
Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.
Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
35mgM05BA07 ACIDUM RISEDRONICUM COMPR. FILM.ACTONEL® SAPTAMANAL 35mg AVENTIS PHARMA AB
318 STRONTIUM RANELATUM *M05BX03
2gM05BX03 STRONTIUM RANELATUM GRAN. PT. SUSP. ORALAOSSEOR 2 g 2g LES LAB. SERVIER
319 COMBINATII (ACIDUM
ALENDRONICUM+COLECALCIFEROLUM) *
M05BB03
Cod restrictie 3001: Tratamentul osteoporozei la pacienti cu scor T</= -2,5 masurat DEXA (coloana vertebrala sau sold).
Cod restrictie 3002 : Tratamentul osteoporozei la pacienti cu scor T</= -2 masurat DEXA (coloana vertebrala sau sold) si istoric de fracturi pe structuri osoase fragile.
Cod restrictie 3003 : Tratamentul osteoporozei la paciente in postmenopauza care au suferit fracturi vertebrale osteoporotice in antecedente.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
70mg/2800UIM05BB03 COMBINATII (ACIDUM
ALENDRONICUM+COLECALCIFEROLUM)
COMPR.
FOSAVANCE 70mg/2800UI 70mg/2800UI MERCK SHARP & DOHME LTD.
320 OXYCODONUM *#N02AA05
Prescriere limitata: Durere severa, invalidanta, care nu raspunde la analgezice non-opioide.
Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.
Risc inalt de aparitie a dependentei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.
45 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
OXYCONTIN® 10 mg 10 mg MUNDIPHARMA GMBH
20 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 20 mg 20 mg MUNDIPHARMA GMBH
40 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 40 mg 40 mg MUNDIPHARMA GMBH
80mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 80 mg 80mg MUNDIPHARMA GMBH
321 DIHYDROCODEINUM *N02AA08
120mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 120 mg 120mg MUNDIPHARMA GMBH
60mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 60 mg 60mg MUNDIPHARMA GMBH
90mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 90 mg 90mg MUNDIPHARMA GMBH
322 COMBINATII (TRAMADOLUM+PARACETAMOLUM)N02AX52
Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.
Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.
37,5mg+325mgN02AX52 COMBINATII
(TRAMADOLUM+PARACETAMOLUM)
COMPR. FILM.
ZALDIAR® 37,5mg+325mg GRUNENTHAL GMBH
323 CLONAZEPAMUMN03AE01
0.5mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL 0.5mg ROCHE ROMANIA S.R.L.
2mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL® 2mg ROCHE ROMANIA S.R.L.
324 PREGABALINUM **# Protocol: N025G;N032GN03AX16
150mgN03AX16 PREGABALINUM CAPS.LYRICA 150 mg 150mg PFIZER LTD.
300mgN03AX16 PREGABALINUM CAPS.LYRICA 300 mg 300mg PFIZER LTD.
75mgN03AX16 PREGABALINUM CAPS.LYRICA 75 mg 75mg PFIZER LTD.
326 PRAMIPEXOLUM *N04BC05
Prescriere limitata: Tratamentul simptomatic al sindromului idiopatic al picioarelor nelinistite, forme moderate/severe.
La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.18mgN04BC05 PRAMIPEXOLUM COMPR.MIRAPEXIN 0,18 mg 0.18mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH
0.7mgN04BC05 PRAMIPEXOLUM COMPR.MIRAPEXIN 0,7 mg 0.7mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH
327 PIRIBEDILUM **N04BXN1
50mgN04BXN1 PIRIBEDILUM DRAJ. ELIB. PREL.PRONORAN® 50 mg LP 50mg LES LAB. SERVIER IND.
328 TIAPRIDUMN05AL03
100mgN05AL03 TIAPRIDUM COMPR.TIAPRIDAL® 100 mg 100mg SANOFI-SYNTHELABO FRANCE
100mg/2mlN05AL03 TIAPRIDUM SOL. INJ.TIAPRIDAL 100 mg/2 ml 100mg/2ml SANOFI-AVENTIS FRANCE
329 BUSPIRONUMN05BE01
Prescriere limitata: Pentru tratamentul de scurta durata al anxietatii.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgN05BE01 BUSPIRONUM COMPR.SPITOMIN 10 mg 10mg EGIS PHARMACEUTICALS PLC
STRESSIGAL 10mg ANFARM HELLAS S.A. PHARMACEUTICALS
5mgN05BE01 BUSPIRONUM COMPR.SPITOMIN 5 mg 5mg EGIS PHARMACEUTICALS PLC
330 MAPROTILINUM *N06AA21
10mgN06AA21 MAPROTILINUM COMPR. FILM.LUDIOMIL® 10 mg 10mg NOVARTIS PHARMA GMBH
25mgN06AA21 MAPROTILINUM COMPR. FILM.LUDIOMIL® 25 mg 25mg NOVARTIS PHARMA GMBH
331 ESCITALOPRAMUM ** Protocol: N009FN06AB10
10mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 10 mg 10mg H. LUNDBECK A/S
5mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 5 mg 5mg H. LUNDBECK A/S
332 TRAZODONUM ** Protocol: N010FN06AX05
150mgN06AX05 TRAZODONUM COMPR. ELIB. PREL.TRITTICO AC 150 mg 150mg ANGELINI FRANCESCO SPA
333 TIANEPTINUM ** Protocol: N011FN06AX14
12.5mgN06AX14 TIANEPTINUM DRAJ.COAXIL® 12.5mg LES LAB. SERVIER IND.
334 MILNACIPRANUM ** Protocol: N002FN06AX17
25mgN06AX17 MILNACIPRANUM CAPS.IXEL 25mg PIERRE FABRE MEDICAMENT
50mgN06AX17 MILNACIPRANUM CAPS.IXEL 50mg PIERRE FABRE MEDICAMENT
46 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
335 DULOXETINUM ** Protocol: N014FN06AX21
30mgN06AX21 DULOXETINUM CAPS. GASTROREZ.CYMBALTA 30mg 30mg ELI LILLY NEDERLAND BV
100mg/50mlN06AX21 DULOXETINUM SOL. PERF.CYMBALTA 60mg 60mg ELI LILLY NEDERLAND BV
336 BUPROPIONUM **#N06AXN1
150mgN06AXN1 BUPROPIONUM COMPR. FILM. ELIB. PREL.WELLBUTRIN SR 150 mg 150mg GLAXO WELLCOME UK LTD.
337 PRAMIRACETAMUM **#N06BX16
600mgN06BX16 PRAMIRACETAMUM COMPR. FILM.PRAMISTAR 600mg F.I.R.M.A. S.p.a. (MENARINI GROUP)
338 VINPOCETINUMN06BX18
10mgN06BX18 VINPOCETINUM COMPR.CAVINTON® FORTE 10mg GEDEON RICHTER LTD.
5mgN06BX18 VINPOCETINUM CAPS.VIMPOCETIN 5 mg 5mg VIM SPECTRUM SRL
5mgN06BX18 VINPOCETINUM COMPR.CAVINTON® 5mg GEDEON RICHTER LTD.
339 BETAHISTINUMN07CA01
16mgN07CA01 BETAHISTINUM COMPR.BETASERC® 16 mg 16mg SOLVAY PHARMACEUTICALS BV
24mgN07CA01 BETAHISTINUM COMPR.BETASERC® 24 mg 24mg SOLVAY PHARMACEUTICALS BV
80mgN07CA01 BETAHISTINUM COMPR.URUTAL 8 mg 80mg A & G MED TRADING S.R.L.
8mgN07CA01 BETAHISTINUM COMPR.BETASERC® 8 mg 8mg SOLVAY PHARMACEUTICALS BV
MICROSER 8mg PRODOTTI FORMENTI
VESTIBO 8 mg 8mg ACTAVIS GROUP HF.
340 COMBINATII (CINNARIZINUM+DIMENHIDRATUM)N07CA52
N07CA52 COMBINATII
(CINNARIZINUM+DIMENHIDRATUM)
COMPR.
ARLEVERT HENNIG ARZNEIMITTEL GMBH & CO.KG
341 HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA ** Protocol: N026FN07XN01
215.2mg/mlN07XN01 HIDROLIZAT DE PROTEINA DIN CREIER DE
PORCINA
SOL. INJ./PERF.
CEREBROLYSIN® 215.2mg/ml EBEWE PHARMA GMBH NFG. KG
342 HYDROXYCHLOROQUINUMP01BA02
200mgP01BA02 HYDROXYCHLOROQUINUM COMPR. FILM.PLAQUENIL® 200mg SANOFI-SYNTHELABO LTD.
343 FENOTEROLUMR03AC04
100µg/dozaR03AC04 FENOTEROLUM SOL. DE INHALAT PRESURIZATABEROTEC N - 100 µg 100µg/doza BOEHRINGER INGELHEIM INT. GMBH
344 BUDESONIDUM *R01AD05
Prescriere limitata: Profilaxia si tratamentul rinitei alergice.
32µg/dozaR01AD05 BUDESONIDUM SPRAY NAZAL SUSP.RHINOCORT® AQUA 32µg/doza ASTRAZENECA AB
50µg/dozaR01AD05 BUDESONIDUM SPRAY NAZ.,SUSP.TAFEN NASAL 50µg/doza LEK PHARMACEUTICALS D.D.
345 FLUTICASONUM *R01AD08
50µg/dozaR01AD08 FLUTICASONUM SPRAY NAZAL SUSP.FLIXONASE® 50µg/doza GLAXOWELLCOME UK LTD.
Profilaxia si tratamentul rinitei alergicePrescriere limitata:
346 MOMETASONUM *R01AD09
50µg/dozaR01AD09 MOMETASONUM SPRAY NAZAL SUSP.NASONEX 50µg/doza SCHERING PLOUGH EUROPE
Profilaxia si tratamentul rinitei alergice.Prescriere limitata:
Tratamentul polipozelor nazale a adultului.Prescriere limitata:
347 COMBINATII (FENOTEROLUM + IPRATROPIUM) *R03AK03
0,020mg+0,050m
g
R03AK03 COMBINATII (FENOTEROLUM +
IPRATROPIUM)
AEROSOL SOL. INHAL.
BERODUAL® N 0,020mg+0,050mg BOEHRINGER INGELHEIM INT. GMBH
348 COMBINATII (SALMETEROLUM+FLUTICASONUM) *R03AK06
Prescriere limitata: Tratament simptomatic al bolii pulmonare cronice obstructive (BPOC) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si
simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici.
Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
25mg/125mgR03AK06 COMBINATII
(SALMETEROLUM+FLUTICASONUM)
AEROSOL SUSP. INHAL.
SERETIDE® 25/125 µg INHALER CFC FREE 25mg/125mg GLAXOWELLCOME UK LTD.
25mg/250mgR03AK06 COMBINATII
(SALMETEROLUM+FLUTICASONUM)
AEROSOL SUSP. INHAL.
SERETIDE® 25/250 µg INHALER CFC FREE 25mg/250mg GLAXOWELLCOME UK LTD.
25mg/50mgR03AK06 COMBINATII
(SALMETEROLUM+FLUTICASONUM)
AEROSOL SUSP. INHAL.
SERETIDE® 25/50 µg INHALER CFC FREE 25mg/50mg GLAXOWELLCOME UK LTD.
47 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
50mg/100mgR03AK06 COMBINATII
(SALMETEROLUM+FLUTICASONUM)
PULB. INHAL.
SERETIDE DISKUS 50/100 50mg/100mg GLAXO WELLCOME UK LIMITED
50mg/250mgR03AK06 COMBINATII
(SALMETEROLUM+FLUTICASONUM)
PULB. INHAL.
SERETIDE DISKUS 50/250 50mg/250mg GLAXOWELLCOME UK LTD.
50mg/500mgR03AK06 COMBINATII
(SALMETEROLUM+FLUTICASONUM)
PULB. INHAL.
SERETIDE DISKUS 50/500 50mg/500mg GLAXOWELLCOME UK LTD.
349 COMBINATII (BUDESONIDUM+FORMOTEROLUM) *R03AK07
Prescriere limitata: Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si
simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici.
Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
160/4.5µgR03AK07 COMBINATII
(BUDESONIDUM+FORMOTEROLUM)
PULB. INHAL.
SYMBIOCORT® TURBUHALER® 160/4,5 µg 160/4.5µg ASTRAZENECA AB
320/9µgR03AK07 COMBINATII
(BUDESONIDUM+FORMOTEROLUM)
PULB. INHAL.
SYMBIOCORT® TURBUHALER® 320/9 µg 320/9µg ASTRAZENECA AB
80/4.5µgR03AK07 COMBINATII
(BUDESONIDUM+FORMOTEROLUM)
PULB. INHAL.
SYMBIOCORT® TURBUHALER® 80/4,5 µg 80/4.5µg ASTRAZENECA AB
350 FLUTICASONUM *R03BA05
Prescriere limitata: Tratamentul de control al astmului bronsic persistent.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.5mg/2mlR03BA05 FLUTICASONUM SUSP. INHAL.FLIXOTIDE® NEBULES® 0,5 mg/2 ml 0.5mg/2ml GLAXO WELLCOME UK LTD.
125µg/dozaR03BA05 FLUTICASONUM SUSP. INHAL. PRESURIZATAFLIXOTIDE 125 INHALER CFC - Free 125µg/doza GLAXO WELLCOME UK LTD.
2mg/2mlR03BA05 FLUTICASONUM SUSP. INHAL.FLIXOTIDE® NEBULES® 2 mg/2 ml 2mg/2ml GLAXO WELLCOME UK LTD.
50µg/dozaR03BA05 FLUTICASONUM SUSP. INHAL. PRESURIZATAFLIXOTIDE® 50 INHALER CFC - Free 50µg/doza GLAXO WELLCOME UK LTD.
352 CICLESONIDUM *R03BA08
Prescriere limitata: Tratamentul de fond al astmului bronsic persistent.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
160µg/dozaR03BA08 CICLESONIDUM SOL. DE INHALAT PRESURIZATAALVESCO 160 INHALER 160µg/doza ALTANA PHARMA AG
80µg/dozaR03BA08 CICLESONIDUM SOL. DE INHALAT PRESURIZATAALVESCO 80 INHALER 80µg/doza ALTANA PHARMA AG
353 TIOTROPIUM *R03BB04
18µgR03BB04 TIOTROPIUM CAPS. CU PULB.INHAL.SPIRIVA® 18 µg 18µg BOEHRINGER INGELHEIM PHARMA GMBH&CO.KG
Pentru tratamentul de intretinere pe termen lung al bronhospasmului si dispneei associate bolii pulmonare obstructive cronicePrescriere limitata:
354 AMINOPHYLLINUMR03DA05
100mgR03DA05 AMINOPHYLLINUM CAPS.MIOFILIN 100 mg 100mg ZENTIVA SA
100mgR03DA05 AMINOPHYLLINUM COMPR.AMINOFILINA EEL 100mg BIO EEL SRL
200mgR03DA05 AMINOPHYLLINUM COMPR.AMINOFILINA 200 mg 200mg ARENA GROUP SA
24mg/mlR03DA05 AMINOPHYLLINUM SOL. INJ.MIOFILIN 24mg/ml ZENTIVA S.A.
355 MONTELUKASTUM *R03DC03
10mgR03DC03 MONTELUKASTUM COMPR. FILM.SINGULAIR® 10mg MERCK SHARP & DOHME ROMANIA S.R.L.
Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu
durata scurta de actiune.
Prescriere limitata:
4mgR03DC03 MONTELUKASTUM COMPR. MAST.SINGULAIR 4mg MERCK SHARP & DOHME S.R.L.
Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu
durata scurta de actiune.
Prescriere limitata:
Tratament astmului bronsic persistent la copii cu varste cuprinse intre 2 si 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.Cod restrictie 2617:
4mg/plicR03DC03 MONTELUKASTUM GRANULESINGULAIR® 4mg/plic MERCK SHARP & DOHME ROMANIA S.R.L.
Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu
durata scurta de actiune.
Prescriere limitata:
Tratament astmului bronsic persistent la copii cu varste cuprinse intre 2 si 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.Cod restrictie 2617:
5mgR03DC03 MONTELUKASTUM COMPR. MAST.SINGULAIR® 5mg MERCK SHARP & DOHME ROMANIA S.R.L.
Tratamentul combinat al astmului bronsic persistent la pacientii cu simptomatologie necontrolata corespunzator cu corticosteroizi inhalatori si beta-2-agonisti cu
durata scurta de actiune.
Prescriere limitata:
Tratament astmului bronsic persistent la copii cu varste cuprinse intre 6 si 14 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.Cod restrictie 2617:
356 FENSPIRIDUMR03DX03
0.2%R03DX03 FENSPIRIDUM SIROPEURESPAL® 0.2% LES LAB. SERVIER IND.
80mgR03DX03 FENSPIRIDUM COMPR. FILM.
48 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
EURESPAL 80 mg 80mg LES LAB. SERVIER IND.
357 ERDOSTEINUMR05CB15
175mg/5mlR05CB15 ERDOSTEINUM PULB. PT. SUSP. ORALAERDOMED® 175 175mg/5ml CSC PHARMACEUTICALS HANDELS GMBH
300mgR05CB15 ERDOSTEINUM CAPS.ERDOMED 300mg MEDICOM INTERNATIONAL SRO
358 DEXTROMETHORPHANUMR05DA09
0.1%R05DA09 DEXTROMETHORPHANUM SIROPHUMEX 0.1% LAB. URGO SA
TUSSIN SIROP 0.1% GLOBAL PHARMACEUTICALS S.R.L.
0.13%R05DA09 DEXTROMETHORPHANUM SIROPHUMEX 0.13% LAB. URGO SA
10mgR05DA09 DEXTROMETHORPHANUM COMPR.TUSSIN 10mg EUROPHARM SA
15mg/5mlR05DA09 DEXTROMETHORPHANUM SIROPROFEDEX 15mg/5ml BIOFARM SA
20mgR05DA09 DEXTROMETHORPHANUM COMPR.TUSSIN FORTE 20mg EUROPHARM SA
3.75mg/5mlR05DA09 DEXTROMETHORPHANUM SOL. ORALAROBITUSSIN JUNIOR 3.75mg/5ml WYETH WHITEHALL EXPORT GMBH
7.5mg/5mlR05DA09 DEXTROMETHORPHANUM SOL. ORALAROBITUSSIN ANTITUSSICUM 7.5mg/5ml WYETH WHITEHALL EXPORT GMBH
359 LEVOCETIRIZINUMR06AE09
5mgR06AE09 LEVOCETIRIZINUM COMPR. FILM.XYZAL® 5mg U.C.B. GMBH
5mg/mlR06AE09 LEVOCETIRIZINUM PIC. ORALE, SOL.XYZAL 5mg/ml U.C.B. GMBH
360 FEXOFENADINUMR06AX26
120mgR06AX26 FEXOFENADINUM COMPR. FILM.ALTIVA 120 mg 120mg RANBAXY UK LTD.
TELFAST® 120 mg 120mg AVENTIS PHARMA DEUTSCHLAND GMBH
180mgR06AX26 FEXOFENADINUM COMPR. FILM.ALTIVA 180 mg 180mg RANBAXY UK LTD.
TELFAST® 180 mg 180mg AVENTIS PHARMA DEUTSCHLAND GMBH
30mgR06AX26 FEXOFENADINUM COMPR. FILM.TELFAST® 30 mg 30mg AVENTIS PHARMA DEUTSCHLAND GMBH
361 DESLORATADINUMR06AX27
0.5mg/mlR06AX27 DESLORATADINUM SIROPAERIUS 0.5mg/ml 0.5mg/ml SP EUROPE
5mgR06AX27 DESLORATADINUM COMPR. FILM.AERIUS 5mg 5mg SP EUROPE
362 GENTAMICINUMS01AA11
0.3%S01AA11 GENTAMICINUM PICATURI OFT.-SOL.OPHTAGRAM® 0,3% 0.3% LAB. CHAUVIN
0.3%S01AA11 GENTAMICINUM SOL. OFT.GENTICOL 0.3% S.I.F.I. SPA
0.3%S01AA11 GENTAMICINUM UNG. OFT.GENTICOL 0.3% S.I.F.I. SPA
OPHTAGRAM® 0,3% 0.3% LAB. CHAUVIN
0.3%S01AA11 GENTAMICINUM PIC. OFT., SOLGENTAMICIN SULPHATE 0.3% E.I.P.I.CO. MED S.R.L.
363 TOBRAMYCINUMS01AA12
0.3%S01AA12 TOBRAMYCINUM UNG. OFT.TOBREX® 0.3% ALCON COUVREUR NV
0.3%S01AA12 TOBRAMYCINUM PIC. OFT., SOL.TOBISOL 0.3% E.I.P.I.CO. MED S.R.L.
3mg/mlS01AA12 TOBRAMYCINUM PIC. OFT.,SOL.TOBREX 3mg/ml ALCON COUVREUR NV
364 NETILMICINUMS01AA23
0.3%S01AA23 NETILMICINUM PICATURI OFT.-SOL.NETTACIN® 0.3% S.I.F.I. SPA
3mg/gS01AA23 NETILMICINUM UNG. OFT.NETTAVISC 3mg/g 3mg/g S.I.F.I. SPA
0.3%S01AA23 NETILMICINUM PIC. OFT., SOLNETTACIN® 0.3% S.I.F.I. SPA
365 OFLOXACINUMS01AX11
0.3%S01AX11 OFLOXACINUM PICATURI OFT.-SOL.FLOXAL® 0.3% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
0.3%S01AX11 OFLOXACINUM UNG. OFT.FLOXAL® 0.3% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
366 DEXAMETHASONUMS01BA01
0.1%S01BA01 DEXAMETHASONUM PICATURI OFT.-SUSP.MAXIDEX® 0.1% ALCON COUVREUR NV
367 BETAMETHASONUMS01BA06
0.1%S01BA06 BETAMETHASONUM SOL. OFT.OPHTAMESONE 0.1% DAR AL DAWA PHARMA S.R.L
368 COMBINATII (NETILMICINUM + DEXAMETHASONUM)S01CA01
49 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
S01CA01 COMBINATII (NETILMICINUM +
DEXAMETHASONUM)
PIC. OFT.,SOL.
NETILDEX S.I.F.I. SPA
S01CA01 COMBINATII (NETILMICINUM +
DEXAMETHASONUM)
PIC. OFT.SOL. UNIDOZA
NETILDEX S.I.F.I. SPA
369 COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)S01CA01
1mg+3mgS01CA01 COMBINATII (TOBRAMYCINUM +
DEXAMETHASONUM)
UNG. OFT.
TOBRADEX® 1mg+3mg ALCON COUVREUR NV
1mg+3mgS01CA01 COMBINATII (TOBRAMYCINUM +
DEXAMETHASONUM)
PICATURI OFT.-SUSP.
TOBRADEX® 1mg+3mg ALCON COUVREUR NV
370 COMBINATII (CHLORAMPHENICOLUM + DEXAMETHASONUM)S01CA01
5mg/ml+1mg/mlS01CA01 COMBINATII (CHLORAMPHENICOLUM +
DEXAMETHASONUM)
PICATURI OFT.-SOL.
SPERSADEX COMP 5mg/ml+1mg/ml NOVARTIS PHARMA GMBH
371 OLOPATADINUMS01GX09
1mg/mlS01GX09 OLOPATADINUM PIC. OFT., SOL.OPATANOL 1mg/ml 1mg/ml ALCON LABORATORIES LTD.
372 RETINOLUMS01XA02
10mg/gS01XA02 RETINOLUM GEL OFT.OCULOTECT 10mg/g NOVARTIS PHARMA GMBH
1219 CARBIMAZOLUMH03BB01
5mgH03BB01 CARBIMAZOLUM COMPR. FILM.CARBIMAZOLE 5 5mg REMEDICA LTD.
50 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G1 INSUFICIENTA CARDIACA CRONICA (CLASA III SAU IV NYHA).
373 ACENOCUMAROLUMB01AA07
2mgB01AA07 ACENOCUMAROLUM COMPR.TROMBOSTOP 2 mg 2mg TERAPIA SA
4mgB01AA07 ACENOCUMAROLUM COMPR.SINTROM® 4mg NOVARTIS PHARMA GMBH
374 DIGOXINUMC01AA05
0.05mg/mlC01AA05 DIGOXINUM SOL. ORALALANOXIN SOLUTIE ORALA 0.05mg/ml THE WELLCOME FOUNDATION LTD.
0.25mgC01AA05 DIGOXINUM COMPR.DIGOXIN 0,25 mg 0.25mg ZENTIVA S.A.
0.5mg/mlC01AA05 DIGOXINUM SOL. INJ.DIGOXIN 0,5 mg/2 ml 0.5mg/ml ZENTIVA S.A.
375 HYDROCHLOROTHIAZIDUMC03AA03
25mgC03AA03 HYDROCHLOROTHIAZIDUM COMPR.NEFRIX 25 mg 25mg ZENTIVA SA
376 FUROSEMIDUMC03CA01Electroliţii serici trebuie să fie verificaţi periodic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg/mlC03CA01 FUROSEMIDUM SOL. INJ.FUROSEMID 20 mg/2 ml 10mg/ml ZENTIVA SA
40mgC03CA01 FUROSEMIDUM COMPR.FUROSEMID ARENA 40 mg 40mg ARENA GROUP S.A.
FUROSEMID EEL 40mg BIO EEL SRL
FUROSEMID LPH 40 mg 40mg LABORMED PHARMA SA
FUROSEMID MCC 40 mg 40mg MAGISTRA C & C SRL
FUROSEMID SLAVIA 40mg SLAVIA PHARM SRL
FUROSEMID ZENTIVA 40mg ZENTIVA SA
377 SPIRONOLACTONUMC03DA01
Electroliţii serici trebuie să fie verificaţi periodic.
Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 100mg GEDEON RICHTER LTD.
25mgC03DA01 SPIRONOLACTONUM COMPR.SPIRONOLACTONA 25 mg 25mg BIO EEL SRL
25mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 25 mg 25mg AC HELCOR PHARMA SRL
SPIRONOLACTONA 25 mg 25mg TERAPIA SA
50mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 50mg GEDEON RICHTER LTD.
50mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 50 mg 50mg AC HELCOR PHARMA SRL
378 METOPROLOLUMC07AB02
100mgC07AB02 METOPROLOLUM COMPR.BETAPROL 100 mg 100mg AC HELCOR PHARMA SRL
BLOXAN 100mg KRKA D.D. NOVO MESTO
EGILOK 100 mg 100mg EGIS PHARMACEUTICALS P.L.C.
METOPRO TAD 100 100mg TAD PHARMA GMBH
METOPROLOL 100 mg 100mg OZONE LABORATORIES LTD.
METOPROLOL AL 100 100mg ALIUD® PHARMA GMBH & CO.KG
METOPROLOL LPH 100 mg 100mg LABORMED PHARMA SA
METOPROLOL MEDICO UNO 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.
METOPROLOL TERAPIA 100 mg 100mg TERAPIA SA
VASOCARDIN® 100 100mg SLOVAKOFARMA
100mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.METOPROLOL RETARD 100 mg 100mg TERAPIA S.A.
100mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 100 mg 100mg ASTRAZENECA AB
190mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 190 mg 190mg HEXAL AG
1mg/mlC07AB02 METOPROLOLUM SOL. INJ.BETALOC 1mg/ml ASTRAZENECA AB
200mgC07AB02 METOPROLOLUM COMPR. ELIB. PREL.VASOCARDIN® SR 200 200mg ZENTIVA AS
25mgC07AB02 METOPROLOLUM COMPR.EGILOK 25 mg 25mg EGIS PHARMACEUTICALS P.L.C.
METOPROLOL 25 mg 25mg ARENA GROUP S.A.
METOPROLOL LPH 25 mg 25mg LABORMED PHARMA SA
METOPROLOL MEDICO UNO 25 mg 25mg MEDICO UNO PHARMACEUTICAL S.R.L.
47.5mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 47,5 mg 47.5mg HEXAL AG
50mgC07AB02 METOPROLOLUM COMPR.BETAPROL 50 mg 50mg AC HELCOR PHARMA SRL
EGILOK 50 mg 50mg EGIS PHARMACEUTICALS P.L.C.
METOPRO TAD 50 50mg TAD PHARMA GMBH
METOPROLOL 50 mg 50mg OZONE LABORATORIES LTD.
METOPROLOL AL 50 50mg ALIUD PHARMA GMBH & CO.KG
METOPROLOL LPH 50 mg 50mg LABORMED PHARMA SA
METOPROLOL MEDICO UNO 50 mg 50mg MEDICO UNO PHARMACEUTICAL S.R.L.
METOPROLOL TERAPIA 50 mg 50mg TERAPIA SA
51 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
50mgC07AB02 METOPROLOLUM COMPR. FILM. ELIB. PREL.BETALOC® ZOC 50 mg 50mg ASTRAZENECA AB
95mgC07AB02 METOPROLOLUM COMPR.FILM.ELIB.MOD.METOSUCCINAT SANDOZ 95 mg 95mg HEXAL AG
379 BISOPROLOLUMC07AB07
2.5mgC07AB07 BISOPROLOLUM COMPR. FILM.CONCOR COR 2,5 mg 2.5mg MERCK KGAA
380 NEBIVOLOLUM **C07AB12
5mgC07AB12 NEBIVOLOLUM COMPR.NEBILET® 5mg BERLIN CHEMIE AG MENARINI GROUP
381 CARVEDILOLUMC07AG02
12,5 mgC07AG02 CARVEDILOLUM COMPR.CARVEDILOL SANDOZ 12,5 mg HEXAL AG
12.5mgC07AG02 CARVEDILOLUM COMPR.ATRAM 12,5 12.5mg ZENTIVA AS
CARVEDILOL 12,5 mg 12.5mg VIM SPECTRUM SRL
CARVEDILOL HELCOR 12,5 mg 12.5mg AC HELCOR PHARMA SRL
CARVEDILOL LPH 12,5 mg 12.5mg LABORMED PHARMA SA
CARVEDILOL TEVA 12,5 mg 12.5mg TEVA PHARMACEUTICAL S.R.L.
CORYOL® 12.5mg KRKA D.D.
DILATREND® 12,5 mg 12.5mg ROCHE ROMANIA S.R.L.
TALLITON® 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.
12.5mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 12,5 mg 12.5mg WORWAG PHARMA GMBH & CO. KG
25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 25 25mg ZENTIVA AS
CARVEDILOL HELCOR 25 mg 25mg AC HELCOR PHARMA SRL
CARVEDILOL LPH 25 mg 25mg LABORMED PHARMA SA
CARVEDILOL SANDOZ 25mg HEXAL AG
CARVEDILOL TEVA 25 mg 25mg TEVA PHARMACEUTICAL S.R.L.
CORYOL® 25mg KRKA D.D.
DILATREND® 25 mg 25mg ROCHE ROMANIA S.R.L.
TALLITON® 25 mg 25mg EGIS PHARMACEUTICALS LTD.
25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 25 mg 25mg WORWAG PHARMA GMBH & CO. KG
3.125mgC07AG02 CARVEDILOLUM COMPR.CORYOL® 3,125 mg 3.125mg KRKA D.D.
6.25mgC07AG02 CARVEDILOLUM COMPR.ATRAM 6,25 6.25mg ZENTIVA AS
CARVEDILOL 6,25 mg 6.25mg VIM SPECTRUM SRL
CARVEDILOL LPH 6,25 mg 6.25mg LABORMED PHARMA SA
CARVEDILOL SANDOZ 6.25mg HEXAL AG
CARVEDILOL TEVA 6,25 mg 6.25mg TEVA PHARMACEUTICAL S.R.L.
CORYOL® 6.25mg KRKA D.D.
DILATREND® 6,25 mg 6.25mg ROCHE ROMANIA S.R.L.
TALLITON 6,25 mg 6.25mg EGIS PHARMACEUTICALS LTD.
6.25mgC07AG02 CARVEDILOLUM COMPR. FILM.CARVEDIGAMMA 6,25 mg 6.25mg WORWAG PHARMA GMBH & CO. KG
382 CAPTOPRILUMC09AA01
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in
utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
12,5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL MCC 12,5 mg 12,5mg MAGISTRA C & C
12.5mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 12,5 mg 12.5mg EGIS PHARMACEUTICALS LTD.
25mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 25 mg 25mg AC HELCOR PHARMA SRL
CAPTOPRIL SINTOFARM 25 mg 25mg SINTOFARM SA
CAPTOPRIL 25 EEL 25mg BIO EEL SRL
CAPTOPRIL 25 mg 25mg EGIS PHARMACEUTICALS LTD.
CAPTOPRIL LPH 25 mg 25mg LABORMED PHARMA SA
CAPTOPRIL MCC 25 mg 25mg MAGISTRA C & C
50 mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL 50 mg 50 mg ARENA GROUP SA
50mgC09AA01 CAPTOPRILUM COMPR.CAPTOPRIL - AC 50 mg 50mg AC HELCOR PHARMA SRL
CAPTOPRIL 50 EEL 50mg BIO EEL SRL
CAPTOPRIL 50 mg 50mg EGIS PHARMACEUTICALS LTD.
CAPTOPRIL LPH 50 mg 50mg LABORMED PHARMA SA
CAPTOPRIL MCC 50 mg 50mg MAGISTRA C & C
383 ENALAPRILUMC09AA02
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in
utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1.25mg/mlC09AA02 ENALAPRILUM SOL. INJ.ENAP® 1.25mg/ml KRKA D.D.
10mgC09AA02 ENALAPRILUM COMPR.EDNYT® 10 mg 10mg GEDEON RICHTER LTD.
ENAHEXAL® 10 mg 10mg HEXAL AG
ENALA TAD 10 10mg TAD PHARMA GMBH
ENALAP 10mg E.I.P.I.CO. MED S.R.L.
ENALAPRIL 10 mg 10mg MAGISTRA C & C
52 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
ENALAPRIL AL 10 10mg ALIUD® PHARMA GMBH & CO.KG
ENALAPRIL FABIOL 10 mg 10mg FABIOL SA
ENALAPRIL LPH 10 mg 10mg LABORMED PHARMA SA
ENALAPRIL SANDOZ 10 mg 10mg SANDOZ SRL
ENALAPRIL TERAPIA 10 mg 10mg TERAPIA SA
ENAM 10 mg 10mg REPREZENTANTA DR. REDDY'S LABORATORIES LTD.
ENAP 10 mg 10mg KRKA D.D. NOVO MESTO
RENITEC 10 mg 10mg MERCK SHARP & DOHME ROMANIA S.R.L.
2.5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 2,5 mg 2.5mg GEDEON RICHTER LTD.
20mgC09AA02 ENALAPRILUM COMPR.EDNYT® 20 mg 20mg GEDEON RICHTER LTD.
ENAHEXAL® 20 mg 20mg HEXAL AG
ENALA TAD 20 20mg TAD PHARMA GMBH
ENALAPRIL 20mg OZONE LABORATORIES LTD.
ENALAPRIL 20 mg 20mg MAGISTRA C & C
ENALAPRIL AL 20 20mg ALIUD® PHARMA GMBH & CO.KG
ENALAPRIL FABIOL 20 mg 20mg FABIOL SA
ENALAPRIL LPH 20 mg 20mg LABORMED PHARMA SA
ENALAPRIL SANDOZ 20 mg 20mg SANDOZ SRL
ENALAPRIL TERAPIA 20 mg 20mg TERAPIA SA
ENAP 20 mg 20mg KRKA D.D. NOVO MESTO
RENITEC 20 mg 20mg MERCK SHARP & DOHME ROMANIA S.R.L.
5mgC09AA02 ENALAPRILUM COMPR.EDNYT® 5 mg 5mg GEDEON RICHTER LTD.
ENAHEXAL® 5 mg 5mg HEXAL AG
ENALA TAD 5 5mg TAD PHARMA GMBH
ENALAPRIL 5 mg 5mg OZONE LABORATORIES LTD.
ENALAPRIL AL 5 5mg ALIUD® PHARMA GMBH & CO.KG
ENALAPRIL LPH® 5 mg 5mg LABORMED PHARMA SA
ENALAPRIL SANDOZ 5 mg 5mg SANDOZ SRL
ENAP 5 mg 5mg KRKA D.D. NOVO MESTO
RENITEC 5 mg 5mg MERCK SHARP & DOHME ROMANIA S.R.L.
384 LISINOPRILUMC09AA03
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in
utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG
LISINOPRIL 10 MEDO 10mg MEDOCHEMIE ROMANIA SRL
LISINOPRIL ANTIBIOTICE 10 mg 10mg ANTIBIOTICE SA
LISINOPRIL SANDOZ 10 mg 10mg HEXAL AG
LISIREN 10 mg 10mg AC HELCOR SRL
MEDAPRIL 10 10mg MEDOCHEMIE LTD.
RANOLIP 10mg RANBAXY U.K. LIMITED
SINOPRYL® 10 10mg ECZACIBASI PHARMACEUTICALS S.R.L.
TONOLYSIN 10 mg 10mg GEDEON RICHTER LTD.
2.5mgC09AA03 LISINOPRILUM COMPR.TONOLYSIN 2,5 mg 2.5mg GEDEON RICHTER LTD.
20mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 20 mg 20mg WORWAG PHARMA GMBH & CO. KG
LISINOPRIL 20 MEDO 20mg MEDOCHEMIE ROMANIA SRL
LISINOPRIL ANTIBIOTICE 20 mg 20mg ANTIBIOTICE SA
LISINOPRIL SANDOZ 20 mg 20mg HEXAL AG
LISIREN 20 mg 20mg AC HELCOR SRL
MEDAPRIL 20 20mg MEDOCHEMIE LTD.
RANOLIP 20mg RANBAXY U.K. LIMITED
TONOLYSIN 20 mg 20mg GEDEON RICHTER LTD.
40mgC09AA03 LISINOPRILUM COMPR.LISINOPRIL ANTIBIOTICE 40 mg 40mg ANTIBIOTICE SA
5mgC09AA03 LISINOPRILUM COMPR.LISIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG
LISINOPRIL 5 MEDO 5mg MEDOCHEMIE ROMANIA SRL
LISINOPRIL SANDOZ 5 mg 5mg HEXAL AG
MEDAPRIL 5 5mg MEDOCHEMIE LTD.
RANOLIP 5mg RANBAXY U.K. LIMITED
TONOLYSIN 5 mg 5mg GEDEON RICHTER LTD.
385 RAMIPRILUMC09AA05
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea fătului in
utero.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1.25mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 1,25 mg 1.25mg RANBAXY U.K. LIMITED
10 mgC09AA05 RAMIPRILUM COMPR.EMREN 10 mg 10 mg GEDEON RICHTER ROMANIA S.A.
VIVACE 10 mg 10 mg ACTAVIS GROUP HF
10mgC09AA05 RAMIPRILUM COMPR.AMPRIL 10 mg 10mg KRKA D.D. NOVO MESTO
PIRAMIL 10 mg 10mg SANDOZ SRL
RAMIGAMMA 10 mg 10mg WORWAG PHARMA GMBH & CO. KG
RAMIPRIL-AC 10 mg 10mg AC HELCOR PHARMA SRL
TRITACE 10 10mg SANOFI - AVENTIS DEUTSCHLAND GMBH
ZENRA 10 10mg ZENTIVA S.A.
10mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 10 mg 10mg RANBAXY U.K. LIMITED
2,5 mgC09AA05 RAMIPRILUM COMPR.
53 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
EMREN 2,5 mg 2,5 mg GEDEON RICHTER ROMANIA S.A.
VIVACE 2,5 mg 2,5 mg ACTAVIS GROUP HF
2.5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 2,5 mg 2.5mg KRKA D.D. NOVO MESTO
PIRAMIL 2,5 mg 2.5mg SANDOZ SRL
RAMIPRIL-AC 2,5 mg 2.5mg AC HELCOR PHARMA SRL
TRITACE® 2,5 2.5mg AVENTIS PHARMA DEUTSCHLAND GMBH
ZENRA 2,5 2.5mg ZENTIVA S.A.
2.5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 2,5 mg 2.5mg RANBAXY U.K. LIMITED
5 mgC09AA05 RAMIPRILUM COMPR.EMREN 5 mg 5 mg GEDEON RICHTER ROMANIA S.A.
VIVACE 5 mg 5 mg ACTAVIS GROUP HF
5mgC09AA05 RAMIPRILUM COMPR.AMPRIL 5 mg 5mg KRKA D.D. NOVO MESTO
PIRAMIL 5 mg 5mg SANDOZ SRL
RAMIGAMMA 5 mg 5mg WORWAG PHARMA GMBH & CO. KG
RAMIPRIL-AC 5 mg 5mg AC HELCOR PHARMA SRL
TRITACE® 5 5mg AVENTIS PHARMA DEUTSCHLAND GMBH
ZENRA 5 5mg ZENTIVA S.A.
5mgC09AA05 RAMIPRILUM COMPR. FILM.RAMIRAN 5 mg 5mg RANBAXY U.K. LIMITED
386 VALSARTANUM ** Protocol: C005IC09CA03
160mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 160 mg 160mg NOVARTIS PHARMA GMBH
80mgC09CA03 VALSARTANUM COMPR. FILM.DIOVAN 80 mg 80mg NOVARTIS PHARMA GMBH
387 CANDESARTANUM CILEXETIL ** Protocol: C005IC09CA06
16mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 16mg ASTRAZENECA AB
8mgC09CA06 CANDESARTANUM CILEXETIL COMPR.ATACAND 8mg ASTRAZENECA AB
Protocol: BB01ISUBLISTA C1-G2 BOLNAVI CU PROTEZE VALVULARE SI VASCULARE.
388 ACENOCUMAROLUM *B01AA07
2mgB01AA07 ACENOCUMAROLUM COMPR.TROMBOSTOP 2 mg 2mg TERAPIA SA
4mgB01AA07 ACENOCUMAROLUM COMPR.SINTROM® 4mg NOVARTIS PHARMA GMBH
SUBLISTA C1-G3 BOLNAVI CU PROCEDURI INTERVENTIONALE PERCUTANE, NUMAI DUPA IMPLANTAREA UNEI PROTEZE
ENDOVASCULARE (STENT).
389 CLOPIDOGRELUM ***B01AC04
75mgB01AC04 CLOPIDOGRELUM COMPR. FILM.PLAVIX 75mg 75mg SANOFI PHARMA - BRISTOL MYERS SQUIBB
54 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: LB01B;LB02BSUBLISTA C1-G4 HEPATITELE CRONICE DE ETIOLOGIE VIRALA B, C SI D.
390 EPOETINUM ALFA ** Protocol: B013KB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
391 EPOETINUM BETA ** Protocol: B013KB03XA01
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
392 RIBAVIRINUM **** Protocol: J002NJ05AB04
200mgJ05AB04 RIBAVIRINUM CAPS.REBETOL 200 mg 200mg SP EUROPE
200mgJ05AB04 RIBAVIRINUM COMPR. FILM.COPEGUS® 200mg ROCHE ROMANIA SRL
393 LAMIVUDINUM **** Protocol: J005NJ05AF05
100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.
10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.
150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.
5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.
395 ENTECAVIRUM **** Protocol: J008NJ05AF10
0,5mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 0,5mg 0,5mg BRISTOL-MYERS SQUIBB PHARMA EEIG
1mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 1mg 1mg BRISTOL-MYERS SQUIBB PHARMA EEIG
396 FILGRASTIMUM (G-CSF) ** Protocol: B013KL03AA02
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
397 INTERFERONUM ALFA 2a **** Protocol: J007NL03AB04
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
18Mui/0.6mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 18Mui/0.6ml ROCHE ROMANIA S.R.L.
3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.
4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.
9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.
3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.
4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.
55 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.
9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.
398 INTERFERONUM ALFA 2b **** Protocol: J006NL03AB05
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
18 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE
30 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE
INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
60 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE
INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
399 PEGINTERFERON alfa-2b **** Protocol: J003NL03AB10
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 100 µg 100µg SP EUROPE
120µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 120 µg 120µg SP EUROPE
150µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 150 µg 150µg SP EUROPE
50µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 50 µg 50µg SP EUROPE
400 PEGINTERFERON alfa-2a **** Protocol: J004NL03AB11
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
135µg/mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ.PEGASYS 135 µg/ml 135µg/ml ROCHE REGISTRATION LTD.
180µg/0.5mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ. IN SERINGA PREUMPLUTAPEGASYS 180 µg/0,5ml 180µg/0.5ml ROCHE REGISTRATION LTD.
401 AMANTADINUM **N04BB01
100mgN04BB01 AMANTADINUM CAPS.VIREGYT®- K 100mg EGIS PHARMACEUTICALS LTD.
SUBLISTA C1-G5 HEPATITA AUTOIMUNA.
402 METHYLPREDNISOLONUMH02AB04
125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.
125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG
16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG
20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.
250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG
32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG
40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.
40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG
4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG
500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.
500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG
403 PREDNISOLONUMH02AB06
250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA
50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 50 50mg MERCK KGAA
404 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
SUBLISTA C1-G06 CIROZA BILIARA PRIMARA, COLANGITA SCLEROZANTA PRIMITIVA, HEPATITA CRONICA SI CIROZE DE
ALTE ETIOLOGII CU COLESTAZA.
405 ACIDUM URSODEOXYCHOLICUMA05AA02
300mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK (R) 250mg DR. FALK PHARMA GMBH
URSOFALK® 250mg DR. FALK PHARMA GMBH
URSOSAN 250mg PRO. MED. CS PRAHA AS
56 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G7 CIROZA HEPATICA.
406 LACTULOSUM *A06AD11
66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV
A06AD11 LACTULOSUMLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG
A06AD11 LACTULOSUMLAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH
66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG
670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH
66.7%A06AD11 LACTULOSUM SIROPLACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG
670mg/mlA06AD11 LACTULOSUM SOL. ORALALAEVOLAC 670mg/ml 670mg/ml FRESENIUS KABI AUSTRIA GMBH
66.7%A06AD11 LACTULOSUM LICHID ORALDUPHALAC® 66.7% SOLVAY PHARMACEUTICALS BV
65%A06AD11 LACTULOSUM SIROPLACTULOSE 65% E.I.P.I.CO. MED S.R.L.
407 RIFAXIMINUM *A07AA11
200mgA07AA11 RIFAXIMINUM COMPR. FILM.NORMIX 200 mg 200mg ALFA WASSERMANN SPA
408 EPOETINUM ALFA ** Protocol: B013KB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
409 EPOETINUM BETA ** Protocol: B013KB03XA01
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
410 FUROSEMIDUMC03CA01Electroliţii serici trebuie să fie verificaţi periodic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mg/mlC03CA01 FUROSEMIDUM SOL. INJ.FUROSEMID 20 mg/2 ml 10mg/ml ZENTIVA SA
40mgC03CA01 FUROSEMIDUM COMPR.FUROSEMID ARENA 40 mg 40mg ARENA GROUP S.A.
FUROSEMID EEL 40mg BIO EEL SRL
FUROSEMID LPH 40 mg 40mg LABORMED PHARMA SA
FUROSEMID MCC 40 mg 40mg MAGISTRA C & C SRL
FUROSEMID SLAVIA 40mg SLAVIA PHARM SRL
FUROSEMID ZENTIVA 40mg ZENTIVA SA
411 SPIRONOLACTONUMC03DA01
Electroliţii serici trebuie să fie verificaţi periodic.
Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgC03DA01 SPIRONOLACTONUM CAPS.
57 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
VEROSPIRON 100mg GEDEON RICHTER LTD.
25mgC03DA01 SPIRONOLACTONUM COMPR.SPIRONOLACTONA 25 mg 25mg BIO EEL SRL
25mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 25 mg 25mg AC HELCOR PHARMA SRL
SPIRONOLACTONA 25 mg 25mg TERAPIA SA
50mgC03DA01 SPIRONOLACTONUM CAPS.VEROSPIRON 50mg GEDEON RICHTER LTD.
50mgC03DA01 SPIRONOLACTONUM COMPR. FILM.ALSPIRON 50 mg 50mg AC HELCOR PHARMA SRL
412 PREDNISOLONUMH02AB06
250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA
50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 50 50mg MERCK KGAA
413 RIBAVIRINUM ****J05AB04
200mgJ05AB04 RIBAVIRINUM CAPS.REBETOL 200 mg 200mg SP EUROPE
200mgJ05AB04 RIBAVIRINUM COMPR. FILM.COPEGUS® 200mg ROCHE ROMANIA SRL
414 LAMIVUDINUM ****J05AF05
100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.
10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.
150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.
5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.
416 ENTECAVIRUM ****J05AF10
0,5mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 0,5mg 0,5mg BRISTOL-MYERS SQUIBB PHARMA EEIG
1mgJ05AF10 ENTECAVIRUM COMPR. FILM.BARACLUDE 1mg 1mg BRISTOL-MYERS SQUIBB PHARMA EEIG
417 FILGRASTIMUM (G-CSF) ** Protocol: B013KL03AA02
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
418 INTERFERONUM ALFA 2a ****L03AB04
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
18Mui/0.6mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 18Mui/0.6ml ROCHE ROMANIA S.R.L.
3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.
4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.
9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.
3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.
4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.
9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.
419 INTERFERONUM ALFA 2b ****L03AB05
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
18 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE
30 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE
INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
60 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE
INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
420 PEGINTERFERON alfa-2b ****L03AB10
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 100 µg 100µg SP EUROPE
120µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 120 µg 120µg SP EUROPE
150µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 150 µg 150µg SP EUROPE
58 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
50µgL03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. INJ.PEGINTRON 50 µg 50µg SP EUROPE
421 PEGINTERFERON alfa-2a ****L03AB11
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
135µg/mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ.PEGASYS 135 µg/ml 135µg/ml ROCHE REGISTRATION LTD.
180µg/0.5mlL03AB11 PEGINTERFERON alfa-2a SOL. INJ. IN SERINGA PREUMPLUTAPEGASYS 180 µg/0,5ml 180µg/0.5ml ROCHE REGISTRATION LTD.
422 AMANTADINUM **N04BB01
100mgN04BB01 AMANTADINUM CAPS.VIREGYT®- K 100mg EGIS PHARMACEUTICALS LTD.
59 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: N030CSUBLISTA C1-G10 LEUCEMII, LIMFOAME, APLAZIE MEDULARA, GAMAPATII MONOCLONALE MALIGNE, MIELOPROLIFERARI
CRONICE SI TUMORI MALIGNE, SINDROAME MIELODISPLAZICE.
423 ONDANSETRONUM ** Protocol: A004CA04AA01
2mg/mlA04AA01 ONDANSETRONUM SOL. INJ.OSETRON 4 mg 2mg/ml DR. REDDY'S LABORATORIES
OSETRON 8 mg 2mg/ml DR. REDDY'S LABORATORIES
2mg/mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.EMESET 4 mg/2 ml 2mg/ml CIPLA (UK) LIMITED
EMESET 8 mg/4 ml 2mg/ml CIPLA (UK) LIMITED
4mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 4 mg 4mg DR. REDDY'S LABORATORIES
SETRONON 4 mg 4mg PLIVA LJUBLJANA D.O.O.
ZOFRAN 4 mg 4mg GLAXO WELLCOME UK LTD.
4mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 4mg 4mg RANBAXY UK LTD.
4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 4mg/2ml 4mg/2ml GLAXO WELLCOME UK LIMITED
4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 4 mg/2 ml 4mg/2ml PLIVA LJUBLJANA D.O.O.
8mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 8 mg 8mg DR. REDDY'S LABORATORIES (UK) LTD
SETRONON 8 mg 8mg PLIVA LJUBLJANA D.O.O.
8mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 8 mg 8mg RANBAXY UK LIMITED
8mg/4mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 8mg/4ml 8mg/4ml GLAXO WELLCOME UK LIMITED
4mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 4 mg 4mg DR. REDDY'S LABORATORIES
SETRONON 4 mg 4mg PLIVA LJUBLJANA D.O.O.
ZOFRAN 4 mg 4mg GLAXO WELLCOME UK LTD.
4mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 4mg 4mg RANBAXY UK LTD.
8mgA04AA01 ONDANSETRONUM COMPR. FILM.OSETRON 8 mg 8mg DR. REDDY'S LABORATORIES (UK) LTD
SETRONON 8 mg 8mg PLIVA LJUBLJANA D.O.O.
8mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 8 mg 8mg RANBAXY UK LIMITED
8mg/4 mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 8 mg/4 ml 8mg/4 ml PLIVA LJUBLJANA D.O.O.
424 GRANISETRONUM ** Protocol: A004CA04AA02
1mgA04AA02 GRANISETRONUM COMPR. FILM.KYTRIL® 1 mg 1mg ROCHE ROMANIA S.R.L.
2mgA04AA02 GRANISETRONUM COMPR. FILM.KYTRIL 2mg F. HOFFMANN LA ROCHE LTD.
3mg/3mlA04AA02 GRANISETRONUM SOL. INJ.KYTRIL 3mg/3ml ROCHE ROMANIA SRL
2mgA04AA02 GRANISETRONUM COMPR. FILM.KYTRIL 2mg F. HOFFMANN LA ROCHE LTD.
425 PALONOSETRONUM ** Protocol: A002C;A004CA04AA05
250 µg/5mlA04AA05 PALONOSETRONUM SOL. INJ.ALOXI 250 µg/5ml HELSINN BIREX PHARMACEUTICALS LTD.
426 EPOETINUM ALFA *** Protocol: L022BB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
427 EPOETINUM BETA *** Protocol: L022BB03XA01
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
60 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
428 DARBEPOETINUM ALFA *** Protocol: L022BB03XA02
10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV
100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV
15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV
150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV
20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV
30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV
300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV
40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV
50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV
500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV
60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV
80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV
429 CYPROTERONUM **G03HA01
50mgG03HA01 CYPROTERONUM COMPR.ANDROCUR 50mg SCHERING AG
Cancer de prostata in stadiu avansat;Cod restrictie 1014:
G03HA01 CYPROTERONUMANDROCUR 50mg SCHERING AG
430 DEXAMETHASONUMH02AB02
8mgH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMETHASONE SODIUM PHOSPHATE 8mg E.I.P.I.CO. MED S.R.L.
8mg/2mlH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMED 8mg/2ml MEDOCHEMIE LTD.
431 ITRACONAZOLUMJ02AC02
100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg TERAPIA S.A.
OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.
ORUNGAL 100mg JANSSEN PHARMACEUTICA NV
432 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
433 POSACONAZOLUM **J02AC04
40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE
Profilaxia si infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc
inalt de a dezvolta infectii fungice masive;
Prescriere limitata:
Profilaxia si infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta
infectii fungice masive.
Prescriere limitata:
434 CASPOFUNGINUM ** Protocol: J010DJ02AX04
50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD
70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD
435 ANAGRELIDUM *** Protocol: L015DL01XX35
0.5mgL01XX35 ANAGRELIDUM CAPS.THROMBOREDUCTIN 0.5mg ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH
436 CICLOSPORINUM *L04AA01
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALA
61 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
EQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
437 MORPHYNUMN02AA01
Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer.
Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide.
Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.
Risc inalt de aparitie a dependentei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI
100mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 100 mg 100mg MUNDIPHARMA GMBH
100mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 100 mg 100mg LANNACHER HEILMITTEL GMBH
10mgN02AA01 MORPHYNUM COMPR. FILM.SEVREDOL 10 mg 10mg MUNDIPHARMA GMBH
10mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 10 mg 10mg MUNDIPHARMA GMBH
10mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 10 mg 10mg LANNACHER HEILMITTEL GMBH
200mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 200 mg 200mg MUNDIPHARMA GMBH
20mgN02AA01 MORPHYNUM COMPR. FILM.SEVREDOL 20 mg 20mg MUNDIPHARMA GMBH
20mg/mlN02AA01 MORPHYNUM SOL. INJ.MORFINA 20 mg/ml 20mg/ml ZENTIVA S.A.
30mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 30 mg 30mg MUNDIPHARMA GMBH
30mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 30 mg 30mg LANNACHER HEILMITTEL GMBH
60mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. MODIF.MST CONTINUS® 60 mg 60mg MUNDIPHARMA GMBH
60mgN02AA01 MORPHYNUM COMPR. FILM. ELIB. PREL.VENDAL® RETARD 60 mg 60mg LANNACHER HEILMITTEL GMBH
438 OXYCODONUMN02AA05
Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer.
Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide.
Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.
Risc inalt de aparitie a dependentei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI
10 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 10 mg 10 mg MUNDIPHARMA GMBH
20 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 20 mg 20 mg MUNDIPHARMA GMBH
40 mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 40 mg 40 mg MUNDIPHARMA GMBH
80mgN02AA05 OXYCODONUM COMPR. FILM. ELIB. MODIF.OXYCONTIN® 80 mg 80mg MUNDIPHARMA GMBH
439 DIHYDROCODEINUMN02AA08
120mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 120 mg 120mg MUNDIPHARMA GMBH
60mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 60 mg 60mg MUNDIPHARMA GMBH
90mgN02AA08 DIHYDROCODEINUM COMPR. ELIB. PREL.DHC CONTINUS 90 mg 90mg MUNDIPHARMA GMBH
440 PETHIDINUMN02AB02
50mg/mlN02AB02 PETHIDINUM SOL. INJ.MIALGIN® 100 mg/2 ml 50mg/ml ZENTIVA SA
441 FENTANYLUM **N02AB03
Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer.
Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide.
Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.
100µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMICFENTANYL SANDOZ 100 µg/h 100µg/h SANDOZ S.R.L.
16.8mg/42.0cmpN02AB03 FENTANYLUM PLASTURE TRANSDERM.DUROGESIC 100 µg/h 16.8mg/42.0cmp JANSSEN PHARMACEUTICA NV
25µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMICFENTANYL SANDOZ 25 µg/h 25µg/h SANDOZ S.R.L.
4.2mg/10.5cmpN02AB03 FENTANYLUM PLASTURE TRANSDERM.DUROGESIC 25 µg/h 4.2mg/10.5cmp JANSSEN PHARMACEUTICA NV
50µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMICFENTANYL SANDOZ 50 µg/h 50µg/h SANDOZ S.R.L.
75µg/hN02AB03 FENTANYLUM PLASTURE TRANSDERMIC
62 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
FENTANYL SANDOZ 75 µg/h 75µg/h SANDOZ S.R.L.
8.4mg/21.0cmpN02AB03 FENTANYLUM PLASTURE TRANSDERM.DUROGESIC 50 µg/h 8.4mg/21.0cmp JANSSEN PHARMACEUTICA NV
442 TRAMADOLUMN02AX02
Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.
Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice (mai putin formelor injenctabile) si concentratiilor corespunzatoare DCI-ului.
100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG
100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 100 100mg ZENTIVA AS
TRAMADOL® RETARD 100mg KRKA D.D.
100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH
100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.
TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
TRAMADOL 100mg KRKA D.D.
TRAMAG 100 100mg MAGISTRA C & C
TRAMAL® 100mg GRUNENTHAL GMBH
100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.
100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH
150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS
150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH
200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 200 200mg ZENTIVA AS
200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH
50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA
MABRON 50 mg 50mg MEDOCHEMIE LTD.
TRALGIT 50 50mg ZENTIVA A.S.
TRAMACALM 50mg AC HELCOR SRL
TRAMADOL 50mg KRKA D.D.
TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA
TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG
TRAMADOL ARENA 50mg ARENA GROUP S.A.
TRAMAL® 50mg GRUNENTHAL GMBH
URGENDOL 50mg MEDICAROM GROUP SRL
50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.
TRAMADOL EEL 50mg BIO EEL SRL
TRAMAG 50 50mg MAGISTRA C & C
50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.
TRAMADOL 50mg/ml KRKA D.D.
TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG
TRAMAL® 100 50mg/ml GRUNENTHAL GMBH
TRAMAL® 50 50mg/ml GRUNENTHAL GMBH
URGENDOL 50mg/ml MEDICAROM GROUP SRL
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG
100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH
443 METHADONUMN07BC02Risc inalt de aparitie a dependentei.
2.5mgN07BC02 METHADONUM COMPR.SINTALGON 2,5 mg 2.5mg ZENTIVA S.A.
444 CODEINUMR05DA04
15mgR05DA04 CODEINUM COMPR.CODEINA FOSFAT 15mg SLAVIA PHARM SRL
CODEINA FOSFAT 15 mg 15mg OZONE LABORATORIES LTD.
CODEINA FOSFAT LPH 15 mg 15mg LABORMED PHARMA SA
CODEINA FOSFORICA 15mg BIO EEL SRL
CODEINA FOSFORICA 15 mg 15mg MAGISTRA C & C
63 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
FARMACOD 15mg FARMACOM SA
FOSFAT DE CODEINA 15 mg 15mg SINTOFARM SA
445 DEFEROXAMINUM **(3) Protocol: V001DV03AC01
500mgV03AC01 DEFEROXAMINUM LIOF. PT. SOL. INJ./PERF.DESFERAL 500mg NOVARTIS PHARMA GMBH
446 DEFERASIROXUM *** Protocol: V002DV03AC03
125mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 125mg 125mg NOVARTIS EUROPHARM LTD.
250mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 250mg 250mg NOVARTIS EUROPHARM LTD.
500mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 500mg 500mg NOVARTIS EUROPHARM LTD.
64 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: NG01GSUBLISTA C1-G11 EPILEPSIE.
447 PHENOBARBITALUMN03AA02
100 mgN03AA02 PHENOBARBITALUM COMPR.FENOBARBITAL 100 mg 100 mg ZENTIVA SA
EpilepsiePrescriere limitata:
100mgN03AA02 PHENOBARBITALUM COMPR.FENOBARBITAL 100 mg 100mg SC ARENA GROUP SA
EpilepsiePrescriere limitata:
10%N03AA02 PHENOBARBITALUM SOL. INJ.FENOBARBITAL 200 mg/ 2 ml 10% ZENTIVA S.A
448 PHENYTOINUMN03AB02
100mgN03AB02 PHENYTOINUM COMPR.FENITOIN 100 mg 100mg GEDEON RICHTER ROMANIA SA
50mg/mlN03AB02 PHENYTOINUM SOL. INJ.PHENHYDAN®SOLUTIE INJECTABILA 50mg/ml DESITIN
449 CLONAZEPAMUMN03AE01
0.5mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL 0.5mg ROCHE ROMANIA S.R.L.
2mgN03AE01 CLONAZEPAMUM COMPR.RIVOTRIL® 2mg ROCHE ROMANIA S.R.L.
450 CARBAMAZEPINUMN03AF01
100mg/5mlN03AF01 CARBAMAZEPINUM SUSP. ORALATIMONIL SIROP 100mg/5ml DESITIN ARZNEIMITTEL GMBH
150mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 150 RETARD 150mg DESITIN
200mgN03AF01 CARBAMAZEPINUM COMPR.CARBAMAZEPIN 200mg SLAVIA PHARM SRL
CARBAMAZEPIN EEL 200mg BIO EEL SRL
CARBAMAZEPINA 200mg OZONE LABORATORIES LTD.
CARBAMAZEPINA ARENA 200 mg 200mg ARENA GROUP SA
CARBAMAZEPINA LPH 200 mg 200mg LABORMED PHARMA SA
CARBAVIM 200mg VIM SPECTRUM SRL
CARBEPSIL 200 200mg AC HELCOR SRL
FINLEPSIN 200mg AWD PHARMA GMBH & CO.KG
NEUROTOP 200mg GEROT PHARMAZEUTIKA GMBH
TAVER 200mg MEDOCHEMIE LTD.
TEGRETOL® 200 200mg NOVARTIS PHARMA GMBH
200mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 200 200mg NOVARTIS PHARMA GMBH
300mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 300 mg 300mg GEROT PHARMAZEUTIKA GMBH
300mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 300 RETARD 300mg DESITIN
400mgN03AF01 CARBAMAZEPINUM COMPR.CARBEPSIL 400 400mg AC HELCOR SRL
TEGRETOL® 400 400mg NOVARTIS PHARMA GMBH
400mgN03AF01 CARBAMAZEPINUM COMPR. FILM. ELIB. PREL.TEGRETOL CR 400 400mg NOVARTIS PHARMA GMBH
400mgN03AF01 CARBAMAZEPINUM COMPR. RET.FINLEPSIN 400 RETARD 400mg AWD PHARMA GMBH & CO.KG
600mgN03AF01 CARBAMAZEPINUM COMPR. ELIB. PREL.NEUROTOP® RETARD 600 mg 600mg GEROT PHARMAZEUTIKA GMBH
600mgN03AF01 CARBAMAZEPINUM COMPR. RET.TIMONIL 600 RETARD 600mg DESITIN
200mgN03AF01 CARBAMAZEPINUM COMPR.FILM.ELIB.PRELFINLEPSIN 200 RETARD 200mg AWD PHARMA GMBH & CO.KG
451 OXCARBAZEPINUMN03AF02
Cod restrictie 1587: Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente
anti-epileptice
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.
300mgN03AF02 OXCARBAZEPINUM COMPR. FILM.TRILEPTAL® 300 mg 300mg NOVARTIS PHARMA GMBH
600mgN03AF02 OXCARBAZEPINUM COMPR. FILM.TRILEPTAL® 600 mg 600mg NOVARTIS PHARMA GMBH
452 ACIDUM VALPROICUM + SARURIN03AG01S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.
1000mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 1000 mg 1000mg DESITIN ARZNEIMITTEL GMBH
150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.ORFIRIL LONG 150 mg 150mg DESITIN ARZNEIMITTEL GMBH
150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 150 mg 150mg GEROT PHARMAZEUTIKA GMBH
150mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 150 150mg DESITIN ARZNEIMITTEL GMBH
200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM.PETILIN 200mg REMEDICA LTD.
200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.DEPAKINE 200 mg 200mg SANOFI-AVENTIS FRANCE
300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.
65 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
ORFIRIL LONG 300 mg 300mg DESITIN ARZNEIMITTEL GMBH
300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 300 mg 300mg GEROT PHARMAZEUTIKA GMBH
300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 300 300mg DESITIN ARZNEIMITTEL GMBH
300mg/5mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPORFIRIL SIROP 300mg/5ml DESITIN ARZNEIMITTEL GMBH
400mg/4mlN03AG01 ACIDUM VALPROICUM + SARURI LIOF. + SOLV. PT. SOL.
DEPAKINE® 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU
SOLUTIE INJECTABILA i.v.
400mg/4ml SANOFI-AVENTIS FRANCE
500mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 500 mg 500mg GEROT PHARMAZEUTIKA GMBH
500mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 500 mg 500mg DESITIN ARZNEIMITTEL GMBH
50mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPCONVULEX® 50mg/ml GEROT PHARMAZEUTIKA GMBH
57.64mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPDEPAKINE 57.64mg/ml SANOFI - AVENTIS FRANCE
600mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 600 600mg DESITIN ARZNEIMITTEL GMBH
300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE CHRONO 300 mg 300mg SANOFI-AVENTIS FRANCE
500mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE® CHRONO 500 mg 500mg SANOFI-AVENTIS FRANCE
453 LAMOTRIGINUM **N03AX09
Cod restrictie 1426: Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.
0.1mg/mlN03AX09 LAMOTRIGINUM SOL. INJ.EPIMIL 100 mg 100mg IVAX PHARMCEUTICALS S.R.O.
EPIZOL 100 mg 100mg KRKA D.D. NOVO MESTO
LAMICTAL 100 mg 100mg THE WELLCOME FOUNDATION LTD.
LAMOLEP 100 mg 100mg GEDEON RICHTER LTD.
LAMOTIRAN 100 mg 100mg RANBAXY UK LTD.
LAMOTRIX 100 mg 100mg MEDOCHEMIE LTD.
PLEXXO® 100 mg 100mg DESITIN ARZNEIMITTEL GMBH
100mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 100 mg 100mg STADA ARZNEIMITTEL AG
LAMOTRIN 100 mg 100mg ACTAVIS GROUP HF.
200mgN03AX09 LAMOTRIGINUM COMPR.LAMOTIRAN 200 mg 200mg RANBAXY UK LTD.
LAMOTRIX 200 mg 200mg MEDOCHEMIE LTD.
25mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 25mg 25mg IVAX PHARMCEUTICALS S.R.O.
EPIZOL 25 mg 25mg KRKA D.D. NOVO MESTO
LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.
LAMOLEP 25 mg 25mg GEDEON RICHTER LTD.
LAMOTIRAN 25 mg 25mg RANBAXY UK LTD.
LAMOTRIX 25 mg 25mg MEDOCHEMIE LTD.
PLEXXO® 25 mg 25mg DESITIN ARZNEIMITTEL GMBH
25mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 25 mg 25mg STADA ARZNEIMITTEL AG
LAMOTRIN 25 mg 25mg ACTAVIS GROUP HF.
25mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.
2mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL® 2 mg 2mg THE WELLCOME FOUNDATION LTD.
50mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 50 mg 50mg IVAX PHARMCEUTICALS S.R.O.
EPIZOL 50 mg 50mg KRKA D.D. NOVO MESTO
LAMICTAL 50 mg 50mg THE WELLCOME FOUNDATION LTD.
LAMOLEP 50 mg 50mg GEDEON RICHTER LTD.
LAMOTIRAN 50 mg 50mg RANBAXY UK LTD.
LAMOTRIX 50 mg 50mg MEDOCHEMIE LTD.
PLEXXO® 50 mg 50mg DESITIN ARZNEIMITTEL GMBH
50mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 50 mg 50mg STADA ARZNEIMITTEL AG
LAMOTRIN 50 mg 50mg ACTAVIS GROUP HF.
5mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 5 mg 5mg THE WELLCOME FOUNDATION LTD.
454 TOPIRAMATUM **N03AX11
Cod restrictie 2797: Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin
administrarea altor merdicamente antiepileptice.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.
100mgN03AX11 TOPIRAMATUM COMPR. FILM.TOPAMAX 100 mg 100mg JOHNSON & JOHNSON D.O.O.
TOPRAN 100 mg 100mg TERAPIA S.A.
200mgN03AX11 TOPIRAMATUM COMPR. FILM.TOPAMAX 200 mg 200mg JOHNSON & JOHNSON D.O.O.
TOPRAN 200 mg 200mg TERAPIA S.A.
25mgN03AX11 TOPIRAMATUM COMPR. FILM.TOPAMAX 25 mg 25mg JOHNSON & JOHNSON D.O.O.
TOPRAN 25 mg 25mg TERAPIA S.A.
50mgN03AX11 TOPIRAMATUM COMPR. FILM.
66 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
TOPAMAX 50 mg 50mg JOHNSON & JOHNSON D.O.O.
TOPRAN 50 mg 50mg TERAPIA S.A.
455 GABAPENTINUM ***N03AX12
Cod restrictie 2664: Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare acestui DCI.
100mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 100 mg 100mg WORWAG PHARMA GMBH & CO. KG
GABALEPT 100 mg 100mg PLIVA LJUBLJANA D.O.O.
300mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 300 mg 300mg WORWAG PHARMA GMBH & CO. KG
GABALEPT 300 mg 300mg PLIVA LJUBLJANA D.O.O.
GABARAN 300 mg 300mg RANBAXY UK LTD.
400mgN03AX12 GABAPENTINUM CAPS.GABAGAMMA 400 mg 400mg WORWAG PHARMA GMBH & CO. KG
GABALEPT 400 mg 400mg PLIVA LJUBLJANA D.O.O.
GABARAN 400 mg 400mg RANBAXY UK LTD.
600mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 600 mg 600mg RANBAXY UK LTD.
800mgN03AX12 GABAPENTINUM COMPR. FILM.GABARAN 800 mg 800mg RANBAXY UK LTD.
456 LEVETIRACETAMUM **N03AX14
Prescriere limitata: Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.
Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat reactii adverse in antecedente la
alte antiepileptice.
Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat interactiuni medicamentoase cu
alte medicamente compensate adecvate.
Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde transferul la alt medicament compensat
adecvat este posibil sa genereze consecinte clinice adverse.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1000mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 1000 mg 1000mg UCB PHARMA SA
100mg/mlN03AX14 LEVETIRACETAMUM SOL. ORALAKEPPRA 100 mg/ml 100mg/ml UCB PHARMA SA
500mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 500 mg 500mg UCB PHARMA LTD
1000mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 1000 mg 1000mg UCB PHARMA SA
500mgN03AX14 LEVETIRACETAMUM COMPR. FILM.KEPPRA 500 mg 500mg UCB PHARMA LTD
457 PREGABALINUM ***N03AX16
Prescriere limitata: Tratamentul adjuvant al epilepsiei la adulţii cu convulsii parţiale, cu sau fără generalizare secundară.
150mgN03AX16 PREGABALINUM CAPS.LYRICA 150 mg 150mg PFIZER LTD.
300mgN03AX16 PREGABALINUM CAPS.LYRICA 300 mg 300mg PFIZER LTD.
75mgN03AX16 PREGABALINUM CAPS.LYRICA 75 mg 75mg PFIZER LTD.
67 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G12 BOALA PARKINSON.
458 TRIHEXYPHENIDYLUMN04AA01
2mgN04AA01 TRIHEXYPHENIDYLUM COMPR.ROMPARKIN® 2 mg 2mg TERAPIA SA
460 COMBINATII (LEVODOPUM + CARBIDOPUM) **N04BA02
100mg+25mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) CAPS. ELIB. MODIF.MADOPAR HBS 100mg+25mg ROCHE ROMANIA S.R.L.
200mg+50mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) COMPR.MADOPAR 250 200mg+50mg ROCHE ROMANIA SRL
MADOPAR® 250 200mg+50mg TERAPIA SA
Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu
inhibitor al decarboxylazei
Cod restrictie 1257:
250mg/25mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) COMPR.ISICOM 250 mg/25 mg 250mg/25mg DESITIN ARZNEIMITTEL GMBH
250mg+25mgN04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM) COMPR.CARBIDOPA / LEVODOPA TEVA 25/250 250mg+25mg TEVA PHARMACEUTICALS SRL
CREDANIL 25/250 250mg+25mg REMEDICA LTD.
NAKOM 250mg+25mg LEK PHARMACEUTICALS D.D.
ZIMOX 250mg+25mg FARAN LABORATORIES S.A.
461 COMBINATII (LEVODOPUM + BENSERAZIDUM) **N04BA02
Cod restrictie 1257: Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu
inhibitor al decarboxylazei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mg+25mgN04BA02 COMBINATII (LEVODOPUM +
BENSERAZIDUM)
CAPS. ELIB. MODIF.
MADOPAR HBS 100mg+25mg ROCHE ROMANIA S.R.L.
200mg+50mgN04BA02 COMBINATII (LEVODOPUM +
BENSERAZIDUM)
COMPR.
MADOPAR 250 200mg+50mg ROCHE ROMANIA SRL
MADOPAR® 250 200mg+50mg TERAPIA SA
250mg/25mgN04BA02 COMBINATII (LEVODOPUM +
BENSERAZIDUM)
COMPR.
ISICOM 250 mg/25 mg 250mg/25mg DESITIN ARZNEIMITTEL GMBH
250mg+25mgN04BA02 COMBINATII (LEVODOPUM +
BENSERAZIDUM)
COMPR.
CARBIDOPA / LEVODOPA TEVA 25/250 250mg+25mg TEVA PHARMACEUTICALS SRL
CREDANIL 25/250 250mg+25mg REMEDICA LTD.
NAKOM 250mg+25mg LEK PHARMACEUTICALS D.D.
ZIMOX 250mg+25mg FARAN LABORATORIES S.A.
462 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONUM)
***
N04BA03
Cod restrictie 2059: Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei
de actiune a unei doze
Cod restrictie 2060: Boala Parkinson la pacienti stabilizati sub tratamentul cu inhibitor de decarboxylase-levodopa in asociere cu entacapone
100mg/25mg/200
mg
N04BA03 COMBINATII
(LEVODOPUM+CARBIDOPUM+ENTACAPONU
M)
COMPR. FILM.
STALEVO 100 mg/25 mg/200 mg 100mg/25mg/200
mg
ORION CORPORATION
150mg/37.5mg/2
00mg
N04BA03 COMBINATII
(LEVODOPUM+CARBIDOPUM+ENTACAPONU
M)
COMPR. FILM.
STALEVO 150 mg/37,5 mg/200 mg 150mg/37.5mg/20
0mg
ORION CORPORATION
50mg/12.5mg/20
0mg
N04BA03 COMBINATII
(LEVODOPUM+CARBIDOPUM+ENTACAPONU
M)
COMPR. FILM.
STALEVO 50 mg/12,5 mg/200 mg 50mg/12.5mg/200
mg
ORION CORPORATION
463 AMANTADINUM **N04BB01
100mgN04BB01 AMANTADINUM CAPS.VIREGYT®- K 100mg EGIS PHARMACEUTICALS LTD.
464 BROMOCRIPTINUMN04BC01
2.5mgN04BC01 BROMOCRIPTINUM DRAJ.BROCRIPTIN 2.5mg BIOFARM SA
Boala ParkinsonPrescriere limitata:
465 ROPINIROLUM **N04BC04
N04BC04 ROPINIROLUM COMPR. FILM.REQUIP 0,25 mg SMITHKLINE BEECHAM PLC T/A
REQUIP 1 mg SMITHKLINE BEECHAM PLC T/A
REQUIP 2 mg SMITHKLINE BEECHAM PLC T/A
REQUIP 5 mg SMITHKLINE BEECHAM PLC T/A
466 PRAMIPEXOLUM **N04BC05La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.18mgN04BC05 PRAMIPEXOLUM COMPR.MIRAPEXIN 0,18 mg 0.18mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH
0.7mgN04BC05 PRAMIPEXOLUM COMPR.
68 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
MIRAPEXIN 0,7 mg 0.7mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH
467 ROTIGOTINUM ***N04BC09
Prescriere limitata: Monoterapie (fără levodopa), pentru tratarea semnelor şi simptomelor bolii Parkinson idiopatice, în stadiu incipient.
Tratament in asociere cu levodopa in perioada de evoluţie şi în stadiile avansate ale bolii Parkinson, când efectul medicamentului levodopa diminuează sau devine
inconstant şi apar fluctuaţii ale efectului terapeutic (fluctuaţii apărute către sfârşitul intervalului dintre doze sau fluctuaţii de tip on-off).
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 2mg/24h 2mg/24h SCHWARZ PHARMA LTD
4mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 4mg/24h 4mg/24h SCHWARZ PHARMA LTD
6mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 6mg/24h 6mg/24h SCHWARZ PHARMA LTD
8mg/24hN04BC09 ROTIGOTINUM PLASTURE TRANSDERMICNEUPRO 8mg/24h 8mg/24h SCHWARZ PHARMA LTD
468 SELEGILINUMN04BD01
Prescriere limitata: Stadiu tardiv al bolii Parkinson ca tratament complementar la pacientii tratati cu levodopa combinat cu inhibitor al decarboxylazei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
5mgN04BD01 SELEGILINUM COMPR.ALS-SELEGILINA 5 mg 5mg ALSIFCOM INTERMED SRL
JUMEX 5 mg 5mg CHINOIN PRIVATE CO. LTD.
SELEGOS 5mg MEDOCHEMIE LTD.
469 RASAGILINUM ***N04BD02
Prescriere limitata: Tratamentul bolii Parkinson idiopatică (BP) ca monoterapie (fără levodopa).
Tratament adjuvant (în asociere cu levodopa) la pacienţii cu fluctuaţii de sfârşit de doză.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1mgN04BD02 RASAGILINUM COMPR.AZILECT 1mg 1mg TEVA PHARMA GMBH
470 ENTACAPONUM ***N04BX02
200mgN04BX02 ENTACAPONUM COMPR. FILM.COMTAN 200mg 200mg NOVARTIS EUROPHARM LTD.
Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de
actiune a unei doze
Cod restrictie 2067:
471 CLOZAPINUM **N05AH02
Prescriere limitata: Tulburari psihotice aparute in cursul bolii Parkinson in situatia in care terapia standard a esuat.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 100 mg 100mg NOVARTIS PHARMA GMBH
25mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 25 mg 25mg NOVARTIS PHARMA GMBH
SUBLISTA C1-G13 MIASTENIA GRAVIS.
472 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
473 METHOTREXATUM (4)L01BA01
L01BA01 METHOTREXATUM
474 AZATHIOPRINUML04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
475 NEOSTIGMINI BROMIDUMN07AA01
0.5mg/mlN07AA01 NEOSTIGMINI BROMIDUM SOL. INJ.MIOSTIN 0,5 mg/ml 0.5mg/ml ZENTIVA S.A.
15mgN07AA01 NEOSTIGMINI BROMIDUM COMPR.NEOSTIGMINA LPH 15 mg 15mg LABORMED PHARMA SA
476 PYRIDOSTIGMINI BROMIDUMN07AA02
60mgN07AA02 PYRIDOSTIGMINI BROMIDUM DRAJ.MESTINON 60 mg 60mg ICN POLFA RZESZOW S.A.
69 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G14 SCLEROZA MULTIPLA.
477 METHYLPREDNISOLONUMH02AB04
125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.
125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG
16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG
20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.
250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG
32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG
40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.
40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG
4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG
500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.
500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG
478 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
480 MITOXANTRONUM *** Protocol: L001GL01DB07
2 mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. PERF.MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL
20mg/10mlL01DB07 MITOXANTRONUM SOL. PERF.NOVANTRONE 20mg/10ml WYETH LEDERLE PHARMA GMBH
2mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. INJ.ONKOTRONE 2mg/ml BAXTER ONCOLOGY GMBH
481 AZATHIOPRINUML04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
70 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G15 BOLI PSIHICE (SCHIZOFRENIE, TULBURARI SCHIZOTIPALE SI DELIRANTE, TULBURARI AFECTIVE
MAJORE, TULBURARI PSIHOTICE ACUTE SI BOLI PSIHICE COPII, AUTISM).
482 ACIDUM VALPROICUM + SARURIN03AG01S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1000mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 1000 mg 1000mg DESITIN ARZNEIMITTEL GMBH
150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.ORFIRIL LONG 150 mg 150mg DESITIN ARZNEIMITTEL GMBH
150mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 150 mg 150mg GEROT PHARMAZEUTIKA GMBH
150mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 150 150mg DESITIN ARZNEIMITTEL GMBH
200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM.PETILIN 200mg REMEDICA LTD.
200mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.DEPAKINE 200 mg 200mg SANOFI-AVENTIS FRANCE
300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. ELIB. PREL.ORFIRIL LONG 300 mg 300mg DESITIN ARZNEIMITTEL GMBH
300mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 300 mg 300mg GEROT PHARMAZEUTIKA GMBH
300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 300 300mg DESITIN ARZNEIMITTEL GMBH
300mg/5mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPORFIRIL SIROP 300mg/5ml DESITIN ARZNEIMITTEL GMBH
400mg/4mlN03AG01 ACIDUM VALPROICUM + SARURI LIOF. + SOLV. PT. SOL.
DEPAKINE® 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU
SOLUTIE INJECTABILA i.v.
400mg/4ml SANOFI-AVENTIS FRANCE
500mgN03AG01 ACIDUM VALPROICUM + SARURI CAPS. MOI GASTROREZ.CONVULEX® 500 mg 500mg GEROT PHARMAZEUTIKA GMBH
500mgN03AG01 ACIDUM VALPROICUM + SARURI MINICOMPR. ELIB. PREL.ORFIRIL LONG 500 mg 500mg DESITIN ARZNEIMITTEL GMBH
50mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPCONVULEX® 50mg/ml GEROT PHARMAZEUTIKA GMBH
57.64mg/mlN03AG01 ACIDUM VALPROICUM + SARURI SIROPDEPAKINE 57.64mg/ml SANOFI - AVENTIS FRANCE
600mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. GASTROREZ.ORFIRIL 600 600mg DESITIN ARZNEIMITTEL GMBH
300mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE CHRONO 300 mg 300mg SANOFI-AVENTIS FRANCE
500mgN03AG01 ACIDUM VALPROICUM + SARURI COMPR. FILM. ELIB. PREL. DIVIZ.DEPAKINE® CHRONO 500 mg 500mg SANOFI-AVENTIS FRANCE
483 LAMOTRIGINUM ** Protocol: N012FN03AX09
100mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 100 mg 100mg IVAX PHARMCEUTICALS S.R.O.
EPIZOL 100 mg 100mg KRKA D.D. NOVO MESTO
LAMICTAL 100 mg 100mg THE WELLCOME FOUNDATION LTD.
LAMOLEP 100 mg 100mg GEDEON RICHTER LTD.
LAMOTIRAN 100 mg 100mg RANBAXY UK LTD.
LAMOTRIX 100 mg 100mg MEDOCHEMIE LTD.
PLEXXO® 100 mg 100mg DESITIN ARZNEIMITTEL GMBH
100mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 100 mg 100mg STADA ARZNEIMITTEL AG
LAMOTRIN 100 mg 100mg ACTAVIS GROUP HF.
200mgN03AX09 LAMOTRIGINUM COMPR.LAMOTIRAN 200 mg 200mg RANBAXY UK LTD.
LAMOTRIX 200 mg 200mg MEDOCHEMIE LTD.
25mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 25mg 25mg IVAX PHARMCEUTICALS S.R.O.
EPIZOL 25 mg 25mg KRKA D.D. NOVO MESTO
LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.
LAMOLEP 25 mg 25mg GEDEON RICHTER LTD.
LAMOTIRAN 25 mg 25mg RANBAXY UK LTD.
LAMOTRIX 25 mg 25mg MEDOCHEMIE LTD.
PLEXXO® 25 mg 25mg DESITIN ARZNEIMITTEL GMBH
25mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 25 mg 25mg STADA ARZNEIMITTEL AG
LAMOTRIN 25 mg 25mg ACTAVIS GROUP HF.
25mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 25 mg 25mg THE WELLCOME FOUNDATION LTD.
2mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL® 2 mg 2mg THE WELLCOME FOUNDATION LTD.
50mgN03AX09 LAMOTRIGINUM COMPR.EPIMIL 50 mg 50mg IVAX PHARMCEUTICALS S.R.O.
EPIZOL 50 mg 50mg KRKA D.D. NOVO MESTO
LAMICTAL 50 mg 50mg THE WELLCOME FOUNDATION LTD.
LAMOLEP 50 mg 50mg GEDEON RICHTER LTD.
LAMOTIRAN 50 mg 50mg RANBAXY UK LTD.
LAMOTRIX 50 mg 50mg MEDOCHEMIE LTD.
PLEXXO® 50 mg 50mg DESITIN ARZNEIMITTEL GMBH
50mgN03AX09 LAMOTRIGINUM COMPR. DISP.LAMOTRIGIN STADA 50 mg 50mg STADA ARZNEIMITTEL AG
71 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
LAMOTRIN 50 mg 50mg ACTAVIS GROUP HF.
5mgN03AX09 LAMOTRIGINUM COMPR. DISP./MAST.LAMICTAL 5 mg 5mg THE WELLCOME FOUNDATION LTD.
484 TRIHEXYPHENIDYLUMN04AA01
2mgN04AA01 TRIHEXYPHENIDYLUM COMPR.ROMPARKIN® 2 mg 2mg TERAPIA SA
485 HALOPERIDOLUMN05AD01
50mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL DECANOAT 50mg/ml GEDEON RICHTER LTD.
5mgN05AD01 HALOPERIDOLUM COMPR.HALDOL 5mg JANSSEN PHARMACEUTICA NV
5mg/mlN05AD01 HALOPERIDOLUM SOL. INJ.HALOPERIDOL 5 mg/ml 5mg/ml GEDEON RICHTER LTD.
2mg/mlN05AD01 HALOPERIDOLUM PIC. ORALE-SOL.HALOPERIDOL 2 mg/ml 2mg/ml GEDEON RICHTER ROMANIA SA
2mg/mlN05AD01 HALOPERIDOLUM PICATURI ORALE-SOL.HALOPERIDOL 2mg/ml TERAPIA SA
486 SERTINDOL ** Protocol: N017FN05AE03
12mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 12 mg 12mg H. LUNDBECK A/S
16mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 16 mg 16mg H. LUNDBECK A/S
20mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 20 mg 20mg H. LUNDBECK A/S
4mgN05AE03 SERTINDOL COMPR. FILM.SERDOLECT 4 mg 4mg H. LUNDBECK A/S
487 ZIPRASIDONUM ** Protocol: N018FN05AE04
20mg/mlN05AE04 ZIPRASIDONUM LIOF. PT. SOL. INJ. + SOLV.ZELDOX® 20 mg/ml 20mg/ml PFIZER EUROPE MA EEIG
40mgN05AE04 ZIPRASIDONUM CAPS.ZELDOX® 40 mg 40mg PFIZER EUROPE MA EEIG
60mgN05AE04 ZIPRASIDONUM CAPS.ZELDOX® 60 mg 60mg PFIZER EUROPE MA EEIG
80mgN05AE04 ZIPRASIDONUM CAPS.ZELDOX® 80 mg 80mg PFIZER EUROPE MA EEIG
488 FLUPENTIXOLUM ** Protocol: N015FN05AF01
20mg/mlN05AF01 FLUPENTIXOLUM SOL. INJ.FLUANXOL DEPOT 20mg/ml H. LUNDBECK A/S
489 ZUCLOPENTHIXOLUM ** Protocol: N019FN05AF05
10mgN05AF05 ZUCLOPENTHIXOLUM COMPR. FILM.CLOPIXOL® 10 mg 10mg H. LUNDBECK A/S
200mg/mlN05AF05 ZUCLOPENTHIXOLUM SOL. INJ.CLOPIXOL® DEPOT 200mg/ml H. LUNDBECK A/S
25mgN05AF05 ZUCLOPENTHIXOLUM COMPR. FILM.CLOPIXOL® 25 mg 25mg H. LUNDBECK A/S
50mg/mlN05AF05 ZUCLOPENTHIXOLUM SOL. INJ.CLOPIXOL ACUPHASE® 50mg/ml H. LUNDBECK A/S
20mg/mlN05AF05 ZUCLOPENTHIXOLUM PIC. ORALE-SOL.CLOPIXOL 20 mg/ml 20mg/ml H. LUNDBECK A/S
490 CLOZAPINUM ** Protocol: N016FN05AH02
100mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 100 mg 100mg NOVARTIS PHARMA GMBH
25mgN05AH02 CLOZAPINUM COMPR.LEPONEX® 25 mg 25mg NOVARTIS PHARMA GMBH
491 OLANZAPINUM ** Protocol: N003FN05AH03
10mgN05AH03 OLANZAPINUM COMPR. FILM.ZYPREXA 10 mg 10mg ELI LILLY NEDERLAND BV
10mgN05AH03 OLANZAPINUM PULB. PT. SOL. INJ.ZYPREXA 10 mg 10mg ELI LILLY NEDERLAND BV
15mgN05AH03 OLANZAPINUM COMPR. ORODISPERSABILEZYPREXA VELOTAB 15 mg 15mg ELI LILLY NEDERLAND BV
20mgN05AH03 OLANZAPINUM COMPR. ORODISPERSABILEZYPREXA VELOTAB 20 mg 20mg ELI LILLY NEDERLAND BV
5mgN05AH03 OLANZAPINUM COMPR. FILM.ZYPREXA 5 mg 5mg ELI LILLY NEDERLAND BV
492 QUETIAPINUM ** Protocol: N005FN05AH04
100mgN05AH04 QUETIAPINUM COMPR. FILM.SEROQUEL 100mg 100mg ASTRAZENECA UK LTD.
200mgN05AH04 QUETIAPINUM COMPR. FILM.SEROQUEL 200 mg 200mg ASTRAZENECA UK LTD.
200mgN05AH04 QUETIAPINUM COMPR. FILM. ELIB. PREL.SEROQUEL XR 200 mg 200mg ASTRAZENECA UK LTD.
300mgN05AH04 QUETIAPINUM COMPR. FILM.SEROQUEL® 300 mg 300mg ASTRAZENECA UK LTD.
300mgN05AH04 QUETIAPINUM COMPR. FILM. ELIB. PREL.SEROQUEL XR 300 mg 300mg ASTRAZENECA UK LTD.
493 SULPIRIDUMN05AL01
200mgN05AL01 SULPIRIDUM COMPR.EGLONYL® 200 mg 200mg SANOFI-SYNTHELABO FRANCE
72 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
50mgN05AL01 SULPIRIDUM CAPS.EGLONYL® 50 mg 50mg SANOFI-SYNTHELABO FRANCE
50mg/mlN05AL01 SULPIRIDUM SOL. INJ.EGLONYL 100 mg/2 ml 50mg/ml SANOFI-AVENTIS FRANCE
494 AMISULPRIDUM ** Protocol: N006FN05AL05
200mgN05AL05 AMISULPRIDUM COMPR. DIVIZ.SOLIAN 200 mg 200mg SANOFI-AVENTIS FRANCE
400mgN05AL05 AMISULPRIDUM COMPR. FILM.SOLIAN® 400 mg 400mg SANOFI-AVENTIS FRANCE
495 RISPERIDONUM ** Protocol: N004FN05AX08
1 mgN05AX08 RISPERIDONUM COMPR. FILM.RISSET 1 mg 1 mg PLIVA LJUBLJANA D.O.O.
1mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 1 mg 1mg EGIS PHARMACEUTICALS P.L.C.
RISPEN 1 1mg ZENTIVA AS
RISPERIDONA 1 mg 1mg ARENA GROUP S.A.
RISPERIDONE TEVA 1 mg 1mg TEVA PHARMACEUTICAL S.R.L.
RISPOLEPT® 1 mg 1mg JANSSEN PHARMACEUTICA NV
TORENDO 1 mg 1mg KRKA D.D. NOVO MESTO
1mgN05AX08 RISPERIDONUM COMPR. ORODISPERSABILERISPOLEPT QUICKLET 1mg JANSSEN PHARMACEUTICA NV
TORENDO Q-TAB 1 mg 1mg KRKA D.D. NOVO MESTO
1mg/mlN05AX08 RISPERIDONUM SOL. ORALARISPOLEPT 1mg/ml JANSSEN PHARMACEUTICA NV
2 mgN05AX08 RISPERIDONUM COMPR. FILM.RISPEN 2 2 mg ZENTIVA AS
RISSET 2 mg 2 mg PLIVA LJUBLJANA D.O.O.
25mgN05AX08 RISPERIDONUM PULB. + SOLV. PT. SOL. INJ.RISPOLEPT CONSTA® 25 mg 25mg JANSSEN PHARMACEUTICA NV
2mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 2 mg 2mg EGIS PHARMACEUTICALS P.L.C.
RISON 2 mg 2mg ACTAVIS GROUP HF.
RISPERIDONA 2 mg 2mg ARENA GROUP S.A.
RISPERIDONE TEVA 2 mg 2mg TEVA PHARMACEUTICALS SRL
RISPOLEPT® 2 mg 2mg JANSSEN PHARMACEUTICA NV
TORENDO 2 mg 2mg KRKA D.D. NOVO MESTO
2mgN05AX08 RISPERIDONUM COMPR. ORODISPERSABILERISPOLEPT QUICKLET 2mg JANSSEN PHARMACEUTICA NV
TORENDO Q-TAB 2 mg 2mg KRKA D.D. NOVO MESTO
37.5mgN05AX08 RISPERIDONUM PULB. + SOLV. PT. SOL. INJ.RISPOLEPT CONSTA® 37,5 mg 37.5mg JANSSEN PHARMACEUTICA NV
3mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 3 mg 3mg EGIS PHARMACEUTICALS P.L.C.
RISON 3 mg 3mg ACTAVIS GROUP HF.
RISPEN 3 3mg ZENTIVA AS
RISPERIDONA 3 mg 3mg ARENA GROUP S.A.
RISPERIDONE TEVA 3 mg 3mg TEVA PHARMACEUTICALS SRL
RISPOLEPT® 3 mg 3mg JANSSEN PHARMACEUTICA NV
RISSET 3 mg 3mg PLIVA LJUBLJANA D.O.O.
TORENDO 3 mg 3mg KRKA D.D. NOVO MESTO
4 mgN05AX08 RISPERIDONUM COMPR. FILM.RISPEN 4 4 mg ZENTIVA AS
4mgN05AX08 RISPERIDONUM COMPR. FILM.RILEPTID 4 mg 4mg EGIS PHARMACEUTICALS P.L.C.
RISON 4 mg 4mg ACTAVIS GROUP HF.
RISPERIDONA 4 mg 4mg ARENA GROUP S.A.
RISPERIDONE TEVA 4 mg 4mg TEVA PHARMACEUTICALS SRL
RISPOLEPT® 4 mg 4mg JANSSEN PHARMACEUTICA NV
RISSET 4 mg 4mg PLIVA LJUBLJANA D.O.O.
TORENDO 4 mg 4mg KRKA D.D. NOVO MESTO
50mgN05AX08 RISPERIDONUM PULB. + SOLV. PT. SOL. INJ.RISPOLEPT CONSTA® 50 mg 50mg JANSSEN PHARMACEUTICA NV
496 ARIPIPRAZOLUM ** Protocol: N007FN05AX12
10mgN05AX12 ARIPIPRAZOLUM COMPR.ABILIFY 10mg 10mg OTSUKA PHARMACEUTICAL EUROPE LTD.
15mgN05AX12 ARIPIPRAZOLUM COMPR.ABILIFY 15mg 15mg OTSUKA PHARMACEUTICAL EUROPE LTD.
498 CITALOPRAMUM ** Protocol: N008FN06AB04
10mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 10 mg 10mg RANBAXY UK LIMITED
LINISAN 10 mg 10mg GEDEON RICHTER ROMANIA S.A.
20mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 20mg 20mg RANBAXY UK LIMITED
LINISAN 20 mg 20mg GEDEON RICHTER ROMANIA S.A.
40mgN06AB04 CITALOPRAMUM COMPR. FILM.CITALORAN 40 mg 40mg RANBAXY UK LIMITED
LINISAN 40 mg 40mg GEDEON RICHTER ROMANIA S.A.
499 ESCITALOPRAMUM ** Protocol: N009FN06AB10
10mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 10 mg 10mg H. LUNDBECK A/S
5mgN06AB10 ESCITALOPRAMUM COMPR. FILM.CIPRALEX 5 mg 5mg H. LUNDBECK A/S
73 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
500 TRAZODONUM ** Protocol: N010FN06AX05
150mgN06AX05 TRAZODONUM COMPR. ELIB. PREL.TRITTICO AC 150 mg 150mg ANGELINI FRANCESCO SPA
501 TIANEPTINUM ** Protocol: N011FN06AX14
12.5mgN06AX14 TIANEPTINUM DRAJ.COAXIL® 12.5mg LES LAB. SERVIER IND.
502 VENLAFAXINUM ** Protocol: N013FN06AX16
150mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 150 mg 150mg WYETH LEDERLE PHARMA GMBH
VELAXIN 150 mg 150mg EGIS PHARMACEUTICALS P.L.C.
37.5mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 37,5 mg 37.5mg EGIS PHARMACEUTICALS PLC
VENLAFAXINA LPH 37,5 mg 37.5mg LABORMED PHARMA SA
75mgN06AX16 VENLAFAXINUM CAPS. ELIB. PREL.EFECTIN ER 75 mg 75mg WYETH LEDERLE PHARMA GMBH
VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS P.L.C.
75mgN06AX16 VENLAFAXINUM COMPR.VELAXIN 75 mg 75mg EGIS PHARMACEUTICALS PLC
VENLAFAXINA LPH 75 mg 75mg LABORMED PHARMA SA
503 MILNACIPRANUM ** Protocol: N002FN06AX17
25mgN06AX17 MILNACIPRANUM CAPS.IXEL 25mg PIERRE FABRE MEDICAMENT
50mgN06AX17 MILNACIPRANUM CAPS.IXEL 50mg PIERRE FABRE MEDICAMENT
504 DULOXETINUM ** Protocol: N014FN06AX21
30mgN06AX21 DULOXETINUM CAPS. GASTROREZ.CYMBALTA 30mg 30mg ELI LILLY NEDERLAND BV
60mgN06AX21 DULOXETINUM CAPS. GASTROREZ.CYMBALTA 60mg 60mg ELI LILLY NEDERLAND BV
SUBLISTA C1-G16 DEMENTE (DEGENERATIVE, VASCULARE, MIXTE).
505 DONEPEZILUM *** Protocol: N020GN06DA02
10mgN06DA02 DONEPEZILUM COMPR. FILM.ARICEPT® 10 mg 10mg PFIZER EUROPE MA EEIG
10mgN06DA02 DONEPEZILUM COMPR. ORODISPERSABILEARICEPT EVESS 10mg PFIZER EUROPE MA EEIG
5mgN06DA02 DONEPEZILUM COMPR. FILM.ARICEPT® 5 mg 5mg PFIZER EUROPE MA EEIG
5mgN06DA02 DONEPEZILUM COMPR. ORODISPERSABILEARICEPT EVESS 5mg PFIZER EUROPE MA EEIG
506 RIVASTIGMINUM *** Protocol: N021GN06DA03
1.5mgN06DA03 RIVASTIGMINUM CAPS.EXELON 1.5mg 1.5mg NOVARTIS EUROPHARM LTD.
3mgN06DA03 RIVASTIGMINUM CAPS.EXELON 3mg 3mg NOVARTIS EUROPHARM LTD.
4.5mgN06DA03 RIVASTIGMINUM CAPS.EXELON 4.5mg 4.5mg NOVARTIS EUROPHARM LTD.
4.6mg/24hN06DA03 RIVASTIGMINUM PLASTURE TRANSDERMICEXELON 4.6mg/24h 4.6mg/24h NOVARTIS EUROPHARM LTD.
6mgN06DA03 RIVASTIGMINUM CAPS.EXELON 6mg 6mg NOVARTIS EUROPHARM LTD.
9.5mg/24hN06DA03 RIVASTIGMINUM PLASTURE TRANSDERMICEXELON 9.5mg/24h 9.5mg/24h NOVARTIS EUROPHARM LTD.
507 GALANTAMINUM *** Protocol: N022GN06DA04
12mgN06DA04 GALANTAMINUM COMPR. FILM.REMINYL® 12 mg 12mg JANSSEN-PHARMACEUTICA NV
16mgN06DA04 GALANTAMINUM CAPS. ELIB. PREL.REMINYL 16 mg 16mg JANSSEN PHARMACEUTICA NV
24mgN06DA04 GALANTAMINUM CAPS. ELIB. PREL.REMINYL 24 mg 24mg JANSSEN PHARMACEUTICA NV
4mgN06DA04 GALANTAMINUM COMPR. FILM.REMINYL® 4 mg 4mg JANSSEN-PHARMACEUTICA NV
4mg/mlN06DA04 GALANTAMINUM SOL. ORALAREMINYL® 4 mg/ml 4mg/ml JANSSEN-PHARMACEUTICA NV
8mgN06DA04 GALANTAMINUM CAPS. ELIB. PREL.REMINYL 8 mg 8mg JANSSEN PHARMACEUTICA NV
8mgN06DA04 GALANTAMINUM COMPR. FILM.REMINYL® 8 mg 8mg JANSSEN-PHARMACEUTICA NV
508 MEMANTINUM *** Protocol: N001FN06DX01
10mgN06DX01 MEMANTINUM COMPR. FILM.EBIXA® 10 mg 10mg H. LUNDBECK A/S
10mg/gN06DX01 MEMANTINUM PIC. ORALE, SOL.EBIXA® 10 mg/g 10mg/g H. LUNDBECK A/S
74 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: L045MSUBLISTA C1-G17 COLAGENOZE MAJORE (LUPUS ERITEMATOS SISTEMIC, SCLERODERMIE, POLI/DERMATOMIOZITA,
VASCULITE SISTEMICE).
509 METHYLPREDNISOLONUM (5)H02AB04
16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG
32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG
4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG
510 CYCLOPHOSPHAMIDUM *L01AA01
1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH
200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.
500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
511 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
512 HYDROXYCHLOROQUINUMP01BA02
200mgP01BA02 HYDROXYCHLOROQUINUM COMPR. FILM.PLAQUENIL® 200mg SANOFI-SYNTHELABO LTD.
75 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G18 POLIARTRITA REUMATOIDA, ARTROPATIA PSORIAZICA, SI ARTRITA JUVENILA.
513 SULFASALAZINUMA07EC01
500mgA07EC01 SULFASALAZINUM COMPR. FILM.SALAZIDIN 500mg AC HELCOR SRL
500mgA07EC01 SULFASALAZINUM COMPR. FILM. GASTROREZ.SULFASALAZIN EN 500mg KRKA D.D. NOVO MESTO
514 BETAMETHASONUMH02AB01
7mg/mlH02AB01 BETAMETHASONUM SUSP. INJ. I.M.DIPROPHOS® 7mg/ml SCHERING PLOUGH EUROPE
515 METHYLPREDNISOLONUM (5)H02AB04
16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG
32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG
4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG
516 METHOTREXATUM (4)L01BA01
L01BA01 METHOTREXATUM
517 CICLOSPORINUM *L04AA01
Prescriere limitata: Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici
cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
518 LEFLUNOMIDUM **L04AA13
Cod restrictie 2643: Tratamentul iniţial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente şi/sau
Cod restrictie 2681: Tratamentul iniţial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente şi/sau
Leflunomide este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitată timp de doi ani după întreruperea tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA13 LEFLUNOMIDUM COMPR. FILM.ARAVA 100mg 100mg SANOFI- AVENTIS DEUTSCHLAND GMBH
10mgL04AA13 LEFLUNOMIDUM COMPR. FILM.ARAVA 10mg 10mg SANOFI- AVENTIS DEUTSCHLAND GMBH
20mgL04AA13 LEFLUNOMIDUM COMPR. FILM.ARAVA 20mg 20mg SANOFI- AVENTIS DEUTSCHLAND GMBH
519 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
520 DICLOFENACUMM01AB05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM01AB05 DICLOFENACUM COMPR. FILM. ELIB. PREL.DICLOTARD® 100 mg 100mg TERAPIA SA
REFEN® RETARD 100mg HEMOFARM S.R.L.
VOLTAREN® RETARD 100mg NOVARTIS PHARMA GMBH
100mgM01AB05 DICLOFENACUM SUPOZ.CLAFEN 100 mg 100mg ANTIBIOTICE SA
DICLOFENAC 100 mg 100mg SINTOFARM SA
DICLOFENAC SODIC 100 mg 100mg MAGISTRA C & C
DICLOGESIC 100 SUPOZITOARE 100mg DAR AL DAWA PHARMA SRL
EPIFENAC 100mg E.I.P.I.CO. MED S.R.L.
VOLTAREN® 100mg NOVARTIS PHARMA GMBH
120mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 120 120mg GEROT PHARMAZEUTIKA GMBH
150mgM01AB05 DICLOFENACUM CAPS. ELIB. PREL.DICLOREUM 150 mg 150mg ALFA WASSERMANN SPA
25mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.RHEUMAVEK 25mg FARAN LABORATORIES S.A.
VOLTAREN® 25 25mg NOVARTIS PHARMA GMBH
25mgM01AB05 DICLOFENACUM COMPR. GASTROREZ.EPIFENAC 25mg E.I.P.I.CO. MED S.R.L.
25mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 25 mg 25mg ARENA GROUP SA
25mg/mlM01AB05 DICLOFENACUM SOL. INJ.RHEUMAVEK 25mg/ml FARAN LABORATORIES S.A.
VOLTAREN® 25mg/ml NOVARTIS PHARMA GMBH
30mg/mlM01AB05 DICLOFENACUM SOL. INJ.
76 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
TRATUL® 30mg/ml GEROT PHARMAZEUTIKA GMBH
50mgM01AB05 DICLOFENACUM CAPS. GASTROREZ.TRATUL 50 50mg GEROT PHARMAZEUTIKA GMBH
50mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.CLAFEN 50 mg 50mg ANTIBIOTICE SA
DICLOFENAC 50 mg 50mg TERAPIA SA
VOLTAREN® 50 50mg NOVARTIS PHARMA GMBH
50mgM01AB05 DICLOFENACUM DRAJ.VOLTAREN RAPID® 50mg NOVARTIS PHARMA GMBH
50mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 50 mg 50mg ARENA GROUP SA
50mgM01AB05 DICLOFENACUM SUPOZ.VOLTAREN® 50mg NOVARTIS PHARMA GMBH
60mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 60 60mg GEROT PHARMAZEUTIKA GMBH
75mgM01AB05 DICLOFENACUM COMPR. ELIB. MODIF.DICLAC® 75 ID 75mg HEXAL AG
75mgM01AB05 DICLOFENACUM SOL. INJ.DICLAC 75mg HEXAL AG
VURDON 75mg HELP S.A. PHARMACEUTICALS
75mg/3mlM01AB05 DICLOFENACUM SOL. INJ.ALMIRAL 75mg/3ml MEDOCHEMIE LTD.
DICLOFENAC 75 mg 75mg/3ml TERAPIA SA
DICLOFENAC AL I.M. 75mg/3ml ALIUD PHARMA GMBH & CO.KG
521 HYDROXYCHLOROQUINUMP01BA02
200mgP01BA02 HYDROXYCHLOROQUINUM COMPR. FILM.PLAQUENIL® 200mg SANOFI-SYNTHELABO LTD.
77 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G19 SPONDILITA ANKILOZANTA.
522 SULFASALAZINUMA07EC01
500mgA07EC01 SULFASALAZINUM COMPR. FILM.SALAZIDIN 500mg AC HELCOR SRL
500mgA07EC01 SULFASALAZINUM COMPR. FILM. GASTROREZ.SULFASALAZIN EN 500mg KRKA D.D. NOVO MESTO
523 BETAMETHASONUMH02AB01
7mg/mlH02AB01 BETAMETHASONUM SUSP. INJ. I.M.DIPROPHOS® 7mg/ml SCHERING PLOUGH EUROPE
524 DICLOFENACUMM01AB05A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgM01AB05 DICLOFENACUM COMPR. FILM. ELIB. PREL.DICLOTARD® 100 mg 100mg TERAPIA SA
REFEN® RETARD 100mg HEMOFARM S.R.L.
VOLTAREN® RETARD 100mg NOVARTIS PHARMA GMBH
100mgM01AB05 DICLOFENACUM SUPOZ.CLAFEN 100 mg 100mg ANTIBIOTICE SA
DICLOFENAC 100 mg 100mg SINTOFARM SA
DICLOFENAC SODIC 100 mg 100mg MAGISTRA C & C
DICLOGESIC 100 SUPOZITOARE 100mg DAR AL DAWA PHARMA SRL
EPIFENAC 100mg E.I.P.I.CO. MED S.R.L.
VOLTAREN® 100mg NOVARTIS PHARMA GMBH
120mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 120 120mg GEROT PHARMAZEUTIKA GMBH
150mgM01AB05 DICLOFENACUM CAPS. ELIB. PREL.DICLOREUM 150 mg 150mg ALFA WASSERMANN SPA
25mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.RHEUMAVEK 25mg FARAN LABORATORIES S.A.
VOLTAREN® 25 25mg NOVARTIS PHARMA GMBH
25mgM01AB05 DICLOFENACUM COMPR. GASTROREZ.EPIFENAC 25mg E.I.P.I.CO. MED S.R.L.
25mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 25 mg 25mg ARENA GROUP SA
25mg/mlM01AB05 DICLOFENACUM SOL. INJ.RHEUMAVEK 25mg/ml FARAN LABORATORIES S.A.
VOLTAREN® 25mg/ml NOVARTIS PHARMA GMBH
30mg/mlM01AB05 DICLOFENACUM SOL. INJ.TRATUL® 30mg/ml GEROT PHARMAZEUTIKA GMBH
50mgM01AB05 DICLOFENACUM CAPS. GASTROREZ.TRATUL 50 50mg GEROT PHARMAZEUTIKA GMBH
50mgM01AB05 DICLOFENACUM COMPR. FILM. GASTROREZ.CLAFEN 50 mg 50mg ANTIBIOTICE SA
DICLOFENAC 50 mg 50mg AC HELCOR PHARMA SRL
VOLTAREN® 50 50mg NOVARTIS PHARMA GMBH
50mgM01AB05 DICLOFENACUM DRAJ.VOLTAREN RAPID® 50mg NOVARTIS PHARMA GMBH
50mgM01AB05 DICLOFENACUM DRAJ. GASTROREZ.DICLOFENAC 50 mg 50mg ARENA GROUP SA
50mgM01AB05 DICLOFENACUM SUPOZ.VOLTAREN® 50mg NOVARTIS PHARMA GMBH
60mgM01AB05 DICLOFENACUM SUPOZ.TRATUL 60 60mg GEROT PHARMAZEUTIKA GMBH
75mgM01AB05 DICLOFENACUM COMPR. ELIB. MODIF.DICLAC® 75 ID 75mg HEXAL AG
75mgM01AB05 DICLOFENACUM SOL. INJ.DICLAC 75mg HEXAL AG
VURDON 75mg HELP S.A. PHARMACEUTICALS
75mg/3mlM01AB05 DICLOFENACUM SOL. INJ.ALMIRAL 75mg/3ml MEDOCHEMIE LTD.
DICLOFENAC 75 mg 75mg/3ml TERAPIA SA
DICLOFENAC AL I.M. 75mg/3ml ALIUD PHARMA GMBH & CO.KG
78 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G22 BOLI ENDOCRINE (GUSA ENDEMICA, INSUFICIENTA SUPRARENALA CRONICA, DIABETUL INSIPID,
MIXEDEMUL ADULTULUI, TUMORI HIPOFIZARE CU EXPANSIUNE SUPRASELARA SI TUMORI NEUROENDOCRINE).
525 CABERGOLINUM ** Protocol: G001CG02CB03
0.5mgG02CB03 CABERGOLINUM COMPR.DOSTINEX 0.5mg PFIZER EUROPE MA EEG
0.5mgG02CB03 CABERGOLINUM COMPR.DOSTINEX 0.5mg PFIZER EUROPE MA EEG
Prevenirea aparitiei lactatiei in lauzie din motive medicalePrescriere limitata:
Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicalaCod restrictie 2659:
Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incompleteCod restrictie 2660:
526 PEGVISOMANTUM **** Protocol: H012EH01AX01
10mgH01AX01 PEGVISOMANTUM LIOF. + SOLV. PT. SOL. INJ.SOMAVERT 10 mg 10mg PFIZER LTD.
20mgH01AX01 PEGVISOMANTUM LIOF. + SOLV. PT. SOL. INJ.SOMAVERT 20 mg 20mg PFIZER LTD.
527 DESMOPRESSINUMH01BA02
0.2mgH01BA02 DESMOPRESSINUM COMPR.MINIRIN 0,2 mg 0.2mg FERRING AB
Diabet insipid.Cod restrictie 1678:
H01BA02 DESMOPRESSINUMMINIRIN 0,2 mg 0.2mg FERRING AB
528 OCTREOTIDUM **** Protocol: H008EH01CB02
100mgH01CB02 OCTREOTIDUM COMPR.SANDOSTATIN® 0.1mg/ml NOVARTIS PHARMA GMBH
10mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.
PRELUNG.SANDOSTATIN LAR 10 mg 10mg NOVARTIS PHARMA GMBH
20mgH01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB.
PRELUSANDOSTATIN LAR 20 mg 20mg NOVARTIS PHARMA GMBH
30mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.
PRELUNG.SANDOSTATIN LAR 30 mg 30mg NOVARTIS PHARMA GMBH
529 LANREOTIDUM **** Protocol: H005E;H006CH01CB03
30mgH01CB03 LANREOTIDUM LIOF. PT. SOL. INJ. + SOLV.SOMATULINE® PR 30 mg 30mg BEAUFOUR IPSEN PHARMA
530 FLUDROCORTISONUMH02AA02
0.1mgH02AA02 FLUDROCORTISONUM COMPR.ASTONIN H 0.1mg MERCK KGAA
531 PREDNISOLONUMH02AB06
250mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 250 250mg MERCK KGAA
50mgH02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - DECORTIN H 50 50mg MERCK KGAA
532 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
533 HYDROCORTISONUMH02AB09
100mgH02AB09 HYDROCORTISONUM LIOF. + SOLV. PT. SOL. INJ.HYDROCORTISONE 100 mg 100mg HEMOFARM S.R.L.
HYDROCORTISONE SUCCINAT SODIC 100mg E.I.P.I.CO. MED S.R.L.
25mg/5mlH02AB09 HYDROCORTISONUM SOL. INJ. I.V.HIDROCORTIZON HEMISUCCINAT 25mg/5ml ZENTIVA S.A.
500mgH02AB09 HYDROCORTISONUM LIOF. PT. SOL. INJ. + SOLV.HYDROCORTISONE 500 mg 500mg HEMOFARM S.R.L.
534 LEVOTHYROXINUMH03AA01
100µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 100 100µg MERCK KGAA
L-THYROXIN 100 BERLIN - CHEMIE 100µg BERLIN CHEMIE AG MENARINI GROUP
200µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 200 200µg MERCK KGAA
25µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 25 25µg MERCK KGAA
50µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 50 50µg MERCK KGAA
L-THYROXIN 50 50µg BERLIN CHEMIE AG MENARINI GROUP
535 KALII IODIDUMH03CA01
100µgH03CA01 KALII IODIDUM COMPR.JODID 100 100µg MERCK KGAA
200µgH03CA01 KALII IODIDUM COMPR.JODID 200 200µg MERCK KGAA
536 BROMOCRIPTINUMG02CB01
2.5mgG02CB01 BROMOCRIPTINUM DRAJ.
79 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
BROCRIPTIN 2.5mg BIOFARM SA
Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicalaPrescriere limitata:
Hiperprolactinemia patologica pentru care tratamentul chirurgical utilizat a dus la rezultate incomplete;Prescriere limitata:
SUBLISTA C1-G23 BOALA WILSON.
537 PENICILLAMINUM **(4)M01CC01
M01CC01 PENICILLAMINUM
80 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G25 BOALA CRONICA DE RINICHI – FAZA PREDIALIZA.
538 PARICALCITOLUM ** Protocol: A005EA11CC07
5 µg/mlA11CC07 PARICALCITOLUM SOL. INJ.ZEMPLAR 5 µg/ml ABBOTT LABORATORIES S.A.
539 COMPLEX DE HIDROXID DE FER (III) SUCROZA ** Protocol: A010NB03AC02
20mg/mlB03AC02 COMPLEX DE HIDROXID DE FER (III)
SUCROZA
SOL. INJ./PERF.
VENOFER® 20mg/ml VIFOR FRANCE S.A.
540 EPOETINUM ALFA ** Protocol: B010NB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
541 EPOETINUM BETA ** Protocol: B009NB03XA01
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
542 DARBEPOETINUM ALFA ** Protocol: B011NB03XA02
10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV
100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV
15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV
150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV
20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV
30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV
300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV
40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV
50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV
500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV
60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV
80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV
544 IRBESARTANUM ** Protocol: C008NC09CA04
150mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 150mg 150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB
300mgC09CA04 IRBESARTANUM COMPR. FILM.APROVEL 300mg 300mg SANOFI PHARMA - BRISTOL MYERS SQUIBB
545 PREDNISONUM Protocol: H002NH02AB07
5mgH02AB07 PREDNISONUM COMPR.
81 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
546 CYCLOPHOSPHAMIDUM Protocol: L027NL01AA01
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
547 CICLOSPORINUM * Protocol: L028NL04AA01Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
548 AZATHIOPRINUM * Protocol: L029NL04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
549 AMINOACIZI INCLUSIV COMBINATII CU POLIPEPTIDE ** Protocol: V004NV06DDN1
V06DDN1 AMINOACIZI INCLUSIV COMBINATII CU
POLIPEPTIDE
COMPR. FILM.
KETOSTERIL® FRESENIUS KABI DEUTSCHLAND GMBH
82 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G26 GLAUCOM.
550 DORZOLAMIDUMS01EC03
20mg/mlS01EC03 DORZOLAMIDUM SOL. OFT.TRUSOPT 20mg/ml MERCK SHARP & DOHME S.R.L.
551 BRINZOLAMIDUMS01EC04
10mg/mlS01EC04 BRINZOLAMIDUM PICATURI OFT.-SUSP.AZOPT 10mg/ml 10mg/ml ALCON LABORATORIES LTD.
552 TIMOLOLUMS01ED01
0.25%S01ED01 TIMOLOLUM PICATURI OFT.-SOL.TIMO-COMOD® 0.25% URSAPHARM ARZNEIMITTEL GMBH&CO.KG
TIMOLOL 0,25% 0.25% E.I.P.I.CO. MED S.R.L.
0.5%S01ED01 TIMOLOLUM PICATURI OFT.-SOL.TIMO-COMOD® 0.5% URSAPHARM ARZNEIMITTEL GMBH&CO.KG
TIMO-GAL® 0.5% TERAPIA SA
TIMOLOL 0,5% 0.5% E.I.P.I.CO. MED S.R.L.
1mg/gS01ED01 TIMOLOLUM GEL OFT.NYOLOL GEL 1mg/g NOVARTIS PHARMA GMBH
2.5mg/mlS01ED01 TIMOLOLUM PIC. OFT.-SOL.TIMOPTIC 2.5mg/ml MERCK SHARP & DOHME ROMANIA S.R.L.
2.5mg/mlS01ED01 TIMOLOLUM PICATURI OFT.-SOL.ARUTIMOL 0,25% 2.5mg/ml CHAUVIN ANKERPHARM GMBH
5mg/mlS01ED01 TIMOLOLUM PIC. OFT.-SOL.TIMOPTIC 5mg/ml MERCK SHARP & DOHME ROMANIA S.R.L.
5mg/mlS01ED01 TIMOLOLUM PICATURI OFT.-SOL.ARUTIMOL 0,5% 5mg/ml CHAUVIN ANKERPHARM GMBH
2.5mg/mlS01ED01 TIMOLOLUM PIC. OFT., SOL.TIMOLOL RPH 0,25% 2.5mg/ml ROMPHARM COMPANY SRL
2.5mg/mlS01ED01 TIMOLOLUM PIC. OFT.,SOL.TIMABAK 2,5 mg/ml 2.5mg/ml LABORATOIRES THEA
5mg/mlS01ED01 TIMOLOLUM PIC. OFT.,SOL.TIMABAK 5 mg/ml 5mg/ml LABORATORIES THEA
TIMOLOL RPH 0,5% 5mg/ml ROMPHARM COMPANY SRL
553 BETAXOLOLUMS01ED02
0.25%S01ED02 BETAXOLOLUM PICATURI OFT.-SUSP.BETOPTIC - S 0.25% ALCON COUVREUR NV
5mg/mlS01ED02 BETAXOLOLUM PIC. OFT.-SOL.BETAX 5mg/ml ROMPHARM SRL
5mg/mlS01ED02 BETAXOLOLUM PIC.OFTALMICE,SOL.BETOPTIC 5mg/ml ALCON COUVREUR NV
5mg/mlS01ED02 BETAXOLOLUM PIC. OFT., SOL.BETAXOLOL 5mg/ml TERAPIA SA
554 CARTEOLOLUMS01ED05
20mg/mlS01ED05 CARTEOLOLUM PICATURI OFT.-SOL.CARTEOL 2% 20mg/ml S.I.F.I. SPA
20mg/mlS01ED05 CARTEOLOLUM PIC. OFTALMICE CU ELIB. PREL.FORTINOL EP 2% 20mg/ml DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
2%S01ED05 CARTEOLOLUM PICATURI OFT.-SOL.CARTEOL 2% 2% S.I.F.I. SPA
555 COMBINATII (BIMATOPROSTUM + TIMOLOLUM)S01ED51
300µg/ml+5mg/m
l
S01ED51 COMBINATII (BIMATOPROSTUM +
TIMOLOLUM)
PIC. OFT.,SOL.
GANFORT 300µg/ml+5mg/ml ALLERGAN PHARMACEUTICALS IRELAND
556 COMBINATII (DORZOLAMIDUM+TIMOLOLUM)S01ED51
S01ED51 COMBINATII (DORZOLAMIDUM+TIMOLOLUM) PIC. OFT.-SOL.COSOPT FARA
CONCENTRATIE
MERCK SHARP & DOHME
557 COMBINATII (LATANOPROSTUM+TIMOLOLUM)S01ED51
S01ED51 COMBINATII
(LATANOPROSTUM+TIMOLOLUM)
SOL. OFT.
XALCOM (R) FARA
CONCENTRATIE
PFIZER EUROPE MA EEI
558 LATANOPROSTUMS01EE01
5,00%S01EE01 LATANOPROSTUM PICATURI OFT.-SOL.XALATAN® 0.005% PFIZER EUROPE MA EEIG
559 BIMATOPROSTUMS01EE03
0,3mg/mlS01EE03 BIMATOPROSTUM PIC. OFT.,SOL.LUMIGAN 0,3mg/ml 0,3mg/ml ALLERGAN PHARMACEUTICALS IRELAND
561 TRAVOPROSTUMS01EE04
40µg/mlS01EE04 TRAVOPROSTUM PICATURI OFT.SOL.TRAVATAN 40µg/ml 40µg/ml ALCON LABORATORIES LTD.
83 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G27 PEMFIGUS.
562 DEXAMETHASONUMH02AB02
8mgH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMETHASONE SODIUM PHOSPHATE 8mg E.I.P.I.CO. MED S.R.L.
8mg/2mlH02AB02 DEXAMETHASONUM SOL. INJ.DEXAMED 8mg/2ml MEDOCHEMIE LTD.
563 METHYLPREDNISOLONUMH02AB04
H02AB04 METHYLPREDNISOLONUM
H02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEI
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.
564 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
565 DAPSONUM (4)J04BA02
J04BA02 DAPSONUM
566 CYCLOPHOSPHAMIDUML01AA01
1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH
200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.
500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
568 CICLOSPORINUM *L04AA01Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
569 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
SUBLISTA C1-G29 BOALA GAUCHER.
570 IMIGLUCERASUM **** Protocol: A008EA16AB02
200UA16AB02 IMIGLUCERASUM PULB. PT.CONC. PT.SOL. PERF.CEREZYME 200U 200U GENZYME EUROPE BV
400UA16AB02 IMIGLUCERASUM PULB. PT.CONC. PT.SOL. PERF.CEREZYME 400U 400U GENZYME EUROPE BV
571 MIGLUSTATUM ****A16AX06
Prescriere limitata: Tratamentul pe cale orală al bolii Gaucher de tip I, uşoară până la moderată.numai la pacienţii care nu pot fi supuşi terapiei de substituţie enzimatică
100mgA16AX06 MIGLUSTATUM CAPS.ZAVESCA 100mg ACTELION REGISTRATION LTD.
84 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C1-G30 BOLI VENERICE (SIFILIS, GONOREE, INFECTIA CU CHLAMIDIA).
572 DOXYCYCLINUMJ01AA02
100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg EUROPHARM SA
DOXICICLINA 100 mg 100mg ANTIBIOTICE SA
DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL
100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.
100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA
DOXICICLINA 100 mg 100mg ANTIBIOTICE SA
DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL
100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.
100mgJ01AA02 DOXYCYCLINUM CAPS.DOXICICLINA 100mg ARENA GROUP SA
DOXICICLINA 100 mg 100mg ANTIBIOTICE SA
DOXICICLINA SANDOZ 100 mg 100mg SANDOZ SRL
100mgJ01AA02 DOXYCYCLINUM COMPR. DISP.UNIDOX SOLUTAB 100mg ASTELLAS PHARMA EUROPE B.V.
573 TETRACYCLINUMJ01AA07
250mgJ01AA07 TETRACYCLINUM CAPS.TETRACICLINA 250 mg 250mg ANTIBIOTICE SA
TETRACICLINA SANDOZ 250 mg 250mg SANDOZ SRL
574 PHENOXYMETHYLPENICILLINUMJ01CE02
1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR.PENICILINA V 1 000 000 U.I. 1000000ui EUROPHARM SA
1000000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1000 1000000ui SANDOZ GMBH
1500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 1500 1500000ui SANDOZ GMBH
400000ui/5mlJ01CE02 PHENOXYMETHYLPENICILLINUM SIROPOSPEN 400 400000ui/5ml SANDOZ GMBH
500000uiJ01CE02 PHENOXYMETHYLPENICILLINUM COMPR. FILM.OSPEN® 500 500000ui SANDOZ GMBH
575 BENZYLPENICILLINUMJ01CE01
1 000 000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G SODICA 1 000 000ui ANTIBIOTICE SA
1000000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G POTASICA 1000000ui ANTIBIOTICE SA
400 000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G SODICA 400 000ui ANTIBIOTICE SA
400000uiJ01CE01 BENZYLPENICILLINUM PULB. PT. SOL. INJ.PENICILINA G POTASICA 400000ui ANTIBIOTICE SA
576 BENZATHINI BENZYLPENICILLINUMJ01CE08
1200000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 1200000ui ANTIBIOTICE SA
600000uiJ01CE08 BENZATHINI BENZYLPENICILLINUM PULB. PT. SUSP. INJ.MOLDAMIN® 600000ui ANTIBIOTICE SA
577 CEFIXIMUMJ01DD08
100mg/5mlJ01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALASUPRAX 100mg/5ml GEDEON RICHTER LTD.
200mgJ01DD08 CEFIXIMUM CAPS.EFICEF® 200 mg 200mg ANTIBIOTICE SA
200mgJ01DD08 CEFIXIMUM COMPR. FILM.SUPRAX 200mg GEDEON RICHTER LTD.
578 ERYTHROMYCINUMJ01FA01
200mgJ01FA01 ERYTHROMYCINUM COMPR.ERITROMAGIS 200 mg 200mg ARENA GROUP SA
ERITROMICINA 200 mg 200mg ANTIBIOTICE SA
ERITROMICINA EUROPHARM 200 mg 200mg EUROPHARM SA
ERITROMICINA SANDOZ 200 mg COMPRIMATE 200mg SANDOZ S.R.L.
200mg/5mlJ01FA01 ERYTHROMYCINUM PULB. PT. SUSP. ORALAERITRO 200 200mg/5ml LEK PHARMATECH SRL
579 AZITHROMYCINUMJ01FA10
Prescriere limitata: Infectii genitale necomplicate cu Chlamydia trachomatis.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 100 mg/5 ml 100mg/5ml SANDOZ SRL
125mgJ01FA10 AZITHROMYCINUM COMPR. FILM.SUMAMED 125 mg 125mg PLIVA LJUBLJANA D.O.O.
200 mg/5 mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 200 mg/5 ml 200 mg/5 ml SANDOZ SRL
200mg/5mlJ01FA10 AZITHROMYCINUM PULB. + SOLV. SUSP. ORALAAZITROX 200 mg/5 ml 200mg/5ml ECZACIBASI PHARMACEUTICALS S.R.L.
200mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALASUMAMED FORTE 200mg/5ml PLIVA LJUBLIJANA D.O.O.
250mgJ01FA10 AZITHROMYCINUM CAPS.AZATRIL 250 mg 250mg BALKANPHARMA RAZGRAD AD
85 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
250mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE 250mg SANDOZ S.R.L.
AZITROX® 250 250mg ZENTIVA AS
500mgJ01FA10 AZITHROMYCINUM LIOF. PT. SOL. PERF.SUMAMED® 500mg PLIVA LJUBLJANA D.O.O.
500mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ S.R.L.
AZITROX® 500 500mg ZENTIVA AS
AZRO® 500 mg 500mg ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED 500 mg 500mg PLIVA LJUBLJANA D.O.O.
ZITROCIN 500 mg 500mg OZONE LABORATORIES LTD.
2gJ01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. SUSP. ORALAZMAX 2 g 2g PFIZER EUROPE MA EEIG
580 CIPROFLOXACINUMJ01MA02
Prescriere limitata: Gonoreea.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED
CIPHIN 250 250mg ZENTIVA A.S.
CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO
CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.
CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.
CIPROLEN® 250 mg 250mg AC HELCOR SRL
CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES
CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.
CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA
100mg/10mlJ01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF.CIPRINOL® 100mg/10ml KRKA D.D.
CIPROFLOXACINA 100 mg/10 ml 100mg/10ml SICOMED SA
100mg/50mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 100mg/50ml KRKA D.D. NOVO MESTO
200mg/100mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 200mg/100ml KRKA D.D. NOVO MESTO
CIPROBAY® 200 200mg/100ml BAYER HEALTHCARE AG
250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA
250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED
CIPHIN 250 250mg ZENTIVA A.S.
CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO
CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.
CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.
CIPROLEN® 250 mg 250mg AC HELCOR SRL
CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES
CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.
CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA
2mg/mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPROBAY® 400 2mg/ml BAYER HEALTHCARE AG
UFEXIL 2mg/ml DEMO SA
400mg/200mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL® 400mg/200ml KRKA D.D.
500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED
CIPHIN 500 500mg ZENTIVA A.S.
CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO
CIPRO QUIN® 500mg ANTIBIOTICE SA
CIPROBAY® 500 500mg BAYER HEALTHCARE AG
CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.
CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L
CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.
CIPROLEN® 500 mg 500mg AC HELCOR SRL
CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES
CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.
CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA
SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS
750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO
Protocol: L034KSUBLISTA C1-G31A BOALA CRONICA INFLAMATORIE INTESTINALA.
582 INFLIXIMABUM ****L04AA12
100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.
583 ADALIMUMABUM ****L04AA17
40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.
86 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: L043MSUBLISTA C1-G31B POLIARTRITA REUMATOIDA.
584 RITUXIMABUM ****L01XC02
10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.
MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.
585 ETANERCEPTUM ****L04AA11
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED
586 INFLIXIMABUM ****L04AA12
100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.
587 ADALIMUMABUM ****L04AA17
40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.
Protocol: L040MSUBLISTA C1-G31C ARTROPATIA PSORIAZICA.
589 ETANERCEPTUM ****L04AA11
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED
590 INFLIXIMABUM ****L04AA12
100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.
591 ADALIMUMABUM ****L04AA17
40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.
Protocol: L041MSUBLISTA C1-G31D SPONDILITA ANKILOZANTA.
592 ETANERCEPTUM ****L04AA11
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED
593 INFLIXIMABUM ****L04AA12
100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.
594 ADALIMUMABUM ****L04AA17
40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.
87 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: L039MSUBLISTA C1-G31E ARTRITA JUVENILA.
595 ETANERCEPTUM ****L04AA11
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED
Protocol: L044LSUBLISTA C1-G31F PSORIAZIS CRONIC SEVER (PLACI).
596 ETANERCEPTUM ****L04AA11
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED
597 INFLIXIMABUM ****L04AA12
100mgL04AA12 INFLIXIMABUM PULB. PT. CONC. PT. SOL. PERF.REMICADE 100 mg 100mg CENTOCOR B.V.
598 EFALIZUMABUM ****L04AA21
100mg/mlL04AA21 EFALIZUMABUM PULB+SOLV.PT.SOL.INJRAPTIVA 100mg/ml 100mg/ml SERONO EUROPE LTD.
599 ADALIMUMABUM ****L04AA17
40mgL04AA17 ADALIMUMABUM SOL. INJ. IN SERINGA PREUMPLUTAHUMIRA 40 mg 40mg ABBOTT LABORATORIES LTD.
88 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. A ) SUBPROGRAMUL DE TRATAMENT SI
MONITORIZARE A PERSOANELOR CU INFECTIE HIV /SIDA SI TRATAMENTUL POSTEXPUNERE
600 SAQUINAVIRUMJ05AE01
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ05AE01 SAQUINAVIRUM CAPS.INVIRASE 200mg 200mg ROCHE REGISTRATION LTD.
500mgJ05AE01 SAQUINAVIRUM COMPR. FILM.INVIRASE 500 mg 500mg ROCHE REGISTRATION LTD.
601 INDINAVIRUMJ05AE02
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ05AE02 INDINAVIRUM CAPS.CRIXIVAN 200mg 200mg MERCK SHARP & DOHME LTD.
400mgJ05AE02 INDINAVIRUM CAPS.CRIXIVAN 400mg 400mg MERCK SHARP & DOHME LTD.
602 RITONAVIRUM **J05AE03
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ05AE03 RITONAVIRUM CAPS. MOINORVIR 100 mg 100mg ABBOTT LABORATORIES LTD.
603 NELFINAVIRUMJ05AE04
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgJ05AE04 NELFINAVIRUM COMPR. FILM.VIRACEPT 250 mg 250mg ROCHE REGISTRATION LTD.
50mg/gJ05AE04 NELFINAVIRUM PULB. PT. SOL. ORALAVIRACEPT 50 mg/g 50mg/g ROCHE REGISTRATION LTD.
605 LOPINAVIRUM+RITONAVIRUM **J05AE06
Prescriere limitata: Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
133.3mg/33.3mgJ05AE06 LOPINAVIRUM+RITONAVIRUM CAPS. MOIKALETRA 133,3mg/33,3mg 133.3mg/33.3mg ABBOTT LABORATORIES LTD.
200mg/50mgJ05AE06 LOPINAVIRUM+RITONAVIRUM COMPR. FILM.KALETRA 200mg/50mg 200mg/50mg ABBOTT LABORATORIES LTD.
80mg/ml+20mg/
ml
J05AE06 LOPINAVIRUM+RITONAVIRUM SOL. ORALA
KALETRA 80mg/ml+20mg/ml 80mg/ml+20mg/ml ABBOTT LABORATORIES LTD.
606 FOSAMPRENAVIRUM **J05AE07
700mgJ05AE07 FOSAMPRENAVIRUM COMPR. FILM.TELZIR 700mg 700mg GLAXO GROUP LTD.
607 ATAZANAVIRUMJ05AE08
Prescriere limitata: Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mgJ05AE08 ATAZANAVIRUM CAPS.REYATAZ 150 mg 150mg BRISTOL-MYERS SQUIBB PHARMA EEIG
200mgJ05AE08 ATAZANAVIRUM CAPS.REYATAZ 200 mg 200mg BRISTOL-MYERS SQUIBB PHARMA EEIG
608 TIPRANAVIRUM **J05AE09
Prescriere limitata: Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000
copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii trebuie sa fi avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1
inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgJ05AE09 TIPRANAVIRUM CAPS. MOIAPTIVUS 250mg 250mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH
609 DARUNAVIRUM **J05AE10
Prescriere limitata: Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000
copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii trebuie sa fi avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1
inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
300mgJ05AE10 DARUNAVIRUM COMPR. FILM.PREZISTA 300mg 300mg JANSSEN-CILAG INTERNATIONAL NV
610 ZIDOVUDINUMJ05AF01
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ05AF01 ZIDOVUDINUM CAPS.RETROVIR® 100mg THE WELLCOME FOUNDATION LTD.
1%J05AF01 ZIDOVUDINUM SOL. ORALARETROVIR® 1% THE WELLCOME FOUNDATION LTD.
611 DIDANOSINUMJ05AF02
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
125mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 125 mg 125mg BRISTOL MYERS SQUIBB KFT
200mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 200 mg 200mg BRISTOL MYERS SQUIBB KFT
89 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
250mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 250 mg 250mg BRISTOL MYERS SQUIBB KFT
400mgJ05AF02 DIDANOSINUM CAPS. GASTROREZ.VIDEX EC 400 mg 400mg BRISTOL MYERS SQUIBB KFT
612 STAVUDINUMJ05AF04
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
15mgJ05AF04 STAVUDINUM CAPS.ZERIT 15 mg 15mg BRISTOL-MYERS SQUIBB PHARMA EEIG
20mgJ05AF04 STAVUDINUM CAPS.ZERIT 20 mg 20mg BRISTOL-MYERS SQUIBB PHARMA EEIG
30mgJ05AF04 STAVUDINUM CAPS.ZERIT 30 mg 30mg BRISTOL-MYERS SQUIBB PHARMA EEIG
40mgJ05AF04 STAVUDINUM CAPS.ZERIT 40 mg 40mg BRISTOL-MYERS SQUIBB PHARMA EEIG
613 LAMIVUDINUMJ05AF05
100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.
10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.
150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.
5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.
614 ABACAVIRUMJ05AF06
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mg/mlJ05AF06 ABACAVIRUM SOL. ORALAZIAGEN 20 mg/ml 20mg/ml GLAXO GROUP LTD.
300mgJ05AF06 ABACAVIRUM COMPR. FILM.ZIAGEN 300 mg 300mg GLAXO GROUP LTD.
615 TENOFOVIRUM DISOPROXIL FUMARATEJ05AF07
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
245mgJ05AF07 TENOFOVIRUM DISOPROXIL FUMARATE COMPR. FILM.VIREAD 245mg 245mg GILEAD SCIENCE INTERNATIONAL LIMITED
616 EMTRICITABINUMJ05AF09
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ05AF09 EMTRICITABINUM CAPS.EMTRIVA 200mg 200mg GILEAD SCIENCE INTERNATIONAL LIMITED
617 NEVIRAPINUMJ05AG01
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ05AG01 NEVIRAPINUM COMPR.VIRAMUNE 200mg 200mg BOEHRINGER INGELHEIM INT. GMBH
50mg/5mlJ05AG01 NEVIRAPINUM SUSP. ORALAVIRAMUNE 50mg/ml 50mg/5ml BOEHRINGER INGELHEIM INT. GMBH
618 EFAVIRENZUMJ05AG03
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ05AG03 EFAVIRENZUM CAPS.STOCRIN 100 mg 100mg MERCK SHARP & DOHME LTD.
50mgJ05AG03 EFAVIRENZUM CAPS.STOCRIN 50 mg 50mg MERCK SHARP & DOHME LTD.
50mgJ05AG03 EFAVIRENZUM COMPR. FILM.STOCRIN 50 mg 50mg MERCK SHARP & DOHME LTD.
600mgJ05AG03 EFAVIRENZUM COMPR. FILM.STOCRIN 600 mg 600mg MERCK SHARP & DOHME LTD.
619 ZIDOVUDINUM+LAMIVUDINUM **J05AR01
Prescriere limitata: Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
150mg/300mgJ05AR01 ZIDOVUDINUM+LAMIVUDINUM COMPR. FILM.COMBIVIR 150mg/300mg 150mg/300mg GLAXO GROUP LTD.
620 ABACAVIRUM+LAMIVUDINUM **J05AR02
Prescriere limitata: Tratamentul infectiei HIV la pacientii in varsta de peste 12 ani si cu greutate corporala > de 40 kg. cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii
per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
600mg/300mgJ05AR02 ABACAVIRUM+LAMIVUDINUM COMPR. FILM.KIVEXA 600mg/300mg 600mg/300mg GLAXO GROUP LTD.
621 ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM **J05AR04
Prescriere limitata: Tratamentul infectiei HIV la pacientii in varsta de peste 12 ani si cu greutate corporala > de 40 kg. cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii
per mL.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
300mg/150mg/30
0mg
J05AR04 ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM COMPR. FILM.
90 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
TRIZIVIR 300mg/150mg/300mg 300mg/150mg/300
mg
GLAXO GROUP LTD.
622 ENFUVIRTIDUM **J05AX07
Prescriere limitata: Tratmentul combinat al infectiei HIV la pacienti experimentati cu esec la tratament caracterizat prin:evidenta replicarii virale in timpul terapiei antiretrovirale continue
sau intolerantei la medicamentele ARV anterior administrate. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1
inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
90mg/mlJ05AX07 ENFUVIRTIDUM PULB. + SOLV. PT. SOL. INJ.FUZEON 90mg/ml 90mg/ml ROCHE REGISTRATION LTD.
623 RIFAXIMINUMA07AA11
200mgA07AA11 RIFAXIMINUM COMPR. FILM.NORMIX 200 mg 200mg ALFA WASSERMANN SPA
624 MICONAZOLUMD01AC02
20mg/gD01AC02 MICONAZOLUM CREMAMICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S
2%D01AC02 MICONAZOLUM CREMAMEDACTER 2% FARAN LABORATORIES S.A.
MICONAZOL NITRAT 2% 2% SLAVIA PHARM SRL
2%D01AC02 MICONAZOLUM GELDERMOZOL 2% PHARCO IMPEX 93 S.R.L.
625 ACICLOVIRUMD06BB03
50mg/gD06BB03 ACICLOVIRUM CREMAACICLOVIR HYPERION 50mg/g HYPERION S.A.
ACIKLOVIR CREMA 50mg/g A & G MED TRADING S.R.L.
5%D06BB03 ACICLOVIRUM CREMAACICLOVIR 5% OZONE LABORATORIES LTD.
ACICLOVIR 5% 5% GEDEON RICHTER ROMANIA SA
CLOVIRAL® 5% 5% ANTIBIOTICE SA
ZOVIRAX 5% THE WELLCOME FOUNDATION LTD.
626 MICONAZOLUMG01AF04
1.2gG01AF04 MICONAZOLUM CAPS. MOI VAG.MICONAL ECOBI 1.2g FARMACEUTICI ECOBI S.A.S
200mgG01AF04 MICONAZOLUM SUPOZ. VAG.MYCOHEAL 200 200mg DAR AL DAWA PHARMA S.R.L
20mg/gG01AF04 MICONAZOLUM CREMA VAG.MICONAL ECOBI 20mg/g FARMACEUTICI ECOBI S.A.S
2mg/mlG01AF04 MICONAZOLUM SOL. VAGINALAMICONAL ECOBI 2mg/ml FARMACEUTICI ECOBI S.A.S
50mgG01AF04 MICONAZOLUM OVULEMICONAL ECOBI 50mg FARMACEUTICI ECOBI S.A.S
2%G01AF04 MICONAZOLUM CREMA VAG.MEDACTER 2% FARAN LABORATORIES S.A.
MYCOHEAL 2% DAR AL DAWA PHARMA S.R.L.
627 OXACILLINUMJ01CF04
250mgJ01CF04 OXACILLINUM CAPS.OXACILINA 250mg FARMACOM SA
OXACILINA 250 mg 250mg ANTIBIOTICE SA
OXACILINA ARENA 250 mg 250mg ARENA GROUP SA
OXACILINA FARMEX 250 mg 250mg FARMEX COMPANY SRL
OXACILINA SANDOZ 250 mg 250mg SANDOZ SRL
500mgJ01CF04 OXACILLINUM CAPS.OXACILINA 500 mg 500mg ANTIBIOTICE SA
OXACILINA ARENA 500 mg 500mg ARENA GROUP SA
OXACILINA FORTE 500 mg 500mg OZONE LABORATORIES LTD.
OXACILINA SANDOZ 500 mg 500mg SANDOZ SRL
OXALIN 500 mg 500mg EUROPHARM SA
500mgJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF. I.M./I.V.OXACILINA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE SA
1gJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF.I.M./I.V.OXACILINA ANTIBIOTICE 1 g 1g ANTIBIOTICE SA
250mgJ01CF04 OXACILLINUM PULB. PT. SOL. INJ./PERF.I.M./I.V.OXACILINA ANTIBIOTICE 250 mg 250mg ANTIBIOTICE SA
628 AMPICILLINUM + SULBACTAMJ01CR01
1g+500mgJ01CR01 AMPICILLINUM + SULBACTAM PULB. PT. SOL. INJ.AMPIPLUS® 1,5 g 1g+500mg ANTIBIOTICE SA
629 AMOXICILLINUM + ACIDUM CLAVULANICUMJ01CR02
Prescriere limitata: Tratamentul de scurta durata la infectiilor bacteriene atunci cand este suspectata rezistenta la amoxicilina.
Infectii la care este dovedita rezistenta la amoxicilina.
A fost raportată hepatotoxicitate la acest medicament.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1.2gJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.AMOXIPLUS 1,2 g 1.2g ANTIBIOTICE SA
1000mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.MEDOCLAV 1000 mg 1000mg MEDOCHEMIE LTD.
1000mg+200mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.AUGMENTIN INTRAVENOS 1.2g 1000mg+200mg BEECHAM GROUP PLC
1062.5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM. ELIB. PREL.AUGMENTIN™ SR 1062.5mg BEECHAM GROUP PLC
125mg+31.25/5m
l
J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA
91 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
MEDOCLAV 156,25 mg/5 ml 125mg+31.25/5ml MEDOCHEMIE LTD.
156.25mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAMOKSIKLAV 156,25mg/5ml 156.25mg/5ml LEK PHARMACEUTICALS D.D.
BIOCLAVID 156.25mg/5ml 156.25mg/5ml SANDOZ GMBH
2000mg+200mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. PERF.AUGMENTIN INTRAVENOS 2,2g 2000mg+200mg BEECHAM GROUP PLC
250/62,5mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 250/62,5 250/62,5mg ASTELLAS PHARMA EUROPE BV
250mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.MEDOCLAV 375 mg 250mg+125mg MEDOCHEMIE LTD.
250mg+62.5mg/5
ml
J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA
MEDOCLAV FORTE 312,5mg/5ml 250mg+62.5mg/5
ml
MEDOCHEMIE LTD.
312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALABIOCLAVID 312.5mg/5ml 312.5mg/5ml SANDOZ GMBH
312.5mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT.SUSP. ORALAAMOKSIKLAV 312.5mg/5ml 312.5mg/5ml LEK PHARMACEUTICALS D.D.
ENHANCIN 312,5 mg/5 ml 312.5mg/5ml RANBAXY UK LIMITED
400mg+57mg/5m
l
J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALA
AUGMENTIN BIS 400mg+57mg/5ml SMITHKLINE BEECHAM PLC
500/125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 500/125 500/125mg ASTELLAS PHARMA EUROPE BV
500mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 625 mg 500mg+125mg BEECHAM GROUP PLC
MEDOCLAV 625 mg 500mg+125mg MEDOCHEMIE LTD.
600mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.AMOXIPLUS 600 mg 600mg ANTIBIOTICE SA
625mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AMOKSIKLAV 2 x 625 mg 625mg LEK PHARMACEUTICALS D.D.
BIOCLAVID 625 mg 625mg SANDOZ GMBH
ENHANCIN 625 mg 625mg RANBAXY UK LIMITED
642.90mg/5mlJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM PULB. PT. SUSP. ORALAAUGMENTIN® ES 642.90mg/5ml SMITHKLINE BEECHAM PLC
875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. DISP.FORCID SOLUTAB 875/125 875mg+125mg ASTELLAS PHARMA EUROPE BV
875mg+125mgJ01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM COMPR. FILM.AUGMENTIN 1 g 875mg+125mg BEECHAM GROUP PLC
630 PIPERACILLINUM + TAZOBACTAMUMJ01CR05
J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH
TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH
631 COMBINATII (CEFOPERAZONUM+SULBACTAM)J01CR50
1g+1gJ01CR50 COMBINATII
(CEFOPERAZONUM+SULBACTAM)
PULB. PT. SOL. INJ.
SULPERAZON® 2 g 1g+1g PFIZER EUROPE MA EEIG
632 CEFTRIAXONUMJ01DD04
0.5gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.NOVOSEF 0,5 g i.v. 0.5g ECZACIBASI PHARMACEUTICALS S.R.L.
1gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.LENDACIN 1 g 1g LEK PHARMACEUTICALS D.D.
NOVOSEF 1 g i.m. 1g ECZACIBASI PHARMACEUTICALS S.R.L.
NOVOSEF 1 g i.v. 1g ECZACIBASI PHARMACEUTICALS S.R.L.
1gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 1 g 1g ANTIBIOTICE SA
CEFTRIAXON 1 g 1g OZONE LABORATORIES LTD.
250mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.LENDACIN 250 mg 250mg LEK PHARMACEUTICALS D.D.
250mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 250 mg 250mg ANTIBIOTICE SA
2gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 2 g 2g ANTIBIOTICE SA
MEDAXONE 2 g 2g MEDOCHEMIE LTD.
2gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. PERF.ROCEPHIN® 2g ROCHE ROMANIA S.R.L.
500mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 500 mg 500mg ANTIBIOTICE SA
0.5gJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ.NOVOSEF 0,5 g i.v. 0.5g ECZACIBASI PHARMACEUTICALS S.R.L.
500mgJ01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./PERF.CEFORT 500 mg 500mg ANTIBIOTICE SA
0.5gJ01DD04 CEFTRIAXONUM PULB. + SOLV. PT. SOL. INJ./PERF.NOVOSEF 0,5 g i.m. 0.5g ECZACIBASI PHARMACEUTICALS S.R.L.
633 CEFIXIMUMJ01DD08
100mg/5mlJ01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALASUPRAX 100mg/5ml GEDEON RICHTER LTD.
200mgJ01DD08 CEFIXIMUM CAPS.EFICEF® 200 mg 200mg ANTIBIOTICE SA
200mgJ01DD08 CEFIXIMUM COMPR. FILM.SUPRAX 200mg GEDEON RICHTER LTD.
92 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
634 CEFOPERAZONUMJ01DD12
1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 1 g 1g MEDICAROM GROUP S.R.L.
MEDOCEF 1 g 1g MEDOCHEMIE LTD.
2gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 2 g 2g MEDICAROM GROUP S.R.L.
MEDOCEF 2 g 2g MEDOCHEMIE LTD.
500mgJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.CEFOZON 500 mg 500mg E.I.P.I.CO. MED S.R.L.
1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ./PERF.I.M./I.V.CEFOZON 1 g 1g E.I.P.I.CO. MED S.R.L.
635 CEFPIROMUMJ01DE02
1gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 1 g 1g LAB. AVENTIS
2gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 2 g 2g LAB. AVENTIS
636 MEROPENEMUMJ01DH02
1gJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 1 g 1g ASTRAZENECA UK LTD.
500mgJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 500 mg 500mg ASTRAZENECA UK LTD.
637 IMIPENEMUM + CILASTATINUMJ01DH51
J01DH51 IMIPENEMUM + CILASTATINUM PULB. PT. SOL. PERF.TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L.
638 SULFAMETHOXAZOLUM + TRIMETHOPRIMUMJ01EE01Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mg/40mg
/5ml
J01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SUSP. ORALA
EPITRIM 200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.
25mg/5mg/mlJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SIROP
SUMETROLIM 25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.
400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
COMPR.
BISEPTRIM 400mg/80mg EUROPHARM SA
CO - TRIM ELL 400mg/80mg ARENA GROUP S.A.
SUMETROLIM 400mg/80mg EGIS PHARMACEUTICALS P.L.C.
TAGREMIN 400mg/80mg ZENTIVA S.A.
400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SOL. PERF.
SEPTRIN 400mg/80mg THE WELLCOME FOUNDATION LTD.
639 SPIRAMYCINUMJ01FA02
1.5 M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 1,5 Mil. UI 1.5 M ui LAB. AVENTIS
3M uiJ01FA02 SPIRAMYCINUM COMPR. FILM.ROVAMYCINE® 3 Mil. UI 3M ui LAB. AVENTIS
640 ROXITHROMYCINUMJ01FA06
150mgJ01FA06 ROXITHROMYCINUM COMPR. FILM.ROKSOLIT 150mg ECZACIBASI ILAC SANAYI VE TICARET AS
ROXAMED® 150 150mg DAR AL DAWA PHARMA S.R.L
641 CLARITHROMYCINUMJ01FA09
125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.
KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.
KLACID® 125mg/5ml ABBOTT SPA
LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.
250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.
FROMILID 250 250mg KRKA D.D. NOVO MESTO
KLABAX 250 mg 250mg TERAPIA S.A.
KLACID® 250mg ABBOTT SPA
KLERIMED® 250 250mg MEDOCHEMIE LTD.
LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.
250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.
LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.
FROMILID 500 500mg KRKA D.D. NOVO MESTO
KLABAX 500 mg 500mg TERAPIA S.A.
KLERIMED® 500 500mg MEDOCHEMIE LTD.
LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.
LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.
KLACID SR 500mg ABBOTT LABORATORIES LTD.
93 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
500mgJ01FA09 CLARITHROMYCINUM LIOF. PT. SOL. PERF.KLACID I.V. 500mg ABBOTT LABORATORIES LTD.
642 AZITHROMYCINUMJ01FA10
100mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 100 mg/5 ml 100mg/5ml SANDOZ SRL
125mgJ01FA10 AZITHROMYCINUM COMPR. FILM.SUMAMED 125 mg 125mg PLIVA LJUBLJANA D.O.O.
200 mg/5 mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALAAZITROMICINA SANDOZ 200 mg/5 ml 200 mg/5 ml SANDOZ SRL
200mg/5mlJ01FA10 AZITHROMYCINUM PULB. + SOLV. SUSP. ORALAAZITROX 200 mg/5 ml 200mg/5ml ECZACIBASI PHARMACEUTICALS S.R.L.
200mg/5mlJ01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALASUMAMED FORTE 200mg/5ml PLIVA LJUBLIJANA D.O.O.
250mgJ01FA10 AZITHROMYCINUM CAPS.AZATRIL 250 mg 250mg BALKANPHARMA RAZGRAD AD
250mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE 250mg SANDOZ S.R.L.
AZITROX® 250 250mg ZENTIVA AS
500mgJ01FA10 AZITHROMYCINUM COMPR. FILM.AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE 500mg SANDOZ S.R.L.
AZITROX® 500 500mg ZENTIVA AS
AZRO® 500 mg 500mg ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED 500 mg 500mg PLIVA LJUBLJANA D.O.O.
ZITROCIN 500 mg 500mg OZONE LABORATORIES LTD.
500mgJ01FA10 AZITHROMYCINUM LIOF. PT. SOL. PERF.SUMAMED® 500mg PLIVA LJUBLJANA D.O.O.
2gJ01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. SUSP. ORALAZMAX 2 g 2g PFIZER EUROPE MA EEIG
643 GENTAMICINUMJ01GB03
40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO
GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH
40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO
GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH
40mg/mlJ01GB03 GENTAMICINUM SOL. PARENT.LYRAMYCIN 40mg/ml MEDICAROM GROUP S.R.L.
80mg/2mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 80mg/2ml KRKA D.D. NOVO MESTO
80mg/2mlJ01GB03 GENTAMICINUM SOL.INJ.PAN - GENTAMICINE 80mg/2ml LAB. PANPHARMA
644 AMIKACINUMJ01GB06
100mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 100 mg/2 ml 100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.
250mg/mlJ01GB06 AMIKACINUM SOL. INJ.AMIKIN 250mg/ml BRISTOL MYERS SQUIBB KFT
500mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 500 mg/2 ml 500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.
645 NETILMICINUMJ01GB07
150mg/1.5mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 150mg/1.5ml SCHERING PLOUGH EUROPE
200mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 200mg/2ml SCHERING PLOUGH EUROPE
50mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 50mg/2ml SCHERING PLOUGH EUROPE
646 OFLOXACINUMJ01MA01
200mgJ01MA01 OFLOXACINUM COMPR. FILM.OFLOXACIN 200 mg 200mg ANTIBIOTICE SA
OFLOXIN 200 200mg ZENTIVA AS
ZANOCIN 200mg RANBAXY UK LIMITED
400mgJ01MA01 OFLOXACINUM COMPR. FILM. ELIB. PREL.ZANOCIN® OD 400 400mg RANBAXY U.K. LIMITED
647 CIPROFLOXACINUMJ01MA02
100mg/10mlJ01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF.CIPRINOL® 100mg/10ml KRKA D.D.
CIPROFLOXACINA 100 mg/10 ml 100mg/10ml SICOMED SA
100mg/50mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 100mg/50ml KRKA D.D. NOVO MESTO
200mg/100mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 200mg/100ml KRKA D.D. NOVO MESTO
CIPROBAY® 200 200mg/100ml BAYER HEALTHCARE AG
250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA
250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED
CIPHIN 250 250mg ZENTIVA A.S.
CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO
CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.
CIPROFLOXACIN 250 mg 250mg LAROPHARM SRL
CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.
CIPROLEN® 250 mg 250mg AC HELCOR SRL
94 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES
CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.
CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA
2mg/mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPROBAY® 400 2mg/ml BAYER HEALTHCARE AG
UFEXIL 2mg/ml DEMO SA
400mg/200mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL® 400mg/200ml KRKA D.D.
500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED
CIPHIN 500 500mg ZENTIVA A.S.
CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO
CIPRO QUIN® 500mg ANTIBIOTICE SA
CIPROBAY® 500 500mg BAYER HEALTHCARE AG
CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.
CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L
CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.
CIPROLEN® 500 mg 500mg AC HELCOR SRL
CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES
CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.
CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA
SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS
750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO
250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED
CIPHIN 250 250mg ZENTIVA A.S.
CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO
CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.
CIPROFLOXACIN 250 mg 250mg LAROPHARM SRL
CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.
CIPROLEN® 250 mg 250mg AC HELCOR SRL
CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES
CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.
CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA
648 PEFLOXACINUMJ01MA03
400mgJ01MA03 PEFLOXACINUM COMPR. FILM.ABAKTAL 400mg LEK PHARMACEUTICALS D.D.
PEFLOXACIN LAROPHARM 400mg LAROPHARM S.R.L.
400mg/5mlJ01MA03 PEFLOXACINUM CONC. PT. SOL. PERF.ABAKTAL 400mg/5ml 400mg/5ml LEK PHARMACEUTICALS D.D.
649 NORFLOXACINUMJ01MA06
400mgJ01MA06 NORFLOXACINUM COMPR. FILM.EPINOR 400mg E.I.P.I.CO. MED S.R.L.
H - NORFLOXACIN 400 mg 400mg AC HELCOR SRL
NOLICIN 400 mg 400mg KRKA D.D. NOVO MESTO
NORFLOX - 400 400mg LEK PHARMATECH SRL
NORFLOXACIN 400 mg 400mg OZONE LABORATORIES LTD.
NORFLOXACIN OZONE 400 mg 400mg OZONE LABORATORIES LTD.
NORFLOXACINA LPH 400 mg 400mg LABORMED PHARMA SA
650 LEVOFLOXACINUMJ01MA12
250mgJ01MA12 LEVOFLOXACINUM COMPR. FILM.LEVOFLOXACINA ACTAVIS 250 mg 250mg ACTAVIS GROUP PTC EHF.
500mgJ01MA12 LEVOFLOXACINUM COMPR. FILM.LEVOFLOXACINA ACTAVIS 500 mg 500mg ACTAVIS GROUP PTC EHF.
TAVANIC® 500mg AVENTIS PHARMA DEUTSCHLAND GMBH
5mg/mlJ01MA12 LEVOFLOXACINUM SOL. PERF.TAVANIC® I.V. 500 mg 5mg/ml AVENTIS PHARMA DEUTSCHLAND GMBH
651 MOXIFLOXACINUMJ01MA14
400mgJ01MA14 MOXIFLOXACINUM COMPR. FILM.AVELOX® 400 mg 400mg BAYER HEALTHCARE AG
400mg/250mlJ01MA14 MOXIFLOXACINUM SOL. PERF.AVELOX® 400 mg/250 ml 400mg/250ml BAYER HEALTHCARE AG
652 VANCOMYCINUMJ01XA01
Prescriere limitata: Tratamentul este initiat in spital pentru infectiile cu germeni sensibili la vancomicina.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1gJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY
1gJ01XA01 VANCOMYCINUM PULB.LIOF.PT.SOL.PERF./INJEDICIN 1g LEK PHARMACEUTICALS D.D.
500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY
1gJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY
1gJ01XA01 VANCOMYCINUM PULB.LIOF.PT.SOL.PERF./INJEDICIN 1g LEK PHARMACEUTICALS D.D.
500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY
500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF./INJ.EDICIN 500mg LEK PHARMACEUTICALS D.D.
653 TEICOPLANINUMJ01XA02
400mgJ01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. INJ.TARGOCID® 400 mg 400mg AVENTIS PHARMA LTD.
95 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
654 COLISTINUMJ01XB01
1000000uiJ01XB01 COLISTINUM PULB. PT. SOL. PERF.COLISTINA ANTIBIOTICE 1000000 UI 1000000ui ANTIBIOTICE SA
655 METRONIDAZOLUMJ01XD01
Prescriere limitata: Tratamentul infectiilor cu anaerobi
Tratamentul infectiilor cu protozoare sensibile la metronidazol:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgJ01XD01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (J01XD01) 250mg ARENA GROUP SA
250mgJ01XD01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS
5g/lJ01XD01 METRONIDAZOLUM SOL. PERF.METRONIDAZOL A 5 g/l 5g/l INFOMED FLUIDS SRL
METRONIDAZOL B 5 g/l 5g/l INFOMED FLUIDS SRL
5mg/mlJ01XD01 METRONIDAZOLUM SOL. PERF.METRONIDAZOL BRAUN 5mg/ml 5mg/ml B. BRAUN MELSUNGEN AG
250mgJ01XD01 METRONIDAZOLUM COMPR.METRONIDAZOL 250 mg (J01XD01) 250mg ARENA GROUP SA
250mgJ01XD01 METRONIDAZOLUM COMPR. FILM.FLAGYL 250mg LABORATOIRE AVENTIS
4%J01XD01 METRONIDAZOLUM SUSP. ORALAFLAGYL 4 % (J01XD01) 4% LABORATOIRE AVENTIS
656 LINEZOLIDUMJ01XX08
100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG
657 KETOCONAZOLUMJ02AB02
Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade.
Tratamentul candidozelor muco-cutanate cronice si candidozelor orofaringiene care nu pot fi tratate cu antifungice locale, la pacientii care prezinta rezistenta sau
intoleranta la fluconazol si intraconazol.
Micoze sistemice la care alte forme de terapie antifungica nu au avut efect.
A fost raportată hepatotoxicitate la ketoconazol.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA
KETOCONAZOL 200 mg 200mg MAGISTRA C & C
KETOSTIN 200 mg 200mg AC HELCOR SRL
NIZORAL 200mg JANSSEN PHARMACEUTICA NV
NIZORAL 200 mg 200mg TERAPIA SA
200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA
KETOCONAZOL 200 mg 200mg SLAVIA PHARM SRL
KETOSTIN 200 mg 200mg AC HELCOR SRL
NIZORAL 200mg JANSSEN PHARMACEUTICA NV
NIZORAL 200 mg 200mg TERAPIA SA
658 FLUCONAZOLUMJ02AC01
Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.
Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.
Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.
Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.
DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG
MYCOMAX® INF 2mg/ml ZENTIVA AS
50mgJ02AC01 FLUCONAZOLUM CAPS.
96 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
659 ITRACONAZOLUMJ02AC02
Prescriere limitata: Aspergiloza sistemica.
Histoplasmoza sistemica.
Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara diseminata.
Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara cronica;
Criptococoza sistemica inclusiv meningeala.
Cromoblastomicoză şi micetom.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg SLAVIA PHARM SRL
OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.
ORUNGAL 100mg JANSSEN PHARMACEUTICA NV
SPORILIN 100 mg 100mg GEDEON RICHTER ROMANIA S.A.
660 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
661 POSACONAZOLUM **J02AC04
Prescriere limitata: Aspergiloză invazivă la pacienţi cu boală rezistentă la amfotericina B sau itraconazol sau la pacienţi care nu tolerează aceste medicamente;
Fusarioză la pacienţii cu boală rezistentă la amfotericina B sau la pacienţi care nu tolerează amfotericina B;
Cromoblastomicoză şi micetom la pacienţii cu boală rezistentă la itraconazol sau la pacienţi care nu tolerează itraconazolul;
Coccidioidomicoză la pacienţi cu boală rezistentă la amfotericina B, itraconazol sau fluconazol sau la pacienţi care nu tolerează aceste medicamente.
Candidoză oro-faringiană: ca terapie de primă intenţie la pacienţii cu forme severe sau la pacienţii cu imunitate scăzută, la care este de aşteptat ca răspunsul la
tratamentul topic să fie scăzut.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE
662 CASPOFUNGINUM ** Protocol: J010DJ02AX04
50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD
70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD
664 RIFABUTINUMJ04AB04
Prescriere limitata: Tratamentul contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi.
Profilaxia contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi cu celule CD4 mai putin de 75 pe milimetru cub.
150mgJ04AB04 RIFABUTINUM CAPS.MYCOBUTIN 150 mg 150mg PFIZER EUROPE MA EEIG
665 ISONIAZIDUMJ04AC01
100mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 100 mg 100mg ANTIBIOTICE SA
300mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 300mg ANTIBIOTICE SA
500mg/10mlJ04AC01 ISONIAZIDUM SOL. INJ.IZONIAZIDA 500 mg 500mg/10ml TERAPIA SA
666 PYRAZINAMIDUMJ04AK01
500mgJ04AK01 PYRAZINAMIDUM COMPR.PIRAZINAMIDA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE S.A.
667 ETHAMBUTOLUMJ04AK02
250mgJ04AK02 ETHAMBUTOLUM COMPR. FILM.ETAMBUTOL 250 mg 250mg ANTIBIOTICE SA
668 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)J04AM02
300mg+150mgJ04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM) CAPS.SINERDOL ISO 300mg+150mg ANTIBIOTICE SA
669 ACICLOVIRUMJ05AB01
200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg ARENA GROUP SA
EUVIROX 200 mg 200mg EUROPHARM SA
200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA
CLOVIRAL 200 mg 200mg ANTIBIOTICE SA
ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.
200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.
97 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
LOVIR 200 mg 200mg RANBAXY UK LIMITED
250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO
400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.
400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.
400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.
670 RIBAVIRINUMJ05AB04
200mgJ05AB04 RIBAVIRINUM CAPS.REBETOL 200 mg 200mg SP EUROPE
200mgJ05AB04 RIBAVIRINUM COMPR. FILM.COPEGUS® 200mg ROCHE ROMANIA SRL
671 GANCICLOVIRUMJ05AB06
Prescriere limitata: Infectii severe cu citomegalovirus (CMV) la pacienti imunocompromisi inclusiv cu localizare oculara.
500mgJ05AB06 GANCICLOVIRUM LIOF. PT. SOL. INJ.CYMEVENE 500mg ROCHE ROMANIA S.R.L.
672 VALACYCLOVIRUMJ05AB11
500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.
673 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
674 BRIVUDINUMJ05ABN1
125mgJ05ABN1 BRIVUDINUM COMPR.BRIVAL® 125mg BERLIN CHEMIE AG MENARINI GROUP
676 PALIVIZUMABUM **J06BB16
Prescriere limitata: Prevenirea bolilor severe ale tractului respirator inferior care necesită spitalizare, provocate de virusul sinciţial respirator (VSR) la copii născuţi la 35 săptămâni de
gestaţie sau mai puţin şi cu vârsta mai mică de 6 luni la începutul sezonului de îmbolnăviri cu VSR sau la copii cu vârsta mai mică de 2 ani care au necesitat tratament
pentru displazie bronhopulmonară în ultimele 6 luni.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ06BB16 PALIVIZUMABUM PULB. + SOLV. PT. SOL. INJ.SYNAGIS 100 mg 100mg ABBOTT LABORATORIES LTD.
50mgJ06BB16 PALIVIZUMABUM PULB. + SOLV. PT. SOL. INJ.SYNAGIS 50 mg 50mg ABBOTT LABORATORIES LTD.
681 FILGRASTIMUM (G-CSF) **L03AA02
Prescriere limitata: Tratamentul neutropeniei persistente (ANC mai mic sau egal cu 1,0 x 109/L) la pacienţii cu infecţie HIV aflaţi în stadii avansate, în scopul scăderii riscului de infecţii
bacteriene în situaţiile în care alte opţiuni în tratamentul neutropeniei sunt inadecvate.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
682 NETILMICINUMS01AA23
0.3%S01AA23 NETILMICINUM PICATURI OFT.-SOL.NETTACIN® 0.3% S.I.F.I. SPA
3mg/gS01AA23 NETILMICINUM UNG. OFT.NETTAVISC 3mg/g 3mg/g S.I.F.I. SPA
0.3%S01AA23 NETILMICINUM PIC. OFT., SOLNETTACIN® 0.3% S.I.F.I. SPA
683 LOMEFLOXACINUMS01AX17
3mg/mlS01AX17 LOMEFLOXACINUM PICATURI OFT.-SOL.OKACIN 3mg/ml NOVARTIS PHARMA GMBH
684 NORFLOXACINUMS03AAN2
0.3%S03AAN2 NORFLOXACINUM PICATURI OFT./AURIC.-SOL.NORFLOX 0.3% CIPLA (UK) LIMITED
685 DEXAMETHASONUMS01BA01
0.1%S01BA01 DEXAMETHASONUM PICATURI OFT.-SUSP.MAXIDEX® 0.1% ALCON COUVREUR NV
1mg/mlS01BA01 DEXAMETHASONUM PIC. OFT. SUSP.DEXAMETAZONA RPH 1mg/ml 1mg/ml ROMPHARM COMPANY SRL
1207 AMPHOTERICINUM B LIPOSOMAL (4)J02AA01
J02AA01 AMPHOTERICINUM B LIPOSOMAL
1208 ATOVAQUONA (4)P01AX06
P01AX06 ATOVAQUONA
1209 FLUCYTOSINUM (4)J02AX01
J02AX01 FLUCYTOSINUM
1210 MEFLOQUINE (4)P01BC02
P01BC02 MEFLOQUINE
1211 MUPIROCINUM (4)R01AX06
R01AX06 MUPIROCINUM
98 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
1212 PAROMOMYCINUM (4)A07AA06
A07AA06 PAROMOMYCINUM
1213 PENTAMIDINUM (4)P01CX01
P01CX01 PENTAMIDINUM
1214 PRIMAQUINUM (4)P01BA03
P01BA03 PRIMAQUINUM
1215 PYRIMETHAMINUM (4)P01BD01
P01BD01 PYRIMETHAMINUM
1216 PYRIMETHAMINUM+SULFADIAZINUM (4)P01BD51
P01BD51 PYRIMETHAMINUM+SULFADIAZINUM
1217 TRIMETHOPRIM (4)J01EA01
J01EA01 TRIMETHOPRIM
99 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. B) SUBPROGRAMUL DE TRATAMENT AL BOLNAVILOR
CU TUBERCULOZA
686 PYRIDOXINUMA11HA02
250 mgA11HA02 PYRIDOXINUM COMPR.VITAMINA B6 250 mg 250 mg ARENA GROUP SA
250mgA11HA02 PYRIDOXINUM COMPR.SICOVIT B6 250 mg 250mg ZENTIVA SA
250mg/5mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 250 mg/5 ml 250mg/5ml ZENTIVA SA
50mg/2mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 50 mg/2ml 50mg/2ml ZENTIVA SA
687 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
688 CLARITHROMYCINUMJ01FA09
125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.
KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.
KLACID® 125mg/5ml ABBOTT SPA
LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.
250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.
FROMILID 250 250mg KRKA D.D. NOVO MESTO
KLABAX 250 mg 250mg TERAPIA S.A.
KLACID® 250mg ABBOTT SPA
KLERIMED® 250 250mg MEDOCHEMIE LTD.
LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.
250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.
LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.
FROMILID 500 500mg KRKA D.D. NOVO MESTO
KLABAX 500 mg 500mg TERAPIA S.A.
KLERIMED® 500 500mg MEDOCHEMIE LTD.
LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.
LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.
KLACID SR 500mg ABBOTT LABORATORIES LTD.
500mgJ01FA09 CLARITHROMYCINUM LIOF. PT. SOL. PERF.KLACID I.V. 500mg ABBOTT LABORATORIES LTD.
691 AMIKACINUMJ01GB06
100mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 100 mg/2 ml 100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.
250mg/mlJ01GB06 AMIKACINUM SOL. INJ.AMIKIN 250mg/ml BRISTOL MYERS SQUIBB KFT
500mg/2mlJ01GB06 AMIKACINUM SOL. INJ.AMIKOZIT® 500 mg/2 ml 500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.
692 OFLOXACINUMJ01MA01
200mgJ01MA01 OFLOXACINUM COMPR. FILM.OFLOXACIN 200 mg 200mg ANTIBIOTICE SA
OFLOXIN 200 200mg ZENTIVA AS
ZANOCIN 200mg RANBAXY UK LIMITED
400mgJ01MA01 OFLOXACINUM COMPR. FILM. ELIB. PREL.ZANOCIN® OD 400 400mg RANBAXY U.K. LIMITED
693 CIPROFLOXACINUMJ01MA02
100mg/10mlJ01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF.CIPRINOL® 100mg/10ml KRKA D.D.
CIPROFLOXACINA 100 mg/10 ml 100mg/10ml SICOMED SA
100mg/50mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 100mg/50ml KRKA D.D. NOVO MESTO
200mg/100mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL 200mg/100ml KRKA D.D. NOVO MESTO
CIPROBAY® 200 200mg/100ml BAYER HEALTHCARE AG
250mgJ01MA02 CIPROFLOXACINUM CAPS.EUCIPRIN 250mg EUROPHARM SA
250mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 250mg RANBAXY UK LIMITED
CIPHIN 250 250mg ZENTIVA A.S.
CIPRINOL 250 mg 250mg KRKA D.D. NOVO MESTO
CIPROCIN 250 mg 250mg E.I.P.I.CO. MED S.R.L.
CIPROFLOXACIN 250 mg 250mg LAROPHARM SRL
100 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CIPROFLOXACINA ALKALOID 250 mg 250mg ALKALOID D.O.O.
CIPROLEN® 250 mg 250mg AC HELCOR SRL
CIPROLET 250 mg 250mg DR. REDDY'S LABORATORIES
CIPROZONE 250 mg 250mg OZONE LABORATORIES LTD.
CUMINOL 250 mg 250mg GEDEON RICHTER ROMANIA
2mg/mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPROBAY® 400 2mg/ml BAYER HEALTHCARE AG
UFEXIL 2mg/ml DEMO SA
400mg/200mlJ01MA02 CIPROFLOXACINUM SOL. PERF.CIPRINOL® 400mg/200ml KRKA D.D.
500mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIFRAN 500mg RANBAXY UK LIMITED
CIPHIN 500 500mg ZENTIVA A.S.
CIPRINOL 500 mg 500mg KRKA D.D. NOVO MESTO
CIPRO QUIN® 500mg ANTIBIOTICE SA
CIPROBAY® 500 500mg BAYER HEALTHCARE AG
CIPROCIN 500 mg 500mg E.I.P.I.CO. MED S.R.L.
CIPRODAR 500mg DAR AL DAWA PHARMA S.R.L
CIPROFLOXACINA ALKALOID 500 mg 500mg ALKALOID D.O.O.
CIPROLEN® 500 mg 500mg AC HELCOR SRL
CIPROLET 500 mg 500mg DR. REDDY'S LABORATORIES
CIPROZONE FORTE 500 mg 500mg OZONE LABORATORIES LTD.
CUMINOL 500 mg 500mg GEDEON RICHTER ROMANIA
SIFLOKS® 500mg ECZACIBASI ILAC SANAYI VE TICARET AS
750mgJ01MA02 CIPROFLOXACINUM COMPR. FILM.CIPRINOL 750 mg 750mg KRKA D.D. NOVO MESTO
694 MOXIFLOXACINUMJ01MA14
400mgJ01MA14 MOXIFLOXACINUM COMPR. FILM.AVELOX® 400 mg 400mg BAYER HEALTHCARE AG
400mg/250mlJ01MA14 MOXIFLOXACINUM SOL. PERF.AVELOX® 400 mg/250 ml 400mg/250ml BAYER HEALTHCARE AG
696 CICLOSERINUMJ04AB01
250mgJ04AB01 CICLOSERINUM CAPS.CICLOSERINA ANTIBIOTICE 250 mg 250mg ANTIBIOTICE S.A.
HELPOCERIN 250mg HELP PHARMACEUTICALS LTD.
697 RIFAMPICINUMJ04AB02
150mgJ04AB02 RIFAMPICINUM CAPS.SINERDOL 150 mg 150mg ANTIBIOTICE SA
300mgJ04AB02 RIFAMPICINUM CAPS.SINERDOL 300 mg 300mg ANTIBIOTICE SA
698 RIFABUTINUMJ04AB04
150mgJ04AB04 RIFABUTINUM CAPS.MYCOBUTIN 150 mg 150mg PFIZER EUROPE MA EEIG
699 CAPREOMYCINUM (4)J04AB30
J04AB30 CAPREOMYCINUM
700 ISONIAZIDUMJ04AC01
100mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 100 mg 100mg ANTIBIOTICE SA
300mgJ04AC01 ISONIAZIDUM COMPR.ISONIAZIDA 300mg ANTIBIOTICE SA
500mg/10mlJ04AC01 ISONIAZIDUM SOL. INJ.IZONIAZIDA 500 mg 500mg/10ml TERAPIA SA
701 PROTIONAMIDUMJ04AD01
250mgJ04AD01 PROTIONAMIDUM COMPR. FILM.PROTIONAMIDA 250 mg 250mg ANTIBIOTICE SA
702 PYRAZINAMIDUMJ04AK01
500mgJ04AK01 PYRAZINAMIDUM COMPR.PIRAZINAMIDA ANTIBIOTICE 500 mg 500mg ANTIBIOTICE S.A.
703 ETHAMBUTOLUMJ04AK02
250mgJ04AK02 ETHAMBUTOLUM COMPR. FILM.ETAMBUTOL 250 mg 250mg ANTIBIOTICE SA
704 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)J04AM02
300mg+150mgJ04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM) CAPS.SINERDOL ISO 300mg+150mg ANTIBIOTICE SA
101 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P3: PROGRAMUL NATIONAL DE ONCOLOGIE.
705 CYPROTERONUM Protocol: L025CG03HA01
50mgG03HA01 CYPROTERONUM COMPR.ANDROCUR 50mg SCHERING AG
706 CYCLOPHOSPHAMIDUML01AA01
1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH
200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.
500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
707 CHLORAMBUCILUML01AA02
Indicat in schemele de tratament al limfomului Hodgkin.
Indicat in schemele de tratament ale anumitor forme de limfoame non-Hodgkin.
Indicat in schemele de tratament al leucemiei limfocitare cronice.
Indicat in schemele de tratament a macroglobulinemiei Waldenstrom.
NOTA:
2mgL01AA02 CHLORAMBUCILUM COMPR. FILM.LEUKERAN 2mg THE WELLCOME FOUNDATION LTD.
708 MELPHALANUML01AA03
Indicat in schemele de tratament al mielomului multiplu.
Indicat in schemele de tratament ale adenocarcinomuluii ovarian avansat.
Indicat in schemele de tratament al cancerului de san avansat.
Indicat in schemele de tratament a policitemia vera.
NOTA:
2mgL01AA03 MELPHALANUM COMPR. FILM.ALKERAN 2 mg 2mg THE WELLCOME FOUNDATION LTD.
709 IFOSFAMIDUML01AA06
1gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 1 g 1g BAXTER ONCOLOGY GMBH
2gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 2 g 2g BAXTER ONCOLOGY GMBH
500mgL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 500 mg 500mg BAXTER ONCOLOGY GMBH
710 BUSULFANUML01AB01
Indicat in schemele de tratament paliativ al fazei cronice in Leucemia Granulocitara Cronica.
Indicat in schemele de tratament a polcitemiei vera.
Indicat in schemele de tratament a mielofibrozei si trombocitemiei esentiale.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2mgL01AB01 BUSULFANUM COMPR. FILM.MYLERAN 2mg THE WELLCOME FOUNDATION LTD.
712 TEMOZOLOMIDUM ** Protocol: L046CL01AX03
Tratamentul glioblastomului multiform nou diagnosticat, în asociere cu radioterapia şi apoi ca monoterapie.
Tratamentul glioamelor maligne, (glioblastomul multiform sau astrocitomul anaplazic), care au prezentat recurenţă sau progresie după terapia standard.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 100 mg 100mg SP EUROPE
20mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 20 mg 20mg SP EUROPE
250mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 250 mg 250mg SP EUROPE
5mgL01AX03 TEMOZOLOMIDUM CAPS.TEMODAL 5 mg 5mg SP EUROPE
L01AX03 TEMOZOLOMIDUMTEMODAL 100 mg 100mg SP EUROPE
L01AX03 TEMOZOLOMIDUMTEMODAL 20 mg 20mg SP EUROPE
L01AX03 TEMOZOLOMIDUMTEMODAL 5 mg 5mg SP EUROPE
713 DACARBAZINUML01AX04
200mgL01AX04 DACARBAZINUM LIOF. PT. SOL. PERF.DALTRIZEN® 200 mg 200mg ACTAVIS S.R.L.
714 METHOTREXATUML01BA01
100mg/mlL01BA01 METHOTREXATUM CONC. PT. SOL. INJ./PERF.METHOTREXAT "EBEWE" 1000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG
METHOTREXAT "EBEWE" 500 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG
METHOTREXAT "EBEWE" 5000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG
10mg/mlL01BA01 METHOTREXATUM SOL. INJ./PERF.METHOTREXAT "EBEWE" 50 mg 10mg/ml EBEWE PHARMA GMBH NFG. KG
50mgL01BA01 METHOTREXATUM PULB. PT. SOL. INJ./PERF.ANTIFOLAN® 50 mg 50mg SINDAN SRL
5mg/mlL01BA01 METHOTREXATUM SOL. INJ.METHOTREXAT "EBEWE" 5 mg 5mg/ml EBEWE PHARMA GMBH NFG. KG
715 PEMETREXEDUM **** Protocol: L047CL01BA04
102 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Tratamentul în asociere cu cisplatină al pacienţilor cu mezoteliom pleural malign nerezecabil fără chimioterapie anterioară.
Tratamentul ca monoterapie al pacienţilor cu cancer pulmonar cu alt tip de celulă decât cu celulă mică, avansat local sau metastazat, după chimioterapie anterioară.
Doze mai mari de 500 mg pe metru pătrat de suprafaţă corporală nu se vor aproba pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de
aprobare.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
500mgL01BA04 PEMETREXEDUM PULB. PT. CONC. PT. SOL. PERF.ALIMTA 500mg 500mg ELI LILLY NEDERLAND BV
716 MERCAPTOPURINUML01BB02
50mgL01BB02 MERCAPTOPURINUM COMPR.PURI - NETHOL 50mg THE WELLCOME FOUNDATION LTD.
717 TIOGUANINUML01BB03
40mgL01BB03 TIOGUANINUM COMPR.LANVIS 40mg THE WELLCOME FOUNDATION LTD.
718 CLADRIBINUML01BB04
Prescriere limitata: Leucemia cu celule paroase.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2mg/mlL01BB04 CLADRIBINUM SOL. INJ.LITAK 2 mg/ml 2mg/ml LIPOMED GMBH
719 FLUDARABINUM **** Protocol: L048CL01BB05
Tratamentul pacienţilor cu leucemie limfocitară cronică cu celule B (LLC), cu rezervă medulară suficientă, care nu au răspuns la tratament sau a căror boală a avansat în timpul
tratamentului cu o schemă conţinând cel puţin un agent alchilant standard sau ulterior acestuia.
NOTA:
10mgL01BB05 FLUDARABINUM COMPR. FILM.FLUDARA® ORAL 10mg SCHERING AG
720 CYTARABINUML01BC01
100mgL01BC01 CYTARABINUM PULB. + SOLV. PT. SOL. INJ.CYTOSAR™ 100 mg 100mg PFIZER EUROPE MA EEIG
20mg/mlL01BC01 CYTARABINUM SOL. INJ.ALEXAN 20mg/ml 20mg/ml EBEWE PHARMA GMBH NFG. KG
50mgL01BC01 CYTARABINUM SUSP. INJ.DEPOCYTE 50mg 50mg SKYEPHARMKA PLC
50mg/mlL01BC01 CYTARABINUM SOL. INJ.ALEXAN 50mg/ml 50mg/ml EBEWE PHARMA GMBH NFG. KG
721 FLUOROURACILUML01BC02
250mg/5mlL01BC02 FLUOROURACILUM SOL. PERF./INJ.FLUOROSINDAN 250mg/5ml 250mg/5ml ACTAVIS S.R.L.
50 mg/gL01BC02 FLUOROURACILUM UNGUENTEFUDIX 50 mg/g ICN HUNGARY CO. LTD.
50mg/mlL01BC02 FLUOROURACILUM CONC. PT. SOL. INJ./PERF.5 - FLUOROURACIL EBEWE 50mg/ml 50mg/ml EBEWE PHARMA GMBH NFG. KG
722 GEMCITABINUM **L01BC05
Prescriere limitata: Terapia asociata a cancerului mamar avansat cu paclitaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina.
Terapia asociata a cancerului ovarian epitelial avansat cu carboplatinum la pacientele cu recadere la mai mult de 6 luni dupa chimioterpia cu derivati de platinum.
Tratamentul de prima intentie al cancerului pulmonar cu alt tip de celule decat cu celule mici, stadiile IIIA sau IIIB sau IV in asociere cu cisplatin.
Tratamentul paliativ al cancerului pulmonar cu alt tip de celule decat cu celule mici avansat local sau metastatic.
Adenocarcinom pancreatic avansat local sau metastatic.
Tratamentul asociat al cancerului vezical avansat local sau metastatic in combinatie cu cisplatin.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1gL01BC05 GEMCITABINUM PULB. PT. SOL. PERF.GEMCITABINA SINDAN 1 g 1g ACTAVIS S.R.L.
200mgL01BC05 GEMCITABINUM PULB. PT. SOL. PERF.GEMCITABINA SINDAN 200 mg 200mg ACTAVIS S.R.L.
723 CAPECITABINUML01BC06
Prescriere limitata: Cancer mamar avansat local sau metastazat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina.
Cancer mamar avansat local sau metastazat in care terapia cu un derivat de antraciclina nu mai este indicata.
Terapia asociata a cancerului mamar avansat local sau metastazat cu docetaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina.
Tratamentul de prima linie al cancerului colorectal metastatic avansat.
Tratamentul adjuvant al cancerului de colon stadiul III (Dukes C), dupa rezectia completa a tumorii primare.
Durata recomandata a tratamentului adjuvant este de 24 de saptamani; nu se compenseaza tratamentul cu Capecitabinum pentru cancerul de colon stadiul II (Dukes B) si
tratamentul adjuvant al pacientilor cu cancer rectal.
NOTA:
150mgL01BC06 CAPECITABINUM COMPR. FILM.XELODA 150 mg 150mg ROCHE REGISTRATION LTD.
500mgL01BC06 CAPECITABINUM COMPR. FILM.XELODA 500 mg 500mg ROCHE REGISTRATION LTD.
724 COMBINATII (TEGAFUR+URACIL)L01BC53
100mg+224mgL01BC53 COMBINATII (TEGAFUR+URACIL) CAPS.UFT 100mg+224mg MERCK KGAA
726 VINCRISTINUML01CA02
1mgL01CA02 VINCRISTINUM LIOF. PT. SOL. INJ./PERF. I.V.SINDOVIN 1 mg 1mg ACTAVIS S.R.L.
727 VINORELBINUML01CA04
10mg/mlL01CA04 VINORELBINUM CONC. PT. SOL. INJ./PERF.VINORELBIN EBEWE 10 mg/ ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG
10mg/mlL01CA04 VINORELBINUM CONC. PT. SOL. PERF.VINORELBIN ACTAVIS 10 mg/ml 10mg/ml ACTAVIS S.R.L.
VINORELBIN TEVA 10 mg/ml 10mg/ml TEVA PHARMACEUTICALS SRL
10mg/mlL01CA04 VINORELBINUM SOL. INJ.NAVELBINE® 10mg/ml LAB. PIERRE FABRE
Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.Prescriere limitata:
103 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.Prescriere limitata:
20mgL01CA04 VINORELBINUM CAPS. MOINAVELBINE 20 mg 20mg PIERRE FABRE MEDICAMENT
Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.Prescriere limitata:
Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.Prescriere limitata:
30mgL01CA04 VINORELBINUM CAPS. MOINAVELBINE 30 mg 30mg PIERRE FABRE MEDICAMENT
Tratamentul cancerului mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina.Prescriere limitata:
Tratamentul de prima intentie singular sau asociat al cancerului pulmonar cu alte celule decat celule mici avansat local sau metastatic.Prescriere limitata:
728 ETOPOSIDUML01CB01
100mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 100mg BRISTOL MYERS SQUIBB KFT
100mg/5mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSID "EBEWE" 100 mg/5 ml 100mg/5ml EBEWE PHARMA GMBH NFG. KG
SINTOPOZID 100 mg/5 ml 100mg/5ml ACTAVIS S.R.L.
20mg/mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSIDE - TEVA 20mg/ml TEVA PHARMACEUTICALS S.R.L.
50mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 50mg BRISTOL MYERS SQUIBB KFT
729 PACLITAXELUM **L01CD01
Prescriere limitata: Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi administrat secvential cu un derivat de antraciclina si ciclofosfamida.
Cancer mamar avansat dupa esecul terapiei anterioare sau intoleranta la un derivat de antraciclina.
Terapia de linia a doua cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum.
Cancer pulmonar cu celule altele decat celule mici avansat local sau metastatic.
Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab si care nu sunt eeligibili pentru tratament cu un derivat de antraciclina.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
6mg/mlL01CD01 PACLITAXELUM CONC. PT. SOL. PERF.ONXOL 6mg/ml 6mg/ml IVAX - PHARMACEUTICALS S.R.O.
PACLITAXEL 6 mg/ml 6mg/ml PHARMEXPRESS S.R.L.
PACLITAXEL EBEWE 6mg/ml 6mg/ml EBEWE PHARMA GES.M.B.H. NFG KG
SINDAXEL 6mg/ml ACTAVIS S.R.L.
730 DOCETAXELUM ** Protocol: L049CL01CD02
Tratamentul adjuvant în asociere cu doxorubicină şi ciclofosfamidă, adjuvant al pacientelor cu cancer mamar operabil, cu ganglioni pozitivi.
Tratamentul în asociere cu doxorubicină, al pacientelor cancer mamar avansat loco-regional sau metastazat, care nu au primit anterior tratament citotoxic pentru această
afecţiune.
Tratamentul in monoterapie al pacientelor cu cancer mamar avansat loco-regional sau metastazat, după eşecul tratamentului citotoxic. Chimioterapia anterioară trebuie să fi
inclus o antraciclină sau un agent alchilant.
Tratamentul în asociere cu trastuzumab, al pacientelor cu cancer mamar metastazat ale căror tumori exprimă în exces HER2 şi care nu au primit anterior chimioterapie pentru
boala metastatică.
Tratamentul în asociere cu capecitabină, al pacientelor cu cancer mamar avansat loco-regional sau metastazat, după eşecul chimioterapiei citotoxice. Tratamentul anterior trebuie
să fi inclus o antraciclină.
Tratamentul pacienţilor cu cancer bronhopulmonar, altul decât cel cu celule mici, avansat loco-regional sau metastazat, după eşecul chimioterapiei sau înainte de aceasta.
Tratamentul în asociere cu cisplatină, al pacienţilor cu cancer bronhopulmonar, altul decât cel cu celule mici, nerezecabil, avansat loco-regional sau metastazat, la pacienţii care
nu au primit anterior chimioterapie pentru această afecţiune.
Tratamentul în asociere cu prednison sau prednisolon, al pacienţilor cu cancer de prostată metastazat, hormono-rezistent.
Tratamentul în asociere cu cisplatină şi 5-fluorouracil, al pacienţilor cu adenocarcinom gastric metastazat, inclusiv adenocarcinom al joncţiunii gastroesofagiene, care nu au
primit anterior chimioterapie pentru boala metastatică.
Tratamentul în asociere cu cisplatină şi 5-fluorouracil de inducţie la pacienţi cu carcinom cu celule scuamoase, al capului şi gâtului, avansat local.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
20mgL01CD02 DOCETAXELUM CONC. + SOLV. PT. SOL. PERF.TAXOTERE 20 mg 20mg AVENTIS PHARMA SA
80mgL01CD02 DOCETAXELUM CONC. + SOLV. PT. SOL. PERF.TAXOTERE 80 mg 80mg AVENTIS PHARMA SA
732 DOXORUBICINUML01DB01
10mgL01DB01 DOXORUBICINUM LIOF. PT. SOL. INJ.ADRIBLASTINA RD 10 mg 10mg ACTAVIS S.R.L.
2mg/mlL01DB01 DOXORUBICINUM CONC. PT. SOL. PERF.CAELYX 2 mg/ml 2mg/ml SP EUROPE
Tratamentul ca monoterapie al cancerului mamar metastatic, la paciente cu risc cardiac crescut.Prescriere limitata:
Tratamentul cancerului ovarian în stadiu avansat, la paciente care nu au răspuns la regimul chimioterapic de primă linie, cu compuşi de platină.Prescriere limitata:
Tratamentul sarcomului Kaposi (SK) corelat cu SIDA (SK-SIDA), la pacienţii cu număr mic de limfocite CD4 (< 200 limfocite CD4/mm3) şi cu afectare mucocutanată sau
viscerală extinsă. Poate fi utilizat în chimioterapia sistemică de primă linie sau în chimioterapia de linia a doua la pacienţii cu SK-SIDA la care boala a avansat sau la
pacienţii cu intoleranţă la tratament, la care s-a administrat anterior chimioterapie sistemică combinată, cuprinzând cel puţin două dintre următoarele chimioterapice:
alcaloid de vinca, bleomicină şi doxorubicină standard (sau altă antraciclină).
Prescriere limitata:
2mg/mlL01DB01 DOXORUBICINUM CONC. PT. SOL. PERF.DOXORUBICIN "EBEWE" 2mg/ml 2mg/ml EBEWE PHARMA GMBH NFG. KG
2mg/mlL01DB01 DOXORUBICINUM PULB. PT. SOL. PERF.SINDROXOCIN 2mg/ml 2mg/ml ACTAVIS S.R.L
2mg/mlL01DB01 DOXORUBICINUM SOL. INJ.DOXORUBICIN TEVA 2 mg/ml 2mg/ml TEVA PHARMACEUTICALS S.R.L
50mgL01DB01 DOXORUBICINUM LIOF. PT. SOL. INJ.ADRIBLASTINA RD 50 mg 50mg ACTAVIS S.R.L.
733 EPIRUBICINUML01DB03
10mgL01DB03 EPIRUBICINUM LIOF. PT. SOL. INJ.EPISINDAN 10 mg 10mg ACTAVIS S.R.L.
FARMORUBICIN RD 10 mg 10mg ACTAVIS S.R.L.
2mg/mlL01DB03 EPIRUBICINUM CONC. PT. SOL. INJ.EPIRUBICIN "EBEWE" 2 mg/ml 2mg/ml EBEWE PHARMA GMBH NFG. KG
50mgL01DB03 EPIRUBICINUM LIOF. PT. SOL. INJ.EPISINDAN 50 mg 50mg ACTAVIS S.R.L.
104 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
FARMORUBICIN® RD 50 mg 50mg ACTAVIS S.R.L.
734 IDARUBICINUML01DB06
10mgL01DB06 IDARUBICINUM CAPS.ZAVEDOS 10mg PFIZER EUROPE MA EEIG
5mgL01DB06 IDARUBICINUM LIOF. PT. SOL. INJ.ZAVEDOS 5 mg 5mg PFIZER EUROPE MA EEIG
735 MITOXANTRONUM **L01DB07
2 mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. PERF.MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL
20mg/10mlL01DB07 MITOXANTRONUM SOL. PERF.NOVANTRONE 20mg/10ml WYETH LEDERLE PHARMA GMBH
2mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. INJ.ONKOTRONE 2mg/ml BAXTER ONCOLOGY GMBH
736 BLEOMYCINUM SULFASL01DC01
15mgL01DC01 BLEOMYCINUM SULFAS LIOF. PT. SOL. INJ.BLEOCIN 15mg EURO NIPPON KAYAKU GMBH
738 CISPLATINUML01XA01
10mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 10 mg 10mg ACTAVIS S.R.L.
10mg/20mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 10 mg/20 ml 10mg/20ml EBEWE PHARMA GMBH NFG. KG
CISPLATIN TEVA 10 mg/20 ml 10mg/20ml TEVA PHARMACEUTICALS S.R.L.
1mg/1mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.SINPLATIN 1 mg/1 ml 1mg/1ml ACTAVIS S.R.L.
25mg/50mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 25 mg/50 ml 25mg/50ml EBEWE PHARMA GMBH NFG. KG
50mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 50 mg 50mg ACTAVIS S.R.L.
50mg/100mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 50 mg/100 ml 50mg/100ml EBEWE PHARMA GMBH NFG. KG
739 CARBOPLATINUML01XA02
10mg/mlL01XA02 CARBOPLATINUM CONC. PT. SOL. PERF.CARBOPLATIN "EBEWE" 10 mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG
CARBOPLATIN ACTAVIS 10mg/ml 10mg/ml ACTAVIS S.R.L.
CARBOPLATIN TEVA 10mg/ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.
740 OXALIPLATINUML01XA03
Prescriere limitata: Cancer colorectal metastazat in combinatie cu 5-FU si acid folic.
Tratament adjuvant al cancerului de colon stadiul III (Dukes C) in combinatie cu 5-FU si acid folic dupa rezectia completa a tumorii primare.
Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
5mg/mlL01XA03 OXALIPLATINUM LIOF. PT. SOL. PERF.ELOXATIN 5 mg/ml 5mg/ml SANOFI-AVENTIS FRANCE
OXALIPLATIN ACTAVIS 5 mg/ml 5mg/ml ACTAVIS S.R.L.
NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..
742 ALEMTUZUMABUM **** Protocol: L024CL01XC04
10mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 10 mg/ml 10mg/ml GENZYME EUROPE BV
30mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 30 mg/ml 30mg/ml GENZYME EUROPE BV
743 RITUXIMABUM **** Protocol: L014CL01XC02
10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.
MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.
10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.
MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.
744 TRASTUZUMABUM **** Protocol: L026CL01XC03
Tratamentul pacienţilor cu neoplasm de sân metastatic cu HER2 amplificat:
a) ca monoterapie în cazul pacienţilor trataţi cu cel puţin două regimuri chimioterapice pentru boala lor metastatică. Chimioterapia anterioară trebuie să fi inclus cel puţin o
antraciclină şi un taxan, cu excepţia cazurilor în care aceste chimioterapice nu erau indicate. Pacienţii pozitivi la receptorii hormonali trebuie de asemenea să fi prezentat un eşec
la tratamentul hormonal, cu excepţia cazurilor în care acest tip de tratament nu a fost indicat
b) în asociere cu Paclitaxel pentru tratamentul pacienţilor care nu au primit chimioterapie pentru boala lor metastatică şi pentru care nu este indicat tratamentul cu antracicline.
Herceptin trebuie folosit numai la pacienţii ale căror tumori prezintă HER2 amplificat la nivel 3+ , determinat prin imunohistochimie.
NOTA:
Trastuzumab nu trebuie utilizat la pacienti cu o fractie de ejectie ventriculara a ventriculului stang mai mica de 45% si/sau cu insuficienta cardiaca simptomatica. Functia cardiaca
trebuie testata.
150mgL01XC03 TRASTUZUMABUM PULB. PT. CONC. PT. SOL. PERF.HERCEPTIN 150mg 150mg ROCHE REGISTRATION LTD.
745 CETUXIMABUM **** Protocol: L037CL01XC06
2mg/mlL01XC06 CETUXIMABUM SOL. PERF.ERBITUX 2mg/ml 2mg/ml MERCK KGAA
5mg/mlL01XC06 CETUXIMABUM SOL. PERF.ERBITUX 5mg/ml 5mg/ml MERCK KGAA
5mg/mlL01XC06 CETUXIMABUM SOL. PERF.ERBITUX 5mg/ml 5mg/ml MERCK KGAA
746 BEVACIZUMABUM **** Protocol: L004CL01XC07
25mg/mlL01XC07 BEVACIZUMABUM CONC. PT. SOL. PERF.AVASTIN 25mg/ml 25mg/ml ROCHE REGISTRATION LTD.
747 IMATINIBUM **** Protocol: L008CL01XE01
105 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
100mgL01XE01 IMATINIBUM CAPS.GLIVEC 100 mg 100mg NOVARTIS EUROPHARM LTD.
100mgL01XE01 IMATINIBUM CAPS.GLIVEC 100 mg 100mg NOVARTIS EUROPHARM LTD.
100mgL01XE01 IMATINIBUM CAPS.GLIVEC 100 mg 100mg NOVARTIS EUROPHARM LTD.
748 ERLOTINIBUM **** Protocol: L031CL01XE03
100mgL01XE03 ERLOTINIBUM COMPR. FILM.TARCEVA 100 mg 100mg ROCHE REGISTRATION LTD.
150mgL01XE03 ERLOTINIBUM COMPR. FILM.TARCEVA 150 mg 150mg ROCHE REGISTRATION LTD.
25mgL01XE03 ERLOTINIBUM COMPR. FILM.TARCEVA 25 mg 25mg ROCHE REGISTRATION LTD.
749 SUNITINIBUM **** Protocol: L042CL01XE04
12,5mgL01XE04 SUNITINIBUM CAPS.SUTENT 12,5 mg 12,5mg PFIZER LIMITED
25mgL01XE04 SUNITINIBUM CAPS.SUTENT 25mg 25mg PFIZER LIMITED
50mgL01XE04 SUNITINIBUM CAPS.SUTENT 50 mg 50mg PFIZER LIMITED
750 SORAFENIBUM **** Protocol: L038CL01XE05
200mgL01XE05 SORAFENIBUM COMPR. FILM.NEXAVAR 200 mg 200mg BAYER HEALTHCARE AG
751 DASATINIBUM **** Protocol: L035CL01XE06
20 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 20mg 20 mg BRISTOL-MYERS SQUIBB PHARMA EEIG
50 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 50mg 50 mg BRISTOL-MYERS SQUIBB PHARMA EEIG
70 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 70mg 70 mg BRISTOL-MYERS SQUIBB PHARMA EEIG
20 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 20mg 20 mg BRISTOL-MYERS SQUIBB PHARMA EEIG
50 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 50mg 50 mg BRISTOL-MYERS SQUIBB PHARMA EEIG
70 mgL01XE06 DASATINIBUM COMPR. FILM.SPRYCEL 70mg 70 mg BRISTOL-MYERS SQUIBB PHARMA EEIG
753 ASPARAGINAZUML01XX02
10000uiL01XX02 ASPARAGINAZUM LIOF. PT. SOL. INJ./PERF.ASPARAGINASE 10000 MEDAC 10000ui MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRÄPARATE
5000uiL01XX02 ASPARAGINAZUM LIOF. PT. SOL. INJ./PERF.ASPARAGINASE 5000 MEDAC 5000ui MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRÄPARATE
754 HYDROXYCARBAMIDUML01XX05
500mgL01XX05 HYDROXYCARBAMIDUM CAPS.HYDREA 500mg BRISTOL MYERS SQUIBB KFT
755 ESTRAMUSTINUML01XX11
140mgL01XX11 ESTRAMUSTINUM CAPS.ESTRACYT 140mg PFIZER EUROPE MA EEIG
757 TOPOTECAMUML01XX17
4mgL01XX17 TOPOTECAMUM PULB.CONC.SOL.PERF.HYCAMTIN 4 mg 4mg SMITHKLINE BEECHAM PLC
758 IRINOTECANUML01XX19
20mg/mlL01XX19 IRINOTECANUM CONC. PT. SOL. PERF.CAMPTO 100 mg/5 ml 20mg/ml PFIZER EUROPE MA EEIG
IRINOTESIN 20mg/ml 20mg/ml ACTAVIS S.R.L.
20mg/mlL01XX19 IRINOTECANUM CONC. PT. SOL. PERF.CAMPTO 100 mg/5 ml 20mg/ml PFIZER EUROPE MA EEIG
IRINOTESIN 20mg/ml 20mg/ml ACTAVIS S.R.L.
759 BORTEZOMIBUM **** Protocol: L012CL01XX32
3.5mgL01XX32 BORTEZOMIBUM PULB. PT. SOL. INJ.VELCADE 3,5 mg 3.5mg JANSSEN-CILAG INTERNATIONAL NV
760 MEGESTROLUML02AB01
160mgL02AB01 MEGESTROLUM COMPR.MEGESIN 160 mg 160mg ACTAVIS S.R.L.
40mg/mlL02AB01 MEGESTROLUM SUSP. ORALAMEGACE 40mg/ml BRISTOL MYERS SQUIBB KFT
761 LEUPRORELINUM **L02AE02
Prescriere limitata: Cancer de prostata hormonodependent avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.LUCRIN DEPOT 11,25mg 11.25mg ABBOTT LABORATORIES S.A.
11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.ELIGARD 22,5 mg 22.5mg ASTELLAS PHARMA EUROPE B.V.
11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.ELIGARD 22,5 mg 22.5mg ASTELLAS PHARMA EUROPE B.V.
11.25mgL02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.ELIGARD 7,5 mg 7.5mg ASTELLAS PHARMA EUROPE B.V.
L02AE02 LEUPRORELINUM LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.LUCRIN DEPOT 3,75mg 3.75mg ABBOTT LABORATORIES
106 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
762 GOSERELINUM **L02AE03
3.6mgL02AE03 GOSERELINUM IMPLANTZOLADEX® 3.6mg ASTRAZENECA UK LTD.
Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 – T4) sau metastatic (echivalent stadiului M1).Prescriere limitata:
Cancer de sân hormonodependent avansat local (echivalent cu stadiul III) sau metastatic (echivalent cu stadiul IV) la femei în premenopauză.Prescriere limitata:
763 TRIPTORELINUM **L02AE04
Prescriere limitata: Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 – T4) sau metastatic (echivalent stadiului M1).
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.1mgL02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SOL. INJ.DIPHERELINE 0,1 mg 0.1mg BEAUFOUR IPSEN PHARMA
11.25mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 11,25 mg 11.25mg BEAUFOUR IPSEN PHARMA
3.75mgL02AE04 TRIPTORELINUM LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.DIPHERELINE® 3,75 mg 3.75mg BEAUFOUR IPSEN PHARMA
764 TAMOXIFENUM L02BA01
10mgL02BA01 TAMOXIFENUM COMPR.TAMONEPRIN® 10 mg 10mg ACTAVIS S.R.L.
TAMOXIFEN 10 TEVA 10mg PHARMACHEMIE BV
10mgL02BA01 TAMOXIFENUM COMPR. FILM.TAMOXIFEN® 10 HEXAL 10mg HEXAL AG
765 FULVESTRANTUM ** Protocol: L003CL02BA03
250mg/5mlL02BA03 FULVESTRANTUM SOL. INJ.FASLODEX 250mg/5ml 250mg/5ml ASTRAZENECA UK LTD.
766 FLUTAMIDUML02BB01
250mgL02BB01 FLUTAMIDUM COMPR.FLUTAN 250mg MEDOCHEMIE LTD.
FLUTASIN® 250 mg 250mg ACTAVIS S.R.L.
767 BICALUTAMIDUML02BB03
150mgL02BB03 BICALUTAMIDUM COMPR. FILM.CASODEX 150 mg 150mg ASTRAZENECA UK LTD.
50mgL02BB03 BICALUTAMIDUM COMPR. FILM.CALUMID 50mg GEDEON RICHTER PLC.
CASODEX 50 mg 50mg ASTRAZENECA UK LTD.
768 AMINOGLUTETHIMIDUML02BG01
250mgL02BG01 AMINOGLUTETHIMIDUM COMPR.ROGLUTEN® 250 mg 250mg ACTAVIS S.R.L.
769 ANASTROZOLUML02BG03
1mgL02BG03 ANASTROZOLUM COMPR. FILM.ARIMIDEX 1mg ACTAVIS S.R.L.
ARIMIDEX 1 mg 1mg ASTRAZENECA UK LTD.
770 LETROZOLUML02BG04
2.5mgL02BG04 LETROZOLUM COMPR. FILM.FEMARA 2,5 mg 2.5mg NOVARTIS PHARMA GMBH
771 EXEMESTANUML02BG06
25mgL02BG06 EXEMESTANUM DRAJ.AROMASIN 25 mg 25mg PFIZER EUROPE MA EEIG
772 FILGRASTIMUM (G-CSF) **L03AA02
Prescriere limitata: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei
mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de
transplant de măduvă osoasă.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
773 PEGFILGRASTIMUM ***L03AA13
Prescriere limitata: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei
mieloide cronice şi a sindroamelor mielodisplazice).
Pentru indicatia mai sus mentionata, o doză de 6 mg (o singură seringă preumplută) de Pegfilgrastimum este recomandată pentru fiecare ciclu de chimioterapie, administrată ca
injecţie subcutanată la aproximativ 24 de ore după chimioterapia citotoxică.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
6mgL03AA13 PEGFILGRASTIMUM SOL. INJ.NEULASTA 6mg 6mg AMGEN EUROPE B.V.
774 INTERFERONUM ALFA 2a *** Protocol: L050CL03AB04
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
18Mui/0.6mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 18Mui/0.6ml ROCHE ROMANIA S.R.L.
3Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 3Mui/0.5ml ROCHE ROMANIA S.R.L.
4.5Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 4.5Mui/0.5ml ROCHE ROMANIA S.R.L.
9Mui/0.5mlL03AB04 INTERFERONUM ALFA 2a SOL. INJ.ROFERON A 9Mui/0.5ml ROCHE ROMANIA S.R.L.
775 INTERFERONUM ALFA 2b *** Protocol: L016CL03AB05
107 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Tratamentul cu interferon alfa a fost asociat cu depresie şi suicid la unii pacienţi. Pacienţii cu istoric de ideaţie suicidară sau boală depresivă trebuie avertizaţi de riscuri. Trebuie
monitorizat statusul psihiatric în timpul tratamentului.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
18 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE
30 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE
INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
60 milioane U.I.L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZAINTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE
INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
777 ACIDUM CLODRONICUM **M05BA02
400mgM05BA02 ACIDUM CLODRONICUM CAPS.BONEFOS® 400 mg 400mg SCHERING OY (SCHERING AG)
SINDRONAT® 400 mg 400mg ACTAVIS S.R.L.
Metastaze osoase consecutive cancerului de san.Prescriere limitata:
Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazicaPrescriere limitata:
Mielomul multipluPrescriere limitata:
60mg/mlM05BA02 ACIDUM CLODRONICUM CONC. PT. SOL. PERF.BONEFOS® 60 mg/ml 60mg/ml SCHERING OY
Tratamentul hipercalcemiei asociata canceruluiPrescriere limitata:
800mgM05BA02 ACIDUM CLODRONICUM COMPR. FILM.BONEFOS® 800 mg 800mg SCHERING OY
Metastaze osoase consecutive cancerului de san.Prescriere limitata:
Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazicaPrescriere limitata:
Mielomul multipluPrescriere limitata:
778 ACIDUM PAMIDRONICUM **M05BA03
Prescriere limitata: Metastaze osoase consecutive cancerului de san.
Tratament de întreţinere in hipercalcemia din cancerele refractare la terapia antineoplazica.
Mielomul multiplu.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
15mgM05BA03 ACIDUM PAMIDRONICUM LIOF.+ SOLV. PT. SOL. PERF.AREDIA® 15 mg 15mg NOVARTIS PHARMA GMBH
15mg/mlM05BA03 ACIDUM PAMIDRONICUM CONC. PT. SOL. PERF.PAMIDRONAT TORREX 15mg/ml TORREX CHIESI PHARMA GMBH
30mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 30 30mg DR. REDDY'S LABORATORIES
60mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 60 60mg DR. REDDY'S LABORATORIES
779 ACIDUM IBANDRONICUM **M05BA06
50mgM05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONDRONAT 50mg 50mg ROCHE REGISTRATION LTD.
Preventia afectarii osoase (fracturi patologice, complicatii osoase care necesita radioterapie sau interventii chirurgicale) la pacientii cu cancer de san si metastaze
osoase.
Prescriere limitata:
6mg/6mlM05BA06 ACIDUM IBANDRONICUM CONC. PT. SOL. PERF.BONDRONAT 6mg/6ml 6mg/6ml ROCHE REGISTRATION LTD.
Preventia afectarii osoase (fracturi patologice, complicatii osoase care necesita radioterapie sau interventii chirurgicale) la pacientii cu cancer de san si metastaze
osoase.
Prescriere limitata:
Tratamentul hipercalcemiei induse de tumora cu sau fara metastaze osoase.Prescriere limitata:
3mg/3mlM05BA06 ACIDUM IBANDRONICUM SOL. INJ. IN SERINGA PREUMPLUTABONVIVA 3mg/3ml 3mg/3ml ROCHE REGISTRATION LTD
780 ACIDUM ZOLEDRONICUM **M05BA08
Prescriere limitata: Prevenirea manifestărilor osoase (fracturi patologice, compresie spinală, iradiere sau chirurgie osoasă sau hipercalcemie indusă de tumori) la pacienţi cu tumori
maligne avansate, cu implicare osoasă.
Tratamentul hipercalcemiei induse de tumori.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
4mgM05BA08 ACIDUM ZOLEDRONICUM PULB. + SOLV. SOL. PERF.ZOMETA 4 mg 4mg NOVARTIS EUROPHARM LTD.
5mg/100mlM05BA08 ACIDUM ZOLEDRONICUM SOL. PERF.ACLASTA 5mg/100ml 5mg/100ml NOVARTIS EUROPHARM LTD.
781 MESNUMV03AF01
400mg/4mlV03AF01 MESNUM SOL. INJ.UROMITEXAN® 400 mg 400mg/4ml BAXTER ONCOLOGY GMBH
782 CALCII FOLINASV03AF03
10mg/mlV03AF03 CALCII FOLINAS SOL. INJ.FOLCASIN 10 mg/ml 10mg/ml ACTAVIS S.R.L.
FOLCASIN® 100 mg/10 ml 10mg/ml ACTAVIS S.R.L.
LEUCOVORIN-TEVA 100 mg/10 ml 10mg/ml TEVA PHARM. IND. LTD.
LEUCOVORIN-TEVA 50 mg/5 ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.
10mg/mlV03AF03 CALCII FOLINAS SOL. INJ.FOLCASIN 10 mg/ml 10mg/ml ACTAVIS S.R.L.
FOLCASIN® 100 mg/10 ml 10mg/ml ACTAVIS S.R.L.
LEUCOVORIN-TEVA 100 mg/10 ml 10mg/ml TEVA PHARM. IND. LTD.
LEUCOVORIN-TEVA 50 mg/5 ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.
10mg/mlV03AF03 CALCII FOLINAS SOL. INJ./PERF.CALCIUMFOLINAT "EBEWE" 10 mg/ml 10mg/ml EBEWE PHARMA GMBH NFG. KG
15mgV03AF03 CALCII FOLINAS CAPS.CALCIUM FOLINAT "EBEWE" 15 mg 15mg EBEWE PHARMA GES.M.B.H. NFG KG
3mg/mlV03AF03 CALCII FOLINAS SOL. INJ.FOLCASIN® 30 mg/10 ml 3mg/ml ACTAVIS S.R.L.
108 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
783 AMIFOSTINUM **V03AF05
375mgV03AF05 AMIFOSTINUM LIOF. PT. SOL. PERF.ETHYOL 375mg SCHERING PLOUGH EUROPE
500mgV03AF05 AMIFOSTINUM LIOF. PT. SOL. PERF.ETHYOL® 500mg SCHERING PLOUGH EUROPE
Protocol: L002GSUBLISTA C2-P4: PROGRAMUL NATIONAL DE BOLI NEUROLOGICE. SUBPROGRAMUL DE TRATAMENT AL SCLEROZEI
MULTIPLE
784 INTERFERONUM BETA 1a ****L03AB07
22µg/0,5mlL03AB07 INTERFERONUM BETA 1a SOL. INJ.REBIF 22 micrograme 22µg/0,5ml SERONO EUROPE LTD.
30µg (6 mil. UI)L03AB07 INTERFERONUM BETA 1a PULB. + SOLV. PT. SOL. INJ.AVONEX 30 µg BIO-SET 30µg (6 mil. UI) BIOGEN IDEC LIMITED
44µgL03AB07 INTERFERONUM BETA 1a SOL. INJ.REBIF 44 micrograme 44µg SERONO EUROPE LTD.
785 INTERFERONUM BETA 1B ****L03AB08
250µg/mlL03AB08 INTERFERONUM BETA 1B PULB. + SOLV. PT. SOL. INJ.BETAFERON 250µg/ml 250µg/ml BAYER SCHERING AG
786 GLATIRAMER ACETAT ****L03AX13
20mg/mlL03AX13 GLATIRAMER ACETAT SOL. INJ.COPAXONE 20mg/ml TEVA PHARMACEUTICALS S.R.L.
787 NATALIZUMABUM ****L04AA23
20mg/mlL04AA23 NATALIZUMABUM CONC. PT. SOL. PERF.TYSABRI 300mg 20mg/ml ELAN PHARMA INTERNATIONAL LTD
A fost raportat la acest medicament leucoencefalopatie multifocala progresiva.
788 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
109 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Protocol: AE01ESUBLISTA C2-P5: PROGRAMUL NATIONAL DE DIABET ZAHARAT.
789 INSULINE UMANEA10AB01
100UI/mlA10AB01 INSULINE UMANE SOL. INJ.HUMULIN R 100UI/ml LILLY FRANCE SAS
100UI/mlA10AB01 INSULINE UMANE SOL. INJ.HUMULIN R 100UI/ml LILLY FRANCE SAS
100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN CARTUSACTRAPID PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN FLACONACTRAPID 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN FLACONACTRAPID 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AB01 INSULINE UMANE SOL. INJ. IN STILOU INJECTOR PREUMPLUTACTRAPID NOVOLET 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN RAPID 100 UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
790 INSULINUM LISPRO **A10AB04
100U/mlA10AB04 INSULINUM LISPRO SOL. INJ.HUMALOG 100 U/ml 100U/ml ELI LILLY NEDERLAND BV
791 INSULINUM ASPART ** Protocol: A016EA10AB05
100UmlA10AB05 INSULINUM ASPART SOL. INJ. IN CARTUSNOVORAPID PENFILL 100 U/ml 100Uml NOVO NORDISK A/S
792 INSULINUM GLULIZINA **A10AB06
100U/mlA10AB06 INSULINUM GLULIZINA SOL. INJ. IN CARTUSAPIDRA 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100U/mlA10AB06 INSULINUM GLULIZINA SOL. INJ. IN FLACONAPIDRA 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100U/mlA10AB06 INSULINUM GLULIZINA SOL. INJ. IN STILOU INJECTOR PREUMPLUTAPIDRA 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
793 INSULINE UMANEA10AC01
100UI/mlA10AC01 INSULINE UMANE SUSP. INJ.HUMULIN N 100UI/ml LILLY FRANCE SAS
100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN STILOU INJECTOR PREUMPLUTINSULATARD NOVOLET 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN CARTUSINSULATARD PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN FLACONINSULATARD 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AC01 INSULINE UMANE SUSP. INJ. IN FLACONINSULATARD 100 UI/ml 100UI/ml NOVO NORDISK A/S
INSUMAN BASAL 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
794 INSULINUM LISPRO ** Protocol: A029EA10AC04
100U/mlA10AC04 INSULINUM LISPRO SOL. INJ.HUMALOG NPL 100 U/ml 100U/ml ELI LILLY NEDERLAND BV
795 INSULINE UMANEA10AD01
A10AD01 INSULINE UMANE SUSP. INJ.HUMULIN M3 100ui/ml LILLY FRANCE S.A.S
100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN STILOU INJECTOR PREUMPLUTINSUMAN COMB 25 100UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
INSUMAN COMB 50 100UI/ml OPTISET 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
MIXTARD 30 NOVOLET 100 UI/ml 100UI/ml NOVO NORDISK A/S
100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN CARTUSINSUMAN COMB 25 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
INSUMAN COMB 50 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
MIXTARD 20 PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S
MIXTARD 30 PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S
MIXTARD 40 PENFILL 100 UI/ml 100UI/ml NOVO NORDISK A/S
100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN FLACONINSUMAN COMB 25 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
INSUMAN COMB 50 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
MIXTARD 30 100UI/ml 100UI/ml NOVO NORDISK A/S
100UI/mlA10AD01 INSULINE UMANE SUSP. INJ. IN FLACONINSUMAN COMB 25 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
INSUMAN COMB 50 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
MIXTARD 30 100UI/ml 100UI/ml NOVO NORDISK A/S
796 INSULINUM LISPRO ** Protocol: A015EA10AD04
100U/mlA10AD04 INSULINUM LISPRO SUSP. INJ.HUMALOG MIX25 100U/ml ELI LILLY NEDERLAND BV
HUMALOG MIX50 100U/ml ELI LILLY NEDERLAND BV
797 INSULINUM ASPART ** Protocol: A018EA10AD05
100UImlA10AD05 INSULINUM ASPART SUSP. INJ. IN STILOU INJECTOR PREUMPLUTNOVOMIX 30 FLEXPEN 100UIml NOVO NORDISK A/S
798 INSULINUM GLARGINE ** Protocol: A024EA10AE04
100UI/mlA10AE04 INSULINUM GLARGINE SOL. INJ. IN CARTUSLANTUS 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
110 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
100UI/mlA10AE04 INSULINUM GLARGINE SOL. INJ. IN FLACONLANTUS 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
100UI/mlA10AE04 INSULINUM GLARGINE SOL. INJ. IN STILOU INJECTOR PREUMPLUTLANTUS OptiSet 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
LANTUS SoloStar 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH
799 INSULINUM DETEMIR ** Protocol: A023EA10AE05
100U/mlA10AE05 INSULINUM DETEMIR SOL. INJ. IN CARTUSLEVEMIR PENFILL 100 U/ml 100U/ml NOVO NORDISK A/S
100U/mlA10AE05 INSULINUM DETEMIR SOL. INJ. IN STILOU INJECTOR PREUMPLUTLEVEMIR FLEXPEN 100 U/ml 100U/ml NOVO NORDISK A/S
800 METFORMINUMA10BA02
1000mgA10BA02 METFORMINUM COMPR.METFORMIN 1000 mg 1000mg ARENA GROUP S.A.
1000mgA10BA02 METFORMINUM COMPR. FILM.GLUCOPHAGE 1000 mg 1000mg MERCK SANTE
METFOGAMMA 1000mg 1000mg WORWAG PHARMA GMBH & CO. KG
SIOFOR 1000 1000mg BERLIN CHEMIE AG MENARINI GROUP
1000mgA10BA02 METFORMINUM COMPR. PT. SOL. ORALAFORMIRAN 1000 mg 1000mg TERAPIA S.A.
500mgA10BA02 METFORMINUM COMPR.DIGUAN® 500 mg 500mg ZENTIVA S.A.
METFORMIN 500 mg 500mg ARENA GROUP SA
500mgA10BA02 METFORMINUM COMPR. ELIB. PREL.GLUCOPHAGE XR 500mg MERCK SANTE S.A.S.
500mgA10BA02 METFORMINUM COMPR. FILM.DIPIMET 500 mg 500mg ANTIBIOTICE SA
GLUCOPHAGE 500 500mg MERCK SANTE
MEGUAN® 500 mg 500mg GEDEON RICHTER ROMANIA SA
METFOGAMMA® 500 500mg WORWAG PHARMA GMBH & CO. KG
METFORMIN AL 500 500mg ALIUD PHARMA GMBH & CO.KG
METFORMIN LPH® 500 mg 500mg LABORMED PHARMA SA
METFORMIN-TEVA 500 mg 500mg TEVA PHARMACEUTICAL S.R.L.
500mgA10BA02 METFORMINUM COMPR. PT. SOL. ORALAFORMIRAN 500 mg 500mg TERAPIA S.A.
850mgA10BA02 METFORMINUM COMPR.DIAFORMIN® 850 mg 850mg TERAPIA SA
METFORMIN 850 mg 850mg ARENA GROUP SA
850mgA10BA02 METFORMINUM COMPR. FILM.GLUCOPHAGE 850 mg 850mg MERCK SANTE
MEDIFOR 850 850mg STD CHEMICALS LTD.
MEGUAN® 850 mg 850mg GEDEON RICHTER ROMANIA SA
METFOGAMMA 850 850mg WORWAG PHARMA GMBH & CO. KG
METFORMIN AL 850 850mg ALIUD PHARMA GMBH & CO.KG
METFORMIN LPH® 850 mg 850mg LABORMED PHARMA SA
METFORMIN-TEVA 850 mg 850mg TEVA PHARMACEUTICAL S.R.L.
SIOFOR® 850 850mg BERLIN CHEMIE AG MENARINI GROUP
850mgA10BA02 METFORMINUM COMPR. PT. SOL. ORALAFORMIRAN 850 mg 850mg TERAPIA S.A.
801 BUFORMINUMA10BA03
100mgA10BA03 BUFORMINUM DRAJ. RET.SILUBIN RETARD 100mg DITA IMPORT EXPORT SRL
802 GLIBENCLAMIDUMA10BB01
1,75 mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID ANTIBIOTICE 1,75 mg 1,75 mg ANTIBIOTICE S.A.
1.75mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID LPH 1,75 mg 1.75mg LABORMED PHARMA SA
GLIBENCLAMID ARENA 1,75 mg 1.75mg ARENA GROUP SA
MANINIL 1,75 mg 1.75mg BERLIN CHEMIE AG MENARINI GROUP
3,5mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID ANTIBIOTICE 3,5 mg 3,5mg ANTIBIOTICE S.A.
3.5mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID ARENA 3,5 mg 3.5mg ARENA GROUP SA
GLIBENCLAMID LPH 3,5 mg 3.5mg LABORMED PHARMA SA
MANINIL 3,5 mg 3.5mg BERLIN CHEMIE AG MENARINI GROUP
5mgA10BB01 GLIBENCLAMIDUM COMPR.GLIBENCLAMID 5 mg 5mg ARENA GROUP SA
803 TOLBUTAMIDUMA10BB03
500mgA10BB03 TOLBUTAMIDUM COMPR.TOLBUTAMID 500mg SINTOFARM SA
804 GLIPIZIDUMA10BB07Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
10mgA10BB07 GLIPIZIDUM COMPR. FILM. ELIB. MODIF.GLUCOTROL XL 10 mg 10mg PFIZER EUROPE MA EEIG
5mgA10BB07 GLIPIZIDUM COMPR.GLIPIZID LPH 5 mg 5mg LABORMED PHARMA SA
5mgA10BB07 GLIPIZIDUM COMPR. FILM. ELIB. MODIF.GLUCOTROL XL 5mg 5mg PFIZER EUROPE MA EEIG
805 GLIQUIDONUMA10BB08Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
111 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
30mgA10BB08 GLIQUIDONUM COMPR.GLURENORM 30mg BOEHRINGER INGELHEIM INT. GMBH
806 GLICLAZIDUMA10BB09Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
30mgA10BB09 GLICLAZIDUM COMPR. ELIB. MODIF.DIAPREL MR 30mg LES LABORATOIRES SERVIER
30mgA10BB09 GLICLAZIDUM COMPR. ELIB. PREL.GLICLAZID MR LPH 30 mg 30mg LABORMED PHARMA SA
80mgA10BB09 GLICLAZIDUM COMPR.DIABREZIDE 80mg L. MOLTENI
ESQUEL® 80 mg 80mg GEDEON RICHTER ROMANIA SA
GLICLAZID LPH 80mg LABORMED PHARMA SA
GLIDIET 80mg MEDICAROM GROUP S.R.L.
80mgA10BB09 GLICLAZIDUM COMPR. DIVIZ.DIAPREL 80mg LES LABORATOIRES SERVIER
807 GLIMEPIRIDUMA10BB12Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1 mgA10BB12 GLIMEPIRIDUM COMPR.AMYX 1 1 mg ZENTIVA A.S.
1mgA10BB12 GLIMEPIRIDUM COMPR.AMARYL 1mg 1mg AVENTIS PHARMA DEUTSCHLAND
GLEMPID 1 mg 1mg EGIS PHARMACEUTICALS P.L.C.
GLIME TAD 1 mg 1mg TAD PHARMA GMBH
GLIMEPIRID LPH 1 mg 1mg LABORMED PHARMA SA
GLIMERAN 1 mg 1mg RANBAXY UK LIMITED
GLIPREX 1 mg 1mg MEDICO UNO PHARMACEUTICAL SRL
MEGLIMID 1 mg 1mg KRKA D.D.
OLTAR 1 mg 1mg BERLIN CHEMIE AG (MENARINI GROUP)
TINERIL 1 mg 1mg GEDEON RICHTER ROMANIA S.A.
2mgA10BB12 GLIMEPIRIDUM COMPR.AMARYL 2 mg 2mg AVENTIS PHARMA DEUTSCHLAND
AMYX 2 2mg ZENTIVA A.S.
DIBIGLIM 2 mg 2mg SANDOZ SRL
GLEMPID 2 mg 2mg EGIS PHARMACEUTICALS P.L.C.
GLIME TAD 2 mg 2mg TAD PHARMA GMBH
GLIMEPIRID LPH 2 mg 2mg LABORMED PHARMA SA
GLIMEPIRIDE 2 mg 2mg ACTAVIS GROUP HF.
GLIMERAN 2 mg 2mg RANBAXY UK LIMITED
GLIPREX 2 mg 2mg MEDICO UNO PHARMACEUTICAL SRL
MEGLIMID 2 mg 2mg KRKA D.D.
TINERIL 2 mg 2mg GEDEON RICHTER ROMANIA S.A.
3mgA10BB12 GLIMEPIRIDUM COMPR.AMARYL 3 mg 3mg AVENTIS PHARMA DEUTSCHLAND
AMYX 3 3mg ZENTIVA A.S.
DIBIGLIM 3 mg 3mg SANDOZ SRL
GLEMPID 3 mg 3mg EGIS PHARMACEUTICALS P.L.C.
GLIME TAD 3 mg 3mg TAD PHARMA GMBH
GLIMEPIRID LPH 3 mg 3mg LABORMED PHARMA SA
GLIMEPIRIDE 3 mg 3mg ACTAVIS GROUP HF.
GLIMERAN 3 mg 3mg RANBAXY UK LIMITED
GLIPREX 3 mg 3mg MEDICO UNO PHARMACEUTICAL SRL
MEGLIMID 3 mg 3mg KRKA D.D.
OLTAR 3 mg 3mg BERLIN CHEMIE AG (MENARINI GROUP)
TINERIL 3 mg 3mg GEDEON RICHTER ROMANIA S.A.
4mgA10BB12 GLIMEPIRIDUM COMPR.AMYX 4 4mg ZENTIVA A.S.
GLEMPID 4 mg 4mg EGIS PHARMACEUTICALS P.L.C.
GLIMERAN 4 mg 4mg RANBAXY UK LIMITED
GLIPREX 4 mg 4mg MEDICO UNO PHARMACEUTICAL SRL
MEGLIMID 4 mg 4mg KRKA D.D.
6mgA10BB12 GLIMEPIRIDUM COMPR.MEGLIMID 6 mg 6mg KRKA D.D.
4mgA10BB12 GLIMEPIRIDUM COMPRTINERIL 4 mg 4mg GEDEON RICHTER ROMANIA S.A.
808 COMBINATII(GLIBENCLAMIDUM+METFORMINUM) Protocol: A027EA10BD02Sulfonilurea poate cauza hipoglicemie, in mod particular la vârstnici
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2,5mg/400mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN
UM)
COMPR. FILM.
GLIBOMET® 2,5mg/400mg LAB. GUIDOTTI SPA
400mg + 2.5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN
UM)
COMPR. FILM.
GLIFORMIN 400mg + 2.5mg LABORMED PHARMA SA
400mg+2.5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN
UM)
CAPS.
BIDIAB 400mg+2.5mg ARENA GROUP SA
500mg/2.5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN
UM)
COMPR. FILM.
GLUCOVANCE® 500 mg/2,5 mg 500mg/2.5mg MERCK SANTE
500mg/5mgA10BD02 COMBINATII(GLIBENCLAMIDUM+METFORMIN
UM)
COMPR. FILM.
112 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
GLUCOVANCE® 500 mg/5 mg 500mg/5mg MERCK SANTE
809 COMBINATII(ROSIGLITAZONUM+METFORMINUM) *** Protocol: A026EA10BD03
1mg/500mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN
UM)
COMPR. FILM.
AVANDAMET 1mg/500mg 1mg/500mg SMITHKLINE BEECHAM PLC
2mg/1000mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN
UM)
COMPR. FILM.
AVANDAMET 2mg/1000mg 2mg/1000mg SMITHKLINE BEECHAM PLC
2mg/500mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN
UM)
COMPR. FILM.
AVANDAMET 2mg/500mg 2mg/500mg SMITHKLINE BEECHAM PLC
4mg/1000mgA10BD03 COMBINATII(ROSIGLITAZONUM+METFORMIN
UM)
COMPR. FILM.
AVANDAMET 4mg/1000mg 4mg/1000mg SMITHKLINE BEECHAM PLC
810 COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM) *** Protocol: A027EA10BD04
4mg/4mgA10BD04 COMBINATII (ROSIGLITAZONUM +
GLIMEPIRIDUM)
COMPR. FILM.
AVAGLIM 4mg/4mg 4mg/4mg SMITHKLINE BEECHAM PLC
8mg/4mgA10BD04 COMBINATII (ROSIGLITAZONUM +
GLIMEPIRIDUM)
COMPR. FILM.
AVAGLIM 8mg/4mg 8mg/4mg SMITHKLINE BEECHAM PLC
811 COMBINATII (PIOGLITAZONUM + METFORMINUM) *** Protocol: A025EA10BD05
15mg/850mgA10BD05 COMBINATII (PIOGLITAZONUM +
METFORMINUM)
COMPR. FILM.
COMPETACT 15mg/850mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD
812 ACARBOSUMA10BF01
100mgA10BF01 ACARBOSUM COMPR.GLUCOBAY® 100 100mg BAYER HEALTHCARE AG
50mgA10BF01 ACARBOSUM COMPR.GLUCOBAY® 50 50mg BAYER HEALTHCARE AG
813 ROSIGLITAZONUM *** Protocol: A020EA10BG02
4mgA10BG02 ROSIGLITAZONUM COMPR. FILM.AVANDIA 4mg 4mg SMITHKLINE BEECHAM PLC
814 PIOGLITAZONUM *** Protocol: A020EA10BG03
15mgA10BG03 PIOGLITAZONUM COMPR.ACTOS 15mg 15mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD
30mgA10BG03 PIOGLITAZONUM COMPR.ACTOS 30mg 30mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD
45mgA10BG03 PIOGLITAZONUM COMPR.ACTOS 45mg 45mg TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD
815 SITAGLIPTINUM *** Protocol: A022EA10BH01
100mgA10BH01 SITAGLIPTINUM COMPR. FILM.JANUVIA 100mg 100mg MERCK SHARP & DOHME LTD.
816 REPAGLINIDUMA10BX02
0.5mgA10BX02 REPAGLINIDUM COMPR.NOVONORM 0,5 mg 0.5mg NOVO NORDISK A/S
1mgA10BX02 REPAGLINIDUM COMPR.NOVONORM 1 mg 1mg NOVO NORDISK A/S
2mgA10BX02 REPAGLINIDUM COMPR.NOVONORM 2 mg 2mg NOVO NORDISK A/S
817 EXENATIDUM *** Protocol: A028EA10BX04
10µg/dozaA10BX04 EXENATIDUM SOL. INJ. IN STILOU INJECTOR PREUMPLUTBYETTA 10µg/doza 10µg/doza ELI LILLY NEDERLAND BV
5µg/dozaA10BX04 EXENATIDUM SOL. INJ. IN STILOU INJECTOR PREUMPLUTBYETTA 5µg/doza 5µg/doza ELI LILLY NEDERLAND BV
818 BENFOTIAMINUMA11DA03
50mgA11DA03 BENFOTIAMINUM DRAJ.BENFOGAMMA 50mg WORWAG PHARMA GMBH & CO. KG
819 COMBINATII **A11DBN1
A11DBN1 COMBINATII CAPS. MOIMILGAMMA® N WORWAG PHARMA GMBH & CO. KG
A11DBN1 COMBINATII SOL. INJ.MILGAMMA® N WORWAG PHARMA GMBH & CO. KG
820 GLUCAGONUMH04AA01
1mgH04AA01 GLUCAGONUM PULB. + SOLV. PT. SOL. INJ.GLUCAGEN HYPOKIT 1 mg 1mg NOVO NORDISK A/S
113 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.1: HEMOFILIE SI TALASEMIE
827 DEFEROXAMINUM **(3) Protocol: V001DV03AC01
500mgV03AC01 DEFEROXAMINUM LIOF. PT. SOL. INJ./PERF.DESFERAL 500mg NOVARTIS PHARMA GMBH
828 DEFERASIROXUM **** Protocol: V002DV03AC03
125mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 125mg 125mg NOVARTIS EUROPHARM LTD.
250mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 250mg 250mg NOVARTIS EUROPHARM LTD.
500mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 500mg 500mg NOVARTIS EUROPHARM LTD.
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.2: EPIDERMOLIZA BULOASA
830 TETRACYCLINUMD06AA04
3,00%D06AA04 TETRACYCLINUM UNGUENTTETRACICLINA CLORHIDRAT 3% ANTIBIOTICE SA
831 ACIDUM FUSIDICUMD06AX01
2,00%D06AX01 ACIDUM FUSIDICUM CREMAFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS
2,00%D06AX01 ACIDUM FUSIDICUM UNGUENTFUCIDIN® 2% LEO PHARMACEUTICAL PRODUCTS
832 SULFADIAZINUMD06BA01
1,00%D06BA01 SULFADIAZINUM CREMADERMAZIN® 1% 1% LEK PHARMACEUTICALS D.D.
833 COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM) Protocol: D001LD07CA01
D07CA01 COMBINATII (ACIDUM FUSIDICUM +
HYDROCORTISONUM)
CREMA
FUCIDIN® H LEO PHARMACEUTICAL PRODUCTS
834 COMBINATII Protocol: D001LD07CC01
D07CC01 COMBINATII CREMABELOGENT A & G MED TRADING S.R.L.
DIPROGENTA® SCHERING PLOUGH EUROPE
TRIDERM® SCHERING PLOUGH EUROPE
D07CC01 COMBINATII UNGUENTBELOGENT A & G MED TRADING S.R.L.
DIPROGENTA® SCHERING PLOUGH EUROPE
TRIDERM SCHERING PLOUGH EUROPE
836 TETRACYCLINUMJ01AA07
250mgJ01AA07 TETRACYCLINUM CAPS.TETRACICLINA 250 mg 250mg EUROPHARM SA
TETRACICLINA SANDOZ 250 mg 250mg SANDOZ SRL
838 PHENYTOINUMN03AB02
100mgN03AB02 PHENYTOINUM COMPR.FENITOIN 100 mg 100mg GEDEON RICHTER ROMANIA SA
50mg/mlN03AB02 PHENYTOINUM SOL. INJ.PHENHYDAN®SOLUTIE INJECTABILA 50mg/ml DESITIN
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.3: HIPERTENSIUNEA
PULMONARA
839 BOSENTANUM ** Protocol: CI01IC02KX01
125mgC02KX01 BOSENTANUM COMPR. FILM.TRACLEER 125 mg 125mg ACTELION REGISTRATION LTD.
Bosentanum este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitată timp de trei luni după întreruperea tratamentului.
840 SILDENAFILUM ** Protocol: CI01IG04BE03
20mgG04BE03 SILDENAFILUM COMPR. FILM.REVATIO 20 mg 20mg PFIZER LTD.
114 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.4: MUCOVISCIDOZA
841 CLARITHROMYCINUMJ01FA09
125mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAFROMILID® 125 mg/5 ml 125mg/5ml KRKA D.D.
KLABAX 125 mg/5 ml 125mg/5ml TERAPIA S.A.
KLACID® 125mg/5ml ABBOTT SPA
LEKOKLAR 125 mg/5 ml 125mg/5ml SANDOZ S.R.L.
250mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 250 250mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 250 mg 250mg OZONE LABORATORIES LTD.
FROMILID 250 250mg KRKA D.D. NOVO MESTO
KLABAX 250 mg 250mg TERAPIA S.A.
KLACID® 250mg ABBOTT SPA
KLERIMED® 250 250mg MEDOCHEMIE LTD.
LEKOKLAR® 250 mg 250mg LEK PHARMACEUTICALS D.D.
250mg/5mlJ01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALAKLABAX 250 mg/5 ml 250mg/5ml TERAPIA S.A.
LEKOKLAR 250 mg/5 ml 250mg/5ml SANDOZ SRL
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM.CLAR 500 500mg MEDICAROM GROUP S.R.L.
CLARITROMICINA 500 mg 500mg OZONE LABORATORIES LTD.
FROMILID 500 500mg KRKA D.D. NOVO MESTO
KLABAX 500 mg 500mg TERAPIA S.A.
KLERIMED® 500 500mg MEDOCHEMIE LTD.
LEKOKLAR® 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. MODIF.KLABAX MR 500 mg 500mg TERAPIA S.A.
LEKOKLAR XL 500 mg 500mg LEK PHARMACEUTICALS D.D.
500mgJ01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL.FROMILID® UNO 500mg KRKA D.D.
KLACID SR 500mg ABBOTT LABORATORIES LTD.
500mgJ01FA09 CLARITHROMYCINUM LIOF. PT. SOL. PERF.KLACID I.V. 500mg ABBOTT LABORATORIES LTD.
842 TOBRAMYCINUM **J01GB01
300mg/5mlJ01GB01 TOBRAMYCINUM SOL. INHAL.TOBI® 300mg/5ml NOVARTIS PHARMA GMBH
Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.Prescriere limitata:
843 DORNAZA ALFA **R05CB13
1mg/mlR05CB13 DORNAZA ALFA SOL. INHAL.PULMOZYME 1mg/ml ROCHE ROMANIA S.R.L.
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.5: BOLI NEUROLOGICE
DEGENERATIVE / INFLAMATORII (POLIRADICULONEVRITA PRIMITIVA, POLINEUROPATIE INFLAMATORIE CRONICA
DEMIELINIZANTA, SCLEROZA LATERALA AMIOTROFICA) SI MIASTENIA GRAVIS
844 RILUZOLUM ** Protocol: N024GN07XX02
50mgN07XX02 RILUZOLUM COMPR. FILM.RILUTEK 50 mg 50mg AVENTIS PHARMA SA
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.6: OSTEOGENEZA
IMPERFECTA
846 ACIDUM PAMIDRONICUM Protocol: M002QM05BA03
15mgM05BA03 ACIDUM PAMIDRONICUM LIOF.+ SOLV. PT. SOL. PERF.AREDIA® 15 mg 15mg NOVARTIS PHARMA GMBH
15mg/mlM05BA03 ACIDUM PAMIDRONICUM CONC. PT. SOL. PERF.PAMIDRONAT TORREX 15mg/ml TORREX CHIESI PHARMA GMBH
30mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 30 30mg DR. REDDY'S LABORATORIES
60mgM05BA03 ACIDUM PAMIDRONICUM LIOF. PT. SOL. PERF. I.V.PAMIRED 60 60mg DR. REDDY'S LABORATORIES
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.7: SINDROM PRADER WILLI
847 SOMATROPINUM ** Protocol: H011QH01AC01
10mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEX x 10mg/1,5ml 10mg/1.5ml NOVO NORDISK A/S
10mg/2mlH01AC01 SOMATROPINUM SOL. INJ.NUTROPINAq 10 mg/2 ml 10mg/2ml IPSEN LIMITED
3,3mg/mlH01AC01 SOMATROPINUM SOL. INJ.OMNITROPE 3,3mg/ml 3,3mg/ml SANDOZ GMBH
4mg (12ui)H01AC01 SOMATROPINUM LIOF. + SOLV. PT. SOL. INJ.ZOMACTON 4mg (12ui) FERING GMBH
5.3mg/ml (16ui)H01AC01 SOMATROPINUM PULB. + SOLV. PT. SOL. INJ.GENOTROPIN® 16 ui (5,3 mg) 5.3mg/ml (16ui) PFIZER EUROPE MA EEIG
5mg/1.5mlH01AC01 SOMATROPINUM SOL. INJ.NORDITROPIN SIMPLEXx 5 mg/1,5 ml 5mg/1.5ml NOVO NORDISK A/S
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.8: BOALA FABRY
848 AGALSIDASUM BETA ** Protocol: A014EA16AB04
35mgA16AB04 AGALSIDASUM BETA PULB. PT. CONC. PT. SOL. PERF.FABRAZYME 35 mg 35mg GENZYME EUROPE BV
115 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.9: BOALA POMPE
849 ALGLUCOSIDASUM ALPHA ** Protocol: A030QA16AB07
50mgA16AB07 ALGLUCOSIDASUM ALPHA PULB. PT. CONC. PT. SOL. PERF.MYOZYME 50mg 50mg GENZYME EUROPE B.V.
116 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P7: PROGRAMUL NATIONAL DE BOLI ENDOCRINE. TRATAMENTUL MEDICAMENTOS AL BOLNAVILOR CU
OSTEOPOROZA, GUSA DATORATA CARENTEI DE IOD SI PROLIFERARII MALIGNE
850 DIHYDROTACHYSTEROLUMA11CC02
0.1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.TACHYSTIN 0.1mg/ml CHAUVIN ANKERPHARM GMBH
1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.A.T. 10® 1mg/ml MERCK KGAA
851 ALFACALCIDOLUMA11CC03
0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL
0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.
852 CALCITRIOLUMA11CC04
0.25µgA11CC04 CALCITRIOLUM CAPS. MOIROCALTROL 0.25µg ROCHE ROMANIA S.R.L.
853 ESTRADIOLUMG03CA03
Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni.
Aceasta limitare este valabila doar pentru formele farmaceutice Sistem terapeutic transdermic si plasture transdermic.
Estradiol trebuie folosit împreuna cu un progestativ oral la femeile nehisterectomizate.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0.06%G03CA03 ESTRADIOLUM GELOESTROGEL® 0.06% LAB. BESINS INTERNATIONAL
0.1%G03CA03 ESTRADIOLUM GELESTREVA® 0.1% LAB. THERAMEX
1mgG03CA03 ESTRADIOLUM COMPR. FILM.ESTROFEM 1 mg 1mg NOVO NORDISK A/S
25µgG03CA03 ESTRADIOLUM COMPR. VAG.VAGIFEM 25µg NOVO NORDISK A/S
25mgG03CA03 ESTRADIOLUM IMPLANTRISELLE 25 mg 25mg ORGANON NV
50µg/24oreG03CA03 ESTRADIOLUM PLASTURE TRANSDERM.CLIMARA 50µg/24ore SCHERING AG
854 TIBOLONUM Protocol: G007NG03DC05
2,5mgG03DC05 TIBOLONUM COMPR.LADYBON 2,5mg ZENTIVA A.S.
2.5mgG03DC05 TIBOLONUM COMPR.LIVIAL® 2,5 mg 2.5mg ORGANON NV
855 ESTRADIOLUMVALERAT+DIENOGEST Protocol: G002NG03FA15
G03FA15 ESTRADIOLUMVALERAT+DIENOGEST DRAJ.KLIMODIEN SCHERING AG
856 RALOXIFENUMG03XC01
Cod restrictie 2647: Monoterapie cu medicamente antiresorbtive pentru tratamentul osteoporozei sexoidoprive la femeile pana la varsta de 60 ani, cu scor T</= -2,5, masurat DEXA
(coloana vertebrala sau sold).
60mgG03XC01 RALOXIFENUM COMPR. FILM.EVISTA 60mg 60mg ELI LILLY NEDERLAND BV
857 TIREOTROPINUM ALFAH01AB01
Prescriere limitata: Anterior administrarii iodului radioactiv pentru tratamentul carcinomului tiroidian diferentiat posttiroidectomie totala.
0.9mgH01AB01 TIREOTROPINUM ALFA PULB. PT. SOL. INJ.THYROGEN 0,9 mg 0.9mg GENZYME EUROPE BV
858 METHYLPREDNISOLONUMH02AB04
125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.
125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG
16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG
20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.
250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG
32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG
40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.
40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG
4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG
500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.
500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG
859 LEVOTHYROXINUMH03AA01
100µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 100 100µg MERCK KGAA
L-THYROXIN 100 BERLIN - CHEMIE 100µg BERLIN CHEMIE AG MENARINI GROUP
200µgH03AA01 LEVOTHYROXINUM COMPR.
117 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
EUTHYROX® 200 200µg MERCK KGAA
25µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 25 25µg MERCK KGAA
50µgH03AA01 LEVOTHYROXINUM COMPR.EUTHYROX® 50 50µg MERCK KGAA
L-THYROXIN 50 50µg BERLIN CHEMIE AG MENARINI GROUP
860 LEVOTHYROXINUM+KALII IODIDUMH03AAN1
H03AAN1 LEVOTHYROXINUM+KALII IODIDUM COMPR.JODTHYROX® 100/130,8 MERCK KGAA
861 THIAMAZOLUMH03BB02
10mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 10 mg 10mg MERCK KGAA
20mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 20 mg 20mg MERCK KGAA
5mgH03BB02 THIAMAZOLUM COMPR. FILM.THYROZOL® 5 mg 5mg MERCK KGAA
862 KALII IODIDUMH03CA01
100µgH03CA01 KALII IODIDUM COMPR.JODID 100 100µg MERCK KGAA
200µgH03CA01 KALII IODIDUM COMPR.JODID 200 200µg MERCK KGAA
863 TERIPARATIDUM ** Protocol: M003MH05AA02
20µg/80µgH05AA02 TERIPARATIDUM SOL. INJ.FORSTEO 20µg/80µg 20µg/80µg ELI LILLY NEDERLAND BV
864 CALCITONINUM (SOMON)H05BA01
100UIH05BA01 CALCITONINUM (SOMON) SOL. INJ.TONOCALCIN 100 UI 100UI ALFA WASSERMANN SPA
100ui/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZ.,SOL.NYLEX 100 UI/doza 100UI/doza PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA
100UI/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.NYLEX® 100UI/ml PROEL E.P. CORONIS SA
200UI/dozaH05BA01 CALCITONINUM (SOMON) SPRAY NAZAL - SOL.MIACALCIC® NASAL 200 200ui/doza NOVARTIS PHARMA GMBH
NYLEX® 200UI/doza PROEL E.P. CORONIS SA
50ui/mlH05BA01 CALCITONINUM (SOMON) SOL. INJ.MIACALCIC® 50ui/ml NOVARTIS PHARMA GMBH
865 ACIDUM ALENDRONICUM ** Protocol: M003MM05BA04
10mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 10 mg 10mg MERCK SHARP & DOHME S.R.L.
70 mgM05BA04 ACIDUM ALENDRONICUM COMPR.TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL
70mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 70 mg 70mg MERCK SHARP & DOHME S.R.L.
866 ACIDUM IBANDRONICUM ** Protocol: M003MM05BA06
3mg/3mlM05BA06 ACIDUM IBANDRONICUM SOL. INJ. IN SERINGA PREUMPLUTABONVIVA 3mg/3ml 3mg/3ml ROCHE REGISTRATION LTD
M05BA06 ACIDUM IBANDRONICUM CONC. PT. SOL. PERF.BONDRONAT 6 mg/6 ml 6mg/6ml ROCHE REGISTRATION L
M05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONDRONAT 50 mg 50mg ROCHE REGISTRATION L
M05BA06 ACIDUM IBANDRONICUM COMPR. FILM.BONDRONAT 50 mg 50mg ROCHE REGISTRATION L
867 ACIDUM RISEDRONICUM ** Protocol: M003MM05BA07
35mgM05BA07 ACIDUM RISEDRONICUM COMPR. FILM.ACTONEL® SAPTAMANAL 35mg AVENTIS PHARMA AB
RISENDROS 35 mg 35mg ZENTIVA A.S.
868 COMBINATII (ACIDUM
ALENDRONICUM+COLECALCIFEROLUM) **
Protocol: M003MM05BB03
70mg/2800UIM05BB03 COMBINATII (ACIDUM
ALENDRONICUM+COLECALCIFEROLUM)
COMPR.
FOSAVANCE 70mg/2800UI 70mg/2800UI MERCK SHARP & DOHME LTD.
869 STRONTIUM RANELATUMM05BX03
2gM05BX03 STRONTIUM RANELATUM GRAN. PT. SUSP. ORALAOSSEOR 2 g 2g LES LAB. SERVIER
872 ACIDUM ZOLEDRONICUM ** Protocol: M001MM05BA08
5mg/100mlM05BA08 ACIDUM ZOLEDRONICUM SOL. PERF.ACLASTA 5mg/100ml 5mg/100ml NOVARTIS EUROPHARM LTD.
M05BA08 ACIDUM ZOLEDRONICUM PULB. + SOLV. SOL. PERF.ZOMETA 4 mg 4mg NOVARTIS EUROPHARM L
1218 CARBIMAZOLUMH03BB01
5mgH03BB01 CARBIMAZOLUM COMPR. FILM.CARBIMAZOLE 5 5mg REMEDICA LTD.
118 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.1:
TRANSPLANT MEDULAR
873 ONDANSETRONUM **A04AA01
A04AA01 ONDANSETRONUM SOL. INJ.OSETRON 4 mg 2mg/ml DR. REDDY'S LABORATO
OSETRON 8 mg 2mg/ml DR. REDDY'S LABORATORIES
2mg/mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.EMESET 4 mg/2 ml 2mg/ml CIPLA (UK) LIMITED
EMESET 8 mg/4 ml 2mg/ml CIPLA (UK) LIMITED
4mgA04AA01 ONDANSETRONUM COMPR. FILM.ONDANSETRON TEVA 4mg 4mg TEVA PHARMACEUTICALS SRL
ONDANTOR 4 mg 4mg SANDOZ SRL
OSETRON 4 mg 4mg DR. REDDY'S LABORATORIES
SETRONON 4 mg 4mg PLIVA LJUBLJANA D.O.O.
ZOFRAN 4 mg 4mg GLAXO WELLCOME UK LTD.
4mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 4mg 4mg RANBAXY UK LTD.
4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 4mg/2ml 4mg/2ml GLAXO WELLCOME UK LIMITED
4mg/2mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 4 mg/2 ml 4mg/2ml PLIVA LJUBLJANA D.O.O.
8mgA04AA01 ONDANSETRONUM COMPR. FILM.ONDANSETRON TEVA 8 mg 8mg TEVA PHARMACEUTICALS SRL
ONDANTOR 8 mg 8mg SANDOZ SRL
OSETRON 8 mg 8mg DR. REDDY'S LABORATORIES (UK) LTD
SETRONON 8 mg 8mg PLIVA LJUBLJANA D.O.O.
ZOFRAN 8 mg 8mg GLAXO WELLCOME UK LTD.
8mgA04AA01 ONDANSETRONUM COMPR. ORODISPERSABILEONDARAN MD 8 mg 8mg RANBAXY UK LIMITED
8mg/4mlA04AA01 ONDANSETRONUM SOL. INJ.ZOFRAN 8mg/4ml 8mg/4ml GLAXO WELLCOME UK LIMITED
8mg/4 mlA04AA01 ONDANSETRONUM SOL. INJ./PERF.SETRONON 8 mg/4 ml 8mg/4 ml PLIVA LJUBLJANA D.O.O.
874 ACIDUM URSODEOXYCHOLICUMA05AA02
Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH
URSOSAN 250mg PRO. MED. CS PRAHA AS
875 REVIPARINUMB01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
878 EPOETINUM ALFAB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml SANDOZ GMBH
879 EPOETINUM BETAB03XA01
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTA
119 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
NEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
880 TICARCILLINUM + ACIDUM CLAVULANICUMJ01CR03
3.2gJ01CR03 TICARCILLINUM + ACIDUM CLAVULANICUM PULB. PT. SOL. INJ./PERF.TIMENTIN 3,2 g 3.2g BEECHAM GROUP PLC
881 PIPERACILLINUM + TAZOBACTAMUMJ01CR05
J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH
TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH
882 MEROPENEMUMJ01DH02
1gJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 1 g 1g ASTRAZENECA UK LTD.
500mgJ01DH02 MEROPENEMUM PULB. PT. SOL. INJ. I.V./PERF.MERONEM IV 500 mg 500mg ASTRAZENECA UK LTD.
883 IMIPENEMUM + CILASTATINUMJ01DH51
J01DH51 IMIPENEMUM + CILASTATINUM PULB. PT. SOL. PERF.TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L.
884 VANCOMYCINUMJ01XA01
1gJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY
1gJ01XA01 VANCOMYCINUM PULB.LIOF.PT.SOL.PERF./INJEDICIN 1g LEK PHARMACEUTICALS D.D.
500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF.VANCOMYCIN TEVA 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY
500mgJ01XA01 VANCOMYCINUM LIOF. PT. SOL. PERF./INJ.EDICIN 500mg LEK PHARMACEUTICALS D.D.
885 TEICOPLANINUMJ01XA02
400mgJ01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. INJ.TARGOCID® 400 mg 400mg AVENTIS PHARMA LTD.
887 LINEZOLIDUMJ01XX08
100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG
888 FLUCONAZOLUMJ02AC01
Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.
Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.
Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.
Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.
DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG
MYCOMAX® INF 2mg/ml ZENTIVA AS
50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
120 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
889 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
890 POSACONAZOLUM **J02AC04
Prescriere limitata: Profilaxia si tratamentul infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care
prezinta risc inalt de a dezvolta infectii fungice masive.
Profilaxia si tratamentul infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de
a dezvolta infectii fungice masive.
40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE
891 CASPOFUNGINUM ** Protocol: J010DJ02AX04
50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD
70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD
893 ACICLOVIRUMJ05AB01
200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg ARENA GROUP SA
EUVIROX 200 mg 200mg EUROPHARM SA
200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA
CLOVIRAL 200 mg 200mg ANTIBIOTICE SA
ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.
200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.
LOVIR 200 mg 200mg RANBAXY UK LIMITED
250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO
400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.
400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.
400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.
894 VALACYCLOVIRUMJ05AB11
500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.
895 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
897 CYCLOPHOSPHAMIDUML01AA01
1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH
200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.
500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
898 MELPHALANUML01AA03
2mgL01AA03 MELPHALANUM COMPR. FILM.ALKERAN 2 mg 2mg THE WELLCOME FOUNDATION LTD.
899 IFOSFAMIDUML01AA06
1gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 1 g 1g BAXTER ONCOLOGY GMBH
2gL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 2 g 2g BAXTER ONCOLOGY GMBH
500mgL01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF.HOLOXAN 500 mg 500mg BAXTER ONCOLOGY GMBH
900 BUSULFANUML01AB01
2mgL01AB01 BUSULFANUM COMPR. FILM.MYLERAN 2mg THE WELLCOME FOUNDATION LTD.
901 METHOTREXATUML01BA01
100mg/mlL01BA01 METHOTREXATUM CONC. PT. SOL. INJ./PERF.
121 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
METHOTREXAT "EBEWE" 1000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG
METHOTREXAT "EBEWE" 500 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG
METHOTREXAT "EBEWE" 5000 mg 100mg/ml EBEWE PHARMA GMBH NFG. KG
10mg/mlL01BA01 METHOTREXATUM SOL. INJ./PERF.METHOTREXAT "EBEWE" 50 mg 10mg/ml EBEWE PHARMA GMBH NFG. KG
50mgL01BA01 METHOTREXATUM PULB. PT. SOL. INJ./PERF.ANTIFOLAN® 50 mg 50mg SINDAN SRL
5mg/mlL01BA01 METHOTREXATUM SOL. INJ.METHOTREXAT "EBEWE" 5 mg 5mg/ml EBEWE PHARMA GMBH NFG. KG
902 FLUDARABINUML01BB05
10mgL01BB05 FLUDARABINUM COMPR. FILM.FLUDARA® ORAL 10mg SCHERING AG
50mgL01BB05 FLUDARABINUM LIOF. PT. SOL. INJ./PERF.FLUDARA 50mg SCHERING AG
903 ETOPOSIDUML01CB01
100mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 100mg BRISTOL MYERS SQUIBB KFT
100mg/5mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSID "EBEWE" 100 mg/5 ml 100mg/5ml EBEWE PHARMA GMBH NFG. KG
SINTOPOZID 100 mg/5 ml 100mg/5ml ACTAVIS S.R.L.
20mg/mlL01CB01 ETOPOSIDUM CONC. PT. SOL. PERF.ETOPOSIDE - TEVA 20mg/ml TEVA PHARMACEUTICALS S.R.L.
50mgL01CB01 ETOPOSIDUM CAPS. MOIVEPESID 50mg BRISTOL MYERS SQUIBB KFT
904 IDARUBICINUML01DB06
10mgL01DB06 IDARUBICINUM CAPS.ZAVEDOS 10mg PFIZER EUROPE MA EEIG
5mgL01DB06 IDARUBICINUM LIOF. PT. SOL. INJ.ZAVEDOS 5 mg 5mg PFIZER EUROPE MA EEIG
905 MITOXANTRONUM **L01DB07
2 mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. PERF.MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL
20mg/10mlL01DB07 MITOXANTRONUM SOL. PERF.NOVANTRONE 20mg/10ml WYETH LEDERLE PHARMA GMBH
2mg/mlL01DB07 MITOXANTRONUM CONC. PT. SOL. INJ.ONKOTRONE 2mg/ml BAXTER ONCOLOGY GMBH
906 CISPLATINUML01XA01
10mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 10 mg 10mg ACTAVIS S.R.L.
10mg/20mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 10 mg/20 ml 10mg/20ml EBEWE PHARMA GMBH NFG. KG
CISPLATIN TEVA 10 mg/20 ml 10mg/20ml TEVA PHARMACEUTICALS S.R.L.
1mg/1mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.SINPLATIN 1 mg/1 ml 1mg/1ml ACTAVIS S.R.L.
25mg/50mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 25 mg/50 ml 25mg/50ml EBEWE PHARMA GMBH NFG. KG
50mgL01XA01 CISPLATINUM LIOF. PT. SOL. PERF.SINPLATIN 50 mg 50mg ACTAVIS S.R.L.
50mg/100mlL01XA01 CISPLATINUM CONC. PT. SOL. PERF.CISPLATIN "EBEWE" 50 mg/100 ml 50mg/100ml EBEWE PHARMA GMBH NFG. KG
907 CARBOPLATINUML01XA02
10mg/mlL01XA02 CARBOPLATINUM CONC. PT. SOL. PERF.CARBOPLATIN "EBEWE" 10 mg/ml 10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG
CARBOPLATIN ACTAVIS 10mg/ml 10mg/ml ACTAVIS S.R.L.
CARBOPLATIN TEVA 10mg/ml 10mg/ml TEVA PHARMACEUTICALS S.R.L.
908 ALEMTUZUMABUM **L01XC04
10mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 10 mg/ml 10mg/ml GENZYME EUROPE BV
30mg/mlL01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF.MABCAMPATH 30 mg/ml 30mg/ml GENZYME EUROPE BV
909 RITUXIMABUM **L01XC02
10mg/mlL01XC02 RITUXIMABUM CONC. PT. SOL. PERF.MABTHERA 100 mg 10mg/ml ROCHE REGISTRATION LTD.
MABTHERA 500 mg 10mg/ml ROCHE REGISTRATION LTD.
910 FILGRASTIMUM (G-CSF) **L03AA02
Prescriere limitata: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei
mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de
transplant de măduvă osoasă.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
911 CICLOSPORINUML04AA01
Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
122 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
913 TACROLIMUSUM **L04AA05
Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH
0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH
1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.
1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH
5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH
914 MYCOPHENOLATUM **L04AA06
180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH
1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.
250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.
MYFENAX 250mg 250mg TEVA PHARMA BV
360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH
500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV
500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
915 DACLIZUMABUM **L04AA08
5mg/mlL04AA08 DACLIZUMABUM CONC. PT. SOL. PERF.ZENAPAX 5 mg/ml 5mg/ml ROCHE REGISTRATION LTD.
916 SIROLIMUS **L04AA10Monitorizarea atentă a pacienţilor este obligatorie
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.
917 ETANERCEPTUM **L04AA11
25mgL04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ.ENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM PULB+SOLV.PT.SOL.INJENBREL 50 mg 50mg WYETH EUROPA LIMITED
25mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 25mg 25mg WYETH EUROPA LIMITED
50mgL04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA PREUMPLUTAENBREL 50mg 50mg WYETH EUROPA LIMITED
918 TRAMADOLUMN02AX02
Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide
Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG
100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 100 mg 100mg LABOPHARM EUROPE LIMITED
TRALGIT SR 100 100mg ZENTIVA AS
TRAMADOL® RETARD 100mg KRKA D.D.
100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH
100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.
TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acutePrescriere limitata:
100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
TRAMADOL 100mg KRKA D.D.
123 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
TRAMAG 100 100mg MAGISTRA C & C
TRAMAL® 100mg GRUNENTHAL GMBH
100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.
Tratamentul de scurta durata al durerii acutePrescriere limitata:
100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.
100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH
150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS
150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH
200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 200 mg 200mg LABOPHARM EUROPE LIMITED
TRALGIT SR 200 200mg ZENTIVA AS
200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH
300mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 300 mg 300mg LABOPHARM EUROPE LIMITED
50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA
MABRON 50 mg 50mg MEDOCHEMIE LTD.
TRALGIT 50 50mg ZENTIVA A.S.
TRAMACALM 50mg AC HELCOR SRL
TRAMADOL 50mg KRKA D.D.
TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA
TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG
TRAMADOL ARENA 50mg ARENA GROUP S.A.
TRAMAL® 50mg GRUNENTHAL GMBH
URGENDOL 50mg MEDICAROM GROUP SRL
50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.
TRAMADOL EEL 50mg BIO EEL SRL
TRAMAG 50 50mg MAGISTRA C & C
50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acutePrescriere limitata:
50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.
TRAMADOL 50mg/ml KRKA D.D.
TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG
TRAMAL® 100 50mg/ml GRUNENTHAL GMBH
TRAMAL® 50 50mg/ml GRUNENTHAL GMBH
URGENDOL 50mg/ml MEDICAROM GROUP SRL
Tratamentul de scurta durata al durerii acutePrescriere limitata:
N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG
100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH
919 DORNAZA ALFA **R05CB13
1mg/mlR05CB13 DORNAZA ALFA SOL. INHAL.PULMOZYME 1mg/ml ROCHE ROMANIA S.R.L.
920 DEFERASIROXUM **V03AC03
125mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 125mg 125mg NOVARTIS EUROPHARM LTD.
250mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 250mg 250mg NOVARTIS EUROPHARM LTD.
500mgV03AC03 DEFERASIROXUM COMPR. DISP.EXJADE 500mg 500mg NOVARTIS EUROPHARM LTD.
921 MESNUMV03AF01
400mg/4mlV03AF01 MESNUM SOL. INJ.UROMITEXAN® 400 mg 400mg/4ml BAXTER ONCOLOGY GMBH
124 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.2:
TRANSPLANT DE CORD
922 REVIPARINUMB01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
923 POLYGELINUMB05AA06
3.5%B05AA06 POLYGELINUM SOL. PERF.HAEMACCEL 3.5% THERASELECT GMBH
924 EPINEPHRINUMC01CA24
1mg/mlC01CA24 EPINEPHRINUM SOL. INJ.ADRENALINA 1 mg 1mg/ml TERAPIA SA
925 PIPERACILLINUM + TAZOBACTAMUMJ01CR05
J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH
TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH
926 CEFOPERAZONUMJ01DD12
1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 1 g 1g MEDICAROM GROUP S.R.L.
MEDOCEF 1 g 1g MEDOCHEMIE LTD.
2gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.LYZONE 2 g 2g MEDICAROM GROUP S.R.L.
MEDOCEF 2 g 2g MEDOCHEMIE LTD.
500mgJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ.CEFOZON 500 mg 500mg E.I.P.I.CO. MED S.R.L.
1gJ01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ./PERF.I.M./I.V.CEFOZON 1 g 1g E.I.P.I.CO. MED S.R.L.
927 IMIPENEMUM + CILASTATINUMJ01DH51
J01DH51 IMIPENEMUM + CILASTATINUM PULB. PT. SOL. PERF.TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L.
928 LINEZOLIDUMJ01XX08
100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG
929 FLUCONAZOLUMJ02AC01
Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.
Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.
Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.
Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.
DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG
MYCOMAX® INF 2mg/ml ZENTIVA AS
50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
125 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
930 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
932 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
933 CICLOSPORINUML04AA01
Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
935 TACROLIMUSUM **L04AA05
Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH
0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH
Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:
1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.
Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:
1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH
Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:
5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH
5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH
Profilaxia rejetului de alogrefă la adulţii cu transplant cardiacPrescriere limitata:
936 MYCOPHENOLATUM **L04AA06
180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH
1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:
250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.
MYFENAX 250mg 250mg TEVA PHARMA BV
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:
360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH
500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV
500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:
500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen cardiac.Prescriere limitata:
126 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.3
TRANSPLANT HEPATIC
937 ACIDUM URSODEOXYCHOLICUMA05AA02
Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH
URSOSAN 250mg PRO. MED. CS PRAHA AS
938 ENOXAPARINUMB01AB05
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
8000ui
anti-Xa/0.8ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 8000ui anti-Xa/0.8ml 8000ui
anti-Xa/0.8ml
LAB. AVENTIS
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
939 REVIPARINUMB01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
940 ILOPROSTUM **B01AC11
20µg/mlB01AC11 ILOPROSTUM CONC. PT. SOL. PERF.ILOMEDIN® 20 20µg/ml SCHERING AG
941 ALTEPLASUM **B01AD02
50mgB01AD02 ALTEPLASUM LIOF. + SOLV. PT. SOL. INJ.ACTILYSE 50mg BOEHRINGER INGELHEIM INT. GMBH
944 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)C03EB01Electroliţii serici trebuie să fie verificaţi periodic.
C03EB01 COMBINATII
(SPIRONOLACTONUM+FUROSEMIDUM)
CAPS.
DIUREX 50 TERAPIA SA
945 DESMOPRESSINUMH01BA02
H01BA02 DESMOPRESSINUMMINIRIN 0,2 mg 0.2mg FERRING AB
0.2mgH01BA02 DESMOPRESSINUM COMPR.MINIRIN 0,2 mg 0.2mg FERRING AB
946 PIPERACILLINUM + TAZOBACTAMUMJ01CR05
J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH
TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH
947 LINEZOLIDUMJ01XX08
100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG
948 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.
127 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
VFEND 50mg 50mg PFIZER LTD.
949 CASPOFUNGINUM ** Protocol: J010DJ02AX04
50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD
70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD
951 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
953 FILGRASTIMUM (G-CSF)L03AA02
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
954 CICLOSPORINUML04AA01
Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
955 TACROLIMUSUM **L04AA05
Prescriere limitata: Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.
Profilaxia rejetului de grefa la pacientii care primesc transplant hepatic alogen.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH
0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH
1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.
1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH
5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH
956 MYCOPHENOLATUM **L04AA06
Prescriere limitata: Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepatic.
180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH
1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepaticPrescriere limitata:
250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.
MYFENAX 250mg 250mg TEVA PHARMA BV
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepaticPrescriere limitata:
360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH
500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV
Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen hepaticPrescriere limitata:
500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
957 SIROLIMUS **L04AA10
1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.
Monitorizarea atentă a pacienţilor este obligatorie
128 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.4
TRANSPLANT RENAL, TRANSPLANT COMBINAT RINICHI SI PANCREAS
958 ACIDUM URSODEOXYCHOLICUMA05AA02
Nu se va prescrie in regim compensat pentru tratamentul litiazei biliareNOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH
URSOSAN 250mg PRO. MED. CS PRAHA AS
959 ALFACALCIDOLUMA11CC03
0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL
0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.
960 ENOXAPARINUMB01AB05
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
8000ui
anti-Xa/0.8ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 8000ui anti-Xa/0.8ml 8000ui
anti-Xa/0.8ml
LAB. AVENTIS
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
961 DALTEPARINUMB01AB04
10000ui/mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 10000 UI/ml 10000ui/ml PFIZER EUROPE MA EEIG
15000ui/0.6mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN15000 UI/0,6 ml 15000ui/0.6ml PFIZER EUROPE MA EEIG
2500ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 2500 UI/0,2 ml 2500ui/0.2ml PFIZER EUROPE MA EEIG
5000ui/0.2mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 5000 UI/0,2 ml 5000ui/0.2ml PFIZER EUROPE MA EEIG
7500ui/0.3mlB01AB04 DALTEPARINUM SOL. INJ.FRAGMIN 7500 UI/0,3 ml 7500ui/0.3ml PFIZER EUROPE MA EEIG
962 REVIPARINUMB01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
963 EPOETINUM ALFAB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
129 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml SANDOZ GMBH
964 EPOETINUM BETAB03XA01
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
965 POLYGELINUMB05AA06
3.5%B05AA06 POLYGELINUM SOL. PERF.HAEMACCEL 3.5% THERASELECT GMBH
966 OCTREOTIDUM ** Protocol: H010CH01CB02
0.1mg/mlH01CB02 OCTREOTIDUM SOL. INJ.SANDOSTATIN® 0.1mg/ml NOVARTIS PHARMA GMBH
10mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.
PRELUNG.SANDOSTATIN LAR 10 mg 10mg NOVARTIS PHARMA GMBH
20mgH01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB.
PRELUSANDOSTATIN LAR 20 mg 20mg NOVARTIS PHARMA GMBH
30mgH01CB02 OCTREOTIDUM PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB.
PRELUNG.SANDOSTATIN LAR 30 mg 30mg NOVARTIS PHARMA GMBH
967 PIPERACILLINUM + TAZOBACTAMUMJ01CR05
J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH
TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH
968 TEICOPLANINUMJ01XA02
400mgJ01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. INJ.TARGOCID® 400 mg 400mg AVENTIS PHARMA LTD.
969 LINEZOLIDUMJ01XX08
100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG
970 KETOCONAZOLUMJ02AB02
Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade.
Candidoza orala la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate
Micoze sistemice la care alte forme de terapie antifungica nu au avut efect.
A fost raportată hepatotoxicitate la ketoconazol.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA
KETOCONAZOL 200 mg 200mg MAGISTRA C & C
KETOSTIN 200 mg 200mg AC HELCOR SRL
NIZORAL 200mg JANSSEN PHARMACEUTICA NV
NIZORAL 200 mg 200mg TERAPIA SA
200mgJ02AB02 KETOCONAZOLUM COMPR.KEFUNGIN 200mg ANTIBIOTICE SA
KETOCONAZOL 200 mg 200mg MAGISTRA C & C
KETOSTIN 200 mg 200mg AC HELCOR SRL
NIZORAL 200mg JANSSEN PHARMACEUTICA NV
NIZORAL 200 mg 200mg TERAPIA SA
971 FLUCONAZOLUMJ02AC01
Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.
Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.
Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.
Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.
130 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.
DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG
MYCOMAX® INF 2mg/ml ZENTIVA AS
50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
972 ITRACONAZOLUMJ02AC02
100mgJ02AC02 ITRACONAZOLUM CAPS.ITRACONAZOL 100 mg 100mg TERAPIA S.A.
OMICRAL 100 mg 100mg MEDICO UNO PHARMACEUTICAL S.R.L.
ORUNGAL 100mg JANSSEN PHARMACEUTICA NV
SPORILIN 100 mg 100mg GEDEON RICHTER ROMANIA S.A.
Sporotricoza sistemicaPrescriere limitata:
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresiePrescriere limitata:
Tratamentul candidozei orofaringiene la pacienti cu imunosupresiePrescriere limitata:
973 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
974 CASPOFUNGINUM ** Protocol: J010DJ02AX04
50mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 50 mg 50mg MERCK SHARP & DOHME LTD
70mgJ02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. SOL. PERF.CANCIDAS 70 mg 70mg MERCK SHARP & DOHME LTD
976 ACICLOVIRUMJ05AB01
200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg SLAVIA PHARM SRL
EUVIROX 200 mg 200mg EUROPHARM SA
200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA
CLOVIRAL 200 mg 200mg ANTIBIOTICE SA
ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.
200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.
LOVIR 200 mg 200mg RANBAXY UK LIMITED
250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO
400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.
400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.
400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.
977 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.
131 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
978 VALACYCLOVIRUMJ05AB11
500mgJ05AB11 VALACYCLOVIRUM COMPR. FILM.VALTREX 500 mg 500mg THE WELLCOME FOUNDATION LTD.
Profilaxia infectiei si bolii cu citomegalovirus in urma transplantului renal la pacientii cu risc de boala cu citomegalovirusPrescriere limitata:
980 CYCLOPHOSPHAMIDUML01AA01
1gL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 1 g 1g BAXTER ONCOLOGY GMBH
200mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. PERF./INJ. I.V.ENDOXAN 200 mg 200mg ACTAVIS S.R.L.
500mgL01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ./PERF.ENDOXAN® 500 mg 500mg BAXTER ONCOLOGY GMBH
50mgL01AA01 CYCLOPHOSPHAMIDUM DRAJ.ENDOXAN® 50 mg 50mg BAXTER ONCOLOGY GMBH
981 FILGRASTIMUM (G-CSF)L03AA02
30MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 30MU/0.5ml AMGEN EUROPE B.V.
48MU/0.5mlL03AA02 FILGRASTIMUM (G-CSF) SOL. INJ.NEUPOGEN® 48MU/0.5ml AMGEN EUROPE B.V.
982 CICLOSPORINUML04AA01
Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
984 TACROLIMUSUM **L04AA05
Prescriere limitata: Profilaxia rejetului de alogrefă la adulţii cu transplant renal.
Tratamentul rejetului de alogrefă rezistent la alte terapii imunosupresoare, la pacienţii adulţi.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH
0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH
1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.
1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH
5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH
985 MYCOPHENOLATUM **L04AA06
Prescriere limitata: Profilaxia rejetului acut de grefă la pacienţii care primesc transplant alogen renal.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH
1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.
250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.
MYFENAX 250mg 250mg TEVA PHARMA BV
360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH
500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV
500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
986 DACLIZUMABUM **L04AA08
Prescriere limitata: Profilaxia rejectiei acute de organ în transplantul renal alogen de novo şi se utilizează concomitent cu o schemă de tratament cu imunosupresoare,
incluzând ciclosporină şi glucocorticoizi, la pacienţii care nu sunt hiperimunizaţi.
5mg/mlL04AA08 DACLIZUMABUM CONC. PT. SOL. PERF.ZENAPAX 5 mg/ml 5mg/ml ROCHE REGISTRATION LTD.
987 BASILIXIMABUM **L04AA09
132 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
Prescriere limitata: Profilaxia rejetului acut de organ în transplantul renal alogen de novo la pacienţii adulţi şi copii. Se utilizează concomitent cu tratamentul imunosupresor cu
ciclosporină microemulsionată şi corticosteroizi, la pacienţii cu mai puţin de 80% anticorpi reactivi, sau în tratament imunosupresor de întreţinere triplu cu
ciclosporină microemulsionată, corticosteroizi şi azatioprină sau mofetil micofenolat.
20mgL04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. INJ./PERF.SIMULECT 20 mg 20mg NOVARTIS EUROPHARM LTD.
988 SIROLIMUS **L04AA10
Prescriere limitata: Profilaxia rejetului de organ la pacienţii adulţi cu transplant renal şi risc imunologic mic sau moderat.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.
989 AZATHIOPRINUML04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
990 ACIDUM ALENDRONICUMM05BA04
10mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 10 mg 10mg MERCK SHARP & DOHME S.R.L.
70 mgM05BA04 ACIDUM ALENDRONICUM COMPR.TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL
70mgM05BA04 ACIDUM ALENDRONICUM COMPR.FOSAMAX 70 mg 70mg MERCK SHARP & DOHME S.R.L.
991 PETHIDINUMN02AB02
50mg/mlN02AB02 PETHIDINUM SOL. INJ.MIALGIN® 100 mg/2 ml 50mg/ml ZENTIVA SA
993 REVIPARINUMB01AB08
B01AB08 REVIPARINUM SOL. INJ.CLIVARIN (R) 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
B01AB08 REVIPARINUM SOL. INJ.CLIVARIN (R) 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
994 POLYGELINUMB05AA06
3.5%B05AA06 POLYGELINUM SOL. PERF.HAEMACCEL 3.5% THERASELECT GMBH
995 LINEZOLIDUMJ01XX08
J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID (R) 100mg/5ml PFIZER EUROPE MA EEI
ZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
J01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID (R) 2mg/ml PFIZER EUROPE MA EEI
ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
J01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID (R) 600mg PFIZER EUROPE MA EEI
ZYVOXID® 600mg PFIZER EUROPE MA EEIG
996 VORICONAZOLUM ** Protocol: J012BJ02AC03
J02AC03 VORICONAZOLUM COMPR. FILM.VFEND (R) 200mg PFIZER LIMITED
VFEND 200mg 200mg PFIZER LTD.
J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND (R) 200mg PFIZER LIMITED
VFEND 200mg 200mg PFIZER LTD.
J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND (R) 40 mg/ml 40mg/ml PFIZER LIMITED
VFEND 40 mg/ml 40mg/ml PFIZER LTD.
J02AC03 VORICONAZOLUM COMPR. FILM.VFEND (R) 50mg PFIZER LIMITED
VFEND 50mg 50mg PFIZER LTD.
998 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
J05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE (R) 450 mg 450mg ROCHE ROMANIA SRL
133 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.6
TRANSPLANT PULMONAR
999 ENOXAPARINUMB01AB05
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
8000ui
anti-Xa/0.8ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 8000ui anti-Xa/0.8ml 8000ui
anti-Xa/0.8ml
LAB. AVENTIS
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
1000 REVIPARINUMB01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
1002 EPINEPHRINUMC01CA24
1mg/mlC01CA24 EPINEPHRINUM SOL. INJ.ADRENALINA 1 mg 1mg/ml TERAPIA SA
1003 PIPERACILLINUM + TAZOBACTAMUMJ01CR05
J01CR05 PIPERACILLINUM + TAZOBACTAMUM LIOF. PT. SOL. INJ.TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH
TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH
1004 LINEZOLIDUMJ01XX08
100mg/5mlJ01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALAZYVOXID® 100mg/5ml PFIZER EUROPE MA EEIG
2mg/mlJ01XX08 LINEZOLIDUM SOL. PERF.ZYVOXID® 2mg/ml PFIZER EUROPE MA EEIG
600mgJ01XX08 LINEZOLIDUM COMPR. FILM.ZYVOXID® 600mg PFIZER EUROPE MA EEIG
1005 FLUCONAZOLUMJ02AC01
Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.
Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.
Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.
Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.
134 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
DIFLAZON® 2mg/ml KRKA D.D.
DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG
MYCOMAX® INF 2mg/ml ZENTIVA AS
50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
1006 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
200mgJ02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
1008 ACICLOVIRUMJ05AB01
200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg ARENA GROUP SA
EUVIROX 200 mg 200mg EUROPHARM SA
200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg TERAPIA SA
CLOVIRAL 200 mg 200mg ANTIBIOTICE SA
ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.
200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.
LOVIR 200 mg 200mg RANBAXY UK LIMITED
250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO
400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.
400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.
400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.
1009 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
1010 CICLOSPORINUML04AA01
Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
1012 MYCOPHENOLATUM **L04AA06
180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH
1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.
250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.
MYFENAX 250mg 250mg TEVA PHARMA BV
360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH
500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV
500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
135 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
1013 BASILIXIMABUM **L04AA09
20mgL04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. INJ./PERF.SIMULECT 20 mg 20mg NOVARTIS EUROPHARM LTD.
1014 AZATHIOPRINUML04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
1015 TRAMADOLUMN02AX02
Prescriere limitata: Durere severa, care nu raspunde la analgezice non-opioide.
Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgN02AX02 TRAMADOLUM COMPR. ELIB. MODIF.TRAMADOLOR® 100 ID 100mg HEXAL AG
100mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 100 mg 100mg LABOPHARM EUROPE LIMITED
TRALGIT SR 100 100mg ZENTIVA AS
TRAMADOL® RETARD 100mg KRKA D.D.
100mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMAL RETARD 100 mg 100mg GRUNENTHAL GMBH
100mgN02AX02 TRAMADOLUM SOL. INJ.MABRON 100mg MEDOCHEMIE LTD.
TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
100mgN02AX02 TRAMADOLUM SUPOZ.TRADOLAN 100mg LANNACHER HEILMITTEL GMBH
TRAMADOL 100mg KRKA D.D.
TRAMAG 100 100mg MAGISTRA C & C
TRAMAL® 100mg GRUNENTHAL GMBH
100mg/2mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 100 100mg/2ml ZENTIVA A.S.
Tratamentul de scurta durata al durerii acute.Prescriere limitata:
100mg/mlN02AX02 TRAMADOLUM PIC. ORALE, SOL.TRALGIT 100mg/ml ZENTIVA A.S.
100mg/mlN02AX02 TRAMADOLUM SOL. ORALATRADOLAN 100mg/ml LANNACHER HEILMITTEL GMBH
150mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.TRALGIT SR 150 150mg ZENTIVA AS
150mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 150 mg 150mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 150 mg 150mg GRUNENTHAL GMBH
200mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 200 mg 200mg LABOPHARM EUROPE LIMITED
TRALGIT SR 200 200mg ZENTIVA AS
200mgN02AX02 TRAMADOLUM COMPR. FILM. ELIB. PREL.TRAMADOL RETARD 200 mg 200mg KRKA D.D. NOVO MESTO
TRAMAL RETARD 200 mg 200mg GRUNENTHAL GMBH
300mgN02AX02 TRAMADOLUM COMPR. ELIB. PREL.NOAX UNO 300 mg 300mg LABOPHARM EUROPE LIMITED
50mgN02AX02 TRAMADOLUM CAPS.K-ALMA® 50mg ANTIBIOTICE SA
MABRON 50 mg 50mg MEDOCHEMIE LTD.
TRALGIT 50 50mg ZENTIVA A.S.
TRAMACALM 50mg AC HELCOR SRL
TRAMADOL 50mg KRKA D.D.
TRAMADOL LPH 50 mg 50mg LABORMED PHARMA SA
TRAMADOL AL 50 50mg ALIUD® PHARMA GMBH & CO.KG
TRAMADOL ARENA 50mg ARENA GROUP S.A.
TRAMAL® 50mg GRUNENTHAL GMBH
URGENDOL 50mg MEDICAROM GROUP SRL
50mgN02AX02 TRAMADOLUM COMPR.TRAMADOL 50 mg 50mg OZONE LABORATORIES LTD.
TRAMADOL EEL 50mg BIO EEL SRL
TRAMAG 50 50mg MAGISTRA C & C
50mgN02AX02 TRAMADOLUM COMPR. FILM.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
50mgN02AX02 TRAMADOLUM SOL. INJ.TRADOLAN 50 mg 50mg LANNACHER HEILMITTEL GMBH
Tratamentul de scurta durata al durerii acutePrescriere limitata:
50mg/mlN02AX02 TRAMADOLUM SOL. INJ.TRALGIT 50 50mg/ml ZENTIVA A.S.
TRAMADOL 50mg/ml KRKA D.D.
TRAMADOL® AL 100 Fiole 50mg/ml ALIUD® PHARMA GMBH & CO.KG
TRAMAL® 100 50mg/ml GRUNENTHAL GMBH
TRAMAL® 50 50mg/ml GRUNENTHAL GMBH
URGENDOL 50mg/ml MEDICAROM GROUP SRL
Tratamentul de scurta durata al durerii acutePrescriere limitata:
N02AX02 TRAMADOLUM PIC. ORALE, SOL.TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO.KG
100mg/mlN02AX02 TRAMADOLUM PICATURI ORALE-SOL.TRAMAL® 100mg/ml GRUNENTHAL GMBH
136 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.7
TRATAMENTUL STARII POSTTRANSPLANT IN AMBULATORIU A PACIENTILOR TRANSPLANTATI
1016 ACIDUM URSODEOXYCHOLICUMA05AA02
Nu se va prescrie in regim compensat pentru tratamentul litiazei biliare.NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgA05AA02 ACIDUM URSODEOXYCHOLICUM CAPS.URSOFALK® 250mg DR. FALK PHARMA GMBH
URSOSAN 250mg PRO. MED. CS PRAHA AS
1017 EPOETINUM ALFA **B03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml SANDOZ GMBH
B03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml SANDOZ GMBH
1018 EPOETINUM BETA **B03XA01
10000ui/mlB03XA01 EPOETINUM BETA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0.5mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
1000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ.NEORECORMON 500UI 1000UI/ml ROCHE REGISTRATION LTD.
20000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ.NEORECORMON MULTIDOZA 100 000UI/ml 20000UI/ml ROCHE REGISTRATION LTD.
2000UIB03XA01 EPOETINUM BETA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
2000ui/0.5mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000ui/0.3mlB03XA01 EPOETINUM BETA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM BETA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM BETA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000ui/0.4mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM BETA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
50000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ.NEORECORMON MULTIDOZA 50 000UI/ml 50000UI/ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000 UI 10000UI/0,6ml ROCHE REGISTRATION L
NEORECORMON 10000UI/0,6ml 10000UI/0,6ml ROCHE REGISTRATION LTD.
10000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ. IN CARTUSNEORECORMON 10000UI/ml 10000UI/ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000 UI 1000UI/0,3ml ROCHE REGISTRATION L
NEORECORMON 1000UI/0,3ml 1000UI/0,3ml ROCHE REGISTRATION LTD.
20000UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 20000UI/0,6ml 20000UI/0,6ml ROCHE REGISTRATION LTD.
137 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
20000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ. IN CARTUSNEORECORMON 20000UI/ml 20000UI/ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000 UI 2000UI/0,3ml ROCHE REGISTRATION L
NEORECORMON 2000UI/0,3ml 2000UI/0,3ml ROCHE REGISTRATION LTD.
30000 UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 30000UI/0,6ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.
3000I/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 3000UI/0,3ml 3000I/0,3ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000 UI 4000UI/0,3ml ROCHE REGISTRATION L
NEORECORMON 4000UI/0,3ml 4000UI/0,3ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000 UI 5000UI/0,3ml ROCHE REGISTRATION L
NEORECORMON 5000UI/0,3ml 5000UI/0,3ml ROCHE REGISTRATION LTD.
B03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500 UI 500UI/0,3ml ROCHE REGISTRATION L
NEORECORMON 500UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION LTD.
60000UI/mlB03XA01 EPOETINUM BETA LIOF. + SOLV. PT. SOL. INJ. IN CARTUSNEORECORMON 60000UI/ml 60000UI/ml ROCHE REGISTRATION LTD.
6000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 6000UI/0,3ml 6000UI/0,3ml ROCHE REGISTRATION LTD.
1019 DARBEPOETINUM ALFA **B03XA02
10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV
100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV
15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV
150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV
20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV
30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV
300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV
40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV
50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV
500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV
60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV
80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV
1021 METHYLPREDNISOLONUMH02AB04
125mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 125 mg 125mg HEMOFARM S.R.L.
125mg/2mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 125mg/2ml PFIZER EUROPE MA EEIG
16mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL A 16 16mg PFIZER EUROPE MA EEIG
20mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 20 mg 20mg HEMOFARM S.R.L.
250mg/4mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 250mg/4ml PFIZER EUROPE MA EEIG
32mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 32 32mg PFIZER EUROPE MA EEIG
40mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 40 mg 40mg HEMOFARM S.R.L.
40mg/1mlH02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV.PT.SOL.INJSOLU - MEDROL ACT-O-VIAL 40mg/1ml PFIZER EUROPE MA EEIG
4mgH02AB04 METHYLPREDNISOLONUM COMPR.MEDROL 4 mg 4mg PFIZER EUROPE MA EEIG
500mgH02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ.LEMOD SOLU 500 mg 500mg HEMOFARM S.R.L.
500mg/7.8mlH02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. INJ.SOLU - MEDROL 500 mg/7,8 ml 500mg/7.8ml PFIZER EUROPE MA EEIG
1022 PREDNISONUMH02AB07
5mgH02AB07 PREDNISONUM COMPR.N - PREDNISON 5mg MEDUMAN SA
PREDNISON 5 mg 5mg SINTOFARM SA
PREDNISON ARENA 5 mg 5mg ARENA GROUP SA
PREDNISON GEDEON RICHTER 5 mg 5mg GEDEON RICHTER ROMANIA SA
PREDNISON MAGISTRA 5 mg 5mg MAGISTRA C & C
1023 SULFAMETHOXAZOLUM + TRIMETHOPRIMUMJ01EE01Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
138 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
200mg/40mg
/5ml
J01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SUSP. ORALA
EPITRIM 200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.
25mg/5mg/mlJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SIROP
SUMETROLIM 25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.
400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
COMPR.
BISEPTRIM 400mg/80mg EUROPHARM SA
CO - TRIM ELL 400mg/80mg BIO EEL SRL
SUMETROLIM 400mg/80mg EGIS PHARMACEUTICALS P.L.C.
TAGREMIN 400mg/80mg ZENTIVA S.A.
400mg/80mgJ01EE01 SULFAMETHOXAZOLUM +
TRIMETHOPRIMUM
SOL. PERF.
SEPTRIN 400mg/80mg THE WELLCOME FOUNDATION LTD.
1024 FLUCONAZOLUMJ02AC01
Prescriere limitata: Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie.
Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie.
Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina.
Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina.
Tratamentul candidozei orofaringiene la pacienti cu imunosupresie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 100 mg 100mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100mg TERAPIA S.A.
FLUCOVIM 100 100mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100mg BALKANPHARMA RAZGRAD AD
150mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 150 mg 150mg KRKA D.D.
DIFLUCAN 150 mg 150mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 150 150mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150mg TERAPIA S.A.
FLUCOVIM 150 150mg VIM SPECTRUM SRL
MYCOMAX 150 150mg ZENTIVA AS
MYCOSYST® 150 mg 150mg GEDEON RICHTER PLC.
200mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 200 mg 200mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200mg TEVA PHARMACEUTICALS SRL
2mg/mlJ02AC01 FLUCONAZOLUM SOL. PERF.DIFLAZON® 2mg/ml KRKA D.D.
DIFLUCAN® 2mg/ml PFIZER EUROPE MA EEIG
MYCOMAX® INF 2mg/ml ZENTIVA AS
50mgJ02AC01 FLUCONAZOLUM CAPS.DIFLAZON 50 mg 50mg KRKA D.D.
DIFLUCAN 50 mg 50mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ® 50 50mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50mg TERAPIA S.A.
FLUCOVIM 50 50mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50mg BALKANPHARMA RAZGRAD AD
50mg/5mlJ02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALADIFLUCAN® 50 mg/5 ml 50mg/5ml PFIZER EUROPE MA EEIG
1025 VORICONAZOLUMJ02AC03
J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.VFEND (R) 200mg PFIZER LIMITED
VFEND 200mg 200mg PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND (R) 40 mg/ml 40mg/ml PFIZER LIMITED
1026 POSACONAZOLUM **J02AC04
Prescriere limitata: Profilaxia si tratamentul infectiilor fungice invazive la pacientii aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care
prezinta risc inalt de a dezvolta infectii fungice masive.
Profilaxia si tratamentul infectiilor fungice invazive la pacientii in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de
a dezvolta infectii fungice masive.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
40mg/mlJ02AC04 POSACONAZOLUM SUSP. ORALANOXAFIL SP 40mg/ml 40mg/ml SP EUROPE
1027 ACICLOVIRUMJ05AB01
200mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 200 mg 200mg SLAVIA PHARM SRL
EUVIROX 200 mg 200mg EUROPHARM SA
200mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 200 mg 200mg EGIS PHARMACEUTICALS P.L.C.
139 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
CLOVIRAL 200 mg 200mg ANTIBIOTICE SA
ZOVIRAX 200mg GLAXO WELLCOME FOUNDATION LTD.
200mgJ05AB01 ACICLOVIRUM COMPR. DISP.ACICLOVIR 200 mg 200mg OZONE LABORATORIES LTD.
LOVIR 200 mg 200mg RANBAXY UK LIMITED
250mgJ05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./PERF.VIROLEX 250mg KRKA D.D. NOVO MESTO
400mgJ05AB01 ACICLOVIRUM CAPS.ACICLOVIR 400 mg 400mg ARENA GROUP S.A.
400mgJ05AB01 ACICLOVIRUM COMPR.ACICLOVIR 400 mg 400mg EGIS PHARMACEUTICALS P.L.C.
400mgJ05AB01 ACICLOVIRUM COMPR. FILM.ACIKLOVIR 400mg A & G MED TRADING S.R.L.
1028 VALGANCICLOVIRUM **J05AB14
Prescriere limitata: Tratamentul de initiere si mentinere pentru retinita cu citomegalovirus (CMV) la pacienti imunocompromisi.
450mgJ05AB14 VALGANCICLOVIRUM COMPR. FILM.VALCYTE® 450 mg 450mg ROCHE ROMANIA SRL
1029 LAMIVUDINUMJ05AF05
100mgJ05AF05 LAMIVUDINUM COMPR. FILM.ZEFFIX 100 mg 100mg GLAXO GROUP LTD.
10mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAEPIVIR 10mg/ml 10mg/ml GLAXO GROUP LTD.
150mgJ05AF05 LAMIVUDINUM COMPR. FILM.EPIVIR 150mg 150mg GLAXO GROUP LTD.
5mg/mlJ05AF05 LAMIVUDINUM SOL. ORALAZEFFIX 5 mg/ml 5mg/ml GLAXO GROUP LTD.
1030 CICLOSPORINUML04AA01
Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mgL04AA01 CICLOSPORINUM CAPS. MOIEQUORAL® 100 mg 100mg IVAX - PHARMACEUTICALS S.R.O.
100mg/mlL04AA01 CICLOSPORINUM SOL. ORALAEQUORAL® 100mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 100mg/ml NOVARTIS PHARMA GMBH
25mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL® 25 mg 25mg HEXAL AG
EQUORAL® 25 mg 25mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 25mg NOVARTIS PHARMA GMBH
50mgL04AA01 CICLOSPORINUM CAPS. MOICICLORAL® HEXAL 50 mg 50mg HEXAL AG
EQUORAL® 50 mg 50mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL® 50mg NOVARTIS PHARMA GMBH
1031 TACROLIMUSUM **L04AA05
Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen renal.
Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen cardiac.
Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen hepatic.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
0,5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 0,5mg 0,5mg ASTELLAS PHARMA GMBH
0.5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 0,5 mg 0.5mg ASTELLAS PHARMA GMBH
1mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 1 mg 1mg ASTELLAS IRELAND CO. LTD.
1mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 1mg 1mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS.PROGRAF® 5 mg 5mg ASTELLAS PHARMA GMBH
5mgL04AA05 TACROLIMUSUM CAPS. ELIB. PREL.ADVAGRAF 5mg 5mg ASTELLAS PHARMA GMBH
5mg/mlL04AA05 TACROLIMUSUM CONC. PT. SOL. PERF.PROGRAF® 5 mg/ml 5mg/ml ASTELLAS PHARMA GMBH
1032 MYCOPHENOLATUM **L04AA06
Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen renal.
Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen cardiac.
Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant alogen hepatic.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
180mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 180 mg 180mg NOVARTIS PHARMA GMBH
1g/5mlL04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALACELLCEPT 1mg/5ml 1g/5ml ROCHE REGISTRATION LTD.
250mgL04AA06 MYCOPHENOLATUM CAPS.CELLCEPT 250mg 250mg ROCHE REGISTRATION LTD.
MYFENAX 250mg 250mg TEVA PHARMA BV
360mgL04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ.MYFORTIC 360 mg 360mg NOVARTIS PHARMA GMBH
500mgL04AA06 MYCOPHENOLATUM CAPS.MYFENAX 500mg 500mg TEVA PHARMA BV
140 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
500mgL04AA06 MYCOPHENOLATUM COMPR. FILM.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
500mgL04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. SOL. PERF.CELLCEPT 500mg 500mg ROCHE REGISTRATION LTD.
1033 SIROLIMUS **L04AA10
Prescriere limitata: Terapie de menţinere, urmare a iniţierii şi stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in unităţi de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
1mgL04AA10 SIROLIMUS COMPR. FILM.RAPAMUNE 1mg 1mg WYETH EUROPA LTD.
1034 AZATHIOPRINUM *L04AX01
50mgL04AX01 AZATHIOPRINUM COMPR. FILM.IMURAN® 50mg THE WELLCOME FOUNDATION LTD.
141 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C2-P10: PROGRAM NATIONAL DE SUPLEERE A FUNCTIEI RENALE LA BOLNAVII CU INSUFICIENTA RENALA
CRONICA.
1035 ALFACALCIDOLUM Protocol: A007EA11CC03
0.25µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0,25 µg 0.25µg TEVA PHARMACEUTICALS SRL
0.50µgA11CC03 ALFACALCIDOLUM CAPS. MOIALPHA D3 0.50 µg 0.50µg TEVA PHARMACEUTICALS S.R.L.
1036 CALCITRIOLUM ** Protocol: A006EA11CC04
0.25µgA11CC04 CALCITRIOLUM CAPS. MOIROCALTROL 0.25µg ROCHE ROMANIA S.R.L.
1037 PARICALCITOLUM ** Protocol: A005EA11CC07
5 µg/mlA11CC07 PARICALCITOLUM SOL. INJ.ZEMPLAR 5 µg/ml ABBOTT LABORATORIES S.A.
1038 HEPARINUM **B01AB01
5000ui/mlB01AB01 HEPARINUM SOL. INJ.HEPARIN 5000ui/ml POLIPHARMA INDUSTRIES S.R.L.
HEPARIN SANDOZ® 25000 UI/5 ml 5000ui/ml SANDOZ GMBH
HEPARINE SODIQUE PANPHARMA 5000ui/ml LAB. PANPHARMA
1039 ENOXAPARINUM **B01AB05
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
8000ui
anti-Xa/0.8ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 8000ui anti-Xa/0.8ml 8000ui
anti-Xa/0.8ml
LAB. AVENTIS
2000ui
anti-Xa/0.2ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 2000ui anti-Xa/0.2ml 2000ui
anti-Xa/0.2ml
LAB. AVENTIS
4000ui
anti-Xa/0,4ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 4000ui anti-Xa/0.4ml 4000ui
anti-Xa/0,4ml
LAB. AVENTIS
6000ui
anti-Xa/0.6ml
B01AB05 ENOXAPARINUM SOL. INJ.
CLEXANE 6000ui anti-Xa/0.6ml 6000ui
anti-Xa/0.6ml
LAB. AVENTIS
1040 NADROPARINUM **B01AB06
11400
uiAXa/0.6ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXODI 11400 UI anti-factor Xa/0,6ml 11400 uiAXa/0.6ml GLAXO GROUP LTD.
15200
uiAXa/0.8ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXODI 15200 UI anti-factor Xa/0,8ml 15200 uiAXa/0.8ml GLAXO GROUP LTD.
2850 ui
AFXa/0.3ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 2850 UI anti-factor Xa/0,3 ml 2850 ui
AFXa/0.3ml
GLAXO GROUP LTD.
3800 ui
AFXa/0.4ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 3800 UI anti-factor Xa/0,4 ml 3800 ui
AFXa/0.4ml
GLAXO GROUP LTD.
5700 ui
AFXa/0.6ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 5700 UI anti-factor Xa/0,6 ml 5700 ui
AFXa/0.6ml
GLAXO GROUP LTD.
7600 ui
AXa/0.8ml
B01AB06 NADROPARINUM SOL. INJ.
FRAXIPARINE® 7600 UI anti-factor Xa/0,8 ml 7600 ui AXa/0.8ml GLAXO GROUP LTD.
1041 REVIPARINUM **B01AB08
1432ui/0.25mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 1432UI/0,25 ml 1432ui/0.25ml ABBOTT GMBH&CO.KG
3436ui/0.6mlB01AB08 REVIPARINUM SOL. INJ.CLIVARIN® 3436 UI/0,6 ml 3436ui/0.6ml ABBOTT GMBH&CO.KG
1042 TINZAPARINUM **B01AB10
10000u ANTIF.
Xa/ml
B01AB10 TINZAPARINUM SOL. INJ.
142 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
INNOHEP 10000u ANTIF.
Xa/ml
LEO PHARMACEUTICAL PRODUCTS
20000u ANTIF.
Xa/ml
B01AB10 TINZAPARINUM SOL. INJ.
INNOHEP 20000u ANTIF.
Xa/ml
LEO PHARMACEUTICAL PRODUCTS
1043 COMPLEX DE HIDROXID DE FER (III) SUCROZA Protocol: A010NB03AC02
20mg/mlB03AC02 COMPLEX DE HIDROXID DE FER (III)
SUCROZA
SOL. INJ./PERF.
VENOFER® 20mg/ml VIFOR FRANCE S.A.
1044 EPOETINUM ALFA ** Protocol: B010NB03XA01
10000ui/mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 10000 UI 10000ui/ml JOHNSON & JOHNSON D.O.O.
1000UI/0,3mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAEPREX® 1000 UI 1000ui/0.5ml JOHNSON & JOHNSON D.O.O.
1000UI/0,5mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 1000UI/0,5ml 1000UI/0,5ml SANDOZ GMBH
EPOKINE 1000 UI/0,5 ml 1000UI/0.5ml RENAMED FARMA S.R.L.
20000UI/0,5mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAEPOKINE 2000 UI/0,5 ml 2000UI/0.5ml RENAMED FARMA S.R.L.
2000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 2000 U.I. 2000UI GULF PHARMACEUTICAL IND. S.R.L.
EPREX® 2000 UI 2000ui/0.5ml JOHNSON & JOHNSON D.O.O.
2000UI/1,0mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 2000UI/1,0ml 2000UI/1,0ml SANDOZ GMBH
EPOKINE 2000 UI/1 ml 2000UI/1ml RENAMED FARMA S.R.L.
3000UI/0,3mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 3000UI/0,3ml 3000UI/0,3ml SANDOZ GMBH
3000ui/0.3mlB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 3000 UI 3000ui/0.3ml JOHNSON & JOHNSON D.O.O.
40 000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPREX® 40 000 UI 40 000UI JOHNSON & JOHNSON D.O.O.
4000UIB03XA01 EPOETINUM ALFA SOL. INJ.EPOPHAR 4000 U.I. 4000UI GULF PHARMACEUTICAL IND. S.R.L.
4000UI/0,4mlB03XA01 EPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTABINOCRIT 4000UI/0,4ml 4000UI/0,4ml SANDOZ GMBH
EPOKINE 4000 UI/0,4 ml 4000UI/0.4ml RENAMED FARMA S.R.L.
EPREX® 4000 UI 4000ui/0.4ml JOHNSON & JOHNSON D.O.O.
4000UI/1mlB03XA01 EPOETINUM ALFA SOL. INJ.EPOKINE 4000 UI/1 ml 4000UI/1ml RENAMED FARMA S.R.L.
1045 EPOETINUM BETA ** Protocol: B009NB03XA01
10000UI/0,6mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 10000UI/0,6ml 10000UI/0,6ml ROCHE REGISTRATION LTD.
1000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 1000UI/0,3ml 1000UI/0,3ml ROCHE REGISTRATION LTD.
2000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 2000UI/0,3ml 2000UI/0,3ml ROCHE REGISTRATION LTD.
4000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 4000UI/0,3ml 4000UI/0,3ml ROCHE REGISTRATION LTD.
5000UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 5000UI/0,3ml 5000UI/0,3ml ROCHE REGISTRATION LTD.
500UI/0,3mlB03XA01 EPOETINUM BETA SOL. INJ. IN SERINGA PREUMPLUTANEORECORMON 500UI/0,3ml 500UI/0,3ml ROCHE REGISTRATION LTD.
1046 DARBEPOETINUM ALFA ** Protocol: B011NB03XA02
10µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 10µg/0.4ml 10µg/0.4ml AMGEN EUROPE BV
100µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 100µg/0.5ml 100µg/0.5ml AMGEN EUROPE BV
15µg/0.375mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 15µg/0.375ml 15µg/0.375ml AMGEN EUROPE BV
150µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 150µg/0.3ml 150µg/0.3ml AMGEN EUROPE BV
20µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 20µg/0.5ml 20µg/0.5ml AMGEN EUROPE BV
30µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 30µg/0.3ml 30µg/0.3ml AMGEN EUROPE BV
300µg/0.6mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 300µg/0.6ml 300µg/0.6ml AMGEN EUROPE BV
40µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 40µg/0.4ml 40µg/0.4ml AMGEN EUROPE BV
50µg/0.5mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 50µg/0.5ml 50µg/0.5ml AMGEN EUROPE BV
500µg/mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 500µg/ml 500µg/ml AMGEN EUROPE BV
60µg/0.3mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 60µg/0.3ml 60µg/0.3ml AMGEN EUROPE BV
80µg/0.4mlB03XA02 DARBEPOETINUM ALFA SOL. INJ. IN SERINGA PREUMPLUTAARANESP 80µg/0.4ml 80µg/0.4ml AMGEN EUROPE BV
1049 SEVELAMER ** Protocol: V003DV03AE02
800mgV03AE02 SEVELAMER COMPR. FILM.
143 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
RENAGEL 800mg 800mg GENZYME EUROPE BV
1050 CINACALCETUM **** Protocol: H003NH05BX01
30mgH05BX01 CINACALCETUM COMPR. FILM.MIMPARA 30 mg 30mg AMGEN EUROPE B.V.
60mgH05BX01 CINACALCETUM COMPR. FILM.MIMPARA 60 mg 60mg AMGEN EUROPE B.V.
90mgH05BX01 CINACALCETUM COMPR. FILM.MIMPARA 90 mg 90mg AMGEN EUROPE B.V.
SUBLISTA C2-P11: PROGRAM NATIONAL DE SANATATE MINTALA. SUBPROGRAMUL TRATAMENTUL
TOXICODEPENDENTELOR
1051 NALTREXONUMN07BB04
50mgN07BB04 NALTREXONUM COMPR. FILM.REVIA 50mg TORREX CHIESI PHARMA GMBH
Naltrexone hydrochloride este contraindicata la pacientii tratati cu medicamente opioide
1052 METHADONUMN07BC02Risc inalt de aparitie a dependentei.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2.5mgN07BC02 METHADONUM COMPR.SINTALGON 2,5 mg 2.5mg ZENTIVA S.A.
1053 COMBINATII ( BUPRENORPHINUM + NALAXONE)N07BC51
Prescriere limitata: Tratamentul dependentei de opioide in cadrul terapiei medicale, sociale si psihologice.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
2mg/0,5mgN07BC51 COMBINATII ( BUPRENORPHINUM +
NALAXONE)
COMPR. SUBLING.
SUBOXONE 2mg/0,5mg 2mg/0,5mg SP EUROPE
8mg/2mgN07BC51 COMBINATII ( BUPRENORPHINUM +
NALAXONE)
COMPR. SUBLING.
SUBOXONE 8mg/2mg 8mg/2mg SP EUROPE
144 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
SUBLISTA C3 - DCI-URI CORESPUNZĂTOARE MEDICAMENTELOR DE CARE BENEFICIAZĂ COPIII PANĂ LA 18 ANI, TINERII
DE LA 18 LA 26 ANI DACA SUNT ELEVI, UCENICI SAU STUDENTI DACĂ NU REALIZEAZĂ VENITURI PRECUM SI GRAVIDE SI
LEHUZE, IN TRATAMENTUL AMBULATORIU IN REGIM DE COMPENSARE 100% DIN PRETUL DE REFERINTĂ
1056 DROTAVERINUMA03AD02
40mg/2mlA03AD02 DROTAVERINUM SOL. INJ.NO - SPA 40 mg/2 ml 40mg/2ml CHINOIN PRIVATE CO. LTD.
1057 ATROPINUMA03BA01
1mg/mlA03BA01 ATROPINUM SOL. INJ.SULFAT DE ATROPINA 1mg/ml ZENTIVA S.A.
1058 BUTYLSCOPOLAMMONII BROMIDUMA03BB01
10mg/mlA03BB01 BUTYLSCOPOLAMMONII BROMIDUM SOL. INJ.SCOBUTIL 10 mg/ml 10mg/ml ZENTIVA SA
20mg/mlA03BB01 BUTYLSCOPOLAMMONII BROMIDUM SOL. INJ.BUSCOPAN 20 mg/ml 20mg/ml BOEHRINGER INGELHEIM INT. GMBH
FARCORELAXIN 20mg/ml PHARCO IMPEX 93 S.R.L.
1059 COMBINATIIA03DA02
A03DA02 COMBINATII COMPR.ALGIFEN COMPRIMATE ZENTIVA SA
PIAFEN ANTIBIOTICE SA
A03DA02 COMBINATII SOL. INJ.ALGIFEN SOLUTIE INJECTABILA ZENTIVA SA
A03DA02 COMBINATII SUPOZ.PIAFEN ANTIBIOTICE SA
1060 COMBINATIIA05BAN3
A05BAN3 COMBINATII SOL. INJ.ASPATOFORT® TERAPIA SA
1061 COMBINATIIA06AD65
A06AD65 COMBINATII PULB. PT. SOL. ORALAENDOFALK DR. FALK PHARMA GMBH
1062 NIFUROXAZIDUMA07AX03
200mgA07AX03 NIFUROXAZIDUM CAPS.ERCEFURYL® 200 mg 200mg SANOFI-SYNTHELABO OTC
1063 RETINOLUMA11CA01
1500000ui/gA11CA01 RETINOLUM PIC. ORALE, SOL.VITAMINA A 1500000ui/g BIOFARM SA
50000uiA11CA01 RETINOLUM CAPS. MOIVITAMINA A FORTE 50000ui BIOFARM SA
1064 DIHYDROTACHYSTEROLUMA11CC02
0.1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.TACHYSTIN 0.1mg/ml CHAUVIN ANKERPHARM GMBH
1mg/mlA11CC02 DIHYDROTACHYSTEROLUM PICATURI ORALE-SOL.A.T. 10® 1mg/ml MERCK KGAA
1065 CALCITRIOLUMA11CC04
0.25µgA11CC04 CALCITRIOLUM CAPS. MOIROCALTROL 0.25µg ROCHE ROMANIA S.R.L.
1066 COLECALCIFEROLUMA11CC05
0,45mg/mlA11CC05 COLECALCIFEROLUM PIC. ORALE, SOL.VITAMINA D3 0,45mg/ml BIOFARM S.A.
0.5mg/mlA11CC05 COLECALCIFEROLUM PIC. ORALE, SOL.VIGANTOL OIL 0.5mg/ml MERCK KGAA
1000UIA11CC05 COLECALCIFEROLUM COMPR.VIGANTOLETTEN 1000 1000UI MERCK KGAA
500UIA11CC05 COLECALCIFEROLUM COMPR.VIGANTOLETTEN 500 500UI MERCK KGAA
1067 COMBINATIIA11CC20
A11CC20 COMBINATII COMPR.FLUOR VIGANTOLETTEN 1000 MERCK KGAA
FLUOR VIGANTOLETTEN 500 MERCK KGAA
1068 THIAMINUMA11DA01
100mg/2mlA11DA01 THIAMINUM SOL. INJ.SICOVIT® B1 100 mg/2 ml 100mg/2ml ZENTIVA SA
10mgA11DA01 THIAMINUM COMPR.SICOVIT® B1 10 mg 10mg ZENTIVA SA
1069 BENFOTIAMINUMA11DA03
50mgA11DA03 BENFOTIAMINUM DRAJ.BENFOGAMMA 50mg WORWAG PHARMA GMBH & CO. KG
1070 COMBINATIIA11DBN1
A11DBN1 COMBINATII CAPS. MOIMILGAMMA® N WORWAG PHARMA GMBH & CO. KG
A11DBN1 COMBINATII SOL. INJ.MILGAMMA® N WORWAG PHARMA GMBH & CO. KG
1071 COMBINATIIA11DBN2
A11DBN2 COMBINATII COMPR. FILM.NEUROMULTIVIT® LANNACHER HEILMITTEL GMBH
1072 ACIDUM ASCORBICUMA11GA01
750mgA11GA01 ACIDUM ASCORBICUM SOL. INJ.
145 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
VITAMINA C ARENA 750 mg 750mg ARENA GROUP S.A.
1073 PYRIDOXINUMA11HA02
250 mgA11HA02 PYRIDOXINUM COMPR.VITAMINA B6 250 mg 250 mg ARENA GROUP SA
250mgA11HA02 PYRIDOXINUM COMPR.SICOVIT B6 250 mg 250mg ZENTIVA SA
250mg/5mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 250 mg/5 ml 250mg/5ml ZENTIVA SA
50mg/2mlA11HA02 PYRIDOXINUM SOL. INJ.SICOVIT B6 50 mg/2ml 50mg/2ml ZENTIVA SA
1074 TOCOFEROLUMA11HA03
200mgA11HA03 TOCOFEROLUM CAPS. MOIVITAMIN E 200 200mg ZENTIVA AS
400mgA11HA03 TOCOFEROLUM CAPS. MOIVITAMIN E 400 400mg ZENTIVA AS
1076 CALCII GLUCONASA12AA03
A12AA03 CALCII GLUCONAS SOL. INJ.GLUCONAT DE CALCIU ZENTIVA SA
GLUCONAT DE CALCIU 10% 10% B. BRAUN MELSUNGEN AG
10,00%A12AA03 CALCII GLUCONAS SOL. INJ.GLUCONAT DE CALCIU ZENTIVA SA
GLUCONAT DE CALCIU 10% 10% B. BRAUN MELSUNGEN AG
1077 METANDIENONUMA14AA03
5mgA14AA03 METANDIENONUM COMPR.NAPOSIM 5 mg 5mg TERAPIA SA
1078 LEVOCARNITINUMA16AA01
100mg/mlA16AA01 LEVOCARNITINUM SOL. ORALACARNIL® 100mg/ml ANFARM HELLAS S.A. PHARMACEUTICALS
10%A16AA01 LEVOCARNITINUM SOL. ORALAMIOCOR 10% ECOBI PHARMACEUTICI
1079 DIVERSEA16AXN1
200mgA16AXN1 DIVERSE DRAJ.ACTOVEGIN® 200mg NYCOMED AUSTRIA GMBH
200mg/5mlA16AXN1 DIVERSE SOL. INJ.ACTOVEGIN® 200mg/5ml NYCOMED AUSTRIA GMBH
80mg/2mlA16AXN1 DIVERSE SOL. INJ.ACTOVEGIN® 80mg/2ml NYCOMED AUSTRIA GMBH
1080 ETAMSYLATUMB02BX01
250mg/2mlB02BX01 ETAMSYLATUM SOL. INJ.ETAMSILAT 250mg/2ml 250mg/2ml ZENTIVA S.A
1081 CARBAZOCHROMI SALICYLASB02BX02
0.3mg/mlB02BX02 CARBAZOCHROMI SALICYLAS SOL. INJ.ADRENOSTAZIN 0.3mg/ml TERAPIA SA
1082 FERROSI FUMARASB03AA02
3,00%B03AA02 FERROSI FUMARAS SUSP. ORALAFERRONAT® 3% IVAX - PHARMACEUTICALS S.R.O.
1083 FERROSI GLUCONASB03AA03
B03AA03 FERROSI GLUCONAS COMPR.ASCOFER ARENA GROUP SA
1084 FERROCHOLINATUMB03ABN1
24mg Fe/mlB03ABN1 FERROCHOLINATUM SOL. ORALA IN PICATURIFER-SOL 24mg Fe/ml E.I.P.I.CO. MED S.R.L.
1085 COMBINATIIB03AD02
B03AD02 COMBINATII CAPS. ELIB. PREL.FERRETAB® LANNACHER HEILMITTEL GMBH
1086 COMBINATIIB03AD03
B03AD03 COMBINATII CAPS.FERRO SANOL GYN SCHWARZ PHARMA AG
B03AD03 COMBINATII DRAJ. ELIB. PREL.TARDYFERON FOL® LAB. PIERRE FABRE
1087 COMBINATIIB03AD04
B03AD04 COMBINATII COMPR. MAST.MALTOFER FOL VIFOR FRANCE S.A.
1088 COMBINATIIB03AE01
B03AE01 COMBINATII CAPS. MOIFERRO - FOLGAMMA® WORWAG PHARMA GMBH & CO. KG
1089 COMBINATIIB03AE10
B03AE10 COMBINATII SOL. ORALATOT'HEMA LAB. INNOTHERA
1090 CYANOCOBALAMINUMB03BA01
1000µg/mlB03BA01 CYANOCOBALAMINUM SOL. INJ.SICOVIT® B12 1000µg/ml 1000µg/ml ZENTIVA S.A.
50µg/mlB03BA01 CYANOCOBALAMINUM SOL. INJ.SICOVIT B12 50µg/ml 50µg/ml ZENTIVA SA
1091 COMBINATIIB03BA51
B03BA51 COMBINATII DRAJ.MILGAMMA® WORWAG PHARMA GMBH & CO. KG
146 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
1092 ALPROSTADILUM **C01EA01
500µgC01EA01 ALPROSTADILUM CONC. PT. SOL. PERF.ALPROSTADIL "PINT" 500 µg 500µg PINT-PHARMA GMBH
1093 COMBINATIIC02LA51
C02LA51 COMBINATII DRAJ.NEOCRYSTEPIN ZENTIVA AS
1094 CODERGOCRINUMC04AE01
0.1%C04AE01 CODERGOCRINUM SOL. ORALA IN PICATURICO-DERGOCRIN 0.1% TERAPIA SA
1mg/mlC04AE01 CODERGOCRINUM SOL. ORALA IN PICATURISECATOXIN 1mg/ml IVAX - PHARMACEUTICALS S.R.O.
0.1%C04AE01 CODERGOCRINUM PICATURI ORALE-SOL.REDERGIN 1 mg/ml 0.1% LEK PHARMACEUTICALS D.D.
1095 COMBINATIIC05AA01
C05AA01 COMBINATII UNGUENTHEMORZON ANTIBIOTICE SA
1096 COMBINATIIC05AA08
C05AA08 COMBINATII SUPOZ.ULTRAPROCT® INTENDIS GmbH
C05AA08 COMBINATII UNGUENT RECTALULTRAPROCT® INTENDIS GmbH
1097 COMBINATIIC05AD01
C05AD01 COMBINATII UNGUENT RECTALDOXIPROCT OM PORTUGUESA S.A.
DOXIPROCT PLUS OM PORTUGUESA S.A.
1098 CALCII DOBESILASC05BX01
500mgC05BX01 CALCII DOBESILAS CAPS.DOXILEK 500mg LEK PHARMACEUTICALS D.D.
DOXIUM 500 500mg OM PORTUGUESA S.A.
1099 TROXERUTINUM (COMBINATII)C05CA54
C05CA54 TROXERUTINUM (COMBINATII) CAPS.GINKOR FORT BEAUFOUR IPSEN PHARMA
1100 CELIPROLOLUMC07AB08
100mgC07AB08 CELIPROLOLUM COMPR. FILM.CELIPRES® 100mg RANBAXY U.K. LIMITED
200mgC07AB08 CELIPROLOLUM COMPR. FILM.CELIPRES® 200mg RANBAXY U.K. LIMITED
1101 COMBINATIIC07NAN1
C07NAN1 COMBINATII CAPS.CALMOGEN EUROPHARM SA
C07NAN1 COMBINATII COMPR.DISTONOVAL FABIOL S.A.
C07NAN1 COMBINATII COMPR. FILM.DISTONOCALM® ZENTIVA S.A.
1102 NIMODIPINUMC08CA06
10mg/50mlC08CA06 NIMODIPINUM SOL. PERF.DILCEREN® 10mg/50ml SLOVAKOFARMA
NIMOTOP® 10mg/50ml BAYER HEALTHCARE AG
30mgC08CA06 NIMODIPINUM COMPR. FILM.NIMOTOP® 30mg BAYER HEALTHCARE AG
1103 ACIDUM NICOTINICUMC10AD02
1000mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 1000 mg 1000mg MERCK KGAA
375mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 375 mg 375mg MERCK KGAA
500mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 500 mg 500mg MERCK KGAA
750mgC10AD02 ACIDUM NICOTINICUM COMPR. ELIB. PREL.NIASPAN 750 mg 750mg MERCK KGAA
1104 ISOCONAZOLUMD01AC05
10mg/1gD01AC05 ISOCONAZOLUM CREMATRAVOGEN 10mg/1g INTENDIS GmbH
1105 KETOCONAZOLUMD01AC08
20mg/gD01AC08 KETOCONAZOLUM CREMAKETOCONAZOL CREMA 20mg/g SC HYPERION SA
2mg/100mgD01AC08 KETOCONAZOLUM CREMAKEFUNGIN 2mg/100mg 2mg/100mg ANTIBIOTICE S.A.
2%D01AC08 KETOCONAZOLUM CREMAKETOCONAZOL 2% TIS FARMACEUTIC SA
NIZORAL 2% JANSSEN PHARMACEUTICA NV
1106 COMBINATIID01AC52
D01AC52 COMBINATII CREMAMYCOHEAL® HC DAR AL DAWA PHARMA S.R.L
1108 DITHRANOLUMD05AC01
0.5%D05AC01 DITHRANOLUM UNGUENTPSORIANOL 0,5% 0.5% HYPERION SA
1%D05AC01 DITHRANOLUM UNGUENT
147 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
PSORIANOL 1% 1% HYPERION SA
1109 COMBINATIID05AXN1
D05AXN1 COMBINATII SOL. CUT.ASORIAN BIOFARM SA
1110 ALCLOMETAZONUM Protocol: D001LD07AB10
0.5mg/gD07AB10 ALCLOMETAZONUM CREMAAFLODERM 0.5mg/g A & G MED TRADING S.R.L.
0.5mg/gD07AB10 ALCLOMETAZONUM UNGUENTAFLODERM 0.5mg/g A & G MED TRADING S.R.L.
1111 FLUOCINOLONI ACETONIDUM Protocol: D001LD07AC04
25,00%D07AC04 FLUOCINOLONI ACETONIDUM UNGUENTFLUOCINOLON ACETONID 0,025% 0.025% LAROPHARM SRL
1112 FLUOCORTOLONUM Protocol: D001LD07AC05
0.25%D07AC05 FLUOCORTOLONUM CREMAULTRALAN CREMA 0.25% INTENDIS GMBH
0.25%D07AC05 FLUOCORTOLONUM UNGUENTULTRALAN UNGUENT 0.25% SCHERING AG
1113 COMBINATII Protocol: D001LD07CB01
D07CB01 COMBINATII CREMANIDOFLOR ANTIBIOTICE SA
D07CB01 COMBINATII UNGUENTPANDERM GULF PHARMACEUTICAL INDUSTRIES S.R.L.
1114 COMBINATII Protocol: D001LD07CC02
D07CC02 COMBINATII UNGUENTFLUOCINOLON N ANTIBIOTICE SA
1115 COMBINATII Protocol: D001LD07XB02
D07XB02 COMBINATII CREMATRIAMCINOLON S ANTIBIOTICE SA
1116 COMBINATII Protocol: D001LD07XC01
D07XC01 COMBINATII SOL. CUT.BELOSALIC A & G MED TRADING S.R.L.
DIPROSALIC SCHERING-PLOUGH EUROPE
D07XC01 COMBINATII UNGUENTBELOSALIC A & G MED TRADING S.R.L.
DIPROSALIC SCHERING-PLOUGH EUROPE
1117 COMBINATII Protocol: D001LD07XC04
D07XC04 COMBINATII CREMATRAVOCORT INTENDIS GmbH
1119 TRETINOINUMD10AD01
0.05%D10AD01 TRETINOINUM CREMARETIN - A® 0.05% JOHNSON & JOHNSON D.O.O.
1121 ERYTHROMYCINUMD10AF02
4gD10AF02 ERYTHROMYCINUM SOL. CUT.ERYFLUID 4g PIERRE FABRE DERMATOLOGIE
1122 COMBINATIID10AF52
40mg/12mg/mlD10AF52 COMBINATII PULB. + SOLV. SOL. CUT.ZINERYT 40mg/12mg/ml ASTELLAS PHARMA EUROPE B.V.
1124 METRONIDAZOLUMG01AF01
500mgG01AF01 METRONIDAZOLUM OVULEFLAGYL 500mg LAB. AVENTIS
1126 COMBINATIIG01AXN1
G01AXN1 COMBINATII COMPR. VAG.COLPOSEPTINE® LAB. THERAMEX
1127 COMBINATIIG01BDN1
G01BDN1 COMBINATII COMPR. VAG.TERGYNAN LAB. BOUCHARA-RECORDATI
1128 MEDROXYPROGESTERONUMG03AC06
150mgG03AC06 MEDROXYPROGESTERONUM SUSP. INJ.DEPO-PROVERA 150mg PFIZER EUROPE MA EEIG
1129 NOMEGESTROLUMG03DB04
5mgG03DB04 NOMEGESTROLUM COMPR.LUTENYL® 5mg LAB. THERAMEX
1130 GONADOTROPHINUM CHORIONICUMG03GA01
Prescriere limitata: Infertilitate anovulatorie.
Pentru tratamentul infertilitatii masculine ca urmare a hipogonadismului hipogonadotrop;
Pentru tratamentul infertilitatii masculine asociata cu deficit de LH;
Pentru tratamentul barbatilor care au insuficienta combinata de GH si gonadotropine si la care absenta caracterelor sexuale secundare indica o intarziere de maturare.
Pentru tratamentul baietilor de peste 16 ani care au manifestari clinice ale hipogonadismului sau ale pubertatii intarziate. Tratamentul nu trebuie sa depaseasca 6 luni.
Cu excepţia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fără
efect (sarcina nu a fost obţinuta). Femeile care au urmat tratament pentru inducerea ovulaţiei cu alte clase de medicamente si nu au obţinut o sarcina necesita evaluare
laparoscopică pentru a exclude alte cauze care împiedica apariţia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puţin douăsprezece luni sau amenoreea sa fie
prezenta de cel puţin sase luni înaintea tratamentului. Înaintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical.
NOTA:
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
5000ui/mlG03GA01 GONADOTROPHINUM CHORIONICUM LIOF. + SOLV. PT. SOL. INJ.PREGNYL 5000 5000ui/ml NV ORGANON
500ui/mlG03GA01 GONADOTROPHINUM CHORIONICUM LIOF. + SOLV. PT. SOL. INJ.PREGNYL 500 500ui/ml ORGANON NV
148 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
1131 MENOTROPINUMG03GA02
75ui FSH / 75ui
LH
G03GA02 MENOTROPINUM LIOF. SI SOLV.PT.SOL.INJ
MENOGON 75ui FSH / 75ui LH FERING GMBH
G03GA02 MENOTROPINUM LIOF. + SOLV. PT. SOL. INJ.MENOPUR FERRING LAEGEMIDLER A/S
1132 COMBINATIIG04BCN1
G04BCN1 COMBINATII GRAN. ORALEURALYT-U MADAUS GMBH
1133 COMBINATIIH03AA03
100µg+20µgH03AA03 COMBINATII COMPR.NOVOTHYRAL® 100 100µg+20µg MERCK KGAA
1134 COMBINATIIJ01CR50
1g+1gJ01CR50 COMBINATII PULB. PT. SOL. INJ.SULPERAZON® 2 g 1g+1g PFIZER EUROPE MA EEIG
250mg+250 mgJ01CR50 COMBINATII CAPS.AMPICLOX 250mg+250 mg EUROPHARM SA
1135 CEFAZOLINUMJ01DB04
1gJ01DB04 CEFAZOLINUM PULB. PT. SOL. INJ.LYZOLIN 1g MEDICAROM GROUP S.R.L.
1136 CEFPIROMUMJ01DE02
1gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 1 g 1g LAB. AVENTIS
2gJ01DE02 CEFPIROMUM PULB. PT. SOL. INJ./PERF.CEFROM® 2 g 2g LAB. AVENTIS
1137 SULFAFURAZOLUMJ01EB05
500mgJ01EB05 SULFAFURAZOLUM COMPR.NEOXAZOL® 500 mg 500mg ZENTIVA S.A.
SULFAFURAZOL 500mg ARENA GROUP SA
1138 ROXITHROMYCINUMJ01FA06
150mgJ01FA06 ROXITHROMYCINUM COMPR. FILM.ROXAMED® 150 150mg DAR AL DAWA PHARMA S.R.L
1139 GENTAMICINUMJ01GB03
Prescriere limitata: Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO
GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH
40mg/mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 40mg/ml KRKA D.D. NOVO MESTO
GENTAMICINA SANDOZ® 40 mg/ml 40mg/ml SANDOZ GMBH
40mg/mlJ01GB03 GENTAMICINUM SOL. PARENT.LYRAMYCIN 40mg/ml MEDICAROM GROUP S.R.L.
80mg/2mlJ01GB03 GENTAMICINUM SOL. INJ.GENTAMICIN KRKA 80mg/2ml KRKA D.D. NOVO MESTO
80mg/2mlJ01GB03 GENTAMICINUM SOL.INJ.PAN - GENTAMICINE 80mg/2ml LAB. PANPHARMA
1140 NETILMICINUMJ01GB07
150mg/1.5mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 150mg/1.5ml SCHERING PLOUGH EUROPE
200mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 200mg/2ml SCHERING PLOUGH EUROPE
50mg/2mlJ01GB07 NETILMICINUM SOL. INJ.NETROMYCINE® 50mg/2ml SCHERING PLOUGH EUROPE
1143 VORICONAZOLUM ** Protocol: J012BJ02AC03
200mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 200mg 200mg PFIZER LTD.
40mg/mlJ02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALAVFEND 40 mg/ml 40mg/ml PFIZER LTD.
50mgJ02AC03 VORICONAZOLUM COMPR. FILM.VFEND 50mg 50mg PFIZER LTD.
1144 COMBINATIIM01AB55
M01AB55 COMBINATII COMPR. GASTROREZ.ARTHROTEC 75 PFIZER EUROPE MA EEIG
M01AB55 COMBINATII SOL. PERF.NEODOLPASSE FRESENIUS KABI AUSTRIA GMBH
M01AB55 COMBINATII SUPOZ.ACECLOFEN ANTIBIOTICE SA
1145 IBUPROFENUMM01AE01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
100mg/5mlM01AE01 IBUPROFENUM SUSP. ORALAIBALGIN BABY 100mg/5ml ZENTIVA AS
IBUGESIC® 100mg/5ml DAR AL DAWA PHARMA S.R.L.
NUROFEN® PENTRU COPII, cu aroma de capsuni 100mg/5ml RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED
NUROFEN® PENTRU COPII, cu aroma de portocala 100mg/5ml RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED
300mgM01AE01 IBUPROFENUM CAPS. ELIB. PREL.PADUDEN® SR 300 mg 300mg TERAPIA SA
149 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
400mgM01AE01 IBUPROFENUM CAPS.MARCOFEN® 400mg EUROPHARM SA
400mgM01AE01 IBUPROFENUM COMPR. FILM.IBUPROFEN 400 400mg CIPLA (UK) LIMITED
PROFINAL 400mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.
REUPROFEN® 400 mg 400mg AC HELCOR SRL
400mgM01AE01 IBUPROFENUM DRAJ.NUROFEN FORTE 400mg RECKITT BENCKISER HEALTHCARE INT. LTD.
600mgM01AE01 IBUPROFENUM COMPR. FILM.IBUPROFEN 600 600mg CIPLA (UK) LIMITED
PROFINAL 600mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.
400mgM01AE01 IBUPROFENUM CAPS.MARCOFEN® 400mg EUROPHARM SA
400mgM01AE01 IBUPROFENUM COMPR. FILM.IBUPROFEN 400 400mg CIPLA (UK) LIMITED
PROFINAL 400mg GULF PHARMACEUTICAL INDUSTRIES S.R.L.
REUPROFEN® 400 mg 400mg AC HELCOR SRL
400mgM01AE01 IBUPROFENUM DRAJ.NUROFEN FORTE 400mg RECKITT BENCKISER HEALTHCARE INT. LTD.
1146 NAPROXENUMM01AE02A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
250mgM01AE02 NAPROXENUM COMPR.REUXEN 250 mg 250mg AC HELCOR PHARMA SRL
500mgM01AE02 NAPROXENUM COMPR.REUXEN 500 mg 500mg AC HELCOR PHARMA SRL
1147 ACIDUM MEFENAMICUMM01AG01A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
Se aplica tuturor denumirilor comerciale, formelor farmaceutice si concentratiilor corespunzatoare DCI-ului.
500mgM01AG01 ACIDUM MEFENAMICUM COMPR. FILM.VIDAN 500mg VIANEX SA
1148 PARECOXIBUMM01AH04
Prescriere limitata: Tratamentul simptomatic antiinflamator la pacientii cu intoleranta la AINS neselective.
40mgM01AH04 PARECOXIBUM PULB. + SOLV. PT. SOL. INJ.DYNASTAT 40mg 40mg PFIZER LIMITED
40mgM01AH04 PARECOXIBUM PULB. PT. SOL. INJ.DYNASTAT 40mg 40mg PFIZER LIMITED
1149 ACIDUM NIFLUMICUMM01AX02A se administra cu precautie la pacientii cu istoric de factori de risc sau afectiuni gastrointestinale.
250mgM01AX02 ACIDUM NIFLUMICUM CAPS.NIFLURIL 250mg BRISTOL MYERS SQUIBB KFT
1150 PHENYLBUTAZONUMM01AA01
250mgM01AA01 PHENYLBUTAZONUM SUPOZ.FENILBUTAZONA 250 mg 250mg SINTOFARM SA
1155 COMBINATIIM02ACN3
M02ACN3 COMBINATII GELPERCUTALGINE LABORATOIRES CHEMINEAU
1156 CHLORZOXAZONUMM03BB03
250mgM03BB03 CHLORZOXAZONUM COMPR.CLORZOXAZON 250 mg 250mg GEDEON RICHTER ROMANIA SA
CLORZOXAZONA 250mg SINTOFARM SA
CLORZOXAZONA 250 mg 250mg ARENA GROUP SA
1157 TOLPERISONUMM03BX04
100mg/mlM03BX04 TOLPERISONUM SOL. INJ.MYDOCALM 100mg/ml GEDEON RICHTER LTD.
150mgM03BX04 TOLPERISONUM COMPR. FILM.MYDOCALM 150mg GEDEON RICHTER LTD.
50mgM03BX04 TOLPERISONUM COMPR. FILM.MYDOCALM 50mg GEDEON RICHTER LTD.
50mgM03BX04 TOLPERISONUM DRAJ.TOLPERISON 50 mg 50mg TERAPIA SA
1158 ACIDUM HIALURONICUMM09AX01
20mg/2mlM09AX01 ACIDUM HIALURONICUM SOL. INJ.HYALGAN® 20mg/2ml CSC PHARMACEUTICALS HANDELS GMBH
1159 COMBINATIIN02AA59
30mg+500mgN02AA59 COMBINATII COMPR.PARADOREN 500mg/30mg 30mg+500mg ARENA GROUP S.A.
60mg+500mgN02AA59 COMBINATII COMPR.PARADOREN 500mg/60mg 60mg+500mg ARENA GROUP S.A.
1160 COMBINATIIN02BA71
N02BA71 COMBINATII COMPR.FASCONAL P GEDEON RICHTER ROMANIA SA
FASCOREM REMEDIA SRL
1161 METAMIZOLUM NATRIUMN02BB02
1g/2mlN02BB02 METAMIZOLUM NATRIUM SOL. INJ.ALGOCALMIN® 1 g/2 ml 1g/2ml ZENTIVA S.A.
500mg/mlN02BB02 METAMIZOLUM NATRIUM PIC. ORALE, SOL.NEVRALGIN 500mg/ml TERAPIA S.A.
150 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
1162 CLORAZEPAS DIKALIIN05BA05
10mgN05BA05 CLORAZEPAS DIKALII CAPS.TRANXENE 10 mg 10mg SANOFI-AVENTIS FRANCE
5mgN05BA05 CLORAZEPAS DIKALII CAPS.TRANXENE 5 mg 5mg SANOFI-AVENTIS FRANCE
1163 TOFISOPAMUMN05BA23
50mgN05BA23 TOFISOPAMUM COMPR.GRANDAXIN 50mg EGIS PHARMACEUTICALS LTD.
1164 MIDAZOLAMUMN05CD08
1mg/mlN05CD08 MIDAZOLAMUM SOL. INJ.DORMICUM® 1mg/ml ROCHE ROMANIA S.R.L.
MIDAZOLAM TORREX 1 mg/ml 1mg/ml TORREX CHIESI PHARMA GMBH
5mg/mlN05CD08 MIDAZOLAMUM SOL. INJ.FULSED 5 mg/ml 5mg/ml TERAPIA S.A.
MIDAZOLAM 5 mg/ml 5mg/ml TERAPIA SA
MIDAZOLAM TORREX 5 mg/ml 5mg/ml TORREX CHIESI PHARMA GMBH
7.5mgN05CD08 MIDAZOLAMUM COMPR. FILM.DORMICUM® 7.5mg ROCHE ROMANIA S.R.L.
DORMICUM® 7,5 mg 7.5mg TERAPIA SA
1165 CINOLAZEPAMUMN05CD13
40mgN05CD13 CINOLAZEPAMUM COMPR.GERODORM® 40mg GEROT PHARMAZEUTIKA GMBH
1166 METHYLFENIDATUM ***N06BA04
18mgN06BA04 METHYLFENIDATUM COMPR. FILM. ELIB. PREL.CONCERTA XL 18 mg 18mg JANSSEN PHARMACEUTICA N.V.
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
36mgN06BA04 METHYLFENIDATUM COMPR. FILM. ELIB. PREL.CONCERTA XL 36 mg 36mg JANSSEN PHARMACEUTICA N.V.
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
54mgN06BA04 METHYLFENIDATUM COMPR. FILM. ELIB. PREL.CONCERTA XL 54 mg 54mg JANSSEN PHARMACEUTICA N.V.
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
1167 ATOMOXETINUM ***N06BA09
10mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 10 mg 10mg ELI LILLY AND COMPANY LIMITED
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
18mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 18 mg 18mg ELI LILLY AND COMPANY LIMITED
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
25mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 25 mg 25mg ELI LILLY AND COMPANY LIMITED
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
40mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 40 mg 40mg ELI LILLY AND COMPANY LIMITED
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
60mgN06BA09 ATOMOXETINUM CAPS.STRATTERA 60 mg 60mg ELI LILLY AND COMPANY LIMITED
Utilizare in tulburare cu deficit de atentie si hiperactivitate.Prescriere limitata:
1168 PYRITINOLUMN06BX02
100mgN06BX02 PYRITINOLUM DRAJ.ENCEPHABOL® 100 mg 100mg MERCK KGAA
200mgN06BX02 PYRITINOLUM DRAJ.ENCEPHABOL® FORTE 200mg MERCK KGAA
80.5mg/5mlN06BX02 PYRITINOLUM SUSP. ORALAENCEPHABOL® SUSPENSIE 80.5mg/5ml MERCK KGAA
1169 PIRACETAMUMN06BX03
1200mgN06BX03 PIRACETAMUM COMPR. FILM.LUCETAM® 1200 mg 1200mg EGIS PHARMACEUTICALS LTD.
NOOTROPIL® 1200 mg 1200mg U.C.B. SA
12gN06BX03 PIRACETAMUM SOL. PERF.NOOTROPIL 12g U.C.B. SA
1gN06BX03 PIRACETAMUM SOL. INJ.NOOTROPIL 1g U.C.B. SA
1g/5mlN06BX03 PIRACETAMUM SOL. INJ.LUCETAM® 1 g 1g/5ml EGIS PHARMACEUTICALS LTD.
MEMOTAL1 g/5 ml 1g/5ml ZENTIVA SA
3g/15mlN06BX03 PIRACETAMUM SOL. INJ.LUCETAM® 3 g 3g/15ml EGIS PHARMACEUTICALS LTD.
400 mgN06BX03 PIRACETAMUM COMPR.PIRACETAM 400 mg 400 mg ANTIBIOTICE SA
400mgN06BX03 PIRACETAMUM COMPR.MEMOTAL 400mg 400mg ZENTIVA S.A
N - PIRACETAM 400mg MEDUMAN SA
PIRACETAM 400mg MAGISTRA C & C
PIRACETAM 400 mg 400mg LAROPHARM SRL
PIRACETAM FARMEX 400 mg 400mg FARMEX COMPANY SRL
400mgN06BX03 PIRACETAMUM COMPR. FILM.LUCETAM 400mg EGIS PHARMACEUTICALS PLC
PIRACETAM 400 mg 400mg GEDEON RICHTER ROMANIA SA
PIRACETAM LPH® 400 mg 400mg LABORMED PHARMA SA
151 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
800mgN06BX03 PIRACETAMUM COMPR. FILM.LUCETAM 800mg EGIS PHARMACEUTICALS PLC
NOOTROPIL® 800 mg 800mg U.C.B. SA
PIRACETAM 800 mg 800mg GEDEON RICHTER ROMANIA SA
PIRACETAM LPH 800 mg 800mg LABORMED PHARMA SA
20%N06BX03 PIRACETAMUM SOL. ORALANOOTROPIL® 20% U.C.B. SA
1170 CINNARIZINUMN07CA02
25mgN07CA02 CINNARIZINUM COMPR.CINARIZIN 25 mg 25mg LAROPHARM SRL
CINARIZINA 25 mg 25mg OZONE LABORATORIES
N-CINARIZINA 25mg MEDUMAN SA
STUGERON 25 mg 25mg TERAPIA SA
1172 TENONITROZOLUMP01AX08
250mgP01AX08 TENONITROZOLUM CAPS. MOI GASTROREZ.ATRICAN 250 mg 250mg LAB. INNOTECH INT.
1173 PYRANTELUMP02CC01
125mgP02CC01 PYRANTELUM COMPR. FILM.HELMINTOX® 125 mg 125mg LAB. INNOTECH INT.
250mgP02CC01 PYRANTELUM COMPR. FILM.HELMINTOX® 250 mg 250mg LAB. INNOTECH INT.
1174 SULFURP03AAN1
8,00%P03AAN1 SULFUR UNGUENTUNGUENT CU SULF 8% 8% GEDEON RICHTER ROMANIA SA
1175 PERMETHRINUMP03AC04
1,00%P03AC04 PERMETHRINUM CREMA CAPILARANIX 1% GLAXO WELLCOME UK LTD.
1176 BENZYLUM BENZOICUMP03AX01
25,00%P03AX01 BENZYLUM BENZOICUM CREMABENZOAT DE BENZIL MK 25% FITERMAN PHARMA S.R.L.
1177 TIXOCORTOLUMR01AD07
1,00%R01AD07 TIXOCORTOLUM SUSP. NAZALAPIVALONE 1% 1% PFIZER EUROPE MA EEG
1178 COMBINATIIR01ADN1
R01ADN1 COMBINATII SPRAY NAZ.,SUSP.BIORINIL FARMILA FARMACEUTICI MILANO SPA
R01ADN1 COMBINATII SUSP. INHAL.FLUORORINIL FARMILA - THEA FARMACEUTICI SPA
1179 COMBINATIIR01BA52
R01BA52 COMBINATII COMPR. ELIB. MODIF.CLARINASE® SCHERING PLOUGH EUROPE
1180 FUSAFUNGINUMR02AB03
50mg/10mlR02AB03 FUSAFUNGINUM SPRAY BUCOFARINGIAN SI NAZAL-SOL.BIOPAROX 50mg/10ml LES LABORATOIRES SERVIER
1181 EPHEDRINI HYDROCHLORIDUMR03CA02
10mg/mlR03CA02 EPHEDRINI HYDROCHLORIDUM SOL. INJ.EFEDRINA 10 mg/ ml 10mg/ml ZENTIVA S.A.
50mg/mlR03CA02 EPHEDRINI HYDROCHLORIDUM SOL. INJ.EFEDRINA 50 mg/ ml 50mg/ml ZENTIVA S.A.
1182 TERBUTALINUMR03CC03
1.5mg/5mlR03CC03 TERBUTALINUM SIROPAIRONYL 1.5mg/5ml SEDICO IMPEX S.R.L.
1183 ACETYLCYSTEINUMR05CB01
300mg/3mlR05CB01 ACETYLCYSTEINUM SOL. INJ.ACC INJECT 300mg/3ml 300mg/3ml HEXAL AG
1184 CARBOCISTEINUMR05CB03
100mg/5mlR05CB03 CARBOCISTEINUM SIROPHUMEX EXPECTORANT PENTRU COPII SI SUGARI 100mg/5ml LAB. URGO
100mg/5mlR05CB03 CARBOCISTEINUM SOL. ORALAFLUIDOL 100mg/5ml 100mg/5ml TIS FARMACEUTIC SA
20mg/mlR05CB03 CARBOCISTEINUM SIROPMUCOTREIS 20mg/ml ECOBI PHARMACEUTICI SAS
2%R05CB03 CARBOCISTEINUM SIROPRHINATHIOL 2% pentru copii si sugari 2% SANOFI-AVENTIS OTC
1186 PROMETHAZINUMR06AD02
30mgR06AD02 PROMETHAZINUM COMPR. FILM.PROMETAZINA ARENA 30 mg 30mg ARENA GROUP S.A.
Pot aparea efecte secundare semnificative
1187 MEQUITAZINUMR06AD07
10mgR06AD07 MEQUITAZINUM COMPR.PRIMALAN® 10 mg 10mg LAB. PIERRE FABRE
1188 MECLOZINUMR06AE05
30mgR06AE05 MECLOZINUM COMPR.EMETOSTOP 30mg SPECIFAR SA
1189 CYPROHEPTADINUMR06AX02
2mg/5mlR06AX02 CYPROHEPTADINUM SIROPBIOHEPT 2mg/5ml BIOFARM S.A.
152 153/
FIRMA PROTOCOLCONCENTRATIEDCI/DENUMIRE COMERCIALA FORMA FARM.
PERITOL 2mg/5ml EGIS PHARMACEUTICALS LTD.
4mgR06AX02 CYPROHEPTADINUM COMPR.PERITOL 4mg EGIS PHARMACEUTICALS LTD.
1190 LORATADINUMR06AX13
1mg/mlR06AX13 LORATADINUM SIROPCLARITINE 1mg/ml SCHERING-PLOUGH EUROPE
SYMPHORAL® 1 mg/ml 1mg/ml GEDEON RICHTER ROMANIA SA
5mg/5mlR06AX13 LORATADINUM SIROPLORATADINA BIOFARM 5mg/5ml 5mg/5ml BIOFARM S.A.
5mg/5mlR06AX13 LORATADINUM SUSP. ORALAFLONIDAN 5mg/5ml LEK PHARMACEUTICALS D.D.
1191 CHLORAMPHENICOLUMS01AA01
0.4%S01AA01 CHLORAMPHENICOLUM PULB. + SOLV. PT. SOL. OFT.SIFICETINA 0.4% S.I.F.I. SPA
1192 ACIDUM FUSIDICUMS01AA13
1,00%S01AA13 ACIDUM FUSIDICUM GEL OFT.FUCITHALMIC® 1% LEO PHARMACEUTICAL PRODUCTS
1193 KANAMYCINUMS01AA24
1,00%S01AA24 KANAMYCINUM UNG. OFT.KANAMICINA SULFAT 1% 1% ANTIBIOTICE SA
1194 COMBINATIIS01AA30
S01AA30 COMBINATII PICATURI OFT.-SOL.ANTIBIOPTAL FARMILA FARMACEUTICI
S01AA30 COMBINATII PULB. + SOLV. PT. SOL. OFT.COLBIOCIN S.I.F.I. SPA
S01AA30 COMBINATII UNG. OFT.ENBECIN POLIPHARMA INDUSTRIES S.R.L.
1195 FLUOROMETHOLONUMS01BA07
1mg/gS01BA07 FLUOROMETHOLONUM UNG. OFT.FLUMETOL S UNGUENT OFTALMIC 1mg/g FARMILA - THEA FARMACEUTICI SPA
2mg/mlS01BA07 FLUOROMETHOLONUM PICATURI OFT.SUSP.FLUMETOL S 2mg/ml FARMILA - THEA FARMACEUTICI SPA
1196 DESONIDUMS01BA11
0.25%S01BA11 DESONIDUM PICATURI OFT.-SOL.PRENACID 0.25% S.I.F.I. SPA
1197 INDOMETACINUMS01BC01
0.1%S01BC01 INDOMETACINUM PICATURI OFT.-SOL.INDOCOLLYRE® 0.1% 0.1% LAB. CHAUVIN
1198 PIROXICAMUMS01BC06
0.5%S01BC06 PIROXICAMUM PIC. OFT., SOL.BRUXICAM 0,5% 0.5% BRUSCHETTINI S.R.L.
1199 PILOCARPINUMS01EB01
2,00%S01EB01 PILOCARPINUM PICATURI OFT.-SOL.DROPIL® 2% BRUSCHETTINI
1200 EMEDASTINUMS01GX06
0.5mg/mlS01GX06 EMEDASTINUM PICATURI OFT.-SOL.EMADINE 0.05% 0.5mg/ml ALCON LABORATORIES LTD.
1201 KETOTIFENUMS01GX08
0.25mg/mlS01GX08 KETOTIFENUM PICATURI OFT.-SOL.ZADITEN 0,25 mg/ml 0.25mg/ml NOVARTIS PHARMA GMBH
1203 NANDROLONUMS01XA11
1,00%S01XA11 NANDROLONUM PICATURI OFT.-SOL.KERATYL® 1% 1% LAB. CHAUVIN
1204 DEXPANTHENOLUMS01XA12
5,00%S01XA12 DEXPANTHENOLUM GEL OFT.CORNEREGEL® 5% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
1205 COMBINATIIS02CA05
S02CA05 COMBINATII SOL. AURICULARA
SOLUTIE AURICULARA CU CLORAMFENICOL SI
FLUOCINOLON
BIOFARM SA
1206 OMALIZUMABUM **R03DX05
Prescriere limitata: Tratamentul adjuvant pentru îmbunătăţirea controlului astmului bronşic la pacienţii adulţi şi adolescenţi (cu vârsta de 12 ani şi peste) cu astm alergic persistent sever
care prezintă test cutanat pozitiv sau hiperreactivitate in vitro la un alergen permanent şi care au funcţia pulmonară redusă (FEV1 <80%), precum şi simptome
frecvente în timpul zilei sau treziri bruşte în cursul nopţii şi care au avut multiple exacerbări astmatice confirmate, în ciuda administrării pe cale inhalatorie de doze
mari de corticosteroizi şi agonişti beta2-adrenergici cu acţiune de lungă durată.
Tratamentul cu Xolair trebuie avut în vedere la pacienţii cu astm bronşic mediat cu certitudine prin intermediul IgE.NOTA:
150mgR03DX05 OMALIZUMABUM PULB+SOLV.PT.SOL.INJ.XOLAIR 150 mg 150mg NOVARTIS EUROPHARM LTD.
75mgR03DX05 OMALIZUMABUM PULB+SOLV.PT.SOL.INJ.XOLAIR 150 mg 150mg NOVARTIS EUROPHARM LTD.
XOLAIR 75 mg 75mg NOVARTIS EUROPHARM LTD.
153 153/
Recommended